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Abstract 
Peripheral nerves have a remarkable ability to regenerate following a transection 
injury. To achieve this, Schwann cells collectively migrate as cords, taking regrowing 
axons across newly formed tissue known as the bridge that forms to reconnect the 
two nerve stumps. The Schwann cell cords themselves are guided by a newly formed 
polarised vasculature that provides a conducive environment for Schwann cell 
migration. Here we show, that in addition to mediating Schwann cell clustering, N-
cadherin is required for contact inhibition of locomotion (CIL) in Schwann cells, which 
may be required to produce an outward force within the cords of collectively migrating 
Schwann cells. Mechanistically we show that N-cadherin regulates CIL independent 
of its traditional mechanism of trans-homodimerisation and independent of 
adherence junction components. Instead, the extracellular domain of N-cadherin is 
sufficient to mediate CIL, which appears to present a repulsion (co-)signal to the 
other cell. We further show, that CIL is disrupted in Schwann cells expressing 
oncogenic Ras in a MEK-dependent manner, not through loss of N-cad, but through 
loss of a distinct signal. Ras-Raf-MEK-ERK signalling alters the mRNA expression 
levels of ephrins and Eph receptors, and we show using Co-IP and mass 
spectrometry, that oncogenic Ras changes the interaction profile of N-cadherin 
proteins and show a potential role for glypican-4 and ephrin-A1 in CIL. Finally, we 
show that migration of Schwann cells along the vasculature is independent of focal 
adhesion complexes, consistent with the more amoeboid-mode of migration 
observed along the blood vessels.  
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Chapter One: Introduction 
 
1.1.  Cell migration during tissue formation and homeostasis 
The development of organs and tissues requires the orchestration of multiple 
processes including cell growth, cell proliferation, survival and movement. Moreover, 
tissues consist of multiple cell types, domains and compartments, each with their 
own unique properties, which requires the cell sorting of initially intermingled cells 
into separate cell populations (Batlle and Wilkinson, 2012). This separation of cell 
compartments by a clear border occurs during a process called boundary formation 
and requires the coordination of multiple signals between different cells types, which 
can be mediated via homotypic or heterotypic interactions. Boundary formation is 
mediated by repulsive signals, which cause the separation of different cell 
populations away from each other, and adhesive signals, which mediates the sorting 
of cells into groups of cells (Batlle and Wilkinson, 2012; Steinberg, 2007). Once the 
boundaries are established they are further exposed to cell movement caused by 
growth and morphogenesis, which includes migrating cells, as well as cell movement 
caused by the proliferation of cells (Batlle and Wilkinson, 2012). In the adult, cellular 
movement occurs in some instances during homeostasis and can be further triggered 
during the regeneration of a tissue following injury and during an immune response. 
Control of cell migration to the appropriate areas to position cell populations is crucial 
to maintain the integrity of tissues. Intermingling of different populations is prevented 
by contact repulsion and contact inhibition of cell movement, however, differential 
adhesion also plays a role (Abercrombie and Heaysman, 1954b; Batlle and 
Wilkinson, 2012; Steinberg, 2007). The movement of cells into inappropriate areas is 
associated with many diseases including tumourigenesis and is central to tumour 
invasion and metastasis (Batlle and Wilkinson, 2012). Thus, it is important to 
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understand how cells recognise and communicate with each other and how these 
controls are lost during the tumourigenic process.  
 
1.1.1. Principles of cell migration 
Cellular movement is a key process during the development of tissues and 
organs and in the adult, cellular movement can be further triggered upon injury, and 
metastasis (Mayor and Etienne-Manneville, 2016). Cells can either migrate as single 
cells or as groups of cells. Single cell migration in vitro is well characterised; cells 
adopt a front to rear polarity, with F-actin-rich membrane protrusions such as 
lamellipodia and filopodia at the front the cell, and a contractile actomyosin rear 
(Figure 1.1) (Reig et al., 2014). Motility of cells is mediated by cycles of i. Actin 
dependent-protrusion extension at the front of the cell, where adhesions of the cell to 
the substrate are formed, ii. Contraction of the cell body, iii. Disassembly of focal 
adhesions at the rear of the cell and iv. Retraction of the rear (Figure 1.1) (Reig et al., 
2014). This front to rear polarisation is achieved by a polarised cytoskeletal 
organisation, which in turn is set by a front to rear activation of RhoGTPases 
including active Rac-1 and Cdc42 at the front of the cell, and active Rho at the back 
of the cell (Figure 1.1) (Nobes and Hall, 1999). Moreover, the rear of the cell is 
defined by active myosin II, required for contraction of the cell body (Figure 1.1) (Reig 
et al., 2014).   
Rho GTPases are the master regulators of the cytoskeletal changes that 
integrate multiple external cues that can control migration, such as adhesion to the 
ECM through integrins, cell-cell interactions and cytokines (Mayor and Etienne-
Manneville, 2016). RhoGTPase family members cycle between the inactive GDP 
bound state and the active GTP bound state, in which they can bind to downstream 
effectors (Sadok and Marshall, 2014). GTPases are regulated by guanine nucleotide 
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exchange factors (GEFs) mediating the exchange from GDP to GTP, and GTPase-
activating proteins (GAPs) that promote hydrolysis of GTP to GDP by increasing their 
intrinsic GTPase activity. Rac-1 and Cdc42 are active at the front of polarised 
migrating cells and promote lamellipodia and filopodia formation respectively by 
regulating actin polymerisation (Nobes and Hall, 1999)  (Figure 1.1). RhoA is 
important for force generation by mediating contractility at the rear of the cell by 
regulating Rho-associated protein kinase (ROCK), but has also been shown to be 
active at the front of the cells where it is required for the initial actin polymerisation 
(Machacek et al., 2009; Narumiya et al., 2009; Pertz et al., 2006).  
Integrin-dependent migration is important for migration along the extracellular 
matrix (Huttenlocher and Horwitz, 2011). Adhesion to substrates such as laminin, 
collagen and fibronectin, through integrins induces cytoskeletal reorganisation and 
the formation of protrusions (Huttenlocher and Horwitz, 2011). Moreover, integrins 
mediate traction forces, which allow the cells to migrate forward (Huttenlocher and 
Horwitz, 2011). Integrins are αβ heterodimers with a large extracellular domain 
through which they connect to the ECM and a cytoplasmic domain, which is 
connected via adaptor proteins to the actin cytoskeleton. Binding specificity for the 
type of substrate is determined by the combination of α and β subunits: e.g. 
fibronectin α5β1 and α4β1; laminin α3β1 and α2β1; collagen α1β1 and α2β1 
(Huttenlocher and Horwitz, 2011). 
As cells migrate, integrins are activated at the front of the cell, where they 
initially form small adhesion complexes named nascent adhesions (Figure 1.1). 
Nascent adhesions can then mature into the larger focal adhesion complexes that 
connect to the actomyosin network allowing traction forces to be exerted to the 
substrate (Figure 1.1) (Huttenlocher and Horwitz, 2011; Mayor and Etienne-
Manneville, 2016). As the cells move forward, disassembly of focal adhesions occurs 
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at the rear of the migrating cells, allowing the cells to detach from the substrate. 
Activation of integrins through interactions with the ECM at the front of the cells 
induces the local activation of RhoGTPases Cdc42 and Rac, which subsequently 
regulate actin polymerisation through the WAVE/Arp2/3 complex (Campellone and 
Welch, 2010). 
 
Figure 1.1. Migrating cells adapt a front to rear polarity. 
Migrating cells adapt a characteristic shape with protrusions such as lamellipodia and 
filopodia at the front of the cell and a retractile rear. a) Migration goes through a cycle 
of i. formation of nascent adhesions to the substrate at the front of the cell. ii. 
protrusion extension and maturation of adhesions to focal adhesion complexes. iii. 
Contraction of the cell body forward. iv. Disassembly of the focal adhesion 
complexes and retraction of the rear. b). The polarised organisation of cells is 
mediated by a polarised cytoskeletal network, with actin polymerisation at the front of 
the cells that pushes the membrane forward and a high myosin activity at the rear of 
the cell. This is in turn set by a polarised activation of Cdc42 and Rac-1 at the front of 
the cell while RhoA is mainly active at the rear of the cell.  
Adapted from Reig et. al. 2015
i ii iviii
a
b
nascent adhesions focal adhesions
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1.1.2. Collective migration 
While single cell migration can occur in vivo, several studies have shown that 
cells often migrate as cohesive groups during embryogenesis, and in the adult during 
regeneration and tumourigenesis (Mayor and Etienne-Manneville, 2016). Different 
modes of collective migration have been described depending on the context 
(Etienne-Manneville, 2014). For example, epithelial cells migrate as large layered 
sheets during wound healing; primordium cells migrate as closely associated cells 
clusters along the lateral line organ in Drosophila; neural crest cells migrate during 
embryogenesis as a loose stream of cells, in which individual cells can be identified 
whilst maintaining constant interaction with each other; and during neo-angiogenesis 
endothelial cells migrate as cords, in which a single tip cell guides the rest of the 
cluster (Aman and Piotrowski, 2010; Etienne-Manneville, 2014; Mayor and Carmona-
Fontaine, 2010; Valentin et al., 2007). Moreover, Schwann cells appear to migrate as 
cellular cords during peripheral nerve regeneration (Parrinello et al., 2010). Although 
the modes of collective migration can differ in organisation, cell types and size, there 
are two common features found in all types of collective migration; firstly the cells at 
the front of the group, the leading edge, are polarised with protrusions emerging from 
the cells in the direction of migration (Mayor and Etienne-Manneville, 2016). 
Secondly, the cells need to interact continuously to maintain a cluster, while the 
interactions need to be dynamic to allow cellular rearrangements to occur. How 
migrating cells can maintain a coherent group while allowing cellular rearrangements 
is a long-standing question.  
The mechanisms of collective migration rely on the same principles as single 
cell migration. However, in collective migration, the polarisation of individual cells is 
altered due to cell-cell interactions (Figure 1.2) (Mayor and Etienne-Manneville, 
2016). These cell-cell interactions create two types of cells in the group: the leading 
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cells which are located on the outside of the group and the follower cells, which are 
located in the middle of the group (Figure 1.2), though follower cells and leader cells 
can interchange position. The leading cells are polarised and have protrusions in the 
direction of migration (Theveneau et al., 2010). In contrast, the follower cells are not 
polarised which is due to cell-cell interactions with the leader cells and the 
surrounding follower cells. Moreover, the polarisation of the leading cells, caused by 
the direct cell-cell interactions with the follower cells allows them to be more 
responsive to extracellular signals such as secreted molecules, which in turn can 
further polarise the cells (Theveneau et al., 2010).  
In addition to direct cell-cell interactions, secreted molecules play a role in 
collective migration (Theveneau et al., 2010; Valentin et al., 2007). For example, the 
chemoattractant SDF-1 stabilises protrusions at the leading edge of neural crest 
cells, which contributes further to the global polarisation of the clusters, which is 
required for directional migration (Theveneau et al., 2010). Moreover, neural crest 
cells migrate as a loose cluster, which means that occasionally cells escape the 
direct interactions and migrate away from the cluster. To counteract this, neural crest 
cells secrete complement factor C3a and express the receptor C3aR (Carmona-
Fontaine et al., 2011). These “co-attraction” molecules attract neural crest cells that 
have migrated away, back to the cluster to maintain the collective migration 
(Carmona-Fontaine et al., 2011).  
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Figure 1.2. Cell polarity mediates single cell and collective migration.  
In a coherent cluster, leader cells have a polarised morphology based on the same 
mechanisms as single cell migration. Polarity in leader cells is stimulated by 
chemokines, interactions with the ECM and interactions with the follower cells. Note 
non-engaged cadherin at the front of the leading cell where it could regulate CIL (see 
below). 
 
1.1.3. Contact inhibition of locomotion  
Contact inhibition of locomotion (CIL) describes the process in which cells upon 
contact stop their migration and change their direction of migration (Figure 1.3) 
(Abercrombie and Heaysman, 1953, 1954b). This process was first described in 
explants of chick heart fibroblast in the 1950s by Abercrombie, who reasoned that 
CIL is required for the directional outward migration of the fibroblasts (Abercrombie 
and Heaysman, 1954b). Indeed, loss of CIL leads to the decreased directional 
migration of several cell types such as neural crest cells and macrophages, causing 
defects in embryogenesis, and the spreading of macrophages respectively 
(Carmona-Fontaine et al., 2008; Stramer et al., 2010). CIL, like axonal guidance, cell 
sorting, cell segregation and boundary formation, prevents intermingling of cells 
through mediating a repulsive force, causing the cells to separate from each other, 
suggesting similar mechanisms could be in place to regulate these different 
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processes (Abercrombie and Heaysman, 1954b; Bashaw and Klein, 2010; Batlle and 
Wilkinson, 2012). A failure of CIL has been associated with tumourigenesis in which 
loss of CIL in cancer cells can lead to the invasion of normal tissues (Abercrombie, 
1979; Astin et al., 2010). Thus, it is important to understand how CIL is regulated.  
 
Figure 1.3. The mechanism of CIL  
CIL is the process by which migrating cells are redirected upon collision, which is 
mediated by a repolarisation of the cell. i) When migrating cells collide, protrusions 
are inhibited at the site of cell-cell contact. ii) New protrusions are formed away from 
the site of cell-cell contact and in the direction of subsequent migration. As a result, 
the cells change their direction of migration.  
 
1.1.4. Repolarisation 
CIL is mediated by a repolarisation of the cells which involves two steps: i) Once 
contact has been made between two cells, protrusions or filopodia at the site of cell-
cell contact are inhibited and collapse; ii) Formation of new protrusions or filopodia 
away from the site of the contact in the direction of migration (Figure 1.3). 
Repolarisation of cells is mediated by a reorganisation of the actin cytoskeleton 
(Nobes and Hall, 1999). Indeed, it has been observed that the actin cytoskeleton is 
disassembled at the site of cell contact, while actin polymerisation is induced at the 
Figure 2
i ii
Figure 3
Adapted from Mayor and Carmona
Adapted from Mayor and Etienne-Manneville, (2016)
-Fontaine (2010) . 
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free edge of the cell, which induces newly formed protrusions (Davis et al., 2015; 
Scarpa et al., 2015). In addition, microtubules have also been shown to play a role in 
CIL as microtubule destabilisation is induced upon cell-cell contact (Batson et al., 
2014) and microtubules are required for repolarising the cell (Kadir et al., 2011; 
Moore et al., 2013). 
Rho GTPases play a key role in CIL by locally modulating the cytoskeleton. For 
example in neural crest cells, a polarised local activation of RhoA induces collapse of 
the protrusions at the site of cell-cell contact and induces repolarisation (Carmona-
Fontaine et al., 2008). Whereas polarised activation of Rac-1 induces formation of 
protrusions at the free edge of the cell (Scarpa et al., 2015; Theveneau et al., 2010). 
Moreover, in the prostate cancer cell line, PC3, the homotypic repulsive response is 
regulated by activating RhoA through the GEF VAV2 at the site of cell-cell contact 
(Astin et al., 2010; Batson et al., 2014). In contrast, the attractive signalling is 
mediated through Cdc42, which is also activated at the site of cell-cell contact and 
regulates filopodia extension (Astin et al., 2010).  
 
1.1.5. From cell-cell recognition to intracellular signalling 
An important feature of CIL is the initial cell-cell contact made when two cells collide, 
which requires recognition followed by a change in the polarisation and direction of 
cell migration. Cell recognition can be mediated by direct contact via surface 
molecules such as adhesion and guidance molecules, which have been implicated in 
CIL during which cell polarity is modulated by locally regulating the activity of Rho 
GTPases (Figure 1.4). For example, repulsive and guidance molecules such as robo 
and slit have been shown to inhibit protrusion formation at cell-cell contacts in 
fibroblasts (Fritz et al., 2015). While in PC3 cells, EphA and EphB receptors and their 
ligands regulate CIL by activating RhoA and Cdc42 respectively (Astin et al., 2010). 
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In contrast, in neural crest cells, the non-canonical Wnt pathway induces a polarised 
RhoA activation (Carmona-Fontaine et al., 2008). Intriguingly, it has recently been 
indicated that adhesive molecules such as cadherins and nectins can regulate CIL in 
neural crest cells and glioblastoma cells (Becker et al., 2013; Matthews et al., 2008; 
Scarpa et al., 2015; Takai et al., 2008; Tanaka et al., 2012; Theveneau et al., 2010). 
Although CIL and adhesion seem to be opposing processes, it could explain how the 
initial contact is made and maintained, while eliciting a downstream repulsive 
response. However, how adhesion receptors can mediate these opposing responses 
remains unclear.  
 
1.1.6. CIL in collective migration 
Although CIL was originally described in single migration, it is now apparent that it is 
required for the collective migration of specific cells during development and for the 
spreading of other cell types. During the collective migration of neural crest cells, it 
has been shown that CIL regulates the polarity of the cells by inhibiting protrusion 
formation at the site of cell-cell contact and by inducing the formation of protrusions 
at the free edge of the outer cells of the cluster (Figure 1.4) (Theveneau et al., 2010). 
This causes a global polarity of the cluster in which the inner cells lack polarity 
whereas the outer leading cells at the front of the group have protrusions in the 
direction of migration. This group behaviour is important for the cluster to be 
responsive to locally secreted molecules and to migrate in a directional manner to a 
gradient of chemotactic factors. Importantly, loss of CIL within the cluster abrogates 
the directional migration of a neural crest cell cluster in response to the 
chemoattractant SDF-1 (Theveneau et al., 2010).  
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Figure 1.4. Cell-cell recognition molecules that mediate CIL 
CIL is required for (a) repolarising cells to redirect cells and (b) polarising the leader 
cells in collective migration. (c) Enlarged inset of (a and b) Showing that CIL is 
regulated by direct cell-cell interactions mediated by various types of surface 
receptors that inactivate Rac-1 and/or activate RhoA through various adaptor 
proteins. This results in actin depolarisation and disassembly of focal adhesions 
resulting in the collapse of protrusions at the site of contact. Rac-1 and Cdc42 are 
activated at the leading edge inducing the polymerisation of actin and a repolarisation 
of the cell in a different direction.  
 
CIL has also been shown to be required for the spreading of several cell 
types including macrophages in Drosophila, fibroblasts and prostate cancer cells in 
vitro and for neural crest cells during development in zebrafish and Xenopus (Batson 
et al., 2014; Carmona-Fontaine et al., 2008; Fritz et al., 2015; Moore et al., 2013; 
Stramer et al., 2010). In these cases, contact-dependent cell repulsion mediates the 
dissemination of individual cells at the edge of the group, away from the denser area 
Figure 2
i ii
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Adapted from Mayor and Carmona
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-Fontaine (2010 ). 
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of cells within the group, resulting in a force, which drives their outward migration and 
the spreading of the cells.  
 
1.1.7. Neuronal-cadherin  
1.1.7.1. Classification and function 
The cadherin superfamily generally plays a role in adhesion and cell-cell recognition 
and has been shown to be important in a wide range of processes such as CIL, 
morphogenesis, cell sorting, cell migration, cell survival, cell proliferation and cell 
signalling (Brasch et al., 2012; Harris and Tepass, 2010). Moreover, aberrant 
expression is associated with tumourigenesis (van Roy, 2014). Cadherins are best 
known as calcium dependent transmembrane surface receptors that cluster together 
in adherence junction complexes and are important for transmitting adhesion forces 
between adjacent cells (Brasch et al., 2012).  
The cadherins are clustered together in the cadherin superfamily based on 
their distinctive and highly conserved extracellular cadherin (EC) domains. The 
superfamily is divided into subtypes based on the number and arrangement of the 
EC domains (Figure 1.5) (Brasch et al., 2012). Neuronal-cadherin (N-cad) which has 
been shown to play a role in CIL, is a Type I classical cadherin. These are single-
pass transmembrane receptors with ectodomains consisting of five tandem EC 
domains and a highly conserved cytoplasmic domain that is indirectly connected to 
the actin cytoskeleton. There are two classes of classical cadherins: Type I 
consisting of six cadherins and Type II consisting of 13 cadherins. There are 
structural differences in the Type I classical cadherins in the distal EC1 domain 
resulting in stronger homophilic adhesions compared to Type II classical cadherins. 
Type I classical cadherins include epithelial cadherin (E-cad) which is mostly 
expressed in epithelial cells, placental cadherin (P-cad), retinal cadherin (R-cad), 
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muscle cadherin (M-cad), vascular endothelial (VE-cad) and N-cad which is 
expressed in neuronal tissues and in heart muscle cells, amongst others.  
Figure 1.5. The cadherin super family 
Cadherins are a large class of calcium dependent adhesion receptors with five or 
more highly conserved EC domains. Classical cadherins, by far the most studied 
cadherins, are connected through the cytoplasmic domain to the actin cytoskeleton 
via its adaptor proteins α-catenin, β-catenin and p120-catenin.  
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1.1.7.2. Trans- and cis-interactions 
Classical cadherins form homophilic cell-cell interactions and often aggregate in 
adherence junction complexes, linking adhesion to the actin cytoskeleton. Both Type 
I and Type II use the same mechanism to establish homophilic trans-interactions 
(Brasch et al., 2012), however, there are slight differences in the homophillic trans-
interactions due to differences in the EC1 domain between the Type I and Type II 
cadherins. Of the five EC domains, only the EC1 domain is engaged in trans-
interactions between the two cadherin molecules (Brasch et al., 2012; Halbleib and 
Nelson, 2006). This interaction is mediated by ‘strand swapping’ between the two 
EC1 domains of the two interacting cadherin molecules. However, the resulting bond 
is only a weak hydrophobic affinity bond (Figure. 1.6). To obtain stronger adhesion, 
molecules aggregate together in micro clusters via: (i) passive diffusion, thought to 
be formed by already present Nano clusters (Yap et al., 2015). The mechanisms 
remain unclear, but trapping in the actin cytoskeleton, lipid driven segregation and 
endocytosis have been suggested to play a role (Brasch et al., 2012; Yap et al., 
2015). (ii) cis-interactions between two cadherins. Unlike trans-interactions, cis-
interactions require the interface between the base of the EC1 domain and the EC2 
domain of the adjacent cadherin (Figure 1.6). Cis-interactions are only formed 
between Type I classical cadherins, as Type II lack the cis interface domains (Brasch 
et al., 2012). 
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Figure 1.6. Formation of N-cadherin complexes 
a) Homophilic trans-interactions are mediated by "strand swapping" of the EC1 
domain. b) Free monomers are closed. This creates a relatively weak affinity bond 
between the two cadherin molecules. c) Cis-interactions between the EC1 and the 
EC2 of adjacent molecules further strengthen adhesion by aggregating multiple 
cadherin molecules into adherence junction complexes. Cis- and trans-interactions 
are dependent on the binding of three calcium ions to each linker between the EC 
domains. d and e) Cadherins in trans-interactions and cis-interactions cluster 
together. 
 
Though cadherins preferentially make homophilic trans-interactions, Type I cadherins 
can make heterotypic trans-interactions with other members of the subtype. 
However, due to differences in the EC1 domain they cannot interact with Type II 
cadherins (Brasch et al., 2012). Intriguingly, cadherins have also been shown to 
make heterotypic cis-interactions with other types of molecules. For example N-cad 
can interact with the fibroblast growth (FGF) receptor, to regulate growth, contact 
Figure 5
a) b)
c) d) e)
Adapted from Brasch et. al. 2012. 
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dependent cell survival and cell motility (Brasch et al., 2012; Suyama et al., 2002; 
Trolice et al., 1997). This interaction is mediated between the EC4 domain of N-
cadherin and the histidine-alanine-valine (HAV)-motif of the FGF receptor (Williams 
et al., 2001). Other studies suggest that N-cadherin interacts through adaptor 
proteins, via its cytoplasmic tail with the Wnt co-receptor Lrp5, to negatively regulate 
Wnt signalling and thereby inhibits osteoblast differentiation (Hay et al., 2009). 
Moreover, interaction of the cytoplasmic tail of robo to N-cadherin via the abl/cable 
complex results in decreased adhesion between neural retinal cells, which is 
important for axonal outgrowth (Rhee et al., 2007; Rhee et al., 2002). It has also 
been reported that E-cad can interact through its extracellular domain with the 
metalloproteinase ADAM10, which cleaves and sheds the extracellular domain of E-
cad, thereby decreasing adhesion which is required for Ephrin/ephB mediated 
segregation (discussed below) (Solanas et al., 2011).  
 
1.1.7.3. Adherence junction components 
Cadherin-mediated adhesion is dependent on its three intracellular interacting 
partners α-catenin, β-catenin, p120-catenin, which are key components of the 
adherence junction complex and which mediate connections to the microtubule and 
actin cytoskeleton (Figure 1.7).   
p120-catenin regulates cadherin stability at the membrane by control of 
cadherin trafficking and degradation (Peglion and Etienne-Manneville, 2013). 
Downregulation of p120-catenin results in decreased cadherin expression in several 
tissues (Davis et al.). Within the p120-catenin binding site there is an endocytic 
dileucine motif and an E3 ubiquitin ligase recognition site. Therefore, when p120-
catenin is not bound to cadherin, endocytosis of the cadherin complex is induced 
(Miyashita and Ozawa, 2007). Moreover, p120-catenin masks two phosphorylation 
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sites within the juxtamembrane domain that can be recognised by the E3 ubiquitin 
ligase Hakai, which targets cadherin for proteasomal degradation (Fujita et al., 2002). 
Though the endocytic signal required for E-cad internalisation is lacking in N-cad, 
some data suggest that p120-catenin can regulate N-cad internalisation and 
recycling in astrocytes (Peglion and Etienne-Manneville, 2013; Peglion et al., 2014). 
P120-catenin has also been found to bind via kinesins to microtubules and this 
interaction has been shown to be important for the export of N-cad from the 
endoplasmic reticulum (ER) to the plasma membrane. In addition to cadherin bound 
p120-catenin, there is a cytoplasmic pool of p120-catenin that can modulate the actin 
cytoskeleton via regulating Rho-GTPases (Peglion and Etienne-Manneville, 2013). 
For example, p120 can directly interact with and inhibit RhoA and has been found to 
activate Cdc42 and Rac-1 by binding to the guanine exchange factor VAV2 
(Anastasiadis et al., 2000; Grosheva et al., 2001; Noren et al., 2000).  
 
Figure 1.7. Cadherin assembles in adherence junction complexes. 
Cadherins interact with α-catenin, β-catenin, p120-catenin to form the adherence 
junction complex, through which cell-adhesion is linked to the cytoskeleton, the main 
function of cadherins. Other roles of cadherins are cell-cell recognition, cell sorting, 
cell migration, cell survival, cell proliferation CIL, and cell signalling. 
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A major function of β-catenin is to link N-cad to α-catenin, which in turn directly 
interacts with actin. β-catenin initially binds to cadherins in the endoplasmic reticulum 
and this binding is important for the proper translocation of cadherin to the membrane 
and to recruit α-catenin to the adherence junctions (Desai et al., 2013; Harris and 
Tepass, 2010). Moreover, loss of β-catenin can lead to decreased adhesion, and 
thus β-catenin is required for destabilising adherence junctions (Rhee et al., 2007; 
Rhee et al., 2002). Other work has suggested roles for β-catenin in cadherin 
endocytosis (Delva and Kowalczyk, 2009).  
α-catenin is the link that couples cadherins to the actin cytoskeleton, which 
allows pulling forces applied on adherence junctions to be transmitted onto the actin 
cytoskeleton (Buckley et al., 2014; le Duc et al., 2010; Nelson and Weis, 2016; 
Yonemura et al., 2010). However, the means by which α-catenin mediates the 
interaction between cadherins and actin remained controversial until recently, as α-
catenin was shown using co-immunoprecipitation (Co-IP) to interact with cadherin 
and β-catenin, but a quaternary complex of actin, N-cad and β-catenin could not be 
shown to interact simultaneously with actin to form a quaternary complex (Aberle et 
al., 1994; Yamada et al., 2005). This showed that α-catenin binds in an allosteric 
fashion, and alternates between binding to β-catenin and actin filaments (Yamada et 
al., 2005). However, this model does not explain how α-catenin can relay pulling 
forces applied on adherence junctions onto the actin cytoskeleton, as this requires a 
simultaneous physical interaction between α-catenin, actin filaments and β-catenin 
(Buckley et al., 2014; Desai et al., 2013; le Duc et al., 2010; Yonemura et al., 2010). 
Recent reports have shown that external tension relayed onto α-catenin, induces a 
conformational change of α-catenin, activating the binding to actin allowing it to 
simultaneously bind to the cadherin/ β-catenin complex and the actin (Buckley et al., 
2014; Yao et al., 2014). Stretching α-catenin to the non-folded protein, also allows for 
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the subsequent binding of vinculin, a tension sensor protein that can localise at the 
adherence junction complexes (le Duc et al., 2010; Yonemura et al., 2010). Vinculin 
binding to α-catenin, in turn prevents folding of opened α-catenin (Yao et al., 2014), 
suggesting vinculin stabilises the open α-catenin form. However, other work has 
shown that α-catenin can form homodimers, which mainly binds to actin and which 
cannot bind to β-catenin, as dimerisation of α-catenin masks the β-catenin-binding 
domain within α-catenin homodimerisation domain (Pokutta and Weis, 2000). The 
role of α-catenin dimers and homodimers is unclear, however they may be important 
for regulating the actin cytoskeleton organisation at the cell contacts (Nelson and 
Weis, 2016), possibly through other adaptor proteins which bind to α-catenin such as 
formin, α-actinin, zonula occludens protein 1 (ZO1), afadin and spectrin (Harris and 
Tepass, 2010). 
 
1.1.8. Cadherins in collective migration and CIL 
Cadherins are required for the collective migration of several cell types such as 
Schwann cells, neural crest cells, astrocytes, endothelial cells, epithelial cells and 
border cells in the Drosophila egg chamber (Kametani and Takeichi, 2007; Parrinello 
et al., 2010; Peglion et al., 2014; Theveneau et al., 2010). Moreover, several reports 
have shown that cadherins plays a role in CIL (Becker et al., 2013; Scarpa et al., 
2015; Tanaka et al., 2012; Theveneau and Mayor, 2010). For instance, in neural 
crest cells a system in which CIL is well characterised, N-cad mediates CIL within the 
neural crest cells cluster by inhibiting protrusion formation at the site of cell-cell 
contact (Theveneau et al., 2010). N-cad locally inhibits Rac-1, thereby establishing a 
polarised activation of Rac-1 in the leader cells. Moreover, this polarisation is 
required for the directional migration in response to SDF-1. However, how N-cad 
regulates Rac-1 is unknown. Previous work by the same group showed that the Wnt 
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signalling pathway is also required for CIL (Carmona-Fontaine et al., 2008). In this 
case, Wnt signalling activates RhoA upon collision at the site of cell contact, locally 
inhibiting protrusion formation. The authors suggest there is a link between the two 
mechanisms, though this remains to be clarified. 
In contrast, other work has shown that cad-11 is required for CIL in neural 
crest cells (Becker et al., 2013). The mechanism by which Cad-11 regulates CIL is 
unknown, but the authors suggest that cadherin-mediated adhesion of two adjacent 
cells is required for CIL, indicating trans-homodimerisation of N-cad is needed to 
induce the repulsion response. Moreover, the authors find that Wnt signalling 
pathway also is required for CIL in neural crest cells, and propose signalling that has 
a similar effect on CIL. Though a direct link between the pathways is not shown. 
In addition, E-cad has also been shown to regulate CIL (Scarpa et al., 2015). 
In contrast to N-cad, E-cad inhibits CIL in non-migratory neural crest cells (an earlier 
developmental stage), which have diminished CIL compared to their migratory neural 
crest cell counter parts. Like N-cad, E-cad regulates CIL by controlling a polarised 
activation of Rac-1. However, in contrast to N-cad, E-cad redistributes Rac-1 activity 
towards the site of cell contact thereby promoting formation of protrusions at the site 
of cell-cell contact, which results in the loss of CIL. Mechanistically the authors show 
that E-cad regulates Rac-1 by sequestering p120-catenin to the junction, which 
subsequently induces Rac-1 activation.  
N-cad has also been shown to regulate heterotopic CIL between U87MG 
glioblastoma cells and normal glial cells (Tanaka et al., 2012). In contrast to the 
mechanism in neural crest cells, in U87MG, it is reported that N-cad controls CIL via 
α-catenin by sequestering Nm23-H1 a nucleotide diphosphate kinase that supresses 
Tiam1 a guanine exchange factor (GEF). Inactive Tiam1 in turn can then no longer 
activate Rac-1, thereby blocking the formation of protrusions at the site of contact.  
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However, cadherins also mediate strong adhesions within collectively migrating 
cells to maintain a cluster. How cadherins can both mediate strong adhesion as well 
as mediate CIL during collective migration remains unclear. Recent work in 
astrocytes has indicated that polarised N-cad expression in migrating cells could play 
a role in mediating both strong adhesion within the cluster while allowing cellular 
rearrangements to occur (Peglion et al., 2014). Free N-cad complexes accumulate at 
the front of the leading cells, whereas N-cad forms adherence junctions with adjacent 
cells at the lateral sides of the leading cells. The adherence junctions on the lateral 
sides are dynamic in the leading cells and undergo constant retrograde flow, from the 
front to the rear of the cell. In contrast, adherence junctions are stable in the follower 
cells. In addition to the polarised recycling of N-cad along the lateral sides of the 
leading cells, there is a high rate of N-cad internalisation at the rear of the cells, 
which is recycled back to the front of the leading cells. Here, N-cad can re-engage in 
junctions and go through the same cycle (Peglion et al., 2014). Overall, this causes a 
strong adhesion at the front and weaker adhesion at the back of the lateral junctions. 
The weaker interactions between leading and trailing cells could trigger a polarisation 
in the trailing cells inducing them to migrate, whereas in the front of the leading edge 
the free pool of N-cad could regulate protrusions and mediate new interactions and 
importantly could mediate CIL.  
 
1.1.9. Guidance molecules 
Another set of molecules reported to regulate CIL are the so called guidance 
molecules, that are maybe best known for their repellent or adhesive properties in the 
nervous system (Bashaw and Klein, 2010). A major role in the pathfinding of growing 
axons is to guide axons to their target. Guidance molecules include membrane bound 
proteins as well as secreted molecules and include Eph receptors and their ligands, 
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semaphorins and slits (Hung and Terman, 2011). Although CIL implies contact 
dependent communication, local secreted signalling also appears to play a role in 
CIL, as the secreted ligand slit and Wnt are required for CIL between fibroblasts and 
NC cells respectively (Carmona-Fontaine et al., 2008; Fritz et al., 2015). 
 
1.1.9.1. Eph receptors and their ligands 
EphA and EphB receptors are a large class of receptor tyrosine kinases (RTK) that 
preferentially bind to the ligands ephrin-A and ephrin-B respectively (Kania and Klein, 
2016). Eph signalling largely results in repulsion responses but in some cases it has 
also been shown to result in adhesion, and as such plays a crucial role in boundary 
formation and compartmentalisation. Moreover, ephrins have been implicated in 
proliferation, apoptosis, cell migration and differentiation. There are ten EphA 
receptors that can bind to five ephrin-A ligands and five EphB receptors that can bind 
to three ephrin-B ligands. Though, EphA4 and EphB2 have been shown to bind the 
ephrin-B ligands and ephrin-A5 respectively (Gale et al., 1996; Himanen et al., 2004). 
The ephrin-A and ephrin-B classes of ligand differ in that ephrin-As are attached to 
the membrane through a glycosylphosphatidylinositol (GPI) anchor, while ephrin-Bs 
have a transmembrane domain and cytoplasmic domain containing a PDZ domain 
through which it can signal into the cell (Figure 1.8). Signalling can occur in both 
directions through receptor “forward signalling” and through ligand “reverse 
signalling” (Figure 1.8).  
Eph receptors are transmembrane proteins that consist of an extracellular 
globular ligand binding domain, a Cys domain, fibronectin domains, transmembrane 
domains, an intracellular Tyr kinase domain, a sterile alpha motif (SAM) and a PDZ 
domain (Kania and Klein, 2016). To activate the Eph receptors efficiently, ephrins 
must bind in the form of multimers, which results in large signalling clusters (Davis et 
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al., 1994). The size of the signalling clusters correlates to the strength of the signal 
(Egea et al., 2005). Upon ligand binding, the kinase domain gets activated which 
leads to autophosphorylation at the juxtamembrane Tyr residues (Kullander et al., 
2001; Zisch et al., 1998). Once activated, Eph receptors can interact with several 
proteins including Vav2, Vav3, ephexin, phosphoinositide 3-kinase (PI3K), and the 
non-catalytic region of Tyr kinase adaptor protein 1 (Nck1) and Nck2 (Kania and 
Klein, 2016). This generally results in cytoskeletal rearrangements through regulation 
of Rho-GTPases, but Eph signalling has also been shown to affect the Ras MAP 
kinase signalling pathway (Kania and Klein, 2016; Lisabeth et al., 2013).  
Forward signalling can be abrogated through dephosphorylation of the 
cytoplasmic domain of the Eph receptor by phosphotyrosine phosphatases. 
Intriguingly, the whole ephrin-Eph complex can be endocytosed into both ephrin and 
Eph expressing cells (Marston et al., 2003). Signalling through the Eph receptor can 
still occur once endocytosed until it is either dephosphorylated and degraded or 
recycled back to the membrane. However, endocytosis is also thought to terminate 
ephrin-Eph signalling (Mann et al., 2003; Marston et al., 2003; Zimmer et al., 2003).  
Reverse signalling occurs through the ephrin-B ligands (Figure 1.8) (Kania 
and Klein, 2016). Contact with the EphB receptor induces phosphorylation of the 
ligand by Src kinases, leading to the recruitment of proteins with PDZ domains. 
Although ephrin-A ligands lack an intracellular domain, some work has suggested 
they can also signal through binding to other membrane bound molecules as well. 
These include p75 receptors, which are expressed by Schwann cells, the neutrophin 
receptor, TrkB and the Ret receptor, which are required for synaptogenesis and 
axonal repulsion (Bonanomi et al., 2012; Lim et al., 2008; Marler et al., 2008).  
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Figure 1.8. Eph and ephrin interactions can induce bidirectional signalling.  
The Eph receptor kinase domain is activated upon interaction with ephrins, which 
induces the recruitment of various adaptor proteins such as GEFs to Vav2 that can 
regulate the activity of Rac-1 and as such protrusion formation and CIL {Kania, 2016 
#251}{Astin, 2010 #8}. Ephrin-A ligands lack an intracellular domain but can signal 
through co-receptors such as p75 {Lim, 2008 #36}. In contrast, the ephrin-B ligands 
do have a cytoplasmic domain that contains a PDZ domain through which it can 
signal to Src kinases {Kania, 2016 #251}. 
 
Importantly, ephrins have been shown to have key roles in axonal path finding and 
cell sorting/segregation and CIL (Astin et al., 2010; Batlle and Wilkinson, 2012; 
Hattori et al., 2000; Lisabeth et al., 2013; Parrinello et al., 2010). Eph signalling can 
mediate cell segregation through regulating repulsion, attraction, as well as adhesion 
and often the processes are associated with each other. For example, Eph signalling 
can decrease adhesion via endocytosis of the ephrin-Eph complexes and adjacent 
adhesive molecules, inducing repulsion and separation of cells. Eph receptors and 
ephrins can also interact and activate metalloproteases such as the ADAM family 
	   38 
members (Hattori et al., 2000). Upon binding of EphA to ephrin-A ligands, ADAM10 
interacts in cis with ephrin-A ligands and cleaves them, resulting in a repulsion 
response (Hattori et al., 2000). In another recent report, in MDCK cells, ADMAM10 
has also been shown to interact in cis with the EphB3 receptor and E-cad (Solanas et 
al., 2011). In this instance, ADAM10 gets activated upon binding of ephrin-B1 to 
EphB3, inducing E-cad shedding between the ephrin-B and EphB expressing cells. 
This causes differential adhesion between the ephrin-B and the EphB expressing 
cells and induces cell sorting of the two different populations. The authors propose 
that this mechanism could be important for the appropriate compartmentalization of 
different cell types within the epithelial layer of the intestine, as both the knockout of 
EphB3 or the specific expression of a dominant negative form of ADAM10 (CR2-
ADAM10ΔMP) in a specific cell type called the Paneth cell, which normally are 
compartmentalised within the stem cell niche of the epithelium, results in the aberrant 
migration of the Paneth cells into unwanted areas of the epithelium (Batlle et al., 
2002; Solanas et al., 2011). Thus, Eph-ephrin signalling can control migration of cells 
by inhibiting their movement into unwanted regions. This is similar to how CIL has 
been suggested to halt migration and prevent cells from invading into other tissues 
(Abercrombie and Heaysman, 1954a), and thus Eph/ephrin signalling could be 
involved in CIL. Indeed, the Eph-ephrin interaction has been shown to promote either 
CIL by inducing a repulsion response at the site of cell-cell contact, or promote 
forward migration by inducing filopodia extension at the site of contact, through 
regulating RhoGTPases activity (Astin et al., 2010). Interestingly, the decision 
between undergoing CIL or continuing forward migration is dependent on the 
concentration and array of ephrins and their receptors present on cells (Astin et al.). 
For example, PC3 cells express both EphA and EphB receptors and express ephrin-
A ligand but only a small amount of ephrin-B2, whereas fibroblasts express low 
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levels of ephrin-A ligands and high levels of ephrin-B2. When two PC3 cells collide 
there is strong activation of the repulsive EphA pathway, inducing RhoA and 
inhibiting protrusion formation, resulting in homotypic CIL. However when a PC3 cell 
meets a fibroblast there is stronger ephrin-B/Ephb3/4 signalling, inducing the 
activation of Cdc42, which promotes forward migration by inducing filopodia 
formation. Thus, Eph receptors and ephrins can have differential effects on CIL.  
 
1.1.9.2. CIL in tumourigenesis 
Loss of cell-cell recognition can cause unwanted movement and intermingling of 
cells, which is fundamental to tumourigenesis, invasion and metastasis. To induce 
tumour spreading, cells need to acquire the ability to migrate and also to lose the 
ability to recognise other cell types (Friedl and Alexander, 2011). 
Compartmentalisation can be mediated through repulsive signals such as ephrins. It 
is therefore not surprising, that aberrant ephrin signalling is associated with 
tumourigenesis (Pasquale, 2010). For example, EphB2 silencing in colorectal cancer 
(CRC) is associated with a poor prognosis (Batlle et al., 2005; Batlle et al., 2002), 
while EphA4 and EphA2 are overexpressed in prostate cancer (Astin et al., 2010; 
Pasquale, 2010). Proper expression of EphB2 and EphB3/ephrin-B1 is required for 
the correct compartmentalisation of different domains in the epithelial layers of the 
intestine (Batlle et al., 2002; Cortina et al., 2007). Interestingly, EphB/ephrinB 
expression is retained in adenomas, which are benign tumours of the intestine, and 
their expression keeps the tumours compartmentalised (Batlle et al., 2002; Cortina et 
al., 2007). However progression of the tumours into aggressive carcinomas is 
associated with the downregulation of EphB2/EphB3/EphB4, with the loss of EphB3 
resulting in the invasion of the epithelium into the muscle layer (Batlle et al., 2005). 
Moreover, ephrin-B expression in tissues surrounding adenomas prevents them from 
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migrating into the ephrin-B expressing tissues, as loss of ephrin-B results in 
expansion of adenomas into the surrounding normal epithelium layer (Cortina et al., 
2007).  
Loss of heterotypic CIL has been proposed to be fundamental for the invasion 
and thus the metastasis of tumours (Abercrombie, 1979; Astin et al., 2010). For 
example, heterotypic CIL between prostate cancer cells PC3 cells and fibroblasts is 
lost (Astin et al., 2010), while mouse sarcoma cells and mouse melanoma cells have 
diminished or lost CIL and are able to invade chick fibroblasts (Abercrombie, 1979). 
However, homotypic CIL has been proposed to remain intact in tumour cells which 
may allow cells to disseminate, similarly to how cells spread during development 
(Astin et al., 2010; Mayor and Carmona-Fontaine, 2010). Homotypic CIL between 
PC3 cells has recently been shown to remain intact and this is required for their 
dissemination, which is mediated by EphA2 and EphA4 (Astin et al., 2010; Batson et 
al., 2014). However, whether homotypic CIL is intact in the majority of cancer cells 
remains to be investigated. 
Many tumour cells are thought to migrate collectively, similarly to migrating 
cells during development. To induce migration in non-motile tumour cells, they need 
to gain the ability to migrate, which includes disrupting existing adhesions (Wells et 
al., 2011). This is often compared to epithelial to mesenchymal transition (EMT) in 
which non-migratory epithelial cells differentiate into migratory mesenchymal cells 
(Scarpa et al., 2015; Theveneau and Mayor, 2012b). EMT is characterised by a 
change from E-cad, which mediates stronger adhesion, to N-cad expression, which is 
associated with lower adhesion and increased cell migration (Scarpa et al., 2015; 
Wells et al., 2011). It is therefore not surprising that tumours change expression in 
adhesion molecules, specifically E-cad to N-cad (Wells et al., 2011). Expression of N-
cad in breast cancer cells induces their motility, invasion and metastasis (Hazan et 
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al., 2000; Nieman et al., 1999; Suyama et al., 2002). Interestingly, the increase of 
migration and invasion is dependent on FGF (Hazan et al., 2000; Nieman et al., 
1999); FGF receptor binding to N-cad, prevents internalisation of the FGF receptor 
and therefore causes sustained signalling (Hazan et al., 2000; Suyama et al., 2002). 
Furthermore, upregulation of N-cadherin could provide the cells with a less adhesive 
but more dynamic phenotype, which is required for collective cell invasion in a 3D 
matrix (Shih and Yamada, 2012). More recently, it has been shown that EMT 
transition of NC cells in Xenopus leavis is mediated by a switch from E-cad to N-cad, 
inducing CIL, which is required for the dispersal of these cells (Scarpa et al., 2015). 
Whether N-cad has a similar role in CIL during tumourigenesis, remains to be 
investigated. 
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1.2. Schwann cell biology 
The structure of a tissue can be compromised upon injury and during the process of 
regeneration, cell movement and proliferation are induced and structures and 
boundaries must be re-established. Regeneration of a tissue is thought to 
recapitulate aspects of developmental processes, however, in contrast to during 
development when tissues grow in a concerted fashion as the organism grows, 
regeneration requires the reforming of appropriate structures within the existing 
structures of the tissue and organism (Poss, 2010). However, very few tissues in the 
adult mammal retain the capability to regenerate following injury. This has been 
attributed to the lack of a suitable a stem cell population, differences in signalling in 
the local environment, and in some cases by the formation of scar tissue (Gurtner et 
al., 2008; Poss, 2010).  
One of the very few tissues in the adult mammal that is capable of some 
regeneration following injury is the peripheral nervous system (PNS). This is 
especially remarkable, as peripheral nerves are highly complex structures that can 
extend over long distances. However, though axonal regeneration has been shown 
to be efficient following mild injuries such as crush of the nerve, regeneration is less 
efficient following a full transection of the nerve, possibly the result of incorrect entry 
of axons into the endoneurial tubes or the growing of axons outside the endoneurial 
tubes (Nguyen et al., 2002).  
The regeneration of a nerve requires coordination of movement and growth of 
several cell types over long distances (Zochodne, 2008). Key to this process are the 
Schwann cells, which upon injury dedifferentiate, proliferate, migrate and remodel the 
local environment (Napoli et al., 2012; Zochodne, 2008). To achieve this, Schwann 
cells must interact intercellularly as well as with other cells within the local 
environment. Moreover, existing interactions in the quiescent nerve must change to 
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allow cellular rearrangement to occur. To understand how Schwann cells can 
regulate the regenerative process, it is important to understand how homotypic and 
heterotypic interactions between Schwann cells and their surrounding cells are 
mediated, both during the development and maintenance of the nerve, as well as in 
the regenerating nerve. 
Schwann cells are the main glial cells of PNS that in the adult exist as two 
types, myelinating Schwann cells, which enwrap and myelinate large calibre axons in 
a 1:1 ratio, and non-myelinating Schwann cells, which can enwrap multiple smaller 
axons in structures called Remak Bundles (Zochodne, 2008). Myelination provides 
efficient saltatory conduction of nerve impulses and therefore, loss or defects in 
myelination leads to loss of conduction and neuropathies (Conforti et al., 2014). 
The nerves in the PNS consist of groups of axons enwrapped by Schwann 
cells, which are bundled together and organised into fascicles (Zochodne, 2008) 
(Figure 1.9). Each fascicle is enclosed by a layer of specialised fibroblasts, called the 
perineurium. Within the fascicles, the endoneurium, which in addition to the axons 
and Schwann cells, consists of ECM, macrophages, fibroblasts, and blood vessels. 
Several fascicles, in turn, are grouped together to make up a larger nerve, and are 
surrounded by the epineurial sheath.  
 
1.2.1. Schwann cell development 
The development of Schwann cells is well characterised, Schwann cells derive from 
neural crest cells through two differentiation intermediates: Schwann cells precursors 
and immature Schwann cells, each characterised by expression of specific 
expression markers (Figure 1.10) (Jessen and Mirsky, 2005).  
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Figure 1.9. Structure of the peripheral nerve 
This cross section of the peripheral nerve shows the complexity of the nerve. The 
peripheral nerve consists of multiple layers, the outer layer the epineurium, which can 
contain several fascicles that are enclosed by the perineurium. Within the fascicles is 
the endoneurium, a densely packed structure, containing groups of myelinated 
axons, Remak bundles, blood vessels, ECM and macrophages.  
 
1.2.2. Neural crest 
Little is known about how neural crest cells differentiate into Schwann cell precursor 
cells. During neurulation, a process occurs whereby neural crest cells separate from 
the neuroepithelial in a process called delamination and migrate away from the 
neural tube in two major streams, to give rise to the glial cells and some neurons of 
the PNS and also differentiate into melanocytes, fibroblasts, smooth muscle cells and 
in the head to cartilage and bones (Theveneau and Mayor, 2012b).  Several factors 
have been shown to regulate the differentiation state of neural crest cells. The 
transcription factor Sox-10 is expressed by neural crest and is required for the 
generation of Schwann cell precursor cells (Jessen and Mirsky, 2005). However, it is  
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Figure 1.10.  The major differentiation steps of the Schwann cell lineage 
Neural crest cells can differentiate into Schwann cell precursors that associate with 
axons, which can group together in bundles.  At this stage, axons and Schwann cells 
are tightly packed and there is little ECM, endothelial cells or fibroblasts, which all 
appear at the time of the transition to immature Schwann cells. Note that Schwann 
cell precursors can also give rise to melanocytes, endoneurial fibroblasts and 
parasympathetic neurons. At the stage of immature Schwann cells, radial sorting 
begins, and Schwann cells associate in a 1:1 ratio and myelinate the larger axons, 
while several smaller axons are bundled together in Remak bundles by non-
myelinating Schwann cells.  
 
expressed by most early neural crest cells and therefore is not solely associated with 
glial cells. Sox-10 is not expressed by neurons and acts to inhibit neurogenesis and 
indirectly regulates gliogenesis through regulation of the ErbB3 receptor, which is an 
important signal in Schwann cell identity (Britsch et al., 2001). ErbB3 is strongly 
expressed by neural crest cells but is down regulated in derivatives with the 
exception of Schwann cells (Birchmeier, 2009). FoxD3 is another transcription factor 
associated with the differentiation of neural crest cells to the Schwann cell lineage, as 
it is expressed by both neural crest cells and Schwann cell progenitors and inhibits 
differentiation into neurons and melanocytes (Nitzan et al., 2013).  
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1.2.3. Schwann cell precursors 
Schwann cell precursors first appear around E12/13 in the mouse (E14/15 rat) and 
are characterised by an upregulation of cadherin-19 (Cad19), which is exclusively 
expressed by the Schwann cell precursors and may play a role in the compaction of 
early nerves (Jessen et al., 2015; Woodhoo and Sommer, 2008). A crucial signalling 
pathway in the developing nerves, is the Neuregulin (NRG)/ErbB pathway. Moreover, 
survival of Schwann cell precursors is dependent on ErbB3, which is also important 
for Schwann cell precursor migration along the developing axon tract and for control 
of cell number and progression of differentiation into Schwann cells (Birchmeier, 
2009; Heermann and Krieglstein, 2012; Jessen et al., 2015; Lyons et al., 2005). The 
ErbB3 receptor is activated upon binding of NRG1, which is expressed by axons 
(Birchmeier, 2009). ErbB3 knockout mice lack Schwann cell precursors and therefore 
indirectly cause nerve degeneration, as axons degenerate in the absence of 
Schwann cell precursors (Hoke, 2006; Riethmacher et al., 1997). As Schwann cell 
precursors are reduced in mice in which neuregulin signalling is absent, the 
development of Schwann cells is dependent on NRG1. In addition, Notch signalling 
between axons and Schwann cell precursors is important for controlling the speed of 
conversion to Schwann cells as Notch signalling controls the upregulation of ErbB3 
receptors on the Schwann cells, making them more susceptible to NRG signalling 
(Woodhoo et al., 2009). Other markers associated with the differentiation step of 
neural crest to Schwann cell precursors are the negative regulators endothelin and 
AP2α (Brennan et al., 2000; Stewart et al., 2001). Aberrant expression of endothelin 
and AP2α leads to either premature appearance of Schwann cell precursors or slows 
down the progression into Schwann cells, respectively.  
Apart from being an intermediate between neural crest and Schwann cells, 
Schwann cell precursors also have functions in the fasciculation of nerves, a process 
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in which axons are grouped together (Jessen et al., 2015). The development of 
axons is initially normal without Schwann cell precursors, however at later stages 
axons become defasciculated and project aberrantly into the target tissues 
(Birchmeier, 2009). Moreover, knockout studies showed that axons die without the 
support of Schwann cells, illustrating the importance of the interdependency between 
Schwann cells and axons (Hoke, 2006; Riethmacher et al., 1997).  
 
1.2.4. Immature Schwann cells   
Immature Schwann cells can be detected in the developing nerve around E15/16 in 
the mouse (E17/18 rat) (Jessen et al., 2015). In contrast to neural crest cells, 
Schwann cell precursors and immature Schwann cells are associated with axons and 
there is an interdependency on the survival between axon and the different Schwann 
cell intermediates (Jessen and Mirsky, 2005). However, unlike Schwann cell 
precursors, immature Schwann cells survival is independent of NRG1, but secrete 
factors including insulin growth factor-2 (IGF-2), platelet-derived growth factor 
(PDGF) and neurotophin3 (NT3), leukaemia inhibitory factor (LIF) and 
lysophophatidic acid, which can enhance the survival of the cells in the absence of 
axons in vitro (Dowsing et al., 1999; Meier et al., 1999; Weiner and Chun, 1999). 
However, prolonged periods of no contact with axons after injury results in cell death 
of Schwann cells in the adult (Hoke, 2006; Sulaiman and Gordon, 2009). The 
transition of Schwann cell precursors to immature Schwann cells is further 
characterised by structural changes of the nerve, which include vascularisation of the 
nerves and the appearance of endoneurial fibroblasts and ECM (Jessen and Mirsky, 
2005). At this time, immature Schwann cells also envelop groups of axons into 
bundles of axons/Schwann cells. In preparation for myelination, Schwann cells start a 
process known as radial sorting, in which individual larger axons associate with 
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Schwann cells in a 1:1 relationship, while several smaller axons are enwrapped by 
single Schwann cells to form the Remak bundles. The mechanism underlying this 
process include interactions between α6β1, α7β1 integrins on the surface of the 
Schwann cells with laminins, which are required for the ensheathment of axons by 
Schwann cells (Berti et al., 2011; Feltri et al., 2002; Pellegatta et al., 2013). 
Concurrently, after birth, Schwann cells begin myelination of the larger axons, while 
non-myelinating Schwann cells continue constructing the Remak bundles.  
 
1.2.5. Myelin regulators and structure  
Myelination of peripheral nerves is important for salutatory conduction and defects in 
myelination are associated with neuropathies, and thus control of the myelination 
process is key for the development of peripheral nerves (Salzer, 2015). Several 
transcriptional regulators have been implicated in the progression of immature 
Schwann cells into myelinating Schwann cells including Krox20, Sox10, Nab1/2 and 
SREBP, which regulate the expression of factors important in the myelination 
process or directly regulate myelin genes (Salzer, 2015). Moreover, Krox20 is a key 
regulator during PNS myelination and regulates the transcription of biosynthetic 
components of myelin lipid synthesis and myelin structural proteins. The heterotypic 
interactions between axons and Schwann cells are crucial for myelin initiation and 
maintenance. The levels of expression of type III NRG1 on the axons sets a 
threshold for myelination by the Schwann cells, and determines the extent of 
myelination (Taveggia et al., 2005). Other molecules are implicated in controlling 
myelination including the adhesion G-protein-coupled receptor (GPCR) Gpr126, 
which is required for radial sorting and initiating myelination but is dispensable for the 
maintenance of myelination (Glenn and Talbot, 2013; Salzer, 2015). Mechanistically, 
Gpr126 increases levels of cAMP (Mogha et al., 2013), an important myelination 
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signal (Glenn and Talbot, 2013).  cAMP in turn can increase of expression of the pro-
meylinating transcription factor Pou3f1 (Monuki et al., 1989) and can drive Krox20 
expression (Kipanyula et al., 2013), and via activation of PKA can activate 
transcription factors, including NF-kB and the CREB family, the latter has been 
suggested to have a role in differentiation of Schwan cells (Arthur-Farraj et al., 2011).  
Another signalling pathway key for initiation of myelination is the PI3K signalling 
pathway, which is downstream from NRG/ErbB signalling (Salzer, 2015). Activation 
of the PI3K pathway results in hypermyelination of axons, which is thought to occur 
via activation of Akt and the subsequent activation of mTOR (Goebbels et al., 2010; 
Goebbels et al., 2012).    
In addition, binding of Lgi4 protein, expressed by Schwann cells, to Adam22 on 
the surface of the axon has a role in promoting myelination, as deletion of either 
result in major defects in myelination (Ozkaynak et al., 2010; Sagane et al., 2005). 
However, Lgi4 and Adam22, appear to be modulators that advance myelination 
beyond the promyelination phase (Bermingham et al., 2006; Kegel et al., 2013; 
Ozkaynak et al., 2010), while NRG1 and Gpr126 are absolutely required for initiation 
of myelination and appear to be the major signals that control myelination.  
The myelin sheath is a polarised structure, both longitudinally as well as radially, 
and can largely be divided into different segments including the Nodes of Ranvier, 
nodes, paranodes, juxta paranodes and internodes (Figure 1.11), each with specific 
physiological functions and array of ion channels, cell adhesion molecules, and 
cytoplasmic adaptors (Corfas et al., 2004). The longest domain is the internode, in 
which the membranes of the Schwann cell and of the axons are in intimate contact. 
Adhesion molecules present in the internode include myelin associated glycoprotein 
(MAG) and Nectin-like (Necl) proteins Necl-1, Necl-2 and Necl-4 that mediate 
interactions between Schwann cells and axons (Maurel et al., 2007; Rasband and 
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Peles, 2015; Spiegel et al., 2007). Interactions between Necl-1 on the axon and Necl-
4 on the surface of Schwann cells are required for myelination, as knockdown of 
either molecule in vitro results in decreased axonal myelination (Maurel et al., 2007; 
Spiegel et al., 2007). Though, Necl1 and Necl4 mediate the myelination of the axons, 
they do not appear to be required for the initial contact between Schwann cells and 
axons (Spiegel et al., 2007).  
 
 
Figure 1.11. Structure of myelinated axons. 
a) Large diameter axons in the PNS are myelinated by Schwann cells in a 1:1 ratio. 
Each segment of a myelinating Schwann cell around the axon is called the internode 
and two myelinating Schwann cells are intersected by nodes. b). Schematic 
longitudinal cut in which the internode, juxtaparanode, paranode and node are 
labelled. At the paranode, Schwann cells interact with axons through paranodal 
junctions. Microvilli emerging from myelinating Schwann cells interact with axons at 
the node. Schwann cells are surrounded by a layer of basal lamina. 
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The Nodes of Ranvier intersect adjacent Schwann cells along the length of the 
axon, and are characterised by the accumulation of Na+ channels and K+ channels 
on the surface of the axons, that are fundamental for salutatory conduction (Rasband 
and Peles, 2015). The Na+ channels are concentrated at the node on the surface of 
the axon by ankyrin G and βIV spectrin that connect the channels to the actin 
cytoskeleton (Berghs et al., 2000; Kordeli et al., 1995). Clustering of Na+ channels 
and K+ channels at the Nodes of Ranvier is mediated through interactions between 
the axonal surface and Schwann cell microvilli, which are structures emanating from 
both ends of the myelinating Schwann cells flanking the internode. The interactions 
between the Schwann cells microvilli and the axon are mediated by the cell adhesion 
molecules (CAM) NF186 on the axon and nrCam on the Schwann cells that interact 
via their ligand gliomedin, which in turn clusters the Na+ channels on the axonal 
membrane through a complex of the ion channels with ankG (Figure 1.12) (Eshed et 
al., 2005; Rasband and Peles, 2015). While Gliomedin is required for the node 
formation, it does not effect the myelination process, (Eshed et al., 2005), consistent 
with the relatively late appearance of microvilli (Rasband and Peles, 2015).  
Other proteins that mediate Schwann cell/axonal interactions include neurofascin 
(NF155), which is located on the surface of Schwann cells at the paranodal junctions, 
which flank the Nodes of Ranvier (Charles et al., 2002). NF155 interacts with an 
axonal complex consisting of GPI-anchored contactin and Caspr. These complexes 
are crucial for the formation of the paranodal loops, as loss of Caspr leads to 
aberrant nerve conductions (Laquerriere et al., 2014). Other molecules that are 
important for Schwann cell/axonal interactions are N-cad and E-cad, which are 
expressed by Schwann cells and play roles in Schwann cell migration, proliferation 
and myelination (Crawford et al., 2008; Fannon et al., 1995; Lewallen et al., 2011; 
Parrinello et al., 2010; Tricaud et al., 2005; Wanner et al., 2006; Wanner and Wood, 
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2002). E-cad is expressed in mature myelinating Schwann cells, where it forms 
autotypic junctions between membranes of a single Schwann cells and plays a role in 
maintaining the architecture of several structures such as the paranodal loops at the 
Nodes of Ranvier and at Schmidt-Lanterman incisures, a structure important for the 
transport of molecules between periaxonal and pericellular cytoplasm (Crawford et 
al., 2008; Fannon et al., 1995; Tricaud et al., 2005). In contrast, N-cad is expressed 
in Schwann cell precursors during the development of the nerve and is important for 
the outgrowth of the nerve (Wanner et al., 2006). Interestingly, after injury, N-cad is 
re-expressed upon the dedifferentiation of Schwann cells and has been suggested to 
provide a scaffold to promote axonal growth and is required to initiate remyelination 
of the axons (Lewallen et al., 2011; Parrinello et al., 2010; Wanner et al., 2006; 
Wanner and Wood, 2002). Moreover, we have previously shown that N-cad is 
required for sorting Schwann cells into clusters, which is important for their collective 
migration, which promotes axonal regrowth following injury (Parrinello et al., 2010).  
In addition, Semaphorin 4F (Sema4F) plays a role in the heterotypic interaction 
between Schwann cells and axons, it is required for the alignment of Schwann cells 
to axon, and controls Schwann cell proliferation (further discussed in Chapter 5) 
(Parrinello et al., 2008).  
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Figure 1.12. The assembly of the Nodes of Ranvier. 
Interaction between the axon and the Schwann cell microvilli, which emanate from 
myelinating Schwann cells that are flanking the internode, are required for assembly 
of the Nodes of Ranvier. These interactions are mediated by NF186 and nrCAM on 
the axon and Schwann cells respectively, which are connected via Gliomedin (Gldn). 
NF186 in turn via interaction of ankG (G), clusters the Na+ channels in the axonal 
membrane, which are concentrated at the Nodes of Ranvier. 
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1.3. Nerve regeneration  
1.3.1. Injury response 
Unlike nerves of the central nervous system (CNS), the nerves of the PNS can 
regenerate following an injury and are able to reconnect to their original targets 
(Navarro, 2009; Nguyen et al., 2002; Zochodne, 2008). Upon injury of the nerve, a 
complex process called Wallerian degeneration is induced, which includes 
degeneration of the axons downstream from the site of injury and Schwann cell 
dissociation, dedifferentiation and proliferation (Conforti et al., 2014). Proximal to the 
site of injury, polarised growth of axons is induced in order to allow regrowth back 
towards their targets (Cattin and Lloyd, 2016). Remarkably, during the regeneration 
process, the normally quiescent, myelinating Schwann cells are triggered to 
dedifferentiate to a more progenitor-like state. Dedifferentiation of Schwann cells is 
mediated by the Ras/Raf/ERK signalling pathway, that induces the reprogramming of 
the cells - including the down regulation of myelin genes (Figure 1.13) (Harrisingh et 
al., 2004). Moreover, the dedifferentiated Schwann cells provide a proliferative pool, 
which are capable of clearing the myelin and axonal debris through phagocytic 
processes, opening of the blood nerve barrier and inducing an inflammatory 
response (Napoli et al., 2012). Other pathways important for the dedifferentiation-
state of Schwann cells include c-Jun, which is induced by ERK and drives the 
dedifferentiation process by negatively regulating the transcription of the myelin 
genes (Parkinson et al., 2008; Woodhoo and Sommer, 2008). In addition, c-Jun has 
a role in axonal regeneration, by promoting axonal survival through regulating 
expression of the secreted neurotrophic factors GDNF and Artemin in Schwann cells 
(Arthur-Farraj et al., 2012; Fontana et al., 2012). Notch signalling has also been 
shown to negatively regulate the myelin genes and its expression is sufficient to 
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revert the myelinating Schwann cells to a demyelinating state (Woodhoo et al., 
2009). 
 
Figure 1.13. Schwann cells orchestrate the regenerative process. 
Ras activation in Schwann cells, following injury, plays a key role during the 
regenerative process, which has multiple affects, including the dedifferentiation to a 
more progenitor like state, secretion of neurogenic factors, opening of the 
blood/nerve barrier and the induction of the immune response.  
 
Following full transection of the nerve, the nerves stumps retract leaving a gap, which 
axons need to cross in order to grow back to their original target (Figure 1.14). Distal 
to the cut, Schwann cells within the distal stump form tube-like structures within their 
original basement membranes called Bands of Büngner, which provide a track 
through which axons can regrow to their original target (Figure 1.14) (Cattin and 
Lloyd, 2016). However, to reach the Bands of Büngner axons face some hurdles; 
axons must pass through a densely packed tissue that forms, through unknown 
mechanisms, at the cut site between the proximal and distal stump, called “the 
bridge”. The bridge consists of a mixture of inflammatory cells, fibroblasts and matrix 
and appears a hostile and non-directional environment that can extend over several 
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millimetres (Figure 1.14). Until recently it was unclear how axons crossed this bridge. 
However, we have shown that Schwann cells play a crucial role in guiding the axons 
across the bridge (Parrinello et al., 2010). 
 
Figure 1.14. Model of the multi-cellular processes involved in the regeneration 
of peripheral nerves. 
a) Injury of the nerve induces the degeneration of axons distal to the site of injury; 
both nerve stumps retract leaving a gap. b) At the site of injury a structure is formed 
called “the bridge”, which consists of matrix, fibroblasts, neutrophils, and 
	   57 
macrophages (the majority cell type). The bridge becomes hypoxic which is 
specifically sensed by the macrophages, which subsequently secrete VEGF-A. c) 
VEGF-A induces the formation of new blood vessels in the bridge that are polarised 
in the direction of subsequent Schwann cell migration. Schwann cells migrate along 
the blood vessels using them as a track, taking axons along with them across the 
bridge. Once the axons re-enter the distal stump they grow through the Bands of 
Bungner back to their targets. d) Axons are remyelinated by Schwann cells and the 
inflammatory response resolves.  
 
To guide axons back to their target, Schwann cells migrate collectively as cellular 
cords, emerging from both stumps until they fully extend across the bridge. We 
showed that the migration of Schwann cells as a collective is fostered by heterotypic 
interactions with fibroblasts, which induce the sorting of the Schwann cells (Parrinello 
et al., 2010). Schwann cells cultured alone, undergo CIL and thus normally repulse 
each other upon contact causing individual cells to migrate away from each other. In 
contrast, in co-cultures of Schwann cells with fibroblasts, Schwann cells switch their 
behaviour from repulsive to adhesive, following a heterotypic interaction with a 
fibroblast, causing the Schwann cells to cluster (Figure 1.15 and 1.16). This 
heterotypic interaction is mediated by EphrinB/EphB2 signalling between fibroblasts 
and Schwann cells, which induces re-localisation of N-cad to the cell-cell junctions 
between Schwann cells, through activation of the transcription factor Sox-2 (Figure 
1.15). Interestingly, Sox-2 does not regulate the mRNA expression levels of N-cad, 
nor does it affect protein levels, but instead induces, through unknown mechanisms, 
N-cad re-localisation to the site of cell-cell junctions. Moreover, this EphB2-mediated 
process is required for nerve regeneration, as loss of EphB2 signalling in vivo results 
in loss of cord formation and loss of directional Schwann cell migration and axonal 
growth (Parrinello et al., 2010). Interestingly, time-lapse analysis of the Schwann 
cells clusters formed in co-cultures with fibroblasts, show that while Schwann cells 
become more adhesive, they don’t become static, but appear very motile and 
dynamic and appeared to attempt to migrate away from each other, reminiscent of 
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repulsive behaviour (Parrinello et al., 2010). This suggests, that the repulsion 
signalling may still be active in the collectively migrating Schwann cells, which could 
be important for the cells to exert forces and move the Schwann cell collective 
forward. This is reminiscent of collectively migrating neural crest cells during 
development, in which CIL is required for mediating the global polarisation of 
individual cells in the direction of migration and also appears to mediate a repulsive 
force outward from the cluster (Scarpa et al., 2015; Theveneau and Mayor, 2010). 
Although, it is clear that Schwann cell clustering is mediated by N-cad re-localisation, 
what mediates homotypic CIL between Schwann cells, and if other homotypic 
interactions between the collectively migrating Schwann cells are required, is 
unknown.  
   
Figure 1.15: Schwann cells change their behaviour following heterotypic 
interactions with fibroblasts. 
i. In vitro, Schwann cells repulse each other upon collision. ii. Upon heterotypic 
contact with fibroblasts, mediated through EphrinB/EphB2 signalling, Schwann cells 
change their behaviour from repulsive to adhesive, inducing Schwann cell clustering. 
Mechanistically we showed that this is mediated by the activation of the transcription 
factor Sox-2 in Schwann cells, which by an unknown mechanism induces the re-
localisation of N-cad to the site of cell-cell junctions (Parrinello et al., 2010).  
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Figure 1.16: Schwann cells migrate as cellular cords required for axonal 
regeneration. 
Schwann cells emerge from both the proximal and distal stumps, into the bridge, 
where they come into contact with fibroblasts. The heterotypic interactions with 
fibroblasts are required to induce Schwann cell sorting into cellular cords. Schwann 
cell migration extends across the bridge, taking along the axons, to guide them back 
to their targets.  
 
1.3.2. Schwann cell migration  
Schwann cell migration plays a key role both during the development of peripheral 
nerves and during the regeneration process (Cattin and Lloyd, 2016; Heermann and 
Schwab, 2013). Little is known about the signals controlling Schwann cell migration 
with most studies focusing on the migration that occurs during the development of 
the peripheral nerve. During development, Schwann cell precursors migrate along 
the growing axons, from the nerve roots to the periphery (Heermann and Schwab, 
2013). Thus Schwann cells must migrate over long distances in order to populate the 
the entire length of the axon. Several studies have shown a crucial role for NRG1 
type III/ ErbB2/3 signalling in Schwann cells migration. NRG1 type III is expressed by 
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the growing axon and induces directional Schwann cell migration along the lateral 
line in zebra fish, and along explants of sympathetic axons (Heermann et al., 2011; 
Lyons et al., 2005). However, inhibition of NRG1 besides blocking migration also 
results in increased apoptosis, but when both apoptosis and NRG1 signalling are 
inhibited Schwann cell migration is restored, suggesting that the effect of NRG1 type 
III on Schwann cell motility is indirect through survival of the Schwann cells 
(Heermann et al., 2011). The authors, suggest that apoptosis might lead to loss of 
contact between neighbouring Schwann cells, resulting in the stalling of migrating 
Schwann cells, with surviving cells migrating backwards to re-contact the group of 
migrating Schwann cells. This phenotype is reminiscent of the collective migration of 
Neural crest cells, which are kept together by the co-attraction molecule C3a 
(Carmona-Fontaine et al., 2011), however, this needs to be further investigated. 
The neurotrophins BDNF and NT3 have also been shown to play a role in 
Schwann cell migration in vitro (Yamauchi et al., 2003, 2004). BDNF is secreted by 
axons and signals via p75 expressed by the Schwann cells, which inhibits Schwann 
cell migration along explants of axons, in a Src-kinase dependent manner (Yamauchi 
et al., 2004). In contrast, neurotrophin NT3 induces Schwann cell migration along the 
axon, through activating the Rho-GTPases Cdc42, and Rac-1 (Yamauchi et al., 
2003, 2004). Other proteins that have been shown to promote Schwann cell motility 
in Boyden chamber assays in vitro are integrins, and GDNF (Cornejo et al., 2010; 
Inoue et al., 2010; Milner et al., 1997). Moreover, erythropoietin has been shown to 
regulate Schwann cell migration, by promoting β1-integrin-dependent Schwann cell 
migration on fibronectin, which is mediated by the direct recruitment of β1-integrin to 
the cell-cell surface of Schwann cells, upon stimulation with erythropoietin (Inoue et 
al., 2010).  
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In contrast to during development, during regeneration Schwann cells migrate 
across the bridge prior to axonal growth, suggesting different mechanisms are in 
place to mediate directional Schwann cell migration (Parrinello et al., 2010). We 
recently showed, how Schwann cells migrate directionally through the apparently 
non-directional environment of the bridge (Cattin et al., 2015). Following severing of 
the nerve, macrophages, along with other inflammatory cells, are recruited to the 
bridge with macrophages being the majority cell type in the bridge (Figure 1.14). The 
bridge region initially lacks blood vessels, and thus becomes hypoxic, which is 
sensed specifically by the macrophages resulting in the subsequent secretion of 
VEGF-A, which in turn induces the formation of a polarised vasculature (Figure 1.14). 
Moreover, while VEGF-A is sufficient to induce the formation of the blood vessels, it 
is not required for Schwann cell migration. However, we also found that  
macrophages secrete unknown factors that increase Schwann cell migration (Cattin 
et al., 2015).  
We also showed that interactions between Schwann cells and blood vessels 
are important for the directionality of the subsequent migrating Schwann cells (Figure 
1.14) (Cattin et al., 2015). Blood vessels promote directional Schwann cell migration 
in two ways, they provide a surface for Schwann cells to migrate on, as in vitro 
analysis showed that Schwann cells cannot migrate within a 3D matrix, but required 
the interaction with the surface of the endothelial cells to move forward (further 
explained in Chapter 5). Moreover, the polarised vasculature provides Schwann cells 
with directionality. This was shown most convincingly, by directing blood vessel 
formation into surrounding tissues which redirected Schwann cell migration and 
axonal growth along the redirected vessels into the surrounding tissue. However, 
what attracts Schwann cells into the bridge and how the blood vessels provide a 
conducive migratory environment remains unclear.  
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1.4. Pathology 
1.4.1. Neuropathies 
As described in the preceding sections, the development and maintenance of healthy 
peripheral nerves is mediated by the interdependent Schwann cell/axon relationship. 
It is therefore not surprising that underlying many neuropathies is aberrant Schwann 
cell/axonal communication (Juarez and Palau, 2012). Charcot-Marie-Tooth disease 
(CMT) is a heterogenous group of inherited peripheral neuropathies that affect both 
motor and sensory nerves and affects 17-40 per 100,000 people. Neuropathies are 
primarily caused by myelination defects, which ultimately lead to axonal 
degeneration. However, there are Schwann cell induced neuropathies that cause 
axonal degeneration independent of demyelination. Alternatively, the disease can be 
the result of a defect in the axon. The affected genes underlying the neuropathies are 
often related to myelin processes including compaction and maintenance of myelin, 
trafficking, transport through myelin, myelin related transcription regulation, as well as 
genes in axonal transport, cell signalling and cytoskeleton formation (Juarez and 
Palau, 2012).  
 There are different types of CMT, CMT Type I are demyelinating forms which 
are characterised by a reduction in nerve conduction velocity, segmental 
demyelination and remyelination, and CMT Type II in which the defect is primarily in 
the axon, which often results in a mild reduction of nerve conduction, and loss of 
axons (Juarez and Palau, 2012). CMT Type I is by far the most prevalent peripheral 
neuropathy and results from autosomal dominant or X-linked mutations, caused by 
mutations in genes including PMP22 that encodes for myelin protein 22, which is 
mainly expressed in compact myelin of Schwann cells (Lupski et al., 1991; 
Raeymaekers et al., 1991), and the myelin protein zero gene (MPZ), which is the 
major protein in the myelin sheath (there are more than 150 mutations in MPZ 
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associated with CMT1B) (Juarez and Palau, 2012), CMTX1, an X-linked gene 
encoding for gap junction protein connexin-32, which is located within the myelin 
sheath, and is important for the transport of ions and nutrients between cells 
(Bergoffen et al., 1993).  
 Other types of CMT that occur less frequently include Type II, which are 
disorders caused by autosomal dominant mutations in axonal genes, CMT Type III 
which is characterised by the thinning of myelin and segmental demyelination, and 
CMT Type IV, which is a rare autosomal recessive neuropathy (Juarez and Palau, 
2012; Suter and Scherer, 2003).  
 
1.4.2. NF1 and NF2 
Additional disorders associated with Schwann cell dysfunction arise in patients with 
Neurofibromatosis Type 1 (NF1) and Type 2 (NF2), which are inherited dominant 
autosomal disorders, in which there is a high risk of tumour formation (Ferner, 2007). 
These are of particular interest for this study, as tumourigenesis is associated with 
loss of heterotypic and homotypic interactions, which can cause loss of inhibition of 
cell movement and CIL, and ultimately result in invasion and metastasis. Indeed, the 
development of the tumours in NF1 and NF2 is characterised by the loss of cell-cell 
recognition molecules (Morrison et al., 2001; Parrinello et al., 2008).  
 
1.4.2.1. Neurofibromatosis Type I 
Though the tumours associated with both NF-1 and NF-2 consist of Schwann cells, 
they are genetically and clinically different. NF1 is a very common disease that 
affects 1 in 3500 people world wide, and is characterised by skin disorders and the 
manifestation of peripheral nerve tumours. NF-1 results from the heterozygous loss 
of the NF1 gene and mainly affects the peripheral nervous system, in which there is 
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an increased risk of developing peripheral nerve sheath tumours called 
neurofibromas (Ferner, 2007). However, loss of NF1 also results in several other 
clinical manifestations such as café au lait macules, Lisch nodules, optic gliomas, 
neoplasias of the haematopoietic system, skin deformation and learning disorders. 
Neurofibromas are benign tumours that can occur along the length of the peripheral 
nerve, they can either be located within the dermis (dermal neurofibromas) or are 
located deeper towards the nerve roots (plexiform neurofibromas). Although benign, 
the plexiform type of neurofibroma can continuously grow, is locally invasive, spreads 
into the surrounding tissue and can affect whole limbs or organs (Figure 1.17) 
(Woodruff, 1999). Furthermore, in 7-13% of NF-1 patients the tumours can transform 
into highly malignant Malignant Peripheral Nerve Sheath Tumours (MPNSTs), which 
usually arise from a pre-existing plexiform neurofibromas, that can invade and 
metastasise (Figure 1.17) (Evans et al., 2002). Thus like during the regenerative 
process Schwann cells appear to become migratory during the tumourigenic process 
(Figure 1.17). 
The NF1 gene encodes for neurofibromin, a cytoplasmic protein containing a 
Ras-GAP domain, which regulates Ras, by promoting the hydrolysis of GTP to GDP, 
thereby inactivating Ras and terminating downstream signalling. Thus loss of NF1 
results in hyperactivation of Ras (Martin et al., 1990; Xu et al., 1990). Neurofibromas 
are complex tumours that contain multiple cell types including increased numbers of 
Schwann cells, fibroblasts and mast cells, and an increase in ECM. Importantly, 
Schwann cells are dedifferentiated and dissociated from the axons. Although 
neurofibromas are a mixture of cells, it is well understood that neurofibromas arise 
from the loss of NF1 in Schwann cells, resulting in the hyper activation of Ras 
(DeClue et al., 1992; Kim et al., 1997). However, genetic studies have suggested that 
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other cell types are also important during the development of the tumours, as well as 
the local environment (Ribeiro et al., 2013; Yang et al., 2008; Zhu et al., 2002). 
 
 
Figure 1.17. Neurofibromas mimic an unrepaired wound. 
Neurofibromas have a similar cellular composition to a regenerating nerve, including 
dedifferentiated and dissociated Schwann cells, inflammatory cells and fibroblasts. 
During nerve regeneration Schwann cells collectively migrate. Similarly, plexiforn 
neurofibromas can spread over long distances and are locally invasive, suggesting 
Schwann cells become motile. While, in MPNST the malignant tumour cells become 
highly invasive and are able to invade into surrounding tissues and metastasise.  
 
Owing to their similar cellular composition, neurofibromas have been described 
as mimicking the injured state and have been referred to as unrepaired wounds 
(Figure 1.17) (Lassmann et al., 1976). Interestingly, similarities can be made 
between Ras signalling during the formation of neurofibromas and peripheral nerve 
regeneration. Activation of the Ras pathway is sufficient to induce many aspects of 
the regenerative response (Napoli et al., 2012). This results in the dedifferentiation of 
the Schwann cells and dissociation from axons. Acting cell-autonomously, Ras 
activation induces Schwann cell dissociation from axons, which is mediated by a loss 
of Sema4F expression by the Schwann cells which indirectly mediates hyper 
proliferation (Parrinello et al., 2008). Non-cell autonomous effects include the loss of 
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the BNB and the induction of the inflammatory response (Napoli et al., 2012), the 
latter is thought to be important for the development of the tumour as there is a large 
influx of inflammatory cells, such as mast cells which changes the tumour 
development (Yang et al., 2008), and thus this suggests that the microenvironment of 
tumours plays an important role in their development.  
Indeed, a large body of evidence suggest that the tumours do not just develop 
from cell-autonomous effects. Studies have shown that loss of NF-1 in Schwann cells 
alone is not sufficient for the formation of neurofibromas, as tumours only develop in 
a Nf-1 heterozygous background, suggesting interactions of Nf-1-/- Schwann cells 
with other Nf-1+/- cell types are required for tumour formation (Yang et al., 2003; Zhu 
et al., 2002). Moreover, in vivo work showed that knockout of NF1 in Schwann cells 
during development does not result in the early formation of tumours, moreover, the 
nerves develop normally (Joseph et al., 2008; Wu et al., 2008; Zheng et al., 2008). 
However, tumours did develop in the adult, when Schwann cells can be seen to start 
dissociating from axons, which ultimately give rise to neurofibromas (Wu et al., 2008; 
Zheng et al., 2008). Interestingly, however, loss of NF1 in the adult does not result in 
many tumours (Joseph et al., 2008). This suggests that loss of NF1 is not sufficient 
to disrupt heterotypic interactions between Schwann cells and axons or lead to the 
dedifferentiation of the cells. Moreover, these results showed that the timing of the 
loss of NF1 at a specific stage during development could also be important to 
predispose Schwann cells to tumour formation at a later stage and suggest additional 
tumour promoting signals from the microenvironment, such as from a inflammatory 
response, are required to trigger the primed Schwann cells for tumour development 
(Parrinello and Lloyd, 2009).  
Recent work from our lab showed that the injury response can play a role in the 
development of tumours and provided further evidence for the importance of the 
	   67 
microenvironment in neurofibroma development (Ribeiro et al., 2013). In this study 
we showed that the wound site provides a tumour-promoting environment, as 
tumours formed with high frequency specifically at the site of injury in mice in which 
NF1 was specifically lost in myelinating Schwann cells in the adult, both in a Nf1+/+ 
and a Nf1+/- background. In contrast, the structure distal to the injury site was not 
affected, indicating that additional (loss of) signals, or interactions of NF1-/- Schwann 
cells with microenvironment at the site of injury are required for the formation of 
tumours (Ribeiro et al., 2013). Thus, this shows that NF1-/- Schwann cells need a 
conducive microenvironment for the development of neurofibromas. 
Although the importance of changes in normal Schwann cell homotypic and 
heterotypic interactions in the development of neurofibromas appears clear, there is 
still surprisingly little known about what mediates these changes in cell/cell 
interactions. 
  
1.4.2.2. Neurofibromatosis Type II 
In contrast to NF1, NF2 is a disease that is characterised by the development of 
benign bilateral Schwannomas and meningiomas, and has a lower incidence of 
approximately 1 in 25,000 (Petrilli and Fernandez-Valle, 2016). NF2 results in 
manifestations both in the CNS and the PNS, which include bilateral vestibular 
schwannomas, peripheral nerve schwannomas, spinal tumours, cranial meningiomas 
and ocular abnormalities (Ferner, 2007). NF2 results from mutations or the loss of 
heterozygosity of the NF2 gene. In Schwannomas loss-of-function or deletion of NF2 
results from the heterozygous loss of the NF2 gene in Schwann cells, with tumours 
resulting through the loss of the two alleles, causing benign tumours that are 
exclusively composed of Schwann cells.  
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The NF2 gene encodes for Merlin, a protein structurally related to the ERM 
proteins ezrin, moesin and radixin, which link the actin cytoskeleton to the cell 
surface (Li et al., 2012). Consistent with the function of ERM proteins, Merlin’s 
activity is dependent on localisation at the cell surface (Shaw et al., 1998). Merlin 
plays a major role in cell-cell recognition, as it has been shown suppress mitogenic 
signalling in a cell density-dependent manner. Merlin has been shown to mediate 
contact inhibition of proliferation (CIP), downstream of the cell-cell cell/substrate 
adhesion receptor CD44, and can localise at the membrane where it is able to bind to 
adherence junction complexes (Morrison et al., 2001; Morrison et al., 2007). 
However, Merlin affects multiple pathways including cell adhesion, integrin signalling, 
ErbB2/ErbB3, Rac signalling, mTOR, pI3K/akt, Wnt signalling and the Hippo 
pathway, to regulate cell survival, proliferation and contact inhibition of cell growth 
(Petrilli and Fernandez-Valle, 2016).  
Thus, loss of cell/cell interactions between Schwann cells appears to play a 
critical role in the development of Schwann cell derived tumours associated with NF1 
and NF2. As discussed in the preceding sections, CIL prevents intermingling of 
different cell populations and can be lost during tumourigenesis, thereby contributing 
to the development and spreading of the tumour. However, whether CIL is lost in 
Schwann cells in NF1 and NF2, and how this attributes to the development of 
tumours is unknown.  
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1.5. Thesis Aims 
In the previous sections, I described the importance of heterotypic and homotypic 
interactions in maintaining the healthy and organised structure of peripheral nerves, 
as well as during cellular movements triggered upon injury of the nerve, and how 
(loss of) these interactions can contribute to the tumourigenesis associated with NF1 
and NF2. I also discussed the importance of Schwann cell migration both during 
development, as well as during the regenerative process, and the role of homotypic 
and heterotypic interactions of Schwann cells. Schwann cells normally undergo CIL 
in vitro, and recent reports showed that CIL is required for cell dispersal and 
collective migration of certain cell types in vivo, suggesting CIL may play a role in 
mediating the collective migration of Schwann cells. However, how CIL is mediated in 
Schwann cells remains unknown. I further discussed how N-cad, a well known 
cell/cell recognition molecule, plays an important role during the collective migration 
of Schwann cells by maintaining a cluster, and has been shown to regulate CIL in 
neural crest cells. However, whether N-cad is required for CIL in Schwann cells, and 
how N-cadherin can mediate these opposing behaviours remains unclear.  
Moreover, I described the importance of the migrating Schwann cells with the 
vasculature, required for the directionality of the migrating cells during the 
regenerative process. However, what mediates the Schwann cell/blood vessel 
interactions, to mediate Schwann cell migration along the vasculature is unknown. 
The principle aim of this thesis was to understand the mechanism by which 
homotypic CIL in Schwann cells is mediated and if CIL is lost during the tumourigenic 
processes associated with NF1. We also wished to understand what mediates the 
heterotypic interactions needed for the efficient migration of Schwann cells along 
blood vessels.  
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Chapter Two: Materials and Methods 
 
2.1. Materials 
2.1.1. Chemicals 
All chemicals unless stated otherwise were bought from Sigma. Inhibitors were 
bought from: Erk inhibitor PD184352 (0.75μM Axon), Fyn inhibitor SU6656 (250nM, 
Santa Cruz). 
 
2.1.2. Constructs and oligos 
Constructs 
N-cadherin full length, the extracellular and intracellular domain of N-cadherin tagged 
with ptdTomato on the C-terminus and inserted into a GFP-N1 expression plasmid, in 
which the GFP was replaced by the dtTomato, were a kind gift from Prof. S. Yamada 
at the University of California (Shih and Yamada, 2012). 
Retroviral constructs 
The Raf-ER and dominant negative form of p53 (human p53175 cDNA) construct were 
in pLXSN retroviral plasmid. H-RasV12 was in pBabe retroviral plasmid. 
 
siRNA oligos 
Double stranded RNA oligos were designed and supplied by Qiagen, scrambled 
siRNA was used a control. Refer to table 2.1 for target sequence and concentration 
used for each oligo. 
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Table 2.1 siRNA oligos 
Gene  Target sequence Concentration  
αE-catenin siRNA 1 AAGAACGCCTGGAAAGCATAA 4nM 
αE-catenin siRNA 2 CAACCGGGACTTGATATACAA 4nM 
β1-integrin siRNA 1 ACAGCTGATTATCGATGCCTA 5nM 
β1-integrin siRNA 2 CAAATTGTGGGTGGTGTACAA 5nM 
Cadherin  2 siRNA 1 TCCCAACATGTTTACAATCAA 1*-2nM 
Cadherin  2 siRNA 2 CAGTATACGTTAATAATTCAA 1*-2nM 
EphB2 siRNA1 CTGGGTGGCCGCGTCATGAA 3nM 
p120-catenin siRNA 1 AGGTCAGATCGTGGAAACCTA 2.5nM 
p120-catenin siRNA 2 ATGCTCGGAACAACAAAGAGTTAA 2.5nM 
Talin 1 siRNA1 CTGAGCGTCGTACAGAATCTA 3nM 
Talin 1 siRNA2 CTGGTCGCTTGCAAGGTCAAA 3nM 
Talin 2 siRNA1 ACCGGGCAAGCTTCTGACTAT 5nM 
Talin 2 siRNA2 ACCGGGCAAGCTTCTGACTAT 5nM 
Glypican-4 siRNA1 CCGACTGGTTACTGATGTCAA 2.5nM 
Glypican-4 siRNA2 CGGTGTAGTTACAGAACTGTA 2.5nM 
* 1nM was used for rescue experiments. 2nM was used for all other experiments. 
 
qPCR Primers 
Primers were designed using Pimer3 tool to specifically target the mRNA by 
annealing to sequences in two exons that are flanking one or more intron(s). Refer to 
table 2.1 for the sequence. 
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Table 2.2 Rt-qPCR primers  
Gene Forward primer (5'-3') Reverse primer (5'-3') 
EphA1 ACACCCCTGTACATGTACCA GCTTCCTCTCCTCGGTAGAT 
EphA2 GTTTACCACCGAGATCCACC TTCAGCGTCTTGATAGCCAC 
EphA3 CACCAACATAGCCATCGACA GATGTTGGGGTGGTCAAACT 
EphA4  CACCATCATCCATTGCTTTG  AAAGGGTTCAGGCCTTTGAT  
EphA5 CACAGAGACCTTGCTGCTAG TTGCCTCCCCTTGTGGTATA 
EphA6 CCACCTTCTATGGCGTGTAC ATGAATCGAAGTCCTGCACC 
EphA7 CAACGGAGTCATCACGGAAT TTAATGGAGGCTGAGGTGGA 
EphA8 GCATGGTGCTTCACATGAAC TGGGACCTCATTGTCTGGAT 
EphB1 TTCAGCATTACAGCACAGGC CAATCGGCCCTTGTACACTT  
EphB2  CAACTGGCTACGGACCAAAT  TCTCCATCCAGTTGGGAAAG  
EphB3  TCGCACAGTAGCAGGTTACG  GCAGACAAGAGCAATGACCA  
EphB4  CATCAAGGTGGACACAGTGG   AAAGAGATGCAAGGAGAGCA 
EphB6  TCCTTCACCA TGACCAGTGA AACCAA TCACCAAGGACAGC 
Ephrin-A1 GAAGGTGACTGTCAATGGCA TGACCAATGCTGTGCAAAAC 
Ephrin-A2 CTTTTCCCTGGGCTTTGAGT TGGACGCACGTAAACTTTCA 
Ephrin-A3 TGGGCTATGAATTCCATGCC AGCAGACGAACACCTTCATC 
Ephrin-A4 GAGACTCCAGGTGTCTGTCT GCAGAAGACGGAGTATTGGG 
Ephrin-A5 GCTGCTCTTTCTGGTGCTCT  GTGGTAGTCACCCCTCTTGGA 
Ephrin-B1 GGAAATCCGCTTTACCATCA  CGTTACGGCATTTGGATCTT 
Ephrin-B2 TCCCTTTGTGAAGCCAAATC  GTCTCCTGCGGTACTTGAGC 
Ephrin-B3 CTGGTGTCTGGACTCAGCCT  AACTTAGGAGAGGAGTGGGGG 
B2M TGACCGTGATCTTTCTGGTG ATTTGAGGTGGGTGGAACTG 
Glypican-4 CATGCTGATGGTGGCAGAGA TCCACAGCCTTGGAAAACCT 
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2.1.3. Buffers 
Table 2.3 western blot and Co-IP buffers  
Solutions Components 
RIPA lysis buffer*  1% Triton X-100, 0.5% sodium deoxycholate, 50mM Tris pH7.5, 
100mM NaCl, 1mM EGTA pH8, 20mM NaF, 100μg/ml PMSF, 
15μg/ml aprotonin, 1mM Na3VO4. 
NP40 buffer* 50mM Tris pH 7.5, 150mM NaCl, 1% NP40. 
s100 buffer** 20mM Tris, 150mM NaCl, 2.5mM EDTA, 1mM EGTA PH 7.5.  
4x Sample buffer  200mM Tris pH 6.8, 8% SDS (BioRad), 40% glycerol, 400mM DTT, 
0.25% bromophenol blue.  
10x Running buffer  50mM Tris pH, 500mM Glycine, 0.1% SDS. 
10x Transfer buffer  200mM Tris, 1.5M Glycine, 20% methanol. 
5% milk/ TBS-T. Skimmed milk powder in 1X TBS-T. 
Stripping buffer 200mM Glycine, pH2.5, 0.4% SDS.  
20X TBS  200mM Tris base pH8, 3M NaCl. 
20X TBS-T 200mM Tris base pH8, 3M NaCl 0.02% Tween-20. 
* Add fresh 1/100 protease cocktail inhibitor mix. 
** Add fresh 1/100 protease cocktail inhibitor mix 1/200 phosphatase inhibitor cocktail 
mix 2, 0.5mM PMSF and 1mM DTT. 
 
2.1.4. Antibodies 
Primary antibodies were used against: N-cadherin (BD transduction); Alpha-catenin 
(Sigma); β-catenin (BD transductions); p120-catenin (BD Transduction); ERK1/2 
(Sigma), mCherry (BioLegend); AKT 1/2/3 (Santa Cruz); β1-integrin (Abcam); Talin 
(Sigma); Alexa-Fluor secondary antibodies were obtained from Invitrogen. 
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Horseradish peroxidase (HRP)-linked antibodies were obtained from GE-healthcare.  
Table 2.4. Immunofluorescence antibodies 
  Antibody Dilution Species Secondary 
N-cadherin 610920 1:1,000 Mouse 1:1,000 
α-catenin C2081 1:1,000 Rabbit 1:1,000 
β-catenin 610153 1:2,000 Mouse 1:1,000 
p120-catenin 61034 1:2,000 Mouse 1:1,000 
Talin T3287 1:500 Mouse 1:1,000 
alexa fluor phalloidin A22283 1:1,000 N/A N/A 
Hoechst   1:1,000 N/A N/A 
 
Table 2.5. Western blot antibodies 
  
% 
acrylamide 
gel 
Antibody Dilution Species Secondary 
ERK1/2 7.5 M5670 1:5,000 Rabbit 1:5,000 
AKT 1/2/3 7.5 H-136 1:2,000 Rabbit 1:5,000 
N-cadherin 7.5 610920 1:10,000 Mouse 1:5,000 
mCherry 7.5 677702 1:1,000 Mouse 1:5,000 
α-catenin 7.5 C2081 1:1,000 Rabbit 1:5,000 
β-catenin 7.5 610153 1:2,000 Mouse 1:5,000 
β1-integrin 7.5 ab52971 1:500 Rabbit 1:5,000 
p120-catenin 7.5 61034 1:500 Mouse 1:5,000 
 
2.1.5. Cell culture 
2.1.5.1. Preparation tissue culture dishes 
For culturing Primary rat Schwann cells, dishes were coated with 80μg/mL poly L-
lysine hydrobromide (PLL) for 20 min at room temperature, washed twice with water 
(Baxter) and dried over night.  
 Cell migration assays and experiments performed on glass coverslips required 
double coating with PLL and laminin. To double coat, the plastic tissue culture dishes 
and glass coverslips were first coated with PLL as described above followed by 
incubating them with 0.01mg/mL laminin in MEM for 1 hour at room temperature and 
aspirated just before seeding the cells.  
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2.1.5.2. Schwann Cells 
Primary rat Schwann cells were extracted from sciatic nerves of postnatal 7 days 
Sprague-Dawley rats. Sciatic nerves were dissected from 10 rats, chopped with a 
scalpel and forceps, re-suspended in digestion buffer (EBSS, 7900 U/mL DNase 
Type IV, 2mg/mL collagenase, 2.5% Trypsin) and agitated 5 times using a 1 mL 
Gilson, before incubating for 15 min at 37C in the water bath to digest the tissue. 
Subsequently the sample was mixed again using 1 mL Gilson, before stopping the 
trypsin reaction using 900 μL of FCS (10%). The cells were centrifuged for 5 min at 
264g, resuspended.in 4 mL panning buffer (0.1%BSA (Invitrogen), L15 medium 
(Gibco)) and filtered using a 40μm strainer (Falcon). Panning of the cells was 
performed by adding the cells to two bacterial dishes coated with CD11b/c (Harlan 
sera Lab mouse anti-rat (MAS 370p clone Ox42) and incubated for 10 min at room 
temperature to filter out the macrophages. Subsequently, the supernatant is 
incubated on two bacterial plates coated with Thy1 antibody (clone Ox7, home made) 
for 10 min at room temperature, to pan out the fibroblasts. These two panning steps 
were performed 3 times, before adding 0.5% BSA to the cells and collecting them by 
spinning for 5 min at 264g. The pellet containing Schwann cells, were subsequently 
re-suspended in low culture DMEM (Lonza) supplemented with 3% FBS, 1 μM 
Forskolin (Abcam), 200mM L-Glutamine (Gibco), GGF, 100μg/mL kanamycin (Gibco) 
and 800μg/mL gentamicin (Gibco). Schwann cells were seeded on to PLL-coated 
and laminin-coated dishes until 3 passages, upon which the cells were cultured on 
PLL-coated plates. Schwann cells were maintained in 10% CO2 and 20% humidity at 
37ºC. Cells were seeded at 5x105 or 1.5x106 per 10cm or 15cm culture plates 
respectively, the medium was replaced the next day and after this every two days 
until confluent.  
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2.1.5.3. Raf-ER cells  
Raf-ER inducible Schwann cells (NR-SC) were produced using retroviral infection 
(see below). NR-SCs were cultured in normal Schwann cell medium without phenol 
red, which has been shown to activate the estrogen receptor. To activate NR, 0.1 μM 
tamoxifen (TMX) dissolved in ethanol (EtOH) was added to the culture for 24, 36 or 
48 hours, ethanol was used as a control solvent. 
 
2.1.5.4. DNp53-Ras cells 
Schwann cells expressing DNp53 and Schwann cells expressing oncogenic Ras (H-
RasV12) (DNp53-Ras) were produced using retroviral infection as described below. 
DNp53 and DNp53-Ras were cultured in the same conditions as normal Schwann 
cells, but were seeded at 3 x105 cells per 10cm dish. 
 
2.1.6. Fibroblasts 
Fibroblasts were collected from the sciatic nerves of 7 days old rats with the 
immunopanning (plates coated with Thy1 antibody) as described above. Upon 
harvesting of the Schwann cells, Fibroblast medium (DMEM containing 10% FBS, 
200mM L-Glutamine, 100μg/mL kanamycin (Gibco) and 800μg/mL gentamicin 
(Gibco)) was added to the plates, and cells were grown to confluency before 
passaging on tissue culture dishes. The cells were cultured in 3% O2, 10% CO2 and 
95% humidity at 37ºC. 
 
2.1.7. HUVECS 
Human umbilical vain endothelial cells (HUVECs) were cultured on gelatin coated 
plastic culture dishes in endothelial cell growth medium-2 (ECGM2, PromoCell) 
containing 100μg/mL kanamycin and 800μg/mL gentamicin (Gibco) in 5% CO2 and 
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20% humidity at 37ºC. Dishes were coated with EmbryoMax 0.1% Gelatin Solution 
(EMD Millipore) for 10 min at 37ºC. 
 
2.1.8. Retroviral infection 
Phoenix ecotrophic retroviral producer cell line were cultured in phoenix 
DMEM containing 10% FBS, 200mM L-Glutamine, 100μg/mL kanamycin 
(Gibco) and 800μg/mL gentamicin (Gibco). Cells were passed through an 18G 
needle to dissociate cells and seeded in a 10 cm culture dish at 5x106. The 
next day the medium was replaced with 4mL of phoenix medium and the cells 
were transiently transfected by dropping on 1860 μL of lipid complexes 
containing the retroviral constructs, and incubating for 4 hours at 37C, before 
replacing the complexes with 6mL of Schwann cell media for 24 hours, to 
concentrate the virus. Subsequently the media was collected and filtered 
through a 0.45μm filter to remove cells and cell debris, before adding 
polybrene (8 μg/mL), which stimulates the infection by the virus into the 
Schwann cells. Schwann cells, which were seeded the previous day at 5x106, 
were incubated with the virus for 2 hours at 37C, to infect the cells with the 
construct, before washing the cells with media and replacing it with 10mL of 
Schwann cell media to let the cells recover. This procedure of collecting the 
virus and infecting the Schwann cells was repeated three times over three 
days, before antibiotic selection of the infected Schwann cells using 
Puromycine (0.5μg/mL) for the pBabe construct, G418 0.4 mg/ml for the 
LXSN constructs. pBird-GFP control vector, which lack antibiotic selection, 
was used to asses the transfection efficiency and as a control for the efficacy 
of the antibiotic-selection of infected cells. For infection of both DNp53 and 
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Rasv12 the cells were infected with DNp53 and the infected cells were 
subsequently infected using the retroviral construct LXSN expressing the H-
Ras-12 construct or the empty LXSN.  
 Formation of complexes: 6.2 μg retroviral construct, was premixed with 15 
μL Attractene reagent (Qiagen) in 1860 μL DMEM and incubated for 15 min at 
room temperature, before adding to the cells drop by drop. 
 
2.2. Methods 
2.2.1. Cell Assays 
2.2.1.1. Dorsal root ganglion neurons (DRG) preparation and co-cultures 
DRGs were obtained from the vertebrae of postnatal day 0/1 Sprague Dawley rats. In 
brief the vertebrae was openen antero-posteriorly using surgical scissors, and 
subsequently the spinal cord was removed to expose the DRG capsules. DRGs were 
extracted using forceps, transferred into icecold L-15 media, and contaminating 
tissue was removed. DRG capsules were then explanted into the centre of PLL- and 
laminin-coated 12 well plates or glass coverslips in 4-well plates. DRG explants were 
incubated at 37C, 95% humidity and 5% CO2 in basal media (F-12 DMEM without 
phenol red, 100ng/mL, 20μg/mL, 100μg/mL transferrin, 100μg/mL BSA Fraction V, 
60ng/mL progesterone, 16μg/mL putrescine, 40ng/mL selenium, 50ng/mL thyroxine, 
50ng/mL tri-Iodo-thyrine). To remove all endogenous mitotic Schwann cells and 
fibroblasts, after 18 hours the media was supplemented with 10M S-phase inhibiter 
β-cytosine-D-arabinofuranoside (AraC). The media was replaced with basal media 
after 24 hours to remove all dead cells, and was continued to be replaced every two 
days upto 5-6 days until the DRG were used. 
 For the association assays Schwann cells were seeded onto 5/6 days old DRG on 
coverslips (1.5x104 cells) and fixed and stained for immunofluorescence after 8 hours 
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or seeded onto 12 well plates (2x104 cells) and imaged for 20 hours using time lapse 
microscopy. Schwann cells infected with Val12 mutant H-Ras or empty vector were 
produced as described previously and seeded onto DRGs 24 hours after infection. 
Scrambled or N-cad siRNA treated Schwann cells were seeded 48 hours post 
transfection. 
 
2.2.1.2. siRNA transfection 
For siRNA transfection 105 cells or 2x105 Schwann cells were seeded per 6 well plate 
or 60mm dish respectively. The next day, medium was replaced prior to transfection 
with fresh 2.3mL or 4.6mL medium per well or dish respectively. siRNA or scrambled 
siRNA were mixed in plain DMEM completed to 100μL before adding 6μL Hiperfect 
(Qiagen) mixed by tapping and incubated for 10 min at room temperature to allow 
complexes to form. For 60mm dishes, the siRNA’s were mixed in a total volume of 
200μL DMEM and 12μL Hiperfect was added. Cells were incubated with the 
complexes for 16 hours and washed once with normal Schwann cell medium.  Cells 
were then further maintained in at 37ºC before either harvesting or seeding for further 
experiments. Knockdown efficiency was determined using western blot analysis, 
Real-Time PCR (RT-qPCR) or immunofluorescence. See table 2.1 for target 
sequence and concentrations used.  
 
2.2.1.3. DNA transfection 
DNA was transfected using Attractene protocol (Qiagen). Briefly 2x105 Schwann cells 
were seeded onto 60mm plate 24 hours prior to transfection. 250ng plasmid of 
interest and 2.25μg carrier vector DNA was incubated with 3.7μL Attractene for 15 
min at room temperature to allow complexes to form. Complexes were then added 
onto the Schwann cells drop by drop and were incubated for 2 hours at 37ºC. pBird 
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was used as control for transfection efficiency.  
 
2.2.1.4. Cell rounding assay 
Schwann cells were seeded at 4x103 onto laminin-coated coverslips. The next day, 
Schwann cells were serum starved and grown in defined media, which contains no 
factors (SATO) (DMEM containing: BSA 100μg/mL, progesterone 60ng/mL, 
Putrescine 800 μg/mL, selenium 2μg/mL, Thyroxine 2.5μg/mL, Triiodothyrine 
50ng/mL). To do this, cells were washed twice quickly and once for 10 min with 
SATO to remove all factors and medium was then replaced with 300μL SATO 
supplemented with IGF (0.1μg/mL) and transferrin (100μg/mL). 18 hours later the 
Ephrin-A1-FC ligands (R&D Systems, 602-A1-200) or Ephrin-A4 FC ligands (R&D 
Systems 569-a4-200) were clustered by premixing ligand 1μg/mL final concentration 
with 10μg/mL affinipure goat anti human IgG (Stratech, Jackson ImmunoResearch, 
109-005-008) (2:1 ligand:Fc ratio) in 100μL PBS. Clusters were allowed to form for 
30 minutes at 37°C, dropped onto Schwann cells and incubated for 20 min at 37°C. 
This was followed by PFA fixation, immunolabeling for Fc and co-staining with 
phalloidin to stain the actin cytoskeleton to visualise the cells morphology. 
 Cell rounding was measured using Fiji, by measuring the length and the width of 
the cells and the cell-rounding index was obtained by dividing the shortest 
measurement through the longest.  
 
2.2.1.5. Repulsion assays 
For repulsion assays 8x103 or 4x103 Schwann cells were seeded onto PLL and 
laminin coated 6 well plates or 12 well plates respectively. Cells were allowed to 
adhere for at least 6 to 18 hours hours before starting the time-lapse microscopy. For 
knockdown experiments cells were seeded either 24 hours, 36 hours, or 69 hours 
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post transfection for N-cad and glypican-4, α-catenin, and p120-catenin siRNA 
respectively. 
 To analyse interactions between scrambled and N-cad knockdown cells, cells were 
treated with 1μM Cell Tracker Red CMTPX Dye or Green CMFDA dye (Invitrogen) 
respectively for 30 min at 37°C and washed once with 3% medium. Subsequently, 1 
hour after treatment 4 x103 scrambled treated cells were mixed with 4 x103 N-cad 
knockdown cells, incubated for at least 16 hours before starting live-imaging using 
time-lapse microscopy.  
 To analyse the effects of oncogenic Ras on CIL, DNp53 and DNp53-Ras cells 
were cultured for 18 hours either in the presence of the inhibitor PD184352 (0.75 μM) 
or DMSO. Cells were then seeded at 3 x103 onto PLL and laminin coated 12 well 
plates in medium containing PD184352 or DMSO. For time-point analysis DNp53 
and DNp53-Ras were imaged for 6 hours before adding the inhibitor PD184352 and 
further imaged for 48 hours.  
 For Schwann cells and fibroblasts co-culture experiments, 2.5x103 cells fibroblasts 
and 3x103 Schwann cells were seeded on to laminin-coated dishes in 5:1 fibroblast 
medium to Schwann cells medium ratio.  
 
2.2.1.6. Repulsion quantification 
Volocity was used to quantify repulsion. Single cells that were not dividing or 
engrossed by debris were tracked until contact with another cell and the initial 
response upon contact was determined. Three types of events were defined: 
Repulsion, cells retract protrusions and change direction of migration; No-repulsion, 
interact for longer than five hours and don’t change direction of migration; Invasion, 
cell migrate on top of another cell with their protrusion and or cell bodies. To ensure a 
specific readout only single cell-cell interactions were quantified. Analysis was done 
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by eye and where possible blind, moreover some experiments were analysed by 
colleagues to avoid unconscious bias. 
 For the mixing experiments, the response of scrambled-treated cells, were 
quantified upon contact with N-cad knockdown cells and vice versa. Similarly, for the 
rescue experiments only the response of N-cad knockdown cells were quantified 
upon contact with a cell expressing, either GFP, the full length of N-cad, the 
extracellular domain of N-cad or the intracellular domain of N-cad.  
 
2.2.1.7. Rescue experiments  
Rescue experiments were performed in a two faceted protocol, first siRNA 
transfection was performed using 1nM of N-cad siRNA1 as described above, 
incubated overnight, and the complexes were removed in the morning and replaced 
with 2mL medium. The following day approximately 4-5 hours after removing siRNA 
complexes, DNA was transfected using Attractene protocol (Qiagen). Briefly, 575ng 
carrier vector, 25ng pBird were and 80ng plasmid DNA carrying either N-cad full 
length, the extracellular domain or the intracellular domain of N-cad were mixed in a 
total volume of 240 μL plain DMEM and incubated with 0.9μL Attractene for 15 min at 
room temperature to allow complexes to form. Complexes were dropped onto 
scrambled-treated or N-cad knockdown cells and were incubated for 2 hours at 37ºC. 
pBird was used as control for transfection efficiency. The following day cells were 
seeded for repulsion assays, or 15x103 cells per 4 well plate were seeded for 
immunofluorescence. Time-lapse was started approximately 6 hours after seeding 
and were imaged for 24 hours. For immunofluorescence the cells were fixed and 
stained 18 hours after seeding. Alternatively, cells were harvested for western 
blotting at 48 hours after knockdown. 
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2.2.1.8. Matrigel assays 
HUVECs tubules were formed by coating 150μL matrigel (Cornig) onto 24 well plates 
on ice, which was subsequently allowed to polymerise at 37ºC for 30 min before 
seeding 2.5x104 HUVECS in normal HUVEC media. Tubules were allowed to form for 
14 hours when 5x103 GFP-labelled Schwann cells treated with either scrambled or 
siRNA targeting Talin or β1-integrin were seeded onto the tubules and immediately 
live-imaged using time-lapse microscopy. Schwann cells were seeded in HUVEC 
media supplemented with 20μg/mL recombinant human neuregulin1-β1 (NRGI) 
(R&D systems) to allow the Schwann cells to migrate. β1-integrin knockdown cell or 
Talin 1 and 2 knockdown cells were seeded 36 hours and 60 hours after knockdown 
respectively and were imaged for 24 hours. 
 
2.2.1.9. 2D migration assays  
For the 2D migration assays, scrambled or siRNA treated (Refer to table 2.1 for 
concentration) cells were seeded at low density (8x103) on PLL and laminin-coated 
dishes and allowed to adhere for approximately 18 hours. Cells were imaged for with 
time-lapse microscopy for 24 hours. β1-integrin knockdown cell or Talin 1 and 2 
knockdown cells were then imaged 36 hours and 60 hours after knockdown 
respectively. 
 
2.2.1.10. Scratch assay 
For the scratch assays cells were seeded for a siRNA knockdown at 1x105, cells, and 
the siRNA transfection was performed as described above (Refer to table 2.1 for 
concentration), and the cells were grown to confluence. At 48 hours after treatment a 
scratch was induced with a sterile tip. The cells were gently washed twice with 
medium to remove any debris and imaged using time-lapse microscopy for 24 hours. 
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Cells at the leading edge were imaged. 
 
2.2.1.11. Cell tracking 
Cells were tracked by their nucleus using velocity for 8 - 12 hours, except for dividing 
cells. Velocity and the directionality were then measured from these tracks using 
macro plugin in excel as described in (Gorelik and Gautreau, 2014). 
 
2.2.2. Microscopy 
2.2.2.1. Time Lapse Microscopy 
Life-imaging was performed at 10x or 20x using a Zeiss Axiovert 200M microscope 
equipped with a Hamamatsu Orca AG camera controlled by Volocity software 
(Improvision) and an environmental chamber which maintained the temperature at 
37ºC and provided a humidified stream of 5% or 10% CO2 in air. Images were taken 
every 10 minutes for 24 or 48 hours 72 hours. 
 
2.2.2.2. Immunofluorescence  
Cells grown on glass coverslips were fixed in 4% paraformaldehyde (PFA) for 10 
minutes at room temperature, permeabilised with 0.3% Triton in PBS for 10 minutes 
at room temperature and blocked with 3% Bovine serum albumin (BSA) in PBS for 1 
hour at room temperature. Coverslips were incubated with primary antibodies (Refer 
to table 2.4 for dilutions) overnight at 4ºC, washed with PBS, incubated with 
secondary antibodies conjugated to Alexa Fluor (Refer to table 2.4 for dilution) for 
one hour at room temperature and washed with PBS before mounting onto 
microscope slides using fluoromount-g (Southern Biotech). All solutions, except 
fluoromount-g, were supplemented with 1mM CaCl2 and 0.5mM MgCl2 to prevent 
disruption of the Ca dependent complexes such as N-cadherin and the cytoskeleton. 
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2.1.1.1. Confocal microscopy 
All images were acquired using an inverted Leica TCS SPE confocal microscope. For 
each experiment the same volume, number of Z-stack and the same setting of 
acquisition were used. All image processing and analysis was done using FIJI 
software. For each image, a projection of the z-stacks was made using Fiji software 
using the maximal intensity.  
 
2.2.3. Protein Analysis 
2.2.3.1. Protein extraction and quantification  
For protein extraction cell media was aspirated from cells which were then washed 
on ice with PBS, followed by snapfreezing at -80ºC to break membranes and 
harvested in 100-150μL RIPA buffer (see table 2.3). Cells were then lysed on ice for 
30 minutes, vortexed every 10 minutes and homogenised using a 26 gauge needle 
(Beckton Dickinson). Cell debris were pelleted by spinning down at 750g for 5 min at 
4ºC, the supernatant was collected and quantified using BCA assay (Pierce, Thermo 
Scientific). 
 
2.2.3.2. Western Blotting  
Western blotting was performed using Hoefer Scientific Instrument apparatus or 
Biorad western blot running kit. 20 to 30μg of proteins were resolved using a Sodium 
Dodecyl Sulfate - polyacrylamide gel electrophoresis (SDS-PAGE). As a size 
reference 5μL of PageRuler Plus Prestained Protein Ladder (Thermo Scientific) was 
loaded. Protein was transferred onto nitrocellulose membrane (Millipore-Immobilon), 
which was then blocked for one hour at room temperature using 5% milk-TBST. The 
membrane was incubated with primary antibodies (refer to table 2.5 for dilutions) 
overnight at 4ºC, washed 3 times for 5 minutes at room temperature with TBST, 
followed by incubation with a secondary antibody conjugated to Horseradish 
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peroxidase (HRP) (refer to table 2.5 for dilutions). Subsequently, membranes were 
washed three times for 10 minutes at room temperature before chemiluminescence 
detecting using Pierce-ECL western blot substrate (Thermo Scientific) or Luminata 
Crescendo Western HRP substrate (EMD-Millipore). Refer to table 2.3 buffer 
composition. 
 
2.2.3.3. Co-immunoprecipitation (Co-IP) 
NR-SCs were seeded at 1.2x106 onto 15cm dishes in duplicate. EtOH or TMX was 
added the following day and incubated for 36 hours before harvesting. Medium was 
aspirated and cells were once washed with 10mL PBS. Cells were scraped in 
approximately 360μL NP40 buffer, lysed on ice for 30 minutes and membranes were 
broken using a 23G needle. Debris was pelleted, by centrifuging at 750g for 5 min at 
4ºC and the supernatant was collected into a fresh tube. Protein concentration was 
then quantified using BCA assay. All subsequent steps were performed at 4ºC. 
Approximately 300μg (1mg for mass spectrometry) protein was pre-cleared using 
10μL of 50% protein G Beads (GE healthcare) (20μL for mass spectrometry 
analysis) by rotating for 15 minutes. Beads were collected and discarded by 
centrifuging at 750g for 1 minute. Pre-cleared supernatant was incubated with 
primary antibodies targeting N-cad (1ug for normal Co-IP or 2ug for mass 
spectrometry) for 2 hours by rotating. The antibody-protein complexes were pulled 
down by rotating the mixture with 20μL of 50% Protein G beads (40 μL for mass 
spectrometry) slurry for 1 hour. Beads were washed 4 times with 500μL NP40 buffer 
by rotating for 5 minutes and were collected by centrifuging at 750g for 1 minute and 
transferred to a clean tube. Finally, the beads were resuspended in 30 μL of 2x 
Leamlli buffer and boiled for 10 minutes at 95C. Refer to table 2.3 buffer composition. 
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2.2.4. Molecular biology 
2.2.4.1. RNA extraction and cDNA synthesis 
RNA extraction was performed using Tri-Reagent according to manufactures 
protocol. RNA concentration was determined using Nanodrop and 500-1000ng of 
RNA was used to synthesize complementary DNA using Superscript II kit 
(Invitrogen). Briefly, RNA was incubated with 0.25μM random hexamers and 0.5μM 
dNTP’s for 5 minutes at 65ºC. Subsequently, the mixture was quickly cooled on ice 
before further incubation with 40U RNaseOUT, 0.02M DTT and 1x first strand buffer 
for 2 min at 25ºC. Superscript II was added at 20U/μL for an initial incubation for 10 
minutes at 25ºC, followed by incubating for 50 minutes at 42ºC and the enzyme 
inactivated by incubating for 20 minutes at 70ºC. 
 
2.2.4.2. RT-qPCR 
For RT-qPCR the MESA Blue qPCR MasterMix Plus kit was used (Eurogentec). For 
each gene MESA Blue was mixed with 100nM forward and reverse primers (refer to 
table 2.2), 23uL was pipetted in to a 96 well. 2μL of template cDNA was added to 
mix, ddH2O was used as a negative control.  
 
Cycle parameters: 
MeteorTaq activation 5 min 95 º  
Amplification (40 cycles): 
Denaturation 15 min  95 ºC 
Annealing/extension  1 min  58 ºC  
Dissociation curve 60-98ºC 
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2.2.5. Cloning 
2.2.5.1. Mutagenesis 
NEB Q5 Site-Directed Mutagenesis Kit (NEB) was used according to manufacturers 
protocol to introduce silent mutations in the N-cad siRNA1 targeting sequence (see 
table 2.1) in the constructs expressing either N-cad full length, or the extracellular 
domain of N-cad, to disrupt the annealing of N-cad siRNA to the constructs. This was 
achieved by introducing four silent mutations in the four codons of the target 
sequence. Primers were designed using the primer design software NEBaseChanger 
and synthesised by sigma:  
 
Forward primer  5’-CACGATAAACAATGAGACTGGGGACATC-3’ 
Reverse primer 5’-AACATATTGGGTGAAGGTGTGCTGGG-3’ 
 
Cycle parameters 
Initial denaturation   98ºC 
Amplification step (25 cycles): 
Denaturation    98ºC  30 sec 
Annealing    65ºC  10 sec 
Extension    72ºC    2 min 
Final extension   72ºC    2 min 
Hold        4ºC   
 
2.2.5.2. Transformation 
High efficiency 10-beta competent E.coli (NEB) were transformed using 5μL of PCR 
product, according to manufacturers protocol. Bacteria were then spread onto Agar 
plates consisting of Lysogeny-broth agar supplemented with 30μg/mL Kanamycin 
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(Gibco) and incubated overnight. Subsequently several colonies were picked and 
grown overnight for a DNA miniprep. 
 DNA was extracted from the bacteria using Zyppy prep (Zymo research) according 
to manufacturers protocol. DNA was then digested with restriction endonucleases 
XhoI (Promega) and NotI (Promega) in the appropriate buffer for 2 hours at 37°C to 
determine if the correct plasmid was obtained. The digested DNA, was resolved on 
0.8% agarose gel. The correct plasmids were sequenced at Eurofins MWG operon to 
determine if mutations were inserted. Subsequently, bacteria transformed with 
plasmids positive for the mutations were grown up for a maxiprep, and DNA was 
extracted using Endo Free maxi prep Kit (Qiagen). 
 
2.2.6. Mass spectrometry  
Similar conditions described for the Co-IP were used to prepare samples for 
qualitative Mass Spec analysis. One sample per condition was used for the Co-IP, 
and 1mg protein as input was used. The proteins were eluted from the beads using 
Laemli buffer. The proteins were then separated on a gel, extracted from the gel, 
digested with trypsin and analysed using the LTQ Orbitrap Velos Pro Mass-spec 
systems (Performed by Proteomics Facility, University of Dundee). The obtained data 
was analysed using the Mascot search engine using the Uniprot DB with Rat as the 
taxonomic filter (Performed by Proteomics Facility, University of Dundee).  
The obtained N-cad pull down lists were compared to the IgG control lists with 
http://www.cmbi.ru.nl/cdd/biovenn/ to filter for background proteins, which were 
removed. Alternatively, as p120-catenin and alpha-catenin were both identified in the 
IgG controls but were associated with a lower protein score than in the N-cad pull 
down lists. These scores range from 1-11,000, in which the higher the score the 
greater confidence that the protein ID is correct and a higher likelihood of a higher 
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abundance in the sample. The N-cad pull down lists were compared to the IgG 
controls, and all protein with a ≥2.5 fold increase in the N-cad pull down lists were 
included. Subsequently, the resulting protein lists from the control (EtOH) and TMX-
treated condition were compared to each other to determine which proteins were 
overlapping and which were specifically identified in each condition and were 
functionally classified and mapped for protein ID using http://pantherdb.org. 
 
2.2.7. Statistics 
Statistics were performed using GraphPad (Prism) software. For all repulsion assays 
grouped analysis was performed using unmatched two-way ANOVA to examine the 
effect of two (or more) independent factors on the response of the protrusions. To 
correct for multiple comparisons, the Sidak method was used, assuming that the 
comparisons are independent. Every (selected) mean were compared to every other 
mean, or in the case of the repulsion assay in the p120 catenin knockdown every 
mean to the control mean. 
 For all velocity analysis and the directionality ratio analysis, where the distribution 
was gaussian, the T-test was performed. In the cases where there was no gaussion 
distribution, the Mann-Whitney test was performed to compare two unmatched 
groups.  
 For the cells rounding analysis the non-parametric Kruskal-Wallis test was 
performed to compare three unmatched groups. 
 For all western quantifications and qPCR analysis one-way ANOVA was 
performed, except for the qPCR analysis of the expression levels of the Eph 
receptors and ligands in the NR-SCs, where the T-Test was performed. 
In all cases p *< 0.05, **<0.01, *** <0.001, n.s. = not significant. 
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Chapter Three: Results I 
Characterising the role of N-cad in contact inhibition of locomotion 
3.1. Chapter introduction  
In the adult peripheral nervous system, Schwann cells make both homotypic 
interactions as well as heterotypic interactions with the axons. These interactions are 
disrupted upon injury of the nerve when the axons degenerate and Schwann cells 
dedifferentiate and express a new array of surface molecules through which they 
establish new interactions with the surrounding cells in the environment. We have 
previously shown that Schwann cells in the bridge make heterotypic interactions with 
fibroblasts, which induces the cell sorting of Schwann cells into cellular cords 
(Parrinello et al., 2010). In vitro analysis of Schwann cell sorting showed that these 
interactions are mediated by ephrin-B to EphB2 signalling between the fibroblasts 
and Schwann cells, which induces a switch in Schwann cell behaviour from repulsive 
to attractive. This attractive homotypic interaction between Schwann cells is 
mediated by a Sox-2 dependent re-localisation of N-cad to the cell-cell junctions. 
Though we observed that Schwann cells normally undergo CIL in vitro, the 
mechanism by which this is regulated is unknown. Moreover, CIL has been shown to 
be important for directional migration and collective migration in vivo (Carmona-
Fontaine et al., 2008; Theveneau et al., 2010). This led to the hypothesis that CIL 
could be important for Schwann cells to migrate in vivo as a collective. Thus, it is 
important to understand the mechanism by which CIL between Schwann cells is 
regulated. 
 
3.2. Characterisation of Schwann cell-Schwann cell recognition 
To understand how Schwann cells recognise each other, Schwann cells were initially 
cultured in vitro and grown to confluence to observe their behaviour and to determine 
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if they form junctions. Schwann cells at low density are singular entities and distribute 
randomly but evenly in the dish. When grown to confluence, Schwann cells form a 
monolayer with wave-like patterns. Importantly, Schwann cells appear to form 
junctions between each other (Figure 3.1A). N-cad is an adhesion and cell-cell 
recognition molecule that can aggregate in adherence junctions (Brasch et al., 2012). 
Moreover, N-cad is expressed in Schwann cells during development and is re-
expressed upon injury in dedifferentiated Schwann cells (Parrinello et al., 2010; 
Wanner et al., 2006; Wanner and Wood, 2002). To test if N-cad mediates cell-cell 
recognition between Schwann cells in vitro, cells were treated either with scrambled, 
or two previously published (Parrinello et al., 2010) independent small interfering 
RNA (siRNA) oligos targeting N-cad for 48 hours and the knockdown was assessed 
using western blot analysis (Figure 3.1B). The efficacy of the knockdown was 
extremely efficient in cells treated with siRNA1 while siRNA2 was slightly less 
efficient but N-cad was still barely detectable compared to control (Figure 3.1B left). 
The knockdown efficiency was quantified, and showed that N-cad was 
downregulated in N-cad knockdown cells by greater than 90% by siRNA1 and 
greater than 85% for siRNA2 (Figure 3.1B right). Moreover, whereas in scrambled-
treated cells N-cad localised at the junctions between Schwann cells, in siRNA 
treated cells N-cad was not detectable at the junctions or within the cell body (Fig 
3.1C, arrows). In addition, the actin cytoskeleton was reorganised to a more cortical 
distribution upon N-cad knockdown, consistent with N-cad regulating the actin 
cytoskeleton, which is a classical feature of N-cad junctions (Fig 3.1C).  
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Figure 3.1. Loss of cell-cell recognition is mediated by a loss of N-cadherin. 
(A) Left: Representative western blot of 3 independent experiments showing N-cad 
protein levels in Schwann cells treated with either 2nM Scrambled (scr), siRNA1 (si1) 
or siRNA2 (si2) for 48 hours. Erk was used as a loading control. Right, quantification 
of N-cad protein expression levels normalised for Erk; Graph represents three 
experiments ± SEM. One-way ANOVA, Dunnett’s multiple comparison test was 
performed. (B) Representative phase contrast images of scr, siRNA1, siRNA2 and 
Schwann cells expressing dominant-negative p53 (DNp53) and oncogenic Ras 
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(DNp53-Ras-SC). Schwann cells expressing oncogenic Ras were obtained through 
retroviral infection of a Ras expressing construct in a dnp53 background to prevent 
exit from the cell cycle (Lloyd et al., 1997). Scale bar 100μm. (C) Representative 
confocal images of scrambled, siRNA1 or siRNA2 treated cells at 36 hours, 
immunostained to detect N-cad (green), F-actin (red) and the nuclei (blue). White 
arrows indicate the cell contacts. Scale bar 20 μM.  
 
Interestingly, the Schwann cells lost the ability to recognise each other to such an 
extent that they grew on top of each other, indicating a potential loss of cell-cell 
recognition (Figure 3.1A). The effect was stronger with siRNA1 compared to siRNA2, 
but this could be due to the differences in the knockdown efficiency. Interestingly, the 
loss of cell-cell recognition in N-cad knockdown cells was reminiscent how Schwann 
cells expressing oncogenic Ras grow on top of each other (Lloyd et al., 1997) (Figure 
3.1A). Ras is a known oncogene whose aberrant activity can result in loss of contact 
inhibition of proliferation and contact inhibition of locomotion (Abercrombie, 1979; 
Ridley et al., 1988), indicating that the loss of cell-cell recognition in N-cad 
knockdown cells could also result in loss of CIL.  
To determine the behaviour of N-cad knockdown cells in terms of CIL, an in 
vitro assay was established in which scrambled or siRNA treated Schwann cells were 
seeded at low density onto laminin-coated dishes and imaged for 24 hours using 
time-lapse microscopy. This allowed us to study the role of N-cad following single 
cell-cell interactions. Migrating control Schwann cells have broad lamellipodia in the 
direction of migration (Movie 3.1). Furthermore, Schwann cells are highly protrusive 
cells that randomly extend and retract many protrusions in different directions, even 
in the absence of other cells (Movie 3.1). Schwann cells can also be found interacting 
with each other through their protrusions. Importantly, Schwann cells retract their 
protrusions upon contact and this is usually followed by a change in their direction of 
migration, which are two features typical of CIL (Movie 3.1) (Abercrombie and 
Heaysman, 1954b). Thus, this indicated that Schwann cell-cell contact elicits a 
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repulsion response. Still images of a video show two migrating cells indicated by the 
blue and green dot colliding upon contact (arrowhead) followed by a change in the 
direction of migration (arrows) (Figure 3.2A). Interestingly, N-cad knockdown 
Schwann cells can be seen to have even more dynamic protrusions (Movie 3.1). 
However, strikingly, in contrast to scrambled treated cells, both cells treated with 
siRNA1 and siRNA2 failed to retract their protrusions upon contact and in many 
cases the cells migrated on top of the other cell (Movie3.1; Figure 3.2A arrow heads), 
suggesting that the normal repulsive behaviour is lost upon loss of N-cad.  
To quantify this behaviour, we looked at single cell-cell interactions and 
determined three different responses of the protrusions after the initial contact was 
made: Repulsion, Schwann cells retract their protrusions and change the direction of 
migration; No-repulsion, Schwann cells interact for longer than 5 hours, do not 
change their direction of migration, or do not migrate away following contact; 
Invasion, Schwann cells continue to migrate with their protrusions or cell bodies 
invading over each other. Using these parameters, as expected, we found that 
almost all scrambled-treated Schwann cells repulsed each other upon contact, while 
only a small proportion of the cells were invasive and almost no no-repulsion could 
be seen (Figure 3.2B; Movie 3.1). This is consistent with previously published results 
(Parrinello et al., 2010). In contrast, when N-cad was downregulated using either 
treated siRNA1 or siRNA2 there was a marked reduction in repulsion events, while 
there was a striking increase in invasion events, indicating that N-cad is required for 
CIL. Importantly, there was hardly any change seen in no-repulsion, suggesting that 
the repulsion signal inhibits forward migration. That the repulsion signal was not 
completely lost can partly be explained by the highly dynamic protrusions that are 
randomly extended and retracted by Schwann cells, even when they are not 
interacting with other cells, which leads to an overestimation of the repulsion events 
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(Figure 3.2A). Together, these results suggest that N-cad regulates CIL between 
Schwann cells by both mediating a repulsion response and blocking forward 
migration, which is consistent with confluent knockdown cells that are on top of each 
other as shown in earlier figure. These findings have parallels with previous studies 
showing N-cad is required for CIL in neural crest cells by inhibiting protrusion 
formation at sites of cell-cell contact (Tanaka et al., 2012; Theveneau et al., 2010).  
Contact dependent repulsion during CIL has been shown to be important to 
drive outward migration of fibroblasts, PC3 cells and neural crest cells during 
development (Batson et al., 2013; Carmona-Fontaine et al., 2008; Fritz et al., 2015; 
Theveneau et al., 2010). Thus, indicating that the dispersal of cells can be an 
indication of CIL. To test if N-cad can block the outward migration of Schwann cells, 
a scratch assay or wound healing assay was performed, by inducing a gap in 
confluent monolayers of cells of scrambled or N-cad siRNA1-treated cells with a tip 
and their behaviour was observed using time-lapse microscopy (Movie 3.2; and 
Figure 3.3). Scrambled-treated Schwann cells migrated efficiently into the gap when 
a scratch was induced, with only a few migrating away from the gap or to the side 
(Movie 3.2; Figure 3.3). This suggests Schwann cells collectively migrate forward into 
the gap. Moreover, when the cells collided upon closure of the gap, scrambled 
treated cells appeared to be repulsed in that they changed direction of migration. In 
contrast, Schwann cells treated with siRNA1 migrated in all directions in a more 
random fashion and many more cells migrated backwards and sideways compared 
to controls (Movie 3.2; Figure 3.3). Importantly, N-cad knockdown Schwann cells 
migrating into the gap did not migrate as far as control cells, which can be seen in the 
still images of the movie (Figure 3.3), suggesting migration is not as efficient and as 
directional due to the loss of the repulsive signal.  
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Figure 3.2. CIL is dependent on N-cad. 
(A) Representative time-lapse images of a CIL assay, showing scrambled or N-cad 
knockdown cells, treated with siRNA1 or siRNA2, that are repulsed or invading 
respectively (arrow heads). The blue and green dots indicate the two interacting 
cells. Arrows indicate the direction of migration. Scale bar 100μm. (B) Quantification 
of A, bar represents the mean of three independent experiments ± SEM in which 30 
cells per experiment were analysed. Related to movie 3.1. 
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Figure 3.3. Outward migration is dependent on N-cad. 
Representative still images from a time-lapse of a scratch assay of scrambled treated 
Schwann cells or N-cad knockdown Schwann cells treated with siRNA1. Dashed line 
indicates the leading edge of the migrating cells. Arrow indicates direction of the gap 
that was introduced with a pipette. Scale bar 100μm. Related to movie 3.2. 
 
To quantify this behaviour, cells were tracked using the nucleus for 12 hours 
and the directionality ratio index (which measures the shortest distance between start 
and end point divided by the length of the trajectory) was calculated. A representative 
graph of the tracks of scrambled cells from a single experiment shows, that most of 
the tracks were orientated towards the gap and that the direction of the tracks does 
not appear to change very often, though a few cells can be found migrating 
backwards towards the end of the track, which is possibly due to repulsion upon 
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migration. In contrast, there was a striking difference in the tracks of the N-cad 
knockdown cells, which were orientated in multiple directions and the tracks 
appeared to change directions more often, suggesting N-cad knockdown cells have 
lost their directionality (Figure 3.4A). To quantify this, the directionality ratio was 
calculated from the tracks of three experiments. A high directionality equals 1 and a 
low directionality equals 0. The vast majority of the scrambled-treated cells showed a 
high directionality ratio, with only a few cells showing a low directionality with an 
average of ±0.5, suggesting scrambled-treated cells migrate in a directional manner 
towards the gap (Figure 3.4B). In contrast, the directionality ratio of N-cad 
knockdown cells was completely shifted to a low directionality ratio, suggesting that 
N-cad and cell-cell repulsive signals are required for directional migration towards the 
gap (Figure 3.4B).  
Moreover, the loss of directionality following N-cad knockdown was not due to 
a decreased velocity, as N-cad knockdown cells appeared to migrate faster than 
scrambled-treated control cells (Movie 3.2). To quantify this, the velocity was 
calculated from the tracks, which showed that there was a marked increase in 
velocity following N-cad knockdown (Figure 3.4C). This suggests that the loss of 
directionality is not due to loss of migration speed. Moreover, similar to N-cad 
knockdown cells at low density, the N-cad knockdown cells in the scratch assay 
appeared to migrate on top of each other, indicating that the loss of directionally 
could be due to loss of CIL (Figure 3.2A, and 3.3; Movie 3.2). 
In addition, the loss of cell recognition is consistent with unpublished work 
performed by a former PhD student, who showed that N-cad knockdown cells 
maintained a high level of proliferation at high density (Wingfield-Digby et. al. 
unpublished thesis). Patrick Wingfield-Digby showed, that in N-cad knockdown cells 
there was a two-fold increase of proliferation at high-density compared to scrambled-
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control, while in low-density, N-cad knockdown had no effect on proliferation. Thus 
suggesting an additional role for N-cad in contact-dependent inhibition of Schwann 
cell proliferation, which is consistent with previous reports in which E-cad is required 
for CIP in epithelial cells (Perrais et al., 2007). Moreover, this suggests that N-cad 
links CIL and CIP at high density, but that additional signals are required to regulate 
CIP. 
Taken together, this data strongly indicate that N-cad is required for cell-cell 
recognition between Schwann cells and for homotypic CIL. 
 
3.3. CIL is independent of trans-homodimerisation 
Next we determined how N-cad regulates CIL. N-cad can transmit adhesive 
forces between neighbouring cells by forming homodimers through interactions in 
trans (Brasch et al., 2012). These homotypic junctions are required for collective 
migration in several cell types including neural crest cells, astrocytes and primordium 
on the zebra fish lateral line and are required for Schwann cell sorting (Parrinello et 
al., 2010; Peglion et al., 2014; Theveneau et al., 2010; Theveneau and Mayor, 
2012a). To understand if CIL requires trans-interactions between N-cad molecules, 
CIL between scrambled-treated cells and N-cad knockdown cells were analysed. To 
do this, scrambled-treated cells were mixed with siRNA1 treated cells and imaged 
using time-lapse microscopy to analyse their response to each other following 
contact. To distinguish the different cell populations scrambled and N-cad siRNA1-
treated cells were labelled with cytotracker red fluorescence or green fluorescence 
respectively. First, as a control, the response between two scrambled-treated cells 
was analysed (Movie 3.3; Figure 3.5). As expected, the two red-labelled scrambled-
treated cells (eg. S1 and eg. S2) repulsed each other upon contact (Movie 3.3; Figure 
3.5). Next, in the same movie, the response between two green-labelled N-cad 
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Figure 3.4. N-cad is required for Schwan cell directionality.  
(A) A representative graph of three independent experiments showing the trajectories 
of scrambled treated cells or N-cad knockdown cells treated with siRNA1. The arrow 
indicates where the gap was introduced. (N=30). (B) Quantification of the 
directionality ratio from the tracks in (A). Mean is indicated by the red line. A total of 
30 cells from three different experiments were quantified. Statistics: T-Test. (C) 
Quantification of the cell velocity using the tracks in (A). Mean is indicated by the red 
line. A total of 30 cells from three different experiments were quantified.  Statistics: 
Mann-Whitney test. 
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knockdown cells (N1 and N2) was analysed, which as expected, invaded each other 
(Movie 3.3; Figure 3.5). Subsequently, the response of a green-labelled knockdown 
cell (eg. S2) was analysed. Surprisingly, while the N-cad knockdown cell (eg. N2) 
invaded another N-cad knockdown cell (N1), it was repulsed upon subsequent 
contact with a scrambled-treated cell (S2). This suggests that N-cad is required to 
present a repulsion signal and induce repulsion, but is not required for the cell to be 
repulsed (Movie 3.3; Figure 3.5). In contrast, when analysing the response of the 
scrambled- treated cells (eg. S2) upon contact with an N-cad knockdown cells (eg. 
N2), in the many of the cases the scrambled-treated cells were not repulsed (Movie 
3.3; Figure 3.5). This confirms that N-cad is required to present a repulsion signal 
and induce repulsion, but not to be repulsed (Movie 3.3; Figure 3.5).  
These different behaviours between scrambled-treated cells and N-cad 
knockdown cells were quantified as shown in the graph in Figure 3.6A. As expected, 
the vast majority of the scrambled-treated cells repulsed each other upon contact, 
while only a few no-repulsion or invasion events were seen (Figure 3.6A). In the N-
cad knockdown cells there was a marked increase in invasion and a decrease in 
repulsion events, while there was no change in no-repulsion events (Figure 3.6A). 
Interestingly, the response of N-cad knockdown cells upon contact with scrambled-
treated cells was similar to how the scrambled control behaved; in that there were 
high levels of repulsion and low levels of invasion. This shows that N-cad knockdown 
cells were still repulsed by scrambled cells meaning a Schwann cell does not need to 
express N-cad to be repulsed (Figure 3.6A). In contrast, there was a distinct 
phenotype in the scrambled cells contacting the N-cad knockdown cells, in that the 
scrambled cells were no longer efficiently repulsed by N-cad knockdown cells and did 
not migrate away following contact, but they also did not invade them as the N-cad 
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knockdown cell had migrated away (Figure 3.5B). This suggests N-cad is required to 
present a repulsion signal. 
Taken together, this indicates that N-cad is required to provide a repulsion 
signal to the other cell, but it is not required for the cell to be repulsed in a N-cad 
dependent manner (Figure 3.6B). Moreover, it suggests that N-cad mediates CIL 
independent of trans-homodimerisation, through which it is known to classically 
signal. 
 
3.4. Assessing the mechanism by which N-cad regulates CIL 
Previous work has indicated that CIL inhibits the formation of protrusions at the site 
of cell-cell contact, which is accomplished by locally rearranging the actin 
cytoskeleton through the cytoskeletal regulators Cdc42, RhoA and Rac-1 (Astin et al., 
2010; Carmona-Fontaine et al., 2008; Scarpa et al., 2015; Theveneau et al., 2010). 
N-cad has been shown to inhibit protrusion formation at the site of cell-cell contact by 
locally inhibiting Rac-1 and redistributing Rac-1 activity to the free edge of the cell 
(Theveneau et al., 2010). Moreover, recent work suggests that E-cad represses CIL 
by distributing Rac-1 activity in a p120-catenin dependent manner (Scarpa et al., 
2015). Other work indicates that N-cad mediates heterotypic CIL between glia and 
the glioblastoma cell line U87MG through α-catenin, which binds to nm23-H1, which 
in turn interacts and inhibits the GEF Tiam1 and therefore inactivates Rac-1. Thus, 
this indicates that N-cad could regulate CIL through its intracellular binding partners 
α-catenin and p120-catenin. However, our data shows that the repulsion signal is 
independent of N-cad trans-homodimerisation and the repulsed cell does not require 
N-cad. Thus, this might suggest that the repulsion signal would be independent of the 
adherence junction complex including the components α-catenin, β-catenin and 
p120-catenin. To test this, a series of knockdowns were performed.  
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Figure 3.5. N-cad mediates CIL independent of trans-homodimerisation. 
(A) Representative still images from a time-lapse of a CIL assay in which red 
fluorescence-labelled scrambled-treated cells (S1 and S2) were mixed with green 
fluorescence-labelled N-cad knockdown cells (N1 and N2). Cells of interest are 
indicated with a red or green dot for scrambled and N-cad knockdown cells 
respectively. Arrows indicate direction of migration. Invasion and repulsion events are 
indicated. Scale bar 100μm. Related to movie 3.3. 
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Figure 3.6. N-cad mediates CIL independent of trans-homodimerisation. 
(A) Quantification of Figure 3.5 in which repulsion, no repulsion and invasion was 
measured between scrambled-treated cells, N-cad knockdown cells or the response 
of scrambled-treated cell by N-cad knockdown cells and vice versa. Graph 
represents mean of three independent experiments in which 30 cells per condition 
were quantified ± SEM. (B) Schematic overview of how N-cad mediates CIL between 
Schwann cells; while N-cad is required to induce a repulsion response it is not 
required for the cell to be repulsed. Related to movie 3.3. 
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In collaboration with an undergraduate student, Mariana Campana, siRNA 
oligos for α-catenin were tested for knockdown efficiency. α-catenin binds to β-
catenin and is the physical link between the actin cytoskeleton and N-cad. There are 
three α-catenin genes: αE-catenin, αN-catenin and αT-catenin which are primarily 
expressed in epithelial, neuronal and heart tissue respectively (Kobielak and Fuchs, 
2004). N-cad can interact with both αE-catenin and αN-catenin (Kobielak and Fuchs, 
2004) and in the adult sciatic nerve E-cad interacts with αE-catenin in myelinating 
Schwann cells (Murata et al., 2006). To test which α-catenin gene is expressed by 
Schwann cells in culture, αE-catenin levels were determined in the different tissues 
and in Schwann cells using RT-qPCR and normalised to the heart (which expresses 
αT-catenin and αE-catenin) for αE-catenin (Figure 3.7A) or the cortex (which mainly 
expresses αN-catenin) for αN-catenin (Figure 3.7B). As expected, αE-catenin is 
expressed by the heart and the sciatic nerve, which is consistent with previous 
reports (Kobielak and Fuchs, 2004; Murata et al., 2006). Importantly, in Schwann 
cells in culture there was a strong expression of αE-catenin compared to the heart 
and sciatic nerve, suggesting dedifferentiated Schwann cells express high levels of 
αE-catenin (Figure 3.7A). In contrast, while αN-catenin could be detected in the 
cortex, it was not detected in sciatic nerve or Schwann cells in culture, suggesting 
Schwann cells do not express αN-catenin (Figure 3.7B). Thus Schwann cells in 
culture express high levels of αE-catenin, while αN-catenin cannot be detected, 
indicating that Schwann cells in culture express αE-catenin.  
Subsequently, αE-catenin was downregulated using two independent siRNA 
oligos for 36 hours and protein expression was analysed using western blot analysis, 
which was probed with an antibody recognising αE-catenin or ERK as a loading 
control. The knockdown was efficient in both Schwann cells treated with siRNA1 or  
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Figure 3.7. Schwann cells express αE-catenin.  
(A) Rt-qPCR analysis of the mRNA expression levels of αE-catenin Schwann cells, 
heart, cortex and sciatic nerve, in which the expression was compared to expression 
levels in the heart. (B) Analysis of mRNA expression levels of αN-catenin in 
Schwann cells, heart, cortex and sciatic nerve, in which the expression was 
compared to expression levels in the heart. Shown are representative graphs of two 
independent experiments. 
 
siRNA2 (Figure 3.8A). However, treating the cells using both siRNA1 and siRNA2 
was extremely efficient, as following knockdown less than 10% of the protein could 
be detected (Figure 3.8A). Therefore, for the following experiments the combination 
of siRNA1 and siRNA2 was used. Importantly, using immunostaining, αE-catenin 
could be detected at the junctions between the scrambled treated cells that are in 
contact with each other, though some perinuclear αE-catenin expression could also 
be detected (Figure 3.8B). However, Schwann cells treated with both siRNA1 and 
siRNA2 no longer appeared to interact with each other and αE-catenin was not 
detectable at the cell junctions (Figure 3.8B, arrow). In addition, loss of αE-catenin 
resulted in more cortical F-actin and stress fibres, suggesting αE-catenin is required 
for modulating the actin cytoskeleton (Figure 3.8B).  
We subsequently determined whether αE-catenin is important for Schwann 
cell-Schwann cell recognition. Intriguingly, although the cells appeared to be unable 
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to form stable junctions, αE-catenin knockdown Schwann cells were still repulsed by 
each other and were indistinguishable from the controls. Thus indicating that αE-
catenin is not required for CIL (Figure 3.9A; Movie 3.4). This was quantified, as 
shown in the graph in Figure 3.9B, which showed that there was no significant 
difference in repulsion, no-repulsion and invasion between Schwann cells treated 
with scrambled or siRNA1 and siRNA2. Thus, αE-catenin is not required for CIL, 
which is consistent with the finding that the repulsion signal is independent of N-cad 
trans-homodimerisation.  
Though knockdown of αE-catenin had no effect on CIL between Schwann 
cells, it appeared that the αE-catenin knockdown cells were migrating faster when 
seeded at low density. To quantify this, the cells were tracked using the nucleus as 
described previously. Scrambled-treated cells behaved normally and migrated as 
expected (Figure 3.9). In contrast, there was an increase in migration speed in αE-
catenin knockdown cells, suggesting that αE-catenin knockdown cells migrate faster. 
We have shown that CIL between Schwann cells is independent of αE-catenin and 
independent of trans-homodimerisation, suggesting N-cad mediates CIL through 
mechanisms independent of its classical function. To test if αE-catenin affects N-cad 
localisation at the membrane, scrambled-treated cells and αE-catenin were fixed and 
immunolabled for N-cad, αE-catenin and stained with phalloidin to visualise the actin 
cytoskeleton. As expected in control cells, junctions were observed between the cells 
(arrowheads) in which N-cad and αE-catenin co-localise, indicating that N-cad and 
αE-catenin are interacting (Figure 3.10A). In contrast, in αE-catenin knockdown cells, 
αE-catenin appears to be completely absent from cell contacts, while N-cad is still 
present at the contact points (arrowheads), suggesting that N-cad is still at the cell 
surface and can homodimerise (Figure 3.10A). Moreover, Western blot analysis 
showed that N-cad expression levels were not changed in Schwann cells following 
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Figure 3.8. αE-catenin knockdown. 
(A) Upper panel: Representative western blot showing the efficiency of αE-catenin 
knockdown with two independent siRNAs compared to scrambled control at 36hours. 
ERK was used a loading control. Lower panel: Quantification of αE-catenin 
expression levels corrected for ERK levels. Bars represent mean of three 
independent experiments ± SEM. One-way ANOVA, Dunnett’s multiple comparison 
test. (B) Representative confocal images of Schwann cells treated with scrambled or 
siRNA1+2 for 36 hours, immunostained for αE-catenin (green), F-actin (red) and the 
nuclei (blue). Cell-contact points are indicated by white arrows that are positive for 
αE-catenin in scrambled treated cells but no αE-catenin can be detected in siRNA1 + 
2 treated cells.  
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knockdown of αE-catenin, suggesting αE-catenin does not affect N-cad expression 
levels (Figure 3.10B). Moreover, while in control cells the actin appears to go into the 
junctions, the actin cytoskeleton appears to be no longer connected to the junctions 
in the majority of the αE-catenin knockdown cells (arrowheads). Thus, this data 
indicates that αE-catenin is required to form stable junctions but is not required for 
CIL.  
We next determined if N-cad mediated CIL requires p120-catenin. p120-
catenin can mediate cytoskeletal changes by regulating Rho-GTPases (Peglion and 
Etienne-Manneville, 2013). Moreover, inhibition of protrusion formation at the site of 
cell-cell contact of non-migratory neural crest by E-cad is dependent on p120-catenin 
(Scarpa et al., 2015). To understand if p120-catenin is regulating CIL in our system, 
we performed a knockdown experiment. Initially, the knockdown for p120-catenin 
was set up using two independent siRNA oligos and a good knockdown of protein 
levels was detected at 72 and 96 hours using western blot analysis, indicating p120-
catenin has a slower turnover than αE-catenin (Figure 3.11A). The protein levels at 
96 hours were quantified using densitometry. The knockdown efficiency was 
reasonable in Schwann cells treated with siRNA1 (>70%), while the knockdown in 
cells treated with siRNA2 was extremely efficient (>85%) (Figure 3.11B). 
Immunofluorescence of p120-catenin showed that in scrambled-treated cells, p120-
catenin was at the cell-cell junctions and in the cytoplasm (Figure 3.11C). Strikingly, 
in p120-catenin knockdown cells, p120-catenin was not detectable in either the 
cytoplasm nor the at the cell-cell contact points (Figure 3.11C, arrows). Moreover, 
while scrambled-treated cells were densely packed and had many junctions, gaps 
could be observed between the p120-catenin knockdown cells, suggesting the cells 
interact in a different way than the scrambled-treated cells. There was also a striking 
change in  
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Figure 3.9. CIL is mediated through αE-catenin independent mechanisms. 
(A) Representative still images from time-lapse microscopy of a CIL assay in which 
Schwann cells were treated with either 5nM scrambled siRNA or αE-catenin 
siRNA1+2 for 36 hours before imaging. Repulsion events are indicated by black 
arrow heads, black arrows indicate the direction of migration. Cells of interest that are 
undergoing a repulsion event are indicated by green and blue dots. Scale bar 
100μm. (B) Quantification of A, bar represents mean of three experiments ± SEM. 50 
cells per condition were quantified. (C) Graph showing the velocity of the tracks form 
scrambled treated cells (dots) or siRNA1+2 treated cells (squares). For each 
condition 30 cells per experiment were tracked for 12 hours. The Red lines represent 
the mean. T-test. Related to movie 3.4. 
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Figure 3.10. αE-catenin is required to form stable junctions. 
(A) Representative confocal images of scrambled-treated and αE-catenin knockdown 
cells at 36 hours, immunostained to detect α-catenin (grey), N-cad (green) and co-
stained for f-actin (red). Note N-cad is still localised at the junctions following αE-
catenin knockdown (arrows). Scale bar 50μm. (B) Representative Western blot 
showing no change in expression of N-cad protein following αE-catenin knockdown 
at 36 hours. ERK was used a loading control. 
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the actin cytoskeleton, which appeared more cortical following p120-catenin 
knockdown, consistent with p120-catenin regulating the actin cytoskeleton (Figure 
3.11B).  
To determine the role of p120-catenin in CIL, scrambled-treated and p120-
catenin knockdown cells were seeded at 72 hours onto laminin coated dishes at low 
density and imaged, using time-lapse microscopy. Scrambled-treated cells behaved 
normally and were repulsed (arrowheads) upon contact, though some events of no-
repulsion were observed (Figure 3.12A). P120-catenin knockdown cells had broader 
lamellipodium than control cells (Figure 3.12A; Movie 3.5). Interestingly, siRNA1 
treated Schwann cells behaved similarly to control cells and were also repulsed 
(arrowheads) upon contact (Movie 3.5; Figure 3.12A and quantified in Figure 3.12B). 
In contrast, in cells treated with siRNA2 repulsion events were less frequent and 
invasion events were slightly more frequent, suggesting a possible role for p120-
catenin in CIL (Movie 3.5; Figure 3.12A and quantified in figure 3.12B). Interestingly, 
this difference in the effect on repulsion and invasion correlated to the differences in 
p120-catenin knockdown.  
To further analyse this effect, the migration speed was analysed in the 
different conditions. Scrambled-treated cells migrated as expected, and there was no 
difference in migration speed in the cells treated with siRNA1 (Figure 3.12C). 
Interestingly, while knockdown of p120-catenin using siRNA2 had a small effect on 
CIL, it had no effect on the velocity of the cells, suggesting that the difference in CIL 
between the two siRNA’s was not due to a difference in migration speed (Figure 
3.12C). 
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Figure 3.11. p120-catenin has a slow turnover. 
(A) Left: Western blot showing the knockdown of p120-catenin using two 
independent siRNAs at 72 hours or 96 hours. ERK was used a loading control. Right: 
quantification of p120-catenin expression levels corrected for ERK, and compared to 
the p120-catenin expression levels in scrambled control. Bars represent the mean of 
three experiments ± SEM. One-way ANOVA, Dunnett’s multiple comparisons test. 
(B) Immunostaining of p120-catenin (green), F-actin (red) and the nuclei (blue) in 
scrambled, siRNA1 and siRNA2 treated cells, at 96 hours. Arrows indicate junctions 
between two cells that are p120-catenin positive in scrambled-treated cells but lost 
following knockdown. Scale bar 20μm. 
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Figure 3.12. N-cad mediates CIL independent of p120-catenin. 
(A) Representative still images from time-lapse microscopy of a CIL assay in which 
cells were treated with either 2.5 nM scrambled siRNA, or p120-catenin siRNA1 or 
siRNA2 for 96 hours before imaging for 24 hours. White arrows indicate direction of 
migration. White arrowheads indicate repulsion events. Cells of interest which are 
undergoing a repulsion event are indicated by green and blue dots. Scale bar 
100μm. (B) Quantification of A. Bar represents four independent experiments ± SEM 
for scrambled and siRNA2. Bar represents mean of three independent experiments ± 
SEM for siRNA1 ≥90 cells from ≥3 experiments were quantified. (C) Velocities from 
the tracks of scrambled (N=30), siRNA1 (N=30) or siRNA2 treated cells (N=30). The 
red lines indicate the mean. One-way ANOVA, Sidak’s multiple comparisons test.. 
Related to movie 3.5. 
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Subsequently we assessed whether there was a difference in the levels of N-
cad, as p120-catenin has been reported to be important for the regulation of 
endocytosis and recycling of cadherins from the membrane (Peglion and Etienne-
Manneville, 2013). Moreover, p120-catenin binding to cadherins masks a 
degradation domain, regulating the proteasomal degradation of cadherins (Fujita et 
al., 2002). Therefore, the decrease in repulsion could be due to a decrease in N-cad 
expression levels. To test if p120-catenin has affects on N-cad levels in Schwann 
cells, protein levels were analysed using Western blot analysis at 96 hours after 
treatment and we found a strong downregulation in N-cad levels, correlating with the 
levels of p120-catenin knockdown (Figure 3.13A). This suggests p120-catenin 
regulates N-cad expression levels in Schwann cells, which is consistent with previous 
reports in other cell types (Nanes et al., 2012; Wehrendt et al., 2016). As p120-
catenin appears to regulate N-cad, we tested if p120-catenin affects N-cad 
localisation at the membrane using immunofluorescence. As expected, in scrambled-
treated cells N-cad localised at the membrane and at cell-cell junctions (arrow) 
(Figure 3.13B). In contrast, in Schwann cells treated with siRNA1 there was a striking 
decrease of N-cad in the cell, although some could still be detected in small puncta at 
cell-cell contacts, consistent with the finding that siRNA1 treated cells can still 
repulse (Figure 3.13B and Figure 3.12B). In Schwann cells treated with siRNA2, 
there was a further decrease of N-cad, with only discrete points of N-cad at the cell-
cell contact observable, correlating with the decrease in repulsion in these cells (Fig 
3.13B and Figure 3.12B). This suggests that p120-catenin regulates N-cad stability at 
the cell surface in Schwann cells, which could be through masking the E3 ubiquitin 
binding sites, endocytosis or gene expression, which is consistent with previous 
reports performed in astrocytes, epithelial cells and HUVECs (Nanes et al., 2012; 
Peglion and Etienne-Manneville, 2013; Wehrendt et al., 2016). Moreover, it suggests 
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that the differential effect on CIL between the cells treated with siRNA1 and siRNA2, 
could be due to differences in N-cad levels at the cell surface. In addition, this 
suggests that low levels of N-cad at the cell-surface are sufficient to mediate CIL 
between Schwann cells. 
Taken together, these data show that CIL is independent of p120-catenin, a 
known intracellular binding partner of N-cad, which is consistent with CIL being 
independent of trans-homodimerisation and independent of α-catenin.  
 
3.5. The extracellular domain of N-cad mediates CIL in Schwann cells 
So far we have shown that N-cad mediates CIL in Schwann cells, which is 
independent of trans-homodimerisation and independent of its cytoplasmic binding 
partners molecules αE-catenin and p120-catenin. To further understand how N-cad 
mediates CIL, we determined which domains of N-cad are required for CIL. To do 
this, constructs expressing different domains of N-cad were expressed in Schwann 
cells lacking endogenous N-cad. N-cad is a transmembrane receptor that has five EC 
domains through which it mediates adhesion and a cytoplasmic tail through which it 
can modulate the actin cytoskeleton (Brasch et al., 2012). To test which domain(s) of 
N-cad are required for CIL, either a mouse full length N-cad or mutants which either 
lack the intracellular domain or the extracellular domain were introduced into 
Schwann cells (Figure 3.14A) (Shih and Yamada, 2012).  
To do this the constructs were expressed in N-cad knockdown cells for two 
reasons: firstly, we have previously shown that overexpression of N-cad in normal 
Schwann cells induces Schwann cells to cluster (Parrinello et al., 2010), thus it is 
important to express physiological levels of N-cad; secondly, we showed here that N-
cad knockdown cells are still repulsed upon contact with an N-cad-expressing cell.  
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Figure 3.13. N-cad expression levels correlates to p120-catenin knockdown. 
(A) Left: Western blot showing the levels of N-cad following p120-catenin knock 
down. ERK was used a loading control. Right: quantification of Western blot of N-cad 
expression levels in p120-catenin knockdown cells compared to expression levels of 
N-cad in scrambled controls at 96 hours. Bar represents mean of three independent 
experiments ± SEM. One-way ANOVA, Dunnett’s multiple comparisons test. (B) 
Representative confocal images of scrambled or p120-catenin knockdown cells at 96 
hours, immunostained for N-cad (green), and costained for F-actin (red) and the 
nuclei (blue). Arrows indicate N-cad positive cell-contacts, which are downregulated 
following p120-catenin knockdown. Scale bar 20μm.  
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Therefore, ideally the response of an N-cad knockdown cell to a cell expressing one 
of the constructs should be measured. To test which domains are involved, the 
following mouse N-cad constructs were used that have been fully characterised (Shih 
and Yamada, 2012): Full length N-cad, N-cad with only the extracellular domain AA1-
746 (Extracellular) and N-cad with only the cytoplasmic domain AA747-906 (Intra 
cellular) that were all tagged with tomato on the C-terminus (Figure 3.14A) (Shih and 
Yamada, 2012). Because the siRNA targeting sequence in the extracellular domain 
of N-cad is highly conserved between mouse and rat, four silent mutations were 
introduced into four codons of the siRNA target sequence, which should inhibit 
binding of the siRNA but should not alter the amino acids and therefore the structure 
of the proteins.  
To test if the proteins were functional in the Schwann cells, the constructs 
were expressed in N-cad knockdown cells in a two step protocol: first N-cad was 
down regulated using siRNA1 which targets nearly all cells, followed by transfection 
of the constructs or empty vector after 24 hours, which targets approximately 20-30% 
of the cells. GFP was co-transfected to follow the successfully transfected cells. After 
a further 24 hours of expression, the proteins were extracted and assessed for the 
levels of the constructs using an antibody recognising the intracellular domain of N-
cad. As expected, endogenous N-cad was down regulated, while low levels of full 
length N-cad could be detected running higher than controls, which was expected 
due to the tomato tag (Figure 3.14B). The extracellular domain fusion protein could 
not be detected, as the antibody recognises the intracellular domain. The intracellular 
domain fusion protein could be detected running lower than control, which would be 
expected due to the lack of the extracellular domain. Moreover, these bands were 
specific as the proteins were also detected using a mCherry antibody that also 
recognises pdtTomato (Figure 14B). Two bands of extracellular domain were 
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Figure 3.14. Expression of N-cad full length and mutants in Schwann cells. 
(A) Illustration of the different N-cad constructs, full length, extracellular and 
intracellular domains tagged with ptdTomato on the C-terminus. The intracellular 
domain of N-cad has an additional Lyn membrane targeting sequence on the N-
terminus to target it to the membrane (B) Representative western blot of N-cad and 
mCherry (that also recognises ptdTomato), showing the expression levels of N-cad 
and the different constructs following N-cad knockdown and overexpression of the 
different constructs 24 hours after overexpression (48 hours after knockdown). ERK 
was used a loading control. 
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efficiency of the DNA transfection, in which, depending on the transfection, only 20-
30% of the cells were targeted. Moreover, the species of the constructs are mouse 
while the endogenous N-cad is rat therefore, there could be a difference in antibody 
binding efficiency between the two species, which could affect the detection of the 
fusion proteins. 
To test if the full length and intracellular constructs are localised at the 
membrane and were able to bind intracellular binding partners, the cells were seeded 
on coverslips, fixed and immunolabelled for tomato, p120 and α-catenin. Full length 
N-cad can be observed engaging in junctions (insets) and as expected p120-catenin 
and α-catenin co-localise at the junctions (insets), suggesting the full length N-cad 
can interact with p120-catenin and α-catenin (Figure 3.15, left panel). In contrast, 
while the intracellular domain of N-cad localised at the membrane (insets) and at the 
sites of cell contact, it does not appear to form junctions, as might be expected 
(Figure 3.15, middle panel). Importantly, there is a strong localisation of p120-catenin 
and α-catenin at the cell contact (insets), which appears to co-localise with the 
intracellular domain of N-cad, suggesting the intracellular domain of N-cad can still 
interact with the intracellular binding partners p120-catenin and α-catenin and 
behaves as might be expected (Figure 3.15, middle panel). The extracellular domain 
of N-cad was localised at the membrane but appeared to have a more vesicular 
localisation than the full length of N-cad and the intracellular domain of N-cad. 
Importantly, the extracellular domain was able to localise at cell-cell contacts and 
appeared to form junctions, suggesting the extracellular domain can homodimerise 
(insets) though to a lesser extent than the full length (Figure 3.15, middle panel). 
However, as would be predicted, p120-catenin appears to be cytoplasmic and does 
not co-localise with the extracellular domain of N-cad at the junctions (inset) (Figure 
3.15, right panel). Moreover, α-catenin could barely be detected in the cells and does 
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not appear to be localised at the cell junctions (inset), which is similar to N-cad 
knockdown cells in which no α-catenin could be detected, suggesting the intracellular 
domain of N-cad does not interact α-catenin (Figure 3.15, middle panel). Thus, this 
shows that the different N-cad constructs are localised and behaving as expected. 
Next we tested if the different constructs affected migration behaviour. To do 
this, the full length of N-cad, the intracellular domain and the extracellular domain 
were expressed in N-cad knockdown cells. As shown earlier, the N-cad knockdown 
cells migrated faster than the scrambled-treated cells (Figure 3.16A). Interestingly, 
cells expressing the full length of N-cad have a similar velocity as the N-cad 
knockdown cells, suggesting that the full length of N-cad could not rescue the 
migration effect (Movie 3.6; quantified in Figure 3.16). Similarly, cells expressing the 
intracellular domain of N-cad had a slight but not significant increase in migration, 
suggesting they behave similarly to N-cad knockdown cells (Movie 3.6; quantified in 
Figure 3.16B). In contrast, cells expressing the extracellular domain of N-cad 
migrated faster than N-cad knockdown cells (Movie 3.6; quantified in Figure 3.16B). 
One reason why the full length may not rescue the increased velocity phenotype of 
N-cad knockdown cells could be the low expression levels of the full-length construct.  
To understand if N-cad full length could rescue the loss of repulsion, it was 
expressed in the N-cad knockdown cells. As the N-cad expressing cell provides a 
repulsion signal to the other cell, but is not required for the N-cad expressing cell to 
be repulsed, only the response of the N-cad knockdown cells to the rescued cells 
were quantified. The controls behaved as expected: GFP-transfected scrambled 
treated cells (green dot) induced repulsion (black arrowhead) to the other cells (blue 
dot) upon contact, while GFP-transfected N-cad knockdown cells (green dot) were 
invasive (white arrowhead) upon contact with knockdown cells (blue dot), suggesting 
transfection does not affect CIL (Figure 3.15A). Crucially, while an N-cad knockdown 
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cell (blue dot) could invade another N-cad knockdown cell (green dot), it was 
subsequently repulsed upon collision with a cell expressing full-length N-cad (red 
dot), these events are now more common and invasion events became less frequent 
compared to N-cad knockdown control (Movie 3.6, Figure 3.17A). Quantification of 
CIL showed, that the rescued cells expressing the full length N-cad, behaved similar 
to scrambled-treated control cells in that they have many repulsion events and only a 
few invasion events, confirming that the loss CIL is specific for N-cad (Figure 3.15A 
and B).  
Subsequently, the intracellular domain and extracellular domain were 
transfected into N-cad knockdown cells and imaged for 24 hours to observe their 
behaviour. Tomato-labelled intracellular domain expressing cells (red dot) were very 
dynamic, evidenced by the and extension and retraction of many protrusions, and in 
many events invaded (white arrowheads) N-cad knockdown cells (blue dot), 
suggesting that the intracellular domain is not sufficient to confer CIL (Movie 3.6; 
Figure 3.18A). In contrast, the tomato-labelled extracellular domain expressing cells 
(red dot) appeared to behave like scrambled-treated control cells (Movie 3.6 Figure 
3.18A). While a N-cad knockdown cell (blue dot) could be observed invading another 
N-cad knockdown cell (green dot) upon contact, the same cell (blue dot) was 
repulsed (black arrowhead) upon contact with a cell expressing the extracellular 
domain of N-cad (red dot), suggesting the extracellular domain is sufficient to 
mediate CIL and that the intracellular domain is not required for this signal (Movie 
3.6; Figure 3.18A). Quantification of CIL showed, that the intracellular-domain 
expressing cells behaved as N-cad knockdown cells in that there were fewer 
repulsion events compared to scrambled-treated cells, and many invasion events 
(>40%), suggesting the intracellular domain is not sufficient to induce CIL (Figure 
3.16B). In contrast, the extracellular domain behaved similarly to scrambled control 
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cells and rescued the N-cad knockdown effect on CIL, with a decrease in invasion 
events and an increase of repulsion events, suggesting that the extracellular domain 
of N-cad is sufficient to mediate CIL (Figure 3.18B).  
Taken together, these results show that the extracellular domain is sufficient 
to mediate CIL and that the intracellular domain is not required. This is consistent 
with the findings that CIL is independent of the adherence junction complex partners 
p120-catenin and α-catenin. Rather, it shows that the extracellular domain of N-cad 
provides a repulsion signal to mediate CIL. 
 
3.6. Chapter discussion and conclusions 
CIL is an important process that prevents intermingling of cells, and is 
important for the directional migration of cells in several systems. We showed that 
loss of N-cad results in a loss of cell-cell recognition and junction formation between 
Schwann cells, leading to the Schwann cells growing on top of each other, which is 
similar to the loss of cell-cell recognition observed between Schwann cells 
expressing oncogenic Ras. N-cad mediates cell-cell interactions in two ways: firstly, 
we showed that N-cad mediates CIL between Schwann cells by regulating repulsion 
and inhibiting the formation of forward protrusions. Moreover, N-cad is required for 
the directional migration of Schwann cells seen in a wound-healing assay. Secondly, 
in unpublished work, it was shown that N-cad regulates CIP, which inhibits the 
proliferation of cells at high density. While, N-cad is classically known to mediate 
adhesion between cells through homophilIic trans-homodimersation and does so in 
Schwann cells (Brasch et al., 2012; Parrinello et al., 2010), we also showed that N-
cad regulates CIL independently of trans- homodimersation and of the classical 
adherence junction complex (Figure 3.19). Rather, N-cad is required to provide a 
repulsion signal to repulse a cell, but is not required for the cell to be repulsed in an 
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Figure 3.15. The different N-cad constructs are functional. 
Representative confocal images showing N-cad knockdown cells overexpressing the 
different ptdTomato tagged (red) N-cad full length, extracellular domain or the 
intracellular domain, immunolabelled with p120-catenin (green) and α-catenin (blue). 
Enlarged insets show area of cell-contacts where the constructs are localised. Scale 
bar 20μm. 
 
 
 
 
 
Figure 3.16. Velocity analysis of Schwann cells overexpressing N-cad mutants. 
(A and B) Velocity of scrambled-treated cells, N-cad knockdown cells treated with 
siRNA1 and (A) siRNA1 N-cad knockdown cells overexpressing the full length of N-
cad (full length) or (B) the extracellular domain of N-cad (extracellular) or the 
intracellular domain of N-cad (intracellular). Cells were tracked for 12 hours. The red 
lines represent the mean. 34 cells per condition from ≥3 independent experiments 
were quantified. Statistics: One-way ANOVA (A) or Two-way ANOVA (B), Sidak’s 
multiple comparisons test 
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Figure 3.17. N-cad full length rescues the N-cad knockdown phenotype. 
(A) Representative still images from a time-lapse movie in which scrambled-treated 
and N-cad knockdown cells were transfected with cytoplasmic GFP and/or 
ptdTomato-tagged full-length of N-cad. Arrows indicate direction of migration. Black 
arrowheads indicate repulsion events. White arrowheads indicate invasion events  
Interacting cells are indicated by blue and green dots (scrambled, siRNA1 ) or blue, 
green, and red dots (siRNA1+full length). Scale bar 100μm. (B) Quantification of A in 
which 45 cells from three independent experiments were quantified. Bars represent 
the mean ± SEM.  
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Figure 3.18. The extracellular domain of N-cad is sufficient to mediate CIL. 
(A) Representative still images from a time-lapse movie in which scrambled-treated 
cells and N-cad knockdown cells were transfected with cytoplasmic GFP and/or the 
extracellular domain of N-cad (siRNA1+extracellular) or the intracellular domain of N-
cad (siRNA1+intracellular) tagged with ptdTomato. Arrows indicate the direction of 
migration. Black arrowheads indicate repulsion events. White arrowheads indicate 
invasion events. Interacting cells are indicated by blue and green dots (scrambled 
and siRNA1) or blue, green and red dots (siRNA1+extracellular and 
siRNA1+intracellular). Scale bar 100μm. (B) Quantification of A in which 72 cells 
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from four independent experiments were quantified. Bars represent the mean ± SEM 
of four independent experiments. Related to movie 3.6. 
 
N-cad dependent manner (Figure 3.19). Consistent with this, adherence junction 
components α-catenin and p120-catenin are not required for CIL between Schwann 
cells. Though p120-catenin does regulate N-cad levels at the membrane, which 
showed that even low levels of N-cad were sufficient to induce CIL. In agreement 
with this, we showed that only the extracellular domain of N-cad is sufficient to 
mediate CIL.  
CIL is thought to have multiple roles, giving cells directionality during 
collective migration, preventing the intermingling of different cell populations and in 
boundary formation preventing the migration of cells into unwanted tissues. Many 
cells types such as fibroblasts migrate in vitro in a directional manner and change 
direction upon contact with another cell (Paddock and Dunn, 1986). Therefore, 
classical CIL quantifications measures the change of direction of migration of the 
cells following contact, by quantifying the vector displacement of a cell before and 
after collision with another cell (Astin et al., 2010; Carmona-Fontaine et al., 2008; 
Paddock and Dunn, 1986). These quantifications, which were originally described for 
fibroblasts, assume the cells will migrate in the same direction unless it meets 
another cell (Paddock and Dunn, 1986). This technique turned out to be inadequate 
for measuring Schwann cell CIL for two reasons: firstly, Schwann cells lack an 
intrinsic directionality and often change their direction of migration randomly, even 
without contact with other cells. Secondly, Schwann cells are highly dynamic cells 
and extend and retract many protrusions, even without the contact of other cells, 
which is even more exaggerated in N-cad knockdown Schwann cells. For this 
reason, it was decided to quantify CIL between Schwann cells by assessing the 
response of protrusions immediately following contact with another cell. To avoid 
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unconscious bias, colleagues who used the same parameters to quantify the same 
experiments, obtained similar results. Moreover, many of the experiments were 
analysed blind and the same results were obtained.  
 
 Figure 3.19 N-cad mediates CIL independent of trans homodimerisation. 
N-cad is classically known to relay signalling, via trans-homodimerisation, into the 
cell through interacting proteins including α-catenin, β-catenin and p120-catenin. In 
contrast, CIL in Schwann cells is mediated by N-cad through a mechanism 
independent of trans-homodimerisation and of its interacting molecules α-catenin, 
p120-catenin and β-catenin. Rather, N-cad provides a repulsion signal to a second 
cell, which is then repulsed.  
 
These findings have shown that in Schwann cells, CIL is regulated through N-
cad, which inhibits the formation of forward protrusions and mediates repulsion, 
which is consistent with findings to a role of N-cad in CIL between neural crest cells 
and the heterotypic CIL seen between glia and glioblastoma cells (Becker et al., 
2013; Scarpa et al., 2015; Tanaka et al., 2012; Theveneau et al., 2010). In neural 
crest cells, N-cad inhibits protrusions at the site of cell-cell contact within a cell 
cluster, repolarising the cells, resulting in the formation of new protrusions at the free 
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edge of the cell (Theveneau et al., 2010). Similarly, N-cad mediates heterotypic CIL 
between glia and a glioblastoma cell line by inhibiting forward migration. In 
agreement with these findings we have found that N-cad is required for CIL, by 
inhibiting protrusions at the site of cell-cell contact and thus blocking forward 
migration.  
CIL is mediated by a repolarisation of cells, which results in a change in 
direction of migration of single cells, or repolarising the formation of protrusions to the 
free edge of cells, of cells migrating as a group (Theveneau et al., 2010). Moreover, 
recent work in neural crest cells showed that inducing protrusions at the free edge of 
the cell, by locally activating Rac, a regulator of protrusions, was sufficient to 
repolarise the cells, disassemble junctions at the cell-cell contact sites and trigger 
CIL (Scarpa et al., 2015). Though it was not directly addressed in this chapter, it 
appears from the movies that CIL in Schwann cells is associated with a change in 
polarisation, as it appears that protrusions are formed at the free edge away from the 
side of cell contact, however further analysis needs to be done to determine whether 
collapse of protrusions at the site of cell-cell contact is accompanied with protrusion 
formation at the free edge of the cell. Moreover, it would be interesting to see if, 
similarly to other systems such as in neural crest cells, glioblastoma, prostate cancer 
cells PC3, and fibroblasts whether Rho-GTPases are involved in mediating CIL (Astin 
et al., 2010; Carmona-Fontaine et al., 2008; Fritz et al., 2015; Scarpa et al., 2015; 
Tanaka et al., 2012; Theveneau et al., 2010). 
Using two separate methodologies we showed that, CIL is independent of α-
catenin and p120-catenin. This was shown first by knocking down α-catenin and 
p120-catenin using siRNA oligos, which did not affect CIL. Secondly, a rescue 
experiment in which the extracellular domain of N-cad was expressed in N-cad 
knockdown cells, showed that is was sufficient to confer CIL. In contrast, while the 
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intracellular domain could interact with α-catenin and p120-catenin, it could not 
rescue CIL. However, in previous studies using neural crest cells, p120-catenin was 
shown to have a role in inhibiting cell-cell repulsion in neural crest cells (Scarpa et 
al., 2015). E-cad supresses repulsion by sequestering p120-catenin, which leads to 
the redistribution of active Rac-1 and formation of protrusions away from the free 
edge of the cell. While not directly addressed by the authors, this could suggest that 
in N-cad expressing migratory neural crest cells, free p120-catenin could play a role 
in CIL by inducing the formation of protrusions at the free edge of the cell. However, 
they showed that p120-catenin knockdown does not affect protrusion formation at the 
free edge of migratory neural crest cells, suggesting that similarly to Schwann cells it 
may not play a role in CIL (Scarpa et al., 2015).  
A separate mechanism was reported in studies in glioblastoma, in which the 
interaction of the nucleotide diphosphate kinase nm23-H with α-catenin, was shown 
to be required to mediate heterotypic CIL between glioblastoma and glial cells 
(Tanaka et al., 2012). In glioblastoma cells, nm23-H suppresses the activity of tiam-1 
a GEF for rac-1 thereby inhibiting Rac-1 activity, which the authors propose blocks 
protrusion formation and mediates CIL. In contrast, we have shown that α-catenin is 
not required for homotypic CIL between Schwann cells. Differences between the 
mechanisms of CIL in glioblastoma in Schwann cells could be attributed to cell type 
differences, or could reflect that homotypic CIL and heterotypic CIL are regulated 
differently.   
Studies of neural crest cells also showed that, overexpression of the 
intracellular domain of E-cad inhibits CIL in migratory cells in a p120-catenin 
dependent manner. Interestingly, similar to neural crest cells prior to EMT, quiescent 
myelinating Schwann cells express E-cad (Fannon et al., 1995). However, whether 
CIL is inhibited in myelinating Schwann cells and if E-cad can inhibit CIL in a similar 
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manner to NC in Schwann cells in unclear. However, as p120-catenin is not required 
for CIL between Schwann cells, this may suggest that E-cad regulates CIL in 
myelinating Schwann cells independently of p120 catenin.    
Though, this work shows that the intracellular binding partners of N-cadherin 
are not involved in CIL, we have not completely excluded this. For example, we have 
not shown whether β-catenin, which is the physical link between N-cad and α-
catenin, is involved in CIL between Schwann cells. However, as the extracellular 
domain of N-cad is sufficient to confer CIL it would seem unlikely. Nevertheless, we 
will test if β-catenin has a role in CIL.  
The somewhat surprising result was that CIL is independent of trans-
homodimerisation and independent of the adherence junction complex, which 
suggests that N-cad may need to interact with another molecule to present a 
repulsion signal. Though N-cad is classically known to trans-homodimerise and 
aggregate in adherence junction complexes, some reports have shown that N-cad 
can interact in cis with other membrane proteins (Suyama et al., 2002; Williams et al., 
2001). Studies in cerebellar neurons have shown that, N-cad can modulate the 
function of the FGF receptor by directly interacting with the FGF binding site (the 
HAV motif of the FGF receptor), which promotes neurite outgrowth (Williams et al., 
2001). Another study in the breast cancer cell line MCF-7, indicated that the 
interaction of the activated FGF receptor with the extracellular domain of N-cad 
prevents internalisation of the receptor, and therefore causes sustained signalling 
through the FGF receptor, resulting in high levels of ERK signalling, which results in 
increased invasion and cell growth (Suyama et al., 2002).  
In contrast, other work suggests that N-cad can modulate signalling by 
binding through its intracellular domain to other receptors such as Robo and LRP5 
(Hay et al., 2009; Rhee et al., 2007). Work done in osteoblasts showed that N-cad 
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interacts indirectly through its intracellular domains via an unknown protein to axin, 
which in turn binds to the Wnt co-receptor LRP5 (Hay et al., 2009; Rhee et al., 2007). 
This interaction, results in increased β-catenin degradation, thereby negatively 
regulating Wnt signalling, which inhibits osteoblast differentiation and bone formation. 
In a different study, it was shown in neural retina cells, that binding of the ligand slit to 
its receptor Robo leads to interactions with N-cad via an intracellular complex of β-
catenin, cables (a cycling-dependent kinase binding protein) and Abl, resulting in 
decreased adhesion of the neurons (Rhee et al., 2007). However, as we have shown 
that CIL can be mediated in Schwann cells by the extracellular domain of N-cad, this 
may suggest these types of interactions are not relevant for the regulation of 
Schwann cell CIL.  
How could N-cad regulate CIL between Schwann cells? Our work suggests 
that N-cad provides a repulsion signal, which is dependent on the extracellular 
domain. Thus it would be tempting to speculate that in Schwann cells, similar to other 
systems, N-cad interacts via its extracellular domain in cis with a co-signal such as 
the FGF-receptor or another molecule to mediate CIL (see next chapter). Another 
possibility is that N-cad regulates the stability or levels of a co-signal at the cell 
surface in a more indirect manner. To further elucidate how N-cad regulates CIL, it 
will be important to determine which EC domain(s) of the extracellular domain of N-
cad are involved in CIL, by expressing mutants lacking these different EC domains in 
N-cad knockdown Schwann cells.  
What is the role of CIL in Schwann cells? During development, Schwann cells 
need to migrate outwards along axons to reach their final target, similarly to neural 
crest cells, which migrate away from the neural tube to their destination (Carmona-
Fontaine et al., 2008; Heermann and Schwab, 2013). Several studies of neural crest 
cells, fibroblasts and PC3 cells have shown that outward migration requires contact-
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dependent repulsive signals resulting in the cells migrating away from each other for 
the dispersal of cells (Batson et al., 2014; Fritz et al., 2015; Theveneau et al., 2010). 
Outward migration in Schwann cells was induced, by inducing a gap in a confluent 
monolayer. This showed that contact dependent migration mediated by N-cad is the 
efficient outward required for migration of Schwann cells, potentially suggesting a role 
for the outward migration of Schwann cells during development. The situation is 
different in the adult following injury when the Schwann cells form clusters mediated 
by increased N-cad at the membrane, and migrate as cellular cords (Parrinello et al., 
2010). This re-localisation of N-cad to the cell junctions between Schwann cells is 
important for the Schwann cells to migrate as a collective and thus appear to have 
purely an adhesive role. However, although Schwann cells switch behaviour from 
repulsive to adhesive, live-imaging of co-cultures of Schwann cells with fibroblasts 
show that the Schwann cells within clusters adhere to each other, but still appear to 
attempt to migrate away from each other (Parrinello et al., 2010). Moreover, the 
cluster as a whole is not static; rather it is dynamic and appears to still move around 
the dish, while remaining as a cluster. This might suggest that the repulsive signal is 
still active in the cluster. In recent work studying neural crest cells, it was suggested 
that traction forces within the migratory cluster are exerted outwards to the edge of 
the clusters (Scarpa et al., 2015). This could also suggest that similar to the role of in 
NC, in Schwann cells CIL could prevent formation of protrusions at side of contact 
and provide a repulsive outward force within the cluster, which could mediate forward 
migration in vivo (Figure 3.2) (Theveneau et al., 2010). These ideas will be tested in 
future experiments. 
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Figure 3.20 Repulsion signal could induce outward forces, which could drive 
the collective migration of Schwann cells.  
 
During collective migration the cells within the cluster need to coordinate cell 
movement, cell speed and the direction of migration. This requires continuous 
communication between neighbouring cells, maintaining continuous strong contacts 
while these interactions may need to remain plastic to allow cellular rearrangements 
to occur. N-cad has been shown in many cell types to mediate adhesion and 
collective migration. Furthermore, N-cad has also been shown to mediate CIL within 
cell clusters and mediate directional migration. However, how N-cad can mediate 
these seemingly contradictory functions is not understood. Here we provide a simple 
solution in which N-cad controls these processes by two distinct mechanisms: firstly, 
N-cad could mediate cell adhesion maintaining a cell cluster through trans-
homodimerisation, transducing adhesive forces onto the actin cytoskeleton through 
adherence junction components α-catenin and β-catenin. Secondly, N-cad could 
mediate inhibition of protrusions and mediate repulsive forces to drive the cluster 
forward, independent of trans-homodimerisation and the adherence junction 
complex, and requiring only the extracellular domain of N-cad and a co-signal (Figure 
3.20). Therefore, it would be interesting to test if Schwann cell clustering is 
dependent on α-catenin, β-catenin and p120-catenin, and determine whether N-cad 
mediates cell clustering and CIL through different mechanisms and the role of all off 
these processes for Schwann cells to successfully guide axons in vivo. 
Force 
Repulsion signal 
N-cad junctions 
	   137	  
 
In conclusion, these data showed that homotypic CIL between Schwann cells in vitro 
is required for cells to recognise each other, and contact dependent migration is 
required for directional migration during “collective” migration. We showed that N-cad 
mediates homotypic CIL between Schwann cells, which is independent of the 
classical adherence junction complex, independent of the intracellular domain of N-
cad and the interacting molecules α- catenin and p120-catenin. Moreover, N-cad is 
not required for a Schwann cell to be repulsed. Rather N-cad provides a repulsion 
signal, possibly through interaction with a co-signal. Moreover, the repulsion signal is 
specifically mediated by the extracellular domain of N-cad, which is sufficient to 
mediate CIL. N-cad could possibly mediate both repulsion and adhesion by 
differentially mediating these processes; adhesion is mediated through the 
adherence junction complex, while CIL is mediated independent of the adherence 
junction complex but requires the extracellular domain to present a repulsion signal.  
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Chapter Four: Results II 
Uncovering the mechanism of homotypic CIL 
4.1. Chapter introduction 
In the previous chapter, we showed that N-cad regulates CIL through a mechanism 
independent of trans-homodimerisation and the proteins associated with the 
intracellular domain. The data suggested that a co-signal is required to present the 
repulsive signal and mediate CIL. To further explore the mechanism by which N-cad 
regulates CIL, we decided to investigate Schwann cells expressing oncogenic Ras. 
These cells, similarly to N-cad knockdown cells, have lost the ability to recognise 
each other (Fig 3.1C). However, previous work from our laboratory has shown that 
this is not due to loss of N-cad, as Ras-expressing cells still express N-cad which 
appeared to be functional. In these unpublished studies, performed by a previous 
PhD student in the lab (Dr. Patrick Wingfield-Digby), it was shown that in co-cultures 
of Schwann cells and DRGs, Schwann cells grab axons in an N-cad dependent 
manner (data not shown), a process important for initial recognition both during 
development and after injury (Jessen and Mirsky, 2005). In addition, Dr. Patrick 
Wingfield-Digby, showed that Schwann cells expressing Ras or a Raf-inducible 
construct (NR-SCs), in which Raf signalling can be hyperactivated upon addition of 
tamoxifen (TMX), can still grab axons (Figure 4.1A), suggesting that hyperactive Raf 
signalling does not impair axonal grabbing by the Schwann cells. This process was 
dependent on N-cad as NR-SCs treated with N-cad siRNA lost the ability to grab 
axons (Figure 4.1B). These results indicate that cells with hyperactivated Ras/Raf 
signalling retain functional N-cad, suggesting that loss of cell-cell recognition in 
Schwann cells expressing oncogenic Ras is due to a separate mechanism. 
Moreover, these findings show that N-cad can mediate very distinct processes 
depending on the context, in that N-cad can regulate Schwann cell clustering, 
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Schwann cell CIL and axonal grabbing (Figure 4.2). How N-cad can regulate these 
three very different processes is unclear, but is likely to involve distinct co-signals.  
 
Figure 4.1. Raf-activated Schwann cells grab axons in an N-cad dependent 
manner.  
(A) Quantification of Schwann cell/axonal grabbing events. Three videos were 
analysed per experiment in which 15-20 Schwann cells were scored. Bars show 
three experiments ± SD. Statistics: two tailed T-test. (B) Quantification of axonal 
grabbing events by control Schwann cells (EtOH) or Raf activated Schwann cells 
(TMX) that were either treated with scrambled siRNA (Scram) or N-cad targeting 
siRNA2 (Ncad-4). Bars represent SD of triplicate videos  (n>15). Shown is a 
representative of two data sets. Statistics: one-way ANOVA Turkey-Kramer Multiple 
comparison T-Test.  
figure 4.1
A
B
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Figure 4.2 N-cad regulates opposing behaviours in Schwann cells. 
Depending on the context, N-cad mediates a) Schwann cell clustering as a result of 
EphB2-induced relocalisation of N-cad to the cell-junctions. b) CIL by mediating 
homotypic repulsion between Schwann cells.  c) Axonal grabbing by Schwann cells.  
 
Neurofibromatosis Type I (NF1) is associated with the formation of neurofibromas, 
which are heterogeneous benign tumours consisting of a mixture of Schwann cells, 
axons, inflammatory cells, vascular cells and perineurial-like cells and enriched in 
extracellular matrix (Parrinello and Lloyd, 2009). Though neurofibromas are benign, 
plexiform neurofibromas can progress to MPNSTs that are highly malignant and 
frequently fatal (Parrinello and Lloyd, 2009). NF1 results from the loss of 
neurofibromin, a Ras GAP, which leads to the hyperactivation of Ras signalling 
(DeClue et al., 1992; Martin et al., 1990; Xu et al., 1990). Though neurofibromas are 
composed of multiple cell types, neurofibromas have been shown to originate from 
Schwann cells (Serra et al., 2000; Zhu et al., 2002). 
Loss of heterotypic interactions between Schwann cells and axons is likely to be 
a key event in tumour formation, as Schwann cells are dedifferentiated and are found 
dissociated from axons in Neurofibromas (Zheng et al., 2008). We have previously 
shown that loss of this heterotypic interaction is partly mediated by loss of 
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Semaphorin 4F (Sema4f) expression, as a result of hyperactive Ras/Raf/MEK/ERK 
signalling. This results in increased proliferation of Schwann cells, as they lose the 
cell-cycle inhibitory signal associated with axonal interaction (Parrinello et al., 2008). 
Thus while Ras-expressing Schwann cells still grab axons, due to N-cad mediated 
interactions, loss of Sema4F expression results in unstable interactions as the cells 
no longer align along the axons.  
Whilst loss of stable axonal interactions is likely to be tumour promoting, Ras-
expressing Schwann cells also no longer recognise each other or other cells such as 
fibroblasts and it is likely that these changes in cell/cell interactions also contribute to 
tumour formation and spread. Thus it is important to understand how Ras 
deregulates homotypic and heterotypic interactions and how these may contribute to 
the onset of tumour formation.   
 
4.2. Assessing homotypic CIL of DNp53-Ras Schwann cells 
In the previous chapter, we briefly described that DNp53-Ras Schwann cells, like N-
cad knockdown cells, lose the ability to form homotypic junctions. As discussed in the 
previous chapter, we use cells in which oncogenic Ras is expressed in Schwann 
cells expressing dominant negative p53 (DNp53) in order to prevent the cells from 
entering into senescence (Lloyd et al., 1997). The lab has previously shown that 
Schwann cells expressing DNp53 (DNp53-SC) behaved like normal cells in respect 
to cell growth (Collins et al., 2012). To determine whether expression of DNp53 
affects cell recognition, DNp53-SCs and DNp53-Ras-SCs were cultured in vitro and 
grown to confluence in the same culture conditions as normal Schwann cells. 
DNp53-SCs formed a confluent monolayer, suggesting they behave like normal 
Schwann cells in respect to cell-cell recognition (Figure 4.3 see also Figure 3.1A). In 
contrast, DNp53-Ras-SCs grew on top of each other, as was described for N-cad 
	   142	  
knockdown cells, suggesting that they can no longer form junctions and are invasive 
(Figure 4.3).  
 
Figure 4.3. Expression of oncogenic Ras induces loss of cell-cell recognition 
in a MEK dependent manner. 
(A) Phase contrast images of Schwann cells expressing DNp53 (DNp53-SC) or 
DNp53 and oncogenic Ras (DNp53-Ras-SC) in the presence of control solvent 
(DMSO) or the MEK1/2 inhibitor PD184352 (0.75μM). Scale bar 100μm.  
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To determine if DNp53-Ras-SCs, like N-cad knockdown cells, have lost CIL, DNp53-
SC and DNp53-Ras-SCs were seeded at low density and CIL was analysed. As 
expected, DNp53-SCs behaved like normal Schwann cells and were repulsed upon 
contact; additionally, very few no-repulsion and invasion events were detected, 
demonstrating that CIL is maintained in DNp53 expressing cells (Movie 4.1; Figure 
4.4A). Strikingly, Schwann cells became highly invasive, following expression of 
oncogenic Ras, recapitulating the phenotype of N-cad knockdown cells, 
demonstrating that they have lost CIL (Movie 4.1; Figure 4.4). However, they do not 
behave identically to the N-cad knockdown cells, in that they appear to be even more 
invasive and their behaviour appears more dynamic, in that they protrude and retract 
their protrusions more rapidly and frequently, apparently independently of contact 
with other cells (Movie 4.1; Figure 4.4A). The repulsion, invasion and no-repulsion 
events were quantified for DNp53-SCs and DNp53-Ras-SCs, which showed that 
DNp53-SCs, like normal cells were repulsed (≥80%) upon contact, with very few 
invasion (≤5%) and no repulsion (≤15%) events observed, indicating DNp53 cells 
behaved like normal cells and CIL remains intact (Figure 4.4B also see Figure 3.2B). 
In contrast, there was a marked decrease in repulsion events (≥2 fold) upon 
expression of oncogenic Ras, and a dramatic increase of invasion events (≥6 fold), 
while no no-repulsion events could be detected (Figure 4.4B). This indicates that CIL 
is lost in Schwann cells expressing oncogenic Ras, which become highly invasive. 
Moreover, the repulsion response is most likely an over representation of real 
repulsion events, as DNp53-Ras-SCs have highly dynamic protrusions, and 
frequently retract their protrusions independently of cell contact, possibly leading to 
the misinterpretation of retraction events upon contact with another cell. 
To elucidate through which pathway Ras abrogates cell-cell recognition we 
added PD184352 (0.75 μM), a specific pharmacological inhibitor of MEK1/2, to 
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DNp53-Ras-SC (Collins et al., 2012). Strikingly, over time, the cells appeared to 
adopt a similar morphology to control cells (Figure 4.3). Importantly, cell-cell contacts 
were restored to control levels as the cells formed a confluent monolayer, indicating 
that oncogenic Ras disrupts cell-cell recognition through MEK dependent 
mechanisms possibly through regulating CIL. To test this, DNp53-Ras-SC or DNp53-
SC were cultured for 18 hours in the presence of PD184352 or control solvent 
(DMSO), subsequently seeded on laminin-coated dishes at low density in the 
presence of inhibitor and imaged for 24 hours using time-lapse microscopy to 
observe their behaviour. Strikingly, treatment of DNp53-Ras-SCs with the MEK 
inhibitor completely restored normal Schwann cell CIL behaviour demonstrating that 
Ras disrupts CIL in a MEK dependent manner (Movie 4.1; Figure 4.4A and quantified 
in 4.4B).  
Thus DNp53-Ras-SC have a similar phenotype to N-cad knockdown cells, in 
that they lose the repulsion signal and become invasive, however Schwann cells 
expressing hyperactive Raf-signalling can still grab axons in an N-cad dependent 
manner suggesting that the Ras/Raf response involves a distinct mechanism. One 
possibility was that loss of CIL in DNp53-Ras-SC was due to the specific loss of N-
cad at sites of homotypic cell-cell contacts. To test this possibility, N-cad protein 
expression levels were first assessed by culturing DNp53-Ras or DNp53-Ras-SC, 
either in the presence of DMSO or PD184352 for 36 hours and the protein was 
harvested for Western blot analysis. As expected, N-cad was expressed by DNp53-
SCs, but the levels were not significantly changed in the DNp53-Ras-SCs or by the 
presence of the MEK inhibitor (Figure 4.5A). This suggests that loss of CIL in DNp53-
Ras-SCs is not the result of aberrant expression levels of N-cad. To analyse whether 
N-cad could be found at cell-cell contact points, DNP53-SCs and DNp53-Ras-SCs 
were treated with DMSO or PD184352 for 24 hours before fixing and 
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immunolabelling for N-cad. As expected, control DNp53-SCs had a similar 
morphology to normal Schwann cells and N-cad localised at the junctions (arrows) 
(Figure 4.5B). In contrast, DNp53-Ras-SCs appeared to have a more rounded 
morphology, and while most of the N-cad localised perinuclearly, it could still be 
found at contact-points between DNp53-Ras-SCs (Figure 4.5B). However, these 
contacts appeared not to be stable, as DNp53-Ras-SCs are highly dynamic and 
invasive (Figure 4.5B; Movie 4.1). Strikingly, junctions were completely recovered 
upon inhibition of MEK, confirming that oncogenic Ras disrupts stable junction 
formation in a MEK dependent manner.  
 
4.3. Assessing homotypic CIL of DNp53-Ras Schwann cells 
N-cad is classically known to form adhesion complexes in which it interacts with other 
cadherin molecules in trans or cis (Brasch et al., 2012). However, as described in the 
previous chapter, N-cad has been shown make heterophilic interactions in cis with 
other molecules such as the FGF receptor, to regulate axonal growth and the 
invasion of MCF-7 cells. Moreover, it has been shown that the FGF receptor interacts 
in cis with a motif present in the EC4 domain of N-cad (Williams et al., 2001). In a 
separate study in epithelial cells, E-cad has been shown to form a complex with 
ADAM10, and EphB2 (Solanas et al., 2011). The interaction of E-cad with ADAM10 
and EphB2 is required for the sorting of EphB2-expressing epithelial cells. Cleavage 
of E-cad by ADAM10 following activation of EphB2 by Ephrin B induces cell sorting of 
the EphB-expressing cells through differential adhesion.  
In initial experiments, we determined how long it takes for DNp53-Ras-SC to 
regain the ability to recognise each other following inhibition with the MEK1/2 
inhibitor, PD184352, in order to determine the kinetics of the mechanisms involved. 
DNp53-Ras-SCs were seeded at low density and imaged for 6 hours before adding 
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Figure 4.4. CIL in Schwann cells expressing Ras is lost in a MEK dependent 
manner. 
(A) Time-lapse microscopy images of DNp53-SCs or DNp53-Ras-SCs in the 
presence of control solvent (DMSO) or MEK inhibitor PD184352 (0.75 μM) for 18 
hours before imaging for a further 24 hours. Interacting cells are indicated by blue 
and green dots. White arrows indicate direction of migration. Black arrowheads 
indicate a repulsion response for DNp53-SC or DNp53-Ras-SC + PD184352 or 
invasion for DNp53-Ras-SC+DMSO. Scale bar 100μm. (B) Quantification of A in 
which 50 cells per condition were analysed. Graph shows the mean ± SEM of three 
independent experiments. Related to movie 4.1. 
12 min 24 min 54 min 0 min 
 
 
0 min 18 min 30 min 42 min 
0 min  36 min 54 min  120 min 
A
B
0
20
40
60
80
100
%
 o
f e
ve
nt
s
Repulsion
No repulsion
Invasion
DNp53 DNp53-Ras DNp53-Ras
- - + PD184352
D
N
p5
3-
S
C
D
N
p5
3-
R
as
-S
C
+ 
D
M
S
O
D
N
p5
3-
R
as
-S
C
+P
D
18
43
52
Figure 4.4
***
***
***
***
n.s.
	   147	  
 
Figure 4.5. Loss of CIL in DNp53-Ras-SCs is not due to aberrant expression of 
N-cad. 
(A) Left: Western blot showing N-cad expression levels in DNp53-SCs (DNp53) or 
DNp53-Ras-SCs (DNp53-Ras) in the presence of DMSO or PD184352 (0.75μM) at 
48 hours. Akt was used a loading control. Right: Quantification of N-cad expression. 
Graph shows three experiments ±SD. Statistics: One-way ANOVA, Dunnett’s multiple 
comparisons test. (B) Representative confocal images of DNp53-SCs or DNp53-Ras-
SCs either in the presence of DMSO or PD184352 for 24 hours, immunostained for 
N-cad (green) and costained with Hoechst to label the nuclei (blue). Arrows indicate 
N-cad positive cell-cell contacts. Scale bar 20μm. 
 
DMSO or PD184352 and then further imaged for another 24 hours. Interestingly, 
DNp53-Ras-SCs treated with PD184352 were initially invasive, however after 
approximately 10 to 14 hours their behaviour changed: cells appeared to slow down, 
spin around in circles, and changed the direction of migration more frequently, before 
starting to migrate again, suggesting a sort of reprogramming of the cell (Movie 4.2). 
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Importantly, while DNp53-Ras-SCs were initially invasive, over time more repulsion 
events could be detected, suggesting MEK inhibition does not affect CIL immediately 
but rather, restores CIL slowly, consistent with a change in gene expression (Movie 
4.2). These results are also consistent with the observation that NR-SCs treated with 
TMX take several hours (>8h) to show a CIL phenotype (unpublished observations). 
To quantify this change in behaviour over time, repulsion, invasion and no repulsion 
events were measured between 0-12 hours and 12-24 hours after adding PD184352 
or control-solvent (DMSO). Between 0-12 hours in PD184352-treated cells there was 
a small increase in repulsion events (from ~20% to ~40%) compared to DMSO 
control, while there was a decrease of invasion events (from ~70% to ~50%), 
suggesting that CIL was restored in some of the cells (Figure 4.6A). From the movies 
however, it could be seen that the majority of these changes took place towards the 
end of the time frame. To quantify this, CIL was measured between 0-8hours after 
adding PD184352 or control-solvent (DMSO). This showed that between these time-
points there was no significant change in repulsion or invasion, consistent with 
longer-term changes being required (Figure 4.6B; Movie 4.2). In contrast, in 
PD184352-treated cells, CIL was completely restored to control levels between 12-24 
hours (Figure 4.6A). This suggests that CIL is restored slowly, indicating that loss of 
CIL in Schwann cells expressing oncogenic Ras is mediated through MEK-
dependent changes in gene expression. 
Strong molecular candidates for a playing role in CIL are the Eph receptors and 
their ligands. They have been shown to play a role in CIL between PC3 cells and 
glioblastoma cells and play a crucial role in cell sorting, such as we observed in 
Schwann cells and has been extensively studied in the sorting of epithelial cells in 
the intestine (Astin et al., 2010; Batlle et al., 2002; Parrinello et al., 2010; Solanas et 
al., 2011; Tanaka et al., 2012). To test if the mRNA expression levels of the Eph 
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receptor family are regulated through the Ras-ERK pathway, DNp53-SCs and 
DNp53-Ras-SC were cultured in the presence of DMSO or PD184352 for 36 hours 
before RNA extraction. Subsequently the mRNA expression levels were assessed by 
RT-qPCR.  
There are in total 10 EphA receptors and six EphB receptors that 
preferentially bind six Ephrin-A ligands and three Ephrin-B ligands respectively. We 
designed primers for the Ephrin-A ligands, Ephrin-A1, -A2, -A3 and -A4, and EphA 
receptors EphA1, A2, A3, A4, A5, A6, A7 and A8. In addition, we used primers 
previously validated by our lab for EphB1, B2, B3, B4, B6, A4, Ephrin-B1, -B2, -B3 
and -A5 (Parrinello et al., 2010). The expression of EphA9, EphB5 and Ephrin-B6 
appear not to be present in the human or mouse genome and so were not analysed 
(Figure 4.7A) (Cunningham et al., 2015).  
 
4.4. A candidate approach to determine the co-signal in CIL 
The expression of EphA6, EphA10, EphB5, Ephrin-A5, and Ephrin-B3 could not be 
detected in either DNp53-SC or DNp53-Ras-SC, suggesting they are not expressed 
in these cells (Figure 4.7A). Moreover, the lack of expression of Ephrin-A5 and 
Ephrin-B3 in DNp53-SCs is consistent with previous results (Parrinello et al., 2010).  
Interestingly, Ras expression had multiple, dramatic effects on the expression 
levels of ephrin ligands and receptors of both families.  
Ephrin-A ligands: All ephrin A ligands were downregulated by Ras expression in a 
MEK-dependent manner. Ephrin-A2 was more strongly downregulated than ephrin-
A1, Ephrin-A3 and Ephrin-A4, and was only partially rescued by MEK inhibition 
indicating other pathways may be involved (Figure 4.7C).  
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Figure 4.6. The kinetics of PD184352 induced CIL restoration in Ras-
expressing cells is slow. 
A) Graph showing a time-course of homotypic CIL between DNp53-Ras-SCs in the 
presence of control solvent (DMSO) or the MEK inhibitor PD184352 (0.75μM). 
Repulsion, no repulsion and invasion events of 30 cells were quantified in two 
timeframes 0-12 hours and 12-24 hours. B) Similar experiment as in (A) in which 
repulsion, no repulsion and invasion events of 26 cells were quantified between 0-8 
hours. Bars represent three independent experiments ±SEM. Related to Movie 4.2. 
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Figure 4.7. Oncogenic Ras induces changes in the mRNA expression of the 
Eph receptor family in a MEK dependent manner. 
(A) Table of Eph receptors and ligands that appear to not be present in the human or 
mouse genome, and not expressed by DNp53-SCs and DNp53-Ras-SCs. (B-C) 
Quantitative RT-q-PCR analysis of Ephrin-A ligands and Ephrin-B ligands in DNp53-
SCs and DNp53-Ras-SCs treated with DMSO or PD184352 (0.75μM) for 36 hours. 
Bars show the mean ±SEM of three experiments. Statistics: Two-way ANOVA 
Sidaks’ multiple comparison test 
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Figure 4.8. Oncogenic Ras induces changes in the mRNA expression of the 
Eph receptor family in a MEK dependent manner.  
(A-C) Quantitative RT-q-PCR analysis of EphA receptors (A and B) and Eph-B 
receptors (C) in DNp53-SCs and DNp53-Ras-SCs treated with DMSO or PD184352 
(0.75μM) for 36 hours. Results are shown relative to the expression in DN-p53SCs. 
Bars show the mean ±SEM of three experiments. Statistics: Two-way ANOVA 
Sidaks’ multiple comparison test 
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Ephrin B ligands: Ephrin-B1 is downregulated in response to Ras, while Ephrin-B2 
is strongly upregulated, suggesting they respond differentially to Ras signalling 
(Figure 4.7B and C). However, both Ephrin-B1 and Ephrin-B2 are regulated by Ras 
in a MEK dependent manner, as expression can be restored to control levels (Figure 
4.7B and C). 
EphA receptors: The majority of these receptors were downregulated following Ras 
expression (EphA1, EphA3, EphA4, EphA7 and EphA8) (Figure 4.8A). EphA1 was 
only slightly down regulated, while EphA3, EphA4, EphA7 and EphA8 were strongly 
downregulated, suggesting the latter are important downstream targets of Ras 
(Figure 4.8A). In contrast EphA2 and EphA5 were upregulated (Figure 4.8A and B). 
There was a dramatic increase in EphA5 expression, in part due to undetectable 
levels in DNp53-SCs, suggesting it is not expressed in these cells and is thus unlikely 
to be involved in regulating CIL between DNp53-SCs (Figure 4.8B). Interestingly, 
apart from EphA1, all expression levels could be restored to control levels following 
MEK inhibition, suggesting Ras regulates these receptors in a MEK-dependent 
manner and so are potential candidates for having a role in CIL (Figure 4.8A). EphA1 
is not regulated by Ras in an ERK dependent manner, suggesting other signals 
regulate its expression and it does not play a role in CIL (Figure 4.8A).  
EphB receptors: EphB receptors are all downregulated upon expression of 
oncogenic Ras, though there is only a weak effect on the expression of EphB4, 
suggesting it is not such an important target of Ras (Figure 4.8C). Interestingly, 
EphB2 and EphB3 are strongly downregulated, which can be rescued almost to 
control levels upon inhibition of MEK, suggesting they have a similar response to Ras 
and are regulated in a MEK dependent manner (Figure 4.8C). EphB6 is also down 
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regulated, though the effect is not as strong compared to EphB2 and EphB3 (Figure 
4.8C).  
All together this shows that Ras regulates the expression of the majority of 
Eph receptors and their ligands, the vast majority in a MEK dependent manner, 
correlating to the regulation of CIL by Ras in a MEK dependent manner.  
Next, we wanted to understand if activating the Raf/MEK/ERK pathway is 
sufficient to induce a change in expression patterns of the ephrins and Eph 
receptors. To test this, NR-SCs were used which express a Raf-inducible construct. 
Initially, cultures of NR-SCs were treated for 36 hours in the presence of TMX 
(0.1μM) or control solvent (ETOH) and grown to confluence to observe their 
behaviour. As expected, control-treated cells formed a confluent monolayer (Figure 
4.9). In contrast, NR-SCs treated with TMX adopted a more ‘spiky’ phenotype, lost 
their homotypic junctions and grew on top of each other, suggesting they lost cell-cell 
recognition and that they behave similar to DNp53-Ras-SCs and N-cad knockdown 
Schwann cells (Figure 4.9). Moreover, it suggests that activation of Raf is sufficient to 
induce loss of cell-cell recognition, consistent with previous studies (Lloyd et al., 
1997).  
Subsequently, it was tested if activating Raf induces a change in the 
expression pattern of the Eph receptors and their ligands. NR-SCs were cultured 
either in the presence of EtOH or TMX for 36 hours before harvesting mRNA and 
analysing the expression of the Eph receptors and theirs ligands using RT-qPCR. 
Interestingly, the ephrin-A ligands were all downregulated showing that activating Raf 
is sufficient to regulate their expression (Figure 4.10 and Figure 4.7C). Importantly, 
the extent of downregulation of Ephrin-A2, Ephrin-A3, and Ephrin-A4 ligands 
appeared to be similar to that seen in DNp53-Ras-SCs (Figure 4.10A and Figure 
4.7C) confirming that regulation of these ligands is through the Ras/Raf/MEK/ERK 
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pathway. In contrast, Ephrin-A1 appeared more strongly downregulated in NR-SCS 
treated with TMX compared to the DMSO-treated DNp53-SCs, which could be due to 
the stronger activation of the ERK signalling pathway in NR-SCs compared to Ras-
expressing cells (Figure 4.10A and Figure 4.7C).  
Moreover the Ephrin-B ligands were also regulated similarly, as ephrin-B1 is 
down regulated while Ephrin-B2 is upregulated, confirming that regulation of these 
ligands is through the Raf/MEK/ERK pathway and that Raf differentially regulates 
these ligands (Figure 4.10A and B and Figure 4.7B and C).  
Of the EphA receptors, EphA2 and EphA-5 were upregulated, while EphA-1, 
EphA3, EphA4 EphA47 and EphA8 were all downregulated, recapitulating the 
expression patterns in Schwann cells expressing oncogenic Ras. This suggests that 
activating Raf is sufficient to regulate the expression of these receptors. Similarly, all 
the EphB receptors were down regulated similarly to how Ras regulated the EphB 
receptors. However EphB6 was not as strongly downregulated compared to Ras, 
suggesting Raf activation is not sufficient to inhibit the expression of EphB6 (Figure 
4.10C see also Figure 4.8C).  
All together, these data demonstrates that Ras signalling has a fundamental role 
in controlling the expression levels of ephrin receptors and their ligands which is 
likely to have dramatic effects on the behaviour of Ras-expressing cells. This 
regulation acts mostly via the Raf/ERK signalling pathway. It remains to be 
determined how these changes affect the behaviour of these cells and the role in 
tumourigenesis. 
 
4.5. The role of ephrins in homotypic CIL 
We have previously shown that cell sorting of fibroblasts and Schwann cells is 
dependent on Ephrin-B to EphB2 signalling, which induces the translocation of N-cad 
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to the membrane in a Sox-2 dependent manner, which causes the Schwann cells to 
cluster (Parrinello et al., 2010). This showed that Ephrin-B to EphB2 signalling is 
important in heterotypic signalling between fibroblasts and Schwann cells. Although 
we showed in co-cultures that upon heterotypic interactions of Schwann cells with 
fibroblasts, Schwann cells switch their behaviour from repulsion to attraction, it does 
 
        
 
 
 
 
 
 
Figure 4.9. Raf-activation is sufficient to induce loss of cell-cell recognition 
between Schwann cells. 
Representative phase-contrast images of Schwann expressing a Raf-inducible 
construct (NR-SC) in the presence of control solvent EtOH (monolayer) and TMX 
(loss of monolayer). 
 
 
NR-SC + EtOH
NR-SC + TMX
Figure 4.9
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Figure 4.10. Raf activation is sufficient to induce changes in mRNA expression 
levels of the Eph receptor family. 
(A-D) Quantitative RT-PCR analysis of Ephrin-A ligands, Ephrin-B ligands, EphA and 
EphB receptors in NR-SCs treated with TMX relative to controls NR-SCs treated with 
EtOH, for 36 hours. Bars show the mean ±SEM of three experiments. Statistics: 
multiple T-Test 
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not necessarily imply that the CIL signal between these cells is also mediated by 
Ephrin-B to EphB2 signalling. To test if Ephrin-B to EphB2 signalling mediates 
heterotypic CIL between fibroblasts and Schwann cells, my colleague Dr. Victor 
Quereda treated Schwann cells either with scrambled siRNA or EphB2 siRNA for 36 
hours before co-culturing with primary fibroblasts, live-imaging for 24 hours and 
analysing CIL. Interestingly, in the vast majority of the cases, upon contact with a 
fibroblast, Schwann cells appeared to “bounce” off the fibroblasts, a process 
associated with the retraction of protrusions and a change in the direction of 
migration suggesting there is heterotypic CIL between Schwann cells fibroblasts 
(Movie 4.3; Figure 4.11A). In contrast, the EphB2 knockdown Schwann cells 
appeared to repulse less frequently upon contact with fibroblasts, but rather there 
was a change in the behaviour of the Schwann cells, with many appearing to no 
longer migrate away following contact, suggesting the Schwann cells were no longer 
repulsed by the fibroblasts (Figure 4.11A; Movie 4.3). Dr. Victor Quereda quantified 
this behaviour and found that knockdown of EphB2 in Schwann cells resulted in a 
large increase in the number of cells that were not repulsed by fibroblasts. However, 
in contrast to Ras-expressing cells, the Schwann cells did not invade the fibroblasts 
suggesting that further signals may be needed for invasion (Figure 4.11A and data 
not shown). This indicates, that CIL between primary fibroblasts and Schwann cells is 
mediated through EphB2 signalling.  
 Given that the EphB2 induced repulsion signal between primary fibroblasts 
and Schwann cells induces Schwann cells clustering, we reasoned that EphB2 would 
not mediate CIL between Schwann cells, as this would also be predicted to cause 
clustering. To confirm this hypothesis, EphB2 was knocked down using siRNA-
targeting EphB2 in Schwann cells and the effects on CIL were analysed. As 
expected, scrambled-treated Schwann cells repulsed upon contact (Figure 4.11B). 
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Figure 4.11. Homotypic CIL and heterotypic CIL in Schwann cells are mediated 
through different mechanisms.  
(A) CIL analysis between primary fibroblasts (pFib) and scrambled- or EphB2 siRNA 
treated Schwann cells. Bars represent mean ±SD of three experiments. (B) 
Quantification of CIL between Schwann cells treated with scrambled siRNA or EphB2 
siRNA. 10 cells per condition were quantified. Bars represent mean ±SEM of three 
experiments. Related to Movie 4.3. 
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Moreover, EphB2 knockdown cells also appeared to behave like control cells, as they 
were also repulsed upon contact, suggesting EphB2 is not required for homotypic 
CIL (Movie 4.3 and quantified in Figure 4.11B). Thus, this data shows that while 
heterotypic CIL between fibroblasts and Schwann cells is dependent on EphB2 
signalling, homotypic CIL is independent of EphB2 signalling. Moreover, N-cad 
appears to regulate homotypic CIL between Schwann cells by both inhibiting forward 
protrusion formation and stimulating repulsion, so loss of N-cad results in invasion. In 
contrast, whilst cells lacking EphB2 are no longer repulsed by fibroblasts they don’t 
invade the cells indicating that the mechanism inhibiting forward protrusion remains 
intact.  
Ephrin-A/EphA signalling has previously been shown to regulate homotypic 
CIL in PC3 cells by halting forward migration (Astin et al., 2010), and has been 
shown to play a role in tumour spread of PC3 cells in vitro, by mediating repulsion 
between the cells resulting in outward migration away from the cell mass, which 
leads to local single cell invasion (Batson et al., 2014). In the previous chapter, we 
showed that N-cad provides a signal, which is required to induce a repulsion 
response, but that it is not required for a cell to be repulsed in a N-cad dependent 
manner. This could suggest that N-cad is involved in presenting a ligand as a 
repulsion signal to the other cell. Interestingly, though Eph receptor engagement with 
its ligands can induce bidirectional signalling through both receptor and ligand, 
Ephrin-A ligands are GPI-linked proteins that do not have a cytoplasmic tail through 
which they can signal (Lisabeth et al., 2013). However, recent work has shown that 
Ephrin-A ligands can also signal back into the cell via interactions with the 
neurotrophin receptors p75, TrKB and Ret to regulate axonal growth (Bonanomi et 
al., 2012; Lim et al., 2008; Marler et al., 2008). Therefore it remains a possibility that 
either the Ephrin-A ligand or receptor could act as a repulsion signal.  
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In initial experiments to test whether EphrinA/EphA signalling may be involved 
in homotypic CIL, Schwann cells were stimulated with pre-clustered Ephrin-A-Fc 
chimeras, which by inducing the retraction of cell protrusions (cell rounding), could 
possibly be an indication of CIL (Astin et al., 2010). The Ephrin-A1 and Ephrin-A4 
ligands mRNA expression levels are regulated by Ras in a MEK dependent manner, 
and their expression correlates with the absence and resumption of CIL in DNp53-
RAS treated with PD1184352 (Figures 4.2B and 4.7C), possibly suggesting they 
could play a role in CIL. Moreover, Ephrin-A1 has been shown to play a role in CIL 
(Astin et al., 2010), and out of the four Ephrin-A ligands, Ephrin-A1 and Ephrin-A4 
appeared to have the highest expression levels based on the mRNA analysis (see 
Table 4.1).  
  Ephrin-A1 Ephrin-A2 Ephrin-A3 Ephrin-A4 
DNp53-SC 0.010 0.003 0.001 0.011 
DNp53-Ras-SC 0.007 0.000 0.001 0.006 
 
Table 4.1 Expression levels of Ephrin-A ligands in DNp53-Schwann cells and 
DNp53-Ras-Schwann cells 
Shown are the ΔΔCT of the mRNA detection levels of Ephrin-A ligands in DNp53-
Schwann cells (DNp53-SCs) and DNp53-Ras-Schwann cells (DNp53-Ras-SCs) 
normalised to the housekeeping gene B2M. N=3  
 
Therefore it was tested if Ephrin-A1 and/or Ephrin-A4 binding can induce 
Schwann cell rounding. To test this, Schwann cells were seeded onto laminin-coated 
coverslips and treated for 20 min with either control-Fc or pre-clustered Ephrin-Fc 
chimeric ligands, before PFA fixation. Subsequently, the coverslips were stained with 
phalloidin to visualise the actin cytoskeleton and the morphology of the cells, and 
immunolabelled for anti-Fc to visualise the EphrinA-Fc and Fc-control chimeras. 
Images were taken using confocal microscopy and maximal projections are shown 
(Figure 4.12A). Ephrin-A1 and Ephrin-A4 localised as small puncta in the Schwann 
cells (insets) (Figure 4.12A middle and right panel), whereas, as might be expected, 
control-Fc cannot be detected as it cannot bind to a receptor (insets) (Figure 4.12A, 
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left panel). This suggests that both Ephrin-A1 and Ephrin-A4 can bind to receptors on 
Schwann cells. However, it appears Ephrin-A4 binds less to Schwann cells than 
Ephrin-A1, suggesting a differential binding of the ligands. As expected, control-Fc-
treated cells had a bipolar morphology and normal actin cytoskeleton organisation, 
suggesting control-Fc does not have an effect on Schwann cells (Figure 4.12A). 
Intriguingly, treatment of the cells with Ephrin-A1-Fc appeared to induce a proportion 
of the cells to round up, suggesting ephrin-A1 binding to the cells induces retraction 
of the cell periphery a feature of CIL (Figure 4.12A middle panel). Moreover, cell 
rounding appeared to be associated with a strong rearrangement of the actin 
cytoskeleton to a more cortical distribution, suggesting Ephrin-A1 ligation regulates 
the actin cytoskeleton. In contrast, Ephrin-A4-Fc-treated cells appeared less affected, 
with fewer cells showing a rounded morphology (Figure 4.12A right panel). Moreover, 
in some of the cells, stress fibres could be observed suggesting Ephrin-A4 binding to 
the cells induces a change in the actin cytoskeleton (Figure 4.12A right panel). To 
quantify the effect on cell rounding, the ratio between the length and width of a cell 
was measured to determine the cell-rounding index. As expected, the majority of the 
control cells have a low cell-rounding index, consistent with the bipolar morphology of 
Schwann cells (Figure 4.12B). In contrast, the Ephrin-A1-Fc treated cells showed a 
marked shift towards a higher cell-rounding index, consistent with a rounding of the 
cells (Figure 4.12B). In Ephrin-A4-Fc-treated cells, there was a slight trend towards a 
higher cell-rounding index but the differences were not significant indicating a minor, 
if any, effect of Ephrin-A4 on cell rounding (Figure 4.12B).  
These results show that both Ephrin-A1 and Ephrin-A4 can bind to Schwann 
cells but the effect of Ephrin-A1 appears to be more potent; Ephrin-A4 induced only a 
mild response upon binding, while Ephrin-A1 induced retraction of the cell periphery, 
which was associated with a rearrangement of the actin cytoskeleton. This could  
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Figure 4.12. Clustered Ephrin-A1 induces Schwann cell rounding. 
(A) Representative confocal images of Schwann cells treated with control-Fc, ephrin-
A1-Fc or Ephrin-A4-Fc, immunostained for anti-Fc (green) and co-stained with 
phalloidin (red) to visualise the actin cytoskeleton and Hoechst to stain the nuclei 
(blue). Insets show a magnification of the actin cytoskeleton and the Ephrin-A 
ligands. Scale bar 20μm. (B) Quantification of (A) in which cell rounding was 
measured. n=75 cells in three independent experiments. Red line represents mean. 
Statistics: One-way ANOVA Kruskal-Wallis test. 
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suggest that Ephrin-A1 may play a role in CIL, however this needs further 
investigation.  
Fyn is a downstream target of Ephrin-A reverse signalling in axons and is 
important for regulating the repulsion response (Lim et al., 2008). To test if Fyn is 
important for homotypic CIL between Schwann cells, Fyn was inhibited by adding the 
Fyn inhibitor SU6656 (250 nM) for one hour before live-imaging the cells for 24 
hours. As expected, the majority of control DMSO-treated Schwann cells, were 
repulsed upon contact (Movie 4.4; Figure 4.13A). However, the SU6656-treated cells 
behaved similarly to control cells suggesting that Fyn is not required for CIL (Movie 
4.4; Figure 4.13A and quantified in 4.13B). However, while Fyn inhibition failed to 
block CIL, it did block cytokinesis (Movie 4.4) consistent with previous reports 
(Yasunaga et al., 1996), demonstrating that the inhibitor was active in these 
experiments.  
 
4.6. Mass spectrometry 
In the second approach to identify a potential N-cad dependent repulsion signal, 
proteins that interact with N-cad in Schwann cells were analysed using Co-IP and 
mass spectrometry (Mass Spec). Moreover, to identify interactions that might be 
disrupted upon the activation of the Ras/Raf/ERK pathway, the interactions were 
compared to those of cells with an activated ERK pathway. To do this, NR-SCs were 
used which allowed a switch between repulsion and invasive behaviours by TMX 
induced Raf activation (Figure 4.10). In order to retain as many interactions as 
possible, preliminary Co-IP experiments were performed in different detergents to 
determine the least stringent conditions in which known interactions could be 
preserved. For these experiments, the NR-SCs were seeded at low density, as upon 
high confluency control NR-SC form stable junctions possibly disrupting interactions  
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Figure 4.13. Fyn inhibition does not affect CIL. 
(A) Representative still images from time-lapse microscopy of a CIL assay in which 
Schwann cells were treated with DMSO or the Fyn inhibitor SU6646 (250nM) for one 
hour before starting imaging. Cells of interest are indicated by green and blue dots. 
Arrows show the direction of migration, arrowheads indicate repulsion events. (B) 
Quantification of (A), 30 cells per condition per experiment were quantified. Bars 
represent mean ±SEM of three experiments. Related to Movie 4.4. 
 
of N-cad with a potential repulsion signal. NR-SCs were cultured for 36 hours either 
in the presence of TMX or control solvent (ETOH). Subsequently, protein was 
harvested using different lysis buffers and immunoprecipitation of N-cad was 
performed followed by Western blotting to detect interacting proteins. For all 
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detergents tested, the interaction between N-cad and the known adherence junction 
complex components could only be detected in the 1% NP40 buffer. Therefore, the 
results for the 1% NP40 lysis buffer are shown, as these were the conditions used for 
later experiments. 
N-cad could be detected in similar amounts in all conditions in the input lanes 
(Figure 4.14) and similar amounts of N-cad were detected in the EtOH and TMX 
conditions following IP of N-cad, consistent with the similar levels of N-cad in these 
cells. As expected, N-cad was not detected in IgG control (Figure 4.14). In these 
conditions, interactions with the known interacting proteins β-catenin, α-catenin and 
p120-catenin could all be detected. Consistent with the findings described in chapter 
3, these interactions were unaffected by activation of the Raf/MEK/ERK signalling 
pathway confirming that activation of this pathway does not affect either the levels of 
N-cad or the ability of N-cad to interact with these junctional proteins. 
These conditions were then used to prepare samples for qualitative Mass 
Spec analysis. The Co-IP was performed on one sample per condition using 1mg 
protein as input, and the proteins were eluted from the beads using Laemmli buffer. 
The proteins were then separated on a gel, the proteins were extracted from the gel, 
digested with trypsin and analysed using the LTQ Orbitrap Velos Pro Mass-spec 
systems (Performed by Proteomics Facility, University of Dundee). The obtained data 
was analysed using the Mascot search engine using the Uniprot DB with rat as the 
taxonomic filter (performed by the Proteomics Facility, University of Dundee).  
The obtained data, showed that in the control (repulsing) cells, there were 
622 proteins identified in the N-cad sample, whereas 588 proteins were identified in 
the IgG control that can be considered background levels (See Table 4.2 and 
appendix for complete lists Tables 1 and 2). In the cells treated with TMX (invasive 
cells), 531 proteins were identified in the IgG control, while 672 proteins were 
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identified in the N-cad sample (See Table 4.2 and appendix Tables 3 and 4 for 
complete lists). 
 
Figure 4.14. Raf-activation does not affect the adherence junction complex. 
Western blot analysis of Co-IP using an antibody to N-cad or control IgG of NR-SCs 
that were treated for 36 hours with EtOH (-) or TMX (+). Blots were probed for N-cad, 
beta-catenin, alpha-catenin or p120-catenin. Shown is a representative blot of three 
independent experiments with similar results. 
 
To filter for background, N-cad pulled down lists were compared to the IgG 
control protein lists using http://www.cmbi.ru.nl/cdd/biovenn/ and the background 
proteins were removed. However, there is a caveat to this approach: N-cad and β-
catenin were identified specifically in N-cad samples of both the EtOH and TMX 
conditions which was consistent with what was found in the Co-IP (Figure 4.14), 
while α-catenin and p120-catenin were also detected in the IgG controls. Thus, by 
excluding α-catenin and p120-catenin, which are known interacting proteins of N-cad, 
valuable data of unknown proteins that could be interacting with N-cad could be lost. 
To avoid this, proteins associated with a relatively low score in the IgG controls could 
be excluded from the analysis. The proteins identified on the lists are associated with 
a score in a range from 1–11,000, in which the higher the score the greater 
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confidence that the protein ID is correct and a higher likelihood of a higher 
abundance in the sample. α-catenin and p120-catenin in the IgG were associated 
with a low score (p120-catenin: EtOH [61] and TMX [116]; α-catenin: EtOH [157]), 
while in the N-cad samples these proteins were associated with a higher score 
(p120-catenin: EtOH [116] and TMX [309]; α-catenin: EtOH [2947.42]) (Appendix 
Tables 1-4). However, we reasoned that the repulsion signal might have a temporal 
or weak interaction with N-cad, and thus might be present in a low abundance and 
potentially have a low score. Therefore we decided to take two parallel approaches: 
first, we included all proteins with a low score and filtered for background by 
removing all proteins on the IgG control protein lists; second, we included all proteins 
with a low score and included all proteins with a large score difference between the 
N-cad samples and IgG controls, using an offset of 2.5 fold difference based on the 
lowest difference between the scores in the N-cad samples and IgG controls of p120-
catenin (12.91 fold increase and 2.66 fold increase in EtOH and TMX samples 
respectively) and α-catenin (18.74 fold increase in the EtOH-treated samples) 
(Appendix Tables 5 and 6). 
 
Table 4.2. Summary of identified proteins. 
Table showing the total number of proteins identified in the IgG controls or in the N-
cad samples in NR-SCs treated with TMX and EtOH. n=1 
 
The resulting protein lists of the first approach showed that there were 207 
proteins identified in the control (EtOH) condition, while there were 262 proteins 
identified in the TMX condition (Appendix Table 7-9). In the second approach in 
which we include all proteins with a ≥2.5 fold difference in N-cad samples, five extra 
proteins were identified in the control cells including α- and p120-catenin and the 
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junction plakoglobin, while in the TMX treated cells an additional 22 proteins, 
including p120-catenin were identified, but most appeared to be background 
(Appendix Tables 5 and 6). Subsequently, the lists obtained from EtOH and TMX 
samples from the first approach were compared to each other to see differences and 
similarities in interactions between the two conditions. Surprisingly, relatively few 
proteins were detected in both conditions, with only 55 proteins being identified 
(Figure 4.15). These proteins included N-cad and β-catenin as expected, and in 
addition included other proteins related to the cytoskeleton such as vimentin, F-actin-
capping protein subunit beta and Myo18 (Appendix Table 7 red highlighted). 
However, nothing was identified that had previously been reported to be involved in 
repulsion signals. In the control (EtOH) condition, 147 proteins were identified (Figure 
4.15; Appendix Table 8), while in the invading cells (TMX) there were 207 proteins 
identified to be interacting with N-cad (Figure 4.15 and Appendix Table 9). This 
suggests that N-cad has a different interacting profile in repulsing (EtOH) and 
invading (TMX) cells, which could contribute to the loss of CIL in ERK activated cells. 
To identify candidates that might be interacting with N-cad to regulate CIL, a 
functional classification analysis was performed based on the protein class, for 
proteins present in the overlapping group, as well as proteins that are unique to EtOH 
or N-cad samples, using http://pantherdb.org. Most of the proteins were mapped and 
classified based on protein function, which included cell adhesion molecules, cell 
junction proteins, and cytoskeletal proteins, however there was nothing identified 
which could suggest a possible role in CIL (Figure 4.16-4.18 and Table 4.4). 
Moreover, molecules that have previously been described to play a role in CIL such 
as Wnt, Slit and Robo could not be detected in any condition. Importantly, while we 
found that Ephrin-A1 induces cell rounding, Ephrin-A1 and other ephrins or Eph 
receptors also were not identified in either the control or TMX condition. Moreover, 
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the FGF receptor, which has previously been reported to bind to N-cad could not be 
detected in the screen, although it has been reported to be expressed by Schwann 
cells (Grothe and Nikkhah, 2001; Williams et al., 2001). This preliminary data 
suggests that N-cad does not interact with these classes of molecules; however, an 
alternate possibility is that the conditions were not appropriate for detecting these 
interactions. 
 
 
 
 
 
Figure 4.15. Mass Spec analysis of N-cad complexes. 
Venn diagram showing the numbers of proteins interacting with N-cad specific to NR-
SCs treated with EtOH or TMX and interacting proteins present in both of the 
conditions. n=1. 
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Figure 4.16. Functional classification of proteins overlapping TMX and EtOH 
samples. 
Pie charts showing the functional classification of proteins identified to be interacting 
in both repulsing (EtOH) and invading (TMX) NR-SCs. A total number of 55 peptides 
were classified, of which 30 were mapped to a protein ID whereas 25 proteins could 
not be mapped. n=1. 
 
 
 
Table 4.3. Overview of proteins overlapping TMX and EtOH samples. 
Table showing proteins mapped in three different protein classes that were identified 
in both EtOH and TMX treated NR-SCs. n=1 
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Figure 4.17. Functional classification of proteins interacting with N-cad in EtOH 
treated samples. 
Pie charts showing the functional classification of proteins identified as interacting 
only in repulsing (EtOH) NR-SCs. A total of 147 proteins were classified of which 62 
were mapped to a protein ID whereas 85 proteins could not be mapped. n=1. 
 
 
 
 
Table 4.4. Overview of proteins interacting with N-cad in EtOH treated 
samples. 
Table showing proteins mapped to three different protein classes that were identified 
in both EtOH and TMX treated NR-SCs. n=1 
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Figure 4.18. Functional classification of proteins interacting with N-cad in TMX 
treated samples. 
Pie charts showing the functional classification of proteins identified as interacting in 
non-repulsing (TMX) NR-SCs. A total of 207 proteins were identified of which 107 
were mapped to a protein ID whereas 100 proteins could not be mapped. n=1. 
  
 
 
 
Table 4-5. Overview of proteins interacting with N-cad in TMX treated samples. 
Table showing proteins mapped to three different protein classes that were identified 
in TMX treated NR-SCs. n=1. 
TMX
Figure 4.18
Table 4.5
total proteins 207
Mapped proteins 107
Unmapped proteins 100
protease
cytoskeletal protein
transporter
transferase
oxidoreductase
lyase
cell adhesion molecule
ligase
nucleic acid binding
signaling molecule
enzyme modulator
calcium-binding protein
defense/immunity protein
hydrolase
transfer/carrier protein
phosphatase
transcription factor
chaperone
structural protein
receptor
Accession Description
G3V852 Protein Tln1 
Q5U302 Alpha-catenin
Accession Description
Q5U302 Alpha-catenin
G3V852 Protein Tln1 
P38650 Cytoplasmic dynein 1 heavy chain 1 
F1LMV9 Coronin (Fragment) 
Q6IFU8 Keratin, type I cytoskeletal 17 
P30427 Plectin 
O88656 Actin-related protein 2/3 complex subunit 1B 
Q3T1K5 F-actin-capping protein subunit alpha-2 
D3ZLC1 Protein Lmnb2 
Q6AYZ1 Tubulin alpha-1C chain 
Accession Description
B5DFB2 Protein Rbbp4
P15999 ATP synthase subunit alpha
Q5XI13 Glutamate-rich WD repeat-containing protein 1
Cytokeletal proteins
Cell Adhesion
Receptor
TMX
Figure 4.18
Table 4.5
total proteins 207
Mapped proteins 107
Unmap ed proteins 100
protease
cytoskeletal protein
transporter
transferase
oxidoreductase
lyase
cell adhesion molecule
ligase
nucleic acid binding
signaling molecule
enzyme modulator
calcium-binding protein
defense/immunity protein
hydrolase
transfer/carrier protein
phosphatase
transcription factor
chaperone
structural protein
receptor
Accession Description
G3V852 Protein Tln1 
Q5U302 Alpha-catenin
Accession Description
Q5U302 Alpha-catenin
G3V852 Protein Tln1 
P38650 Cytoplasmic dynein 1 heavy chain 1 
F1LMV9 Coronin (Fragment) 
Q6IFU8 Keratin, type I cytoskeletal 17 
P30427 Plectin 
O88656 Actin-related protein 2/3 complex subunit 1B 
Q3T1K5 F-actin-capping protein subunit lpha-2 
D3ZLC1 Protein Lmnb2 
Q6AYZ1 Tubulin alpha-1C chain 
Accession Description
B5DFB2 Protein Rbbp4
P15999 ATP synthase subunit alpha
Q5XI13 Glutamate-rich WD repeat-containing protein 1
Cytokeletal proteins
Cell Adhesion
Receptor
	   174	  
There were many proteins that could not be mapped for protein ID (TMX 
specific (100), EtOH specific (85); EtOH and TMX (26)) and whilst the majority of 
these proteins appeared to be related to mRNA processing and thus appeared to be 
background, some of these proteins appeared to be related to cytoskeletal proteins 
and cell junction proteins (Figure 4.16-4.18; Appendix Tables 7-9 See blue 
highlighted and yellow highlighted). One protein, glypican-4, identified specifically in 
the control (repulsing) cells, was of particular interest (Appendix Table 8 red 
highlighted). Glypicans are GPI-linked, heparan sulphate proteoglycan (HSPG) 
proteins located at the cell surface, and have been described to modulate the 
signalling of Wnt, Hedgehog, fibroblast growth factor, bone morphogenetic proteins 
and Slit and Robo either by promoting or inhibiting signalling (Filmus et al., 2008). 
Moreover, glypicans have been shown to play a role in axonal guidance by mediating 
repulsion, suggesting it could play a role in CIL in Schwann cells (Blanchette et al., 
2015; Filmus et al., 2008). Importantly, glypican-4 is only identified in the repulsing 
cells and not in the invading cells (TMX), suggesting that the interaction is lost upon 
Raf-activation, which correlates with the loss of CIL in ERK activated cells.  
To test a potential role of glypican-4 in CIL in Schwann cells, we performed 
some preliminary experiments. We initially set up a siRNA knockdown in Schwann 
cells using two independent oligos, and for both siRNA1 and siRNA2 an efficient 
knockdown (≥80%) of mRNA was detected by RT-qPCR at 36 hours (Figure 4.19). 
However, the knockdown could not be detected at protein levels due to the lack of an 
available antibody.  
To determine the role of glypican-4 in homotypic CIL in Schwann cells, 
scrambled, siRNA1 and siRNA2 treated cells were seeded at low density and as we 
do not know the turnover rate of glypican-4 protein levels in Schwann cells, cells 
were imaged for 72 hours following treatment with the siRNAs for 24 hours. 
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Figure 4.19. Glypican-4 siRNA knockdown is efficient. 
Graph showing RT-qPCR analysis of the mRNA expression levels of glypican-4 in 
scrambled-treated, or glypican-4 knockdown cells, treated with either siRNA 1 or 
siRNA2 for 36 hours. Results are shown relative to the expression in scrambled-
treated cells. Bars represent the mean of three experiments ±SEM. Two-way ANOVA 
Dunnett’s-multiple comparison test. 
 
Interestingly, the siRNA1 or siRNA2 treated cells appeared to be initially repulsed 
upon contact, however, many of the glypican-4 knockdown cells changed their 
behaviour around 48 hours after knockdown, when they appeared to be no longer 
repulsed upon contact, but adhered together and formed clusters, suggesting a role 
for glypican-4 in CIL (Figure 4.20 and Movie 4.5). This loss of CIL was quantified and 
strikingly, there was a marked decrease in repulsion events (siRNA1 ≥15%; siRNA2 
≥40%), and a dramatic increase in no-repulsion events (siRNA1 ≥20%; siRNA2 ≥ 
40%), while there was no change in invasion events, suggesting glypican-4 is 
required for CIL (Figure 4.20B). Moreover, this was not due to a decrease in velocity 
(Figure 4.20C). Surprisingly however, in contrast to the N-cad knockdown cells, 
which were invasive, glypican-4 knockdown cells appeared to be more adhesive, 
suggesting glypican-4 knockdown cells form adherence junctions. To test if glypican-
4 affected N-cad at the cell-cell junctions, glypican-4 knockdown cells were seeded 
onto coverslips and immunolabelled for N-cad. As expected, scrambled-treated cells 
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formed N-cad junctions between them (Figure 4.21). Interestingly, there appeared to 
be no increase of N-cad levels at the cell-cell junctions between glypican-4 
knockdown cells, suggesting glypican-4 does not affect N-cad levels (Figure 4.21). 
However, some of the junctions appeared tighter (arrows) in glypican-4 knockdown 
cells, suggesting the junctions are more stable, possibly because the repulsion signal 
is lost. This needs further investigation. These preliminary results show that glypican-
4 is required for CIL, by blocking the repulsion response. However, the interaction of 
N-cad with glypican-4 needs to be validated and further analysis needs to be done to 
determine the role of glypican-4 in CIL in Schwann cells. 
All together these results show that N-cad interacts with its cytoplasmic binding 
partners β-catenin, α-catenin and p120-catenin both in repulsing and invading cells, 
which is consistent with the findings in Chapter 3. Moreover, this preliminary data 
suggests that the Mass Spec specifically identified proteins interacting with N-cad 
and suggests that N-cad interacts with a different array of proteins in repulsing and 
invading cells. While this data suggests N-cad does not interact with known 
molecules that regulate CIL, it did identify a potential candidate, glypican-4, in the 
repulsing cells, which in preliminary experiments appears to play a role in CIL. This 
shows that this methodology provides a tractable system to identify proteins that 
differentially interact with N-cad and that may have a potential role in CIL.  
 
4.7. Chapter conclusions and discussion  
In this chapter, we showed that Schwann cells expressing DNp53 have intact 
CIL, while oncogenic Ras disrupts CIL in an ERK-dependent manner. Reminiscent of 
N-cad knockdown cells, Schwann cells expressing oncogenic Ras are invasive 
(Figure 4.19). Interestingly, loss of CIL by Ras-expressing cells is not caused by 
altered expression or functionality of N-cad, as N-cad can still localise at cell-cell  
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Figure 4.20. Glypican-4 is required for CIL in Schwann cells. 
(A) Representative phase-contrast images of time-lapse analysis a CIL assay in 
which cells were treated with scrambled siRNA or siRNA targeting glypican-4 (siRNA 
1 and siRNA 2) for 24 hours before imaging for 72 hours. Shown are images taken 
between 48 hours and 72 hours after siRNA knockdown. White arrows indicate the 
direction of migration. Arrowheads indicate repulsion or no-repulsion events. Note 
that the glypican-4 knockdown cells adhere upon contact. Cells of interest are 
indicated by blue and green dots. Scale bar 100μm. (B) CIL analysis in which 
repulsion, no-repulsion and invasion were quantified. 30 cells per experiment in each 
condition were analysed. Related to Movie 4.5. (C) Velocity analysis in which <30 
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cells of three independent cell were quantified. siRNA1 and siRNA2 were tested 
separately, and were normalised for the average velocity of the Scrambled-treated 
cells and then combined in one graph. T-Test was performed.  
 
 
 
Figure 4.21. Glypican-4 does not appear to affect N-cad levels at membrane 
junctions. 
Representative confocal images of cells treated with scrambled siRNA or siRNA 
targeting glypican-4 (siRNA 1 and siRNA 2) for 96 hours that were fixed and 
immunostained for N-cad (green) and costained with Hoechst (blue) and phalloidin to 
visualise F-actin (red). N-cad positive junctions are indicated with arrows. Scale bar 
50μm n=2 
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contacts, and Raf-activated cells are still able to grab axons, a property of Schwann 
cells, in an N-cad dependent manner (Figure 4.22). Moreover, the junction 
components α-catenin, β-catenin and p120-catenin still interact with N-cadherin as 
detected by Co-IP (Figure 4.22). Rather, oncogenic Ras disrupts CIL through loss of 
a distinct co-signal. This work, together with others’, also showed that N-cad 
regulates three very distinct processes namely: CIL, cell clustering and axonal 
grabbing, further suggesting the need for co-signals to mediate these distinct 
responses. In the case of cell clustering, Ephrin-B/EphB2 can be considered as a co-
signal as, via Sox2, it triggers a relocalisation of N-cad to the cell-surface, which in 
some way is sufficient to overcome the repulsion signals, resulting in the formation of 
stable cell junctions.  
In an attempt to uncover the mechanisms involved, the role of ephrins was 
explored as these proteins have been shown to be involved in CIL in other systems. 
The major, unexpected finding was the dramatic and numerous changes in the 
expression of both the ephrin ligands and their receptors in response to activation of 
the Ras/Raf/MEK/ERK signalling pathway indicating a likely important role for this 
pathway in controlling both the transcriptional pattern of expression and based on 
this, how cells recognise each other and other cell types. 
A particularly intriguing finding was that inhibiting MEK was sufficient to fully 
revert the morphology of Ras-transformed Schwann cells and re-establish cell-cell 
recognition. This also correlated with the restoration of the expression levels of the 
majority of the Eph receptors and their ligands, consistent with a potential role in 
mediating CIL. This may have important implications for the invasive properties of 
Ras-expressing cancer cells and should be further explored. 
We further showed that homotypic and heterotypic CIL involves distinct 
mechanisms in that while heterotypic CIL between Schwann cells and fibroblasts is 
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EphB2 dependent, homotypic CIL between Schwann cells is EphB2 independent 
(Figure 4.23). However, both processes are disrupted by Ras-signalling and the 
mechanisms behind this remain to be determined, however the strong 
downregulation of EphB2 levels following Ras expression is likely to play a role in 
heterotypic CIL between fibroblasts and Schwann cells. 
In preliminary experiments to address the potential role of the ephrin-A family 
in homotypic CIL, we showed that pre-clustered Ephrin-A1 induced retraction of the 
Schwann cell periphery, which was associated with a change of the actin 
cytoskeleton, suggesting it was capable of inducing a repulsion signal in Schwann 
cells. In contrast, while Ephrin-A4 could bind to Schwann cells it appeared to have 
only a mild effect on the retraction of the cell periphery. This work further showed that 
Fyn, which has been shown to be a downstream target of Ephrin-A and mediates 
axonal repulsion, does not mediate CIL between Schwann cells, suggesting reverse 
signalling through the Ephrin-A ligand is not required for CIL.  
Using a combination of Co-IP and mass spectrometry, we attempted to 
identify a possible N-cad dependent repulsion signal and tested if this was lost in Erk 
activated Schwann cells. We successfully identified known interacting binding 
partners such as β-catenin, which was interacting with N-cad both in the repulsing 
and invading cells showing we could specifically identify proteins interacting with N-
cad. However, while we could detect α-catenin and p120-catenin, they were also 
found in the IgG controls, suggesting further optimisation of the methodology is 
needed. These preliminary experiments further showed that Raf activation 
completely changes the interacting profile of N-cad, suggesting that this could 
possibly be a mechanism by which CIL is lost in ERK activated cells (Figure 4.22). 
Moreover, a potential candidate, glypican-4, was identified interacting with N-cad in 
the repulsing cells, which appeared to be lost in invading cells, suggesting it could 
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play an role important in mediating CIL. In preliminary experiments, we addressed 
the role of glypican-4 in CIL in Schwann cells using siRNA knockdown, which 
showed that loss of glypican-4 results in the loss of the repulsion response, which 
causes the cells to adhere together, suggesting it could play a role in CIL.  
Thus, these preliminary experiments show that we have established a robust 
system to identify the N-cad dependent repulsion signal. However, this needs to be 
reproduced and further optimisation of the methodology is required to avoid loss of 
proteins with a temporal or weak interaction perhaps by using a non-membrane 
permeable cross linker such as 3,3’-Dithiobis(sulfosuccinimidylpropionate) (DTSSP). 
Moreover, interactions of the extracellular domain with a potential co-signal could be 
targeted specifically by the use of the extracellular domain tagged with mCherry and 
Co-IP for mCherry.  
Figure 4.22. Schematic overview of effects of oncogenic Ras on CIL.  
A diagram showing that while normal Schwann cells repulse upon contact, following 
hyperactive signalling of Ras, Schwann cells lose repulsion and become highly 
invasive. It is unclear how Ras disrupts CIL, however Ras regulates the expression 
patterns of the Eph receptor and ligands, the majority in a MEK dependent manner. 
Moreover, Ras does not change the interaction of N-cad with p120-catenin, α-catenin 
and β-catenin, nor does it appear to change the function of N-cad as Raf activated 
Schwann cells can still grab axons in an N-cad-dependent manner. However it does 
appear to change the interaction with glypican-4. 
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Figure 4.23. Heterotypic and homotypic CIL between Schwann cells and 
fibroblasts are differentially mediated. 
i. Heterotypic interactions between Schwann cells and fibroblasts induces a switch in 
the behaviour of Schwann cells from repulsive to attractive. Mechanistically, Ephrin-
B/EphB2 repulsive signalling induces the activation of Sox-2 that in turn induces the 
relocalisation of N-cad to the cell-cell junctions, causing Schwann cells to cluster. ii. 
Schwann cells are repulsed upon contact in a N-cad dependent manner, preliminary 
data suggests a role for Ephrin-A1 or possibly glypican-4. In contrast, while EphB2 
mediates heterotypic CIL between fibroblasts and Schwann cells, homotypic CIL 
between Schwann cells is EphB2 independent.  
 
 
4.7.1. Loss of cell-cell recognition in NF1   
Losing cell-cell recognition is a hallmark of cancer, which can cause 
unwanted movement of cells and invasion of tissues, and eventually metastasis 
(Hanahan and Weinberg, 2011).  A longstanding question is how cancer cells lose 
cell-cell recognition and how this contributes to the formation and progression of 
tumours and ultimately metastasis. Neurofibromas are benign tumours that are highly 
disorganised and are thought to resemble the injured nerve (Lassmann et al., 1976; 
Parrinello and Lloyd, 2009). Neurofibromas have a similar cell composition to the 
injured nerve, including fibroblasts, mast cells, and dedifferentiated Schwann cells. 
Additionally, Schwann cells in neurofibromas have the ability to hyperproliferate, and 
may also be found dissociated from axons (Kim et al., 1997; Parrinello et al., 2010) 
This suggests, that the heterotypic and homotypic interactions that normally keep 
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Schwann cells quiescent are lost during the formation of the tumour. Moreover, it 
suggests that the Schwann cells become migratory. Though it is well established that 
NF1 results from hyperactive Ras signalling, how heterotypic interactions and 
homotypic interactions are lost during tumourigenesis of NF1 is unclear. We have 
recently shown in vitro, using DRGs explants with Schwann cells which recapitulates 
the nerve interactions, that activating Raf in myelinating Schwann cells was sufficient 
to induce Schwann cell dissociation from the axons (Parrinello et al., 2008). 
Moreover, we showed that the heterotypic interaction between Schwann cells was 
mediated by Sema4F, and that loss of Sema4F in Schwann cells was sufficient to 
induce Schwann cell dissociation. Moreover, loss of these interactions via 
knockdown of Sema4F resulted in increased proliferation of Schwann cells in the 
DRG Schwann cell co-cultures. Now we show that in addition to losing heterotypic 
cell-cell interactions, Schwann cells expressing oncogenic Ras lose homotypic cell-
cell recognition in an ERK-dependent manner. We show that loss of cell-cell 
recognition results from loss of CIL between Schwann cells expressing oncogenic 
Ras, which become highly invasive and appear to protrude and extend their 
protrusions more frequently, consistent with previous reports (Dow et al., 2008; Lloyd 
et al., 1997; Ridley et al., 1988). 
How could loss of homotypic CIL contribute to tumourigenesis of NF-1? The 
mechanisms of tumour cell migration rely on the same principles of cell migration 
during normal processes such as migration during development and wound healing 
(Friedl and Alexander, 2011). Likewise, it is thought that while heterotypic CIL 
between cancer cells and surrounding cells is impaired, allowing invasion of 
surrounding tissues, homotypic CIL remains intact during tumourigenesis, which 
could contribute to cancer dissemination (Abercrombie, 1979; Astin et al., 2010; 
Batson et al., 2014). Recent reports showed that CIL between prostate cancer cells 
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PC3 remained intact, a process mediated by EphA2/EphA4 (Astin et al., 2010). 
Moreover, using chamber assays and cancer cell spheroid migrations assays, it was 
shown that homotypic CIL is required for the cell dispersal of PC3 cells, which could 
be a potential mechanism of the dispersal of prostate cancer cells from the tumour 
leading to local single cell invasion (Astin et al., 2010; Batson et al., 2014). In 
contrast, in this work we showed that homotypic CIL between Schwann cells 
expressing oncogenic Ras is lost, and the cells become invasive, suggesting loss of 
CIL of Schwann cells in neurofibromas. Though neurofibromas are benign tumours 
and do not metastasise, Schwann cells are frequently found dissociated from the 
axons, suggesting Schwann cells become motile. Interestingly, NF1-/- cells extracted 
from the peripheral nerve, are more invasive and migratory than their NF1+/+ counter 
parts in vitro (Kim et al., 1997; Sheela et al., 1990). Thus this could suggest that loss 
of homotypic CIL in Ras Schwann cells could allow Schwann cells to break away 
from existing contacts, which could contribute to increased migration and local 
invasion into the surrounding tissues. However, this needs to be further tested.  
Ras is thought to play a role in tumourigenesis by inducing hyperproliferation, 
cell migration and invasion (Pylayeva-Gupta et al., 2011). Ras was originally 
identified as an oncogene using focus-formation assays which by definition permit a 
cell to overcome the constraints of a confluent monolayer and proliferate- suggesting 
a change in cell:cell recognition (Der et al., 1982; Goldfarb et al., 1982; Parada et al., 
1982; Santos et al., 1982; Shih and Weinberg, 1982). Since then, multiple studies 
have shown that oncogenic Ras expression induces loss of cell-cell recognition but 
the mechanisms remain poorly understood (Pylayeva-Gupta et al., 2011). As for 
many cells, activation of Ras signalling pathways in Schwann cells results in the cells 
growing on top of each other, and we showed that this is associated with a loss of 
CIL, suggesting these two properties may be linked. But how does oncogenic Ras 
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disrupt CIL in Schwann cells? Following our findings that N-cad knockdown cells also 
lose CIL, grow on top of each other and somewhat resemble Ras-transformed cells, 
we considered that inhibition of N-cad was a potential mechanism. Moreover, 
cadherin switching from E-cad to N-cad expression has been shown to play a major 
role in regulating migration and invasion in tumour cells and aberrant expression of 
N-cad is associated with poor prognosis (Berx and van Roy, 2009; Wheelock et al., 
2008). However, somewhat to our surprise, we find that Ras-expressing cells 
maintain similar levels of functional N-cad. However unlike normal cells, Ras 
Schwann cells appear to be unable to make stable homotypic cell-cell junctions, even 
though N-cad is localised at transient cell-cell contacts. Intriguingly, while N-cad 
mediated homotypic CIL is severely impaired, the N-cad mediated heterotypic 
interaction of axonal grabbing by Schwann cells remains unaffected by hyper-
activated Ras/Raf signalling, suggesting N-cad is still functional and that hyperactive 
Ras/Raf-signalling differentially affects these processes, probably through abrogating 
a co-signal required for CIL. We also show using a combination of Co-IP and Mass 
Spec that hyperactive Ras signalling does not affect the interaction of N-cad with the 
adherence junction components α-catenin, β-catenin and p120-catenin, consistent 
with our findings that CIL is independent of the intracellular domain, and independent 
of the intracellular binding partners of N-cad. However, preliminary data from our 
Mass Spec analysis suggests that hyperactive Raf signalling changes the N-cad 
interacting profile. Of particular interest is the interaction of N-cad with glypican-4, a 
HSPGs, which have been suggested to play a role in axonal guidance, directional 
migration and CIL (Blanchette et al., 2015; Fritz et al., 2015; Matthews et al., 2008).  
Interestingly, preliminary results showed that glypican-4 plays a role in CIL 
mediating a repulsion response. This is consistent with a role of glypican in mediating 
a netrin/Slit-mediated repulsion response of axons during the larval development in 
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C. elegans (Blanchette et al., 2015). Intriguingly, in contrast to loss of N-cad, loss of 
glypican-4 does not result in invasion, rather blocks the repulsion response, which 
causes the cells to adhere together. This contradictory result is probably due to N-
cad still being at the membrane, which might be stabilised in adherence junction 
complexes upon loss of the repulsion signal. Alternatively, rather than mediating 
repulsion, glypican-4 may directly regulates the levels of N-cad at the membrane, 
and the observed adhesiveness in Schwann cells upon loss of glypican-4 is due to 
increased levels of N-cad at the membrane. Preliminary results argue against this, as 
there appears no obvious difference of N-cad levels at the junctions between 
scrambled-treated and glypican-4 knockdown cells. However, it could be that subtle 
changes in N-cad protein levels and trafficking are missed. This needs further 
investigation. Moreover, another possibility in the difference between the invasive 
phenotype in N-cad knockdown cells and the clustering phenotype in glypican-4 
knockdown cells may be that the repulsion signal is still present.  
What could be the role of glypican-4 in CIL? Glypicans are GPI-linked 
proteins that have been shown to modulate signalling pathways, by stabilising or 
interfering with the ligand/receptor interactions of pathways including BMP, FGF and 
Hedgehogs signalling as well as pathways shown to play a role in CIL such as Wnt, 
Robo and Slit (Blanchette et al., 2015; Filmus et al., 2008). For example, glypican 
has been shown to inhibit Hedgehog signalling by competing for the ligand, 
preventing it from binding to the receptor, or enhance Wnt signalling by stabilising the 
interactions between ligand and receptor (Capurro et al., 2005; Capurro et al., 2008). 
This suggests, that glypican-4 may not be the repulsion signal, but possibly stabilises 
an interaction between N-cad and a repulsion signal (such as Ephrin-A1) and the 
receptor on the receiving cell. However, the role of glypican-4 in CIL between 
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Schwann cells needs be further investigated and will be a priority in future 
experiments.  
Aberrant expression of Eph receptors and their ligands have been associated 
with invasion, metastasis of several tumours including melanoma, prostate, breast 
and colon cancers and lung carcinoma (Pasquale, 2010). However, the overall 
picture is somewhat complex and confusing, and future studies are needed to clarify 
the complexities involved. Ephrins have been reported to be tumour promoting or 
tumour suppressive, depending on the tumour type and study. Moreover, ephrins 
have been implicated in boundary formation, cell segregation and CIL, which could 
all be predicted to have a role in cancer. Here we show that the Ras/Raf/Mek/ERK 
pathway induces dramatic and several changes in the mRNA expression levels of 
ephrins, suggesting ephrins have a crucial role in tumourigenesis of the Schwann 
cells in NF-1. In some compelling studies of the small intestine, the role of ephrins 
have been shown to have an important role in cell boundary control in normal tissue 
with loss of these controls associated with the early stages of tumour formation 
(Batlle et al., 2002). In these studies, it was found that EphB2 and EphB3 are 
required for compartmentalisation of Paneth cells in the crypt of the normal 
epithelium by preventing intermingling of the EphB and ephrin-B cell populations. 
Loss of EphB2 or EphB3 results in the aberrant positioning of Paneth cells, indicating 
EphB signalling is crucial for boundary formation. Later studies showed, that EphB 
suppresses tumour progression of adenomas into carcinomas (Batlle et al., 2005; 
Cortina et al., 2007). EphB2 and EphB3 are required to keep adenomas 
compartmentalised and prevent growth and migration into the surrounding tissues 
(Cortina et al., 2007). At the transition of adenomas into carcinomas CRC, EphB2, 
EphB3 and EphB4 are downregulated, the tumours become highly invasive and 
invade the surrounding tissues (Batlle et al., 2005). Moreover, later studies showed 
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that EphB mediates compartmentalisation by cell sorting of Ephrin-B and EphB 
expressing cells through regulating differential adhesion (Solanas et al., 2011).  
Similarly, in a previous study we found that that Ephrin-B/EphB2 signalling 
between fibroblasts and Schwann cells induces Schwann cell sorting, through N-cad 
re-localisation to Schwann cell junctions, which is required for the Schwann cells to 
migrate as a collective following a nerve injury (Parrinello et al., 2010). In this study, 
we show that Ephrin-B/EphB2 signalling mediates heterotypic CIL between 
fibroblasts and Schwann cells suggesting this could mediate the cell sorting of the 
two populations. Moreover, we showed that following hyper-activating Ras, EphB2 
and EphB3 are downregulated, and in preliminary data (not shown) my colleague 
found that Schwann cells expressing oncogenic Ras lose heterotypic CIL, become 
invasive and migrate over fibroblasts. This could suggest that in neurofibromas, 
which consist of a mixed cell population including fibroblasts, that loss of heterotypic 
CIL could contribute to the unwanted movement of the Schwann cells, however this 
needs to be further tested.  
 Other studies have shown that EphA2 is frequently upregulated in tumours 
such as melanoma, prostate, breast and colon cancers and lung carcinoma 
(Pasquale, 2010). EphA2 induces cells migration and invasion in several cancer cell 
lines (Pasquale, 2010; Taddei et al., 2011). Interestingly in the breast cancer cell line 
MCF17, EphA2 is upregulated in a MEK dependent way, while Ephrin-A1 is 
downregulated by Ras in a MEK dependent manner (Macrae et al., 2005). Similarly, 
we report here in Schwann cells expressing oncogenic Ras that EphA2 is 
upregulated, while Ephrin-A1 is slightly down regulated in a MEK dependent manner 
indicating common regulatory mechanisms in distinct cell types. However, whether 
aberrant signalling of Eph receptors and their ligands are responsible for the Ras-
induced loss of homotypic CIL between Schwann cells remains undetermined. 
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4.7.2. Repulsion signals  
In the previous chapter we showed that N-cad induces a repulsion response 
independent of the adherence junction complex, independent of trans-
homodimerisation, and that N-cad is not required for the cell to be repulsed in a N-
cad dependent manner. Rather N-cad mediates repulsion through the extracellular 
domain, by providing a repulsion signal to the other cell. N-cad is not required for the 
cell to be repulsed in a N-cad dependent manner, thus N-cad induces forward 
signalling but not “reverse signalling”. This is reminiscent of Ephrin-A/EphA 
signalling, which typically only induces forward signalling, as Ephrin-A is a GPI-linked 
protein and typically does not induce reverse signalling (Kania and Klein, 2016). 
Consistent with this hypothesis, we show here that stimulating the Schwann cells 
with pre-clustered Ephrin-A1, a GPI-linked protein, induces retraction of the cell 
periphery and reorganises the actin cytoskeleton. This is consistent with previous 
studies of the prostate cancer cell line PC3, in which pre-clustered Ephrin-A induces 
cell rounding/ retraction of the cell periphery in a RhoA/MyosinII dependent manner 
(Astin et al., 2010; Parri et al., 2007). Moreover, it was shown that Ephrin-A1 and 
Ephrin-A5 can inhibit migration in transwell migration assays, and that Ephrin-A5 is 
sufficient to induce CIL (Astin et al., 2010). This could suggest that similarly, Ephrin-
A1 could mediate CIL between Schwann cells. However, whether Ephrin-A1 does 
indeed mediate CIL in Schwann cells is unclear. One possibility we considered is that 
there is a direct interaction between N-cad and Ephrin-A1, with N-cad acting in some 
way to “present” the signal. Arguing against this hypothesis is that in preliminary data 
we failed to detect Ephrin-A1 or any other ephrins by Mass Spec, suggesting it does 
not interact with N-cad. However, as discussed previously, this could be due to a low 
binding affinity to N-cad, or a very temporal interaction. A further possibility could be 
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a much more indirect mechanism. In future studies, optimisation of the 
methodologies will be carried out to search for interacting proteins using the 
extracellular domain of N-cad as bait. Moreover, the role of Ephrin-A1 and other 
members of the family will be determined using siRNA studies, inhibitor studies and 
analysis of downstream effectors such as src, RhoA and MyoII. Moreover, the 
sufficiency of the signals will be explored using repulsion assays such as stripe 
assays in which stripes of Ephrin-A are coated using microcontact printing. Moreover, 
it would be interesting to see if an interaction between glypican-4 and Ephrin-A1 is 
required to mediate CIL.   
Ephrin-A does not typically induce a bidirectional signal, as it is GPI-linked 
protein, however, there are exceptions which involve Ephrin-A interacting with other 
cell surface receptors (Bonanomi et al., 2012; Lim et al., 2008; Marler et al., 2008). In 
axons, Ephrin-A engagement has been shown to induce reverse signalling through 
interactions with the neurotrophin receptors Ret, TrkB and p75 to mediate repulsion, 
branching and synaptogenesis of the axons (Bonanomi et al., 2012; Lim et al., 2008; 
Marler et al., 2008). These studies showed that Ephrin-A2 and Ephrin-A5 can interact 
with p75, and that this interaction is required for the repulsion of growing axons of 
retinal ganglion cells explants in response to EphA7 (Lim et al., 2008). The authors 
propose that p75 transduces the Ephrin-A reverse signal, which results in 
phosphorylation of Fyn, a known downstream target of Ephrin-A. However, whether 
Fyn is required for the repulsion of retinal ganglion cells was not reported. In contrast, 
in a study in PC3 cells, reverse signalling through Ephrin-A ligands was not required 
to mediate CIL (Astin et al., 2010). In this study we showed that whilst specific Fyn 
inhibition was able to block cytokinesis in Schwann cells, Fyn is not required for CIL 
between Schwann cells. This suggests, that CIL is not mediated through Ephrin-A 
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reverse signalling, consistent with Ephrin-A1 inducing cell rounding, and consistent 
with N-cad providing a repulsion signal that does not induce reverse signalling.  
In conclusion, we propose a model in which N-cad mediates CIL independent 
of trans-homodimerisation, independent of the intracellular domain and the 
adherence junction components α-, β- and p120-catenin through which N-cad 
typically signals (Figure 4.24). Rather, N-cad provides a repulsion signal, to the other 
cell, possibly through interaction of the extracellular domain with a co-signal. 
Preliminary data indicates that glypican-4 or Ephrin-A1 are potential candidates 
(Figure 4.24) 
 
 
Figure 4.24 N-cad mediates repulsion possibly through interaction with a co-
signal. 
CIL in Schwann cells is mediated by N-cad through a mechanism independent of 
trans-homodimerisation and of its interacting molecules α-catenin, p120-catenin and 
β-catenin. Rather, N-cad provides a repulsion signal into the other cell, which is then 
repulsed. We propose that this co-signal could be Ephrin-A1 which induces cell 
rounding, or glypican-4 which preliminary work shows to specifically interacts with N-
cad in Schwann cells that are repulsive, but this interaction is lost in cells that are 
invasive.
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Chapter Five: Results III 
Uncovering the mechanism of heterotypic Schwann cell-endothelial cell 
interactions 
5.1. Chapter introduction 
In the previous two chapters we described that the adhesion molecule N-cad 
mediates CIL by providing a signal to the contacting cell. CIL can polarise cells in the 
direction of migration and as such can be required for directional migration of 
individual cells (Carmona-Fontaine et al., 2008). Similarly, in collective migration, CIL 
mediates polarisation of the leader cells, which is required for the directional 
migration of the group (Theveneau et al., 2010). The polarity and collective migration 
of cells is further mediated through soluble factors secreted in the local environment 
such as cytokines, and through interactions with ECM via adhesion molecules such 
as integrins (Mayor and Etienne-Manneville, 2016). We have previously shown that 
upon injury, collective Schwann cell migration is required for axonal regeneration 
(Parrinello et al., 2010). To achieve this, Schwann cells need to migrate across a new 
‘bridge’ of tissue that forms between the two nerve stumps and consists of 
inflammatory cells, fibroblasts and ECM. One of the major questions was how 
Schwann cells could migrate directionally through this densely-packed tissue, and 
how Schwann cell migration is induced. In recently published work, we showed that 
polarised blood vessels form in the bridge prior to Schwann cell migration (Cattin et 
al., 2015). We showed that Schwann cells associate with the blood vessels in the 
bridge. Moreover, as discussed in the introduction, the polarised blood vessels 
provide directionality to the migrating Schwann cells, which use the vasculature as a 
track.  
The Schwann cell-endothelial cell interaction could be recapitulated in vitro, 
by culturing Human Umbilical Vein Endothelial Cells (HUVECs) in fibrin gels together 
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with GFP-labelled Schwann cells. In these assays, the HUVECs form tubule-like 
structures and importantly, Schwann cells associated with the tubules and migrated 
along them {Cattin, 2015 #61}. Correlative light electron microscopy (CLEM) showed 
that there were discrete but direct interactions between the Schwann cells and 
endothelial cells suggesting that Schwann cells could migrate via direct interactions 
with the blood vessel surface. Moreover, Schwann cells within the 3D matrix in the 
absence of blood vessels failed to migrate. This provides a mechanism to control SC 
migration within new tissue by limiting migration through the matrix, but permitting 
migration along the surface of endothelial cells thus providing directionality to this 
process.  
To further understand the nature of the Schwann cell interactions with the 
endothelial cells and to determine how Schwann cells migrate along the blood 
vessels, we looked at molecules that could mediate these direct interactions. The 
work we present here has been published and was done in collaboration with Dr. 
Anne-Laure Cattin. 
 
5.2. Assessing the role of β1-integrin on Schwann cell migration   
From the analysis of time-lapse imaging it appeared that Schwann cells migrating in 
3D along HUVEC tubules in fibrin gels appeared to adopt a more amoeboid-like 
mode of migration, which is characterised by protrusion extension at the front of the 
cell and an actomyosin dependent contraction of the rear (Cattin et al., 2015; 
Lammermann and Sixt, 2009; Liu et al., 2015). In contrast, Schwann cells in 2D 
migrate in a classical adhesion-dependent manner with large lamellipodia forming in 
the subsequent direction of migration (Figure 3.1. Movie 5.1). Cells adhere and 
transduce forces to the substratum through focal adhesion complexes, in which 
integrins link the substratum and the cytoskeleton. Binding to specific types of 
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substrate is dependent on the types of integrins expressed. Laminin staining of the 
fibrin tubules showed that they express laminin, suggesting Schwann cells could use 
this as a substrate to migrate along (Cattin et al., 2015). β1-integrin is required for 
adhesion to laminin, which is expressed by Schwann cells. Moreover, Schwann cell 
migration on 2D-laminin is blocked when β1-integrin is inhibited using function-
blocking antibodies (Milner et al., 1997). To understand if β1-integrin is required for 
Schwann cell migration in 2D, we set up a knockdown protocol, treating the cells with 
two independent siRNAs targeting β1-integrin for 36 hours before harvesting for 
protein analysis using Western blot analysis. β1-integrin was detected by Western 
blot in scrambled-treated cells but was efficiently downregulated following treatment 
with either siRNA1 or siRNA2 (>90%) (Figure 5.1A). Subsequently, scrambled-
treated cells or siRNA treated Schwann cells were seeded at low density onto 
laminin-coated dishes, imaged for 24 hours using time-lapse microscopy and 
analysed for their migratory behaviour. Scrambled-treated Schwann cells migrated 
normally with broad lamellipodia (Movie 5.1 and Figure 5.1B). However, the majority 
of the siRNA1 or siRNA2 treated Schwann cells adopted a rounder morphology and 
migration was severely impaired, showing that β1-integrin is required for Schwann 
cell migration on laminin in 2D (Movie 5.1; Figure 5.1B). To quantify this, the speed of 
migration was measured. Scrambled-treated cells showed a wide distribution of 
migration velocities, of between 0 and 2.5 arbitrary units (Figure 5.1C). In contrast, 
the majority of cells treated with siRNA1 showed a decrease in migration speed with 
an even greater effect seen in the cells treated with siRNA2, with the majority of the 
cells severely impaired in their migration (Figure 5.1C). However, the effect seen in 
the quantification of the velocity of the β1-integrin knockdown cells appeared to be 
less striking than the videos suggested. This is likely due to the movement of the 
nucleus in the cell, likely causing an overestimation of the velocity in non-migrating  
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Figure 5.1. β1-integrin is required for 2D Schwann cell migration. 
A. Western blot analysis of β1 integrin protein in Schwann cells treated with 5nM 
scrambled siRNA (scr), siRNA 1 (si1) or siRNA 2 (si2) for 36 hours. This experiment 
was done by Dr. Anne-Laure Cattin. B. Representative still images of time-lapse 
microscopy of scrambled-treated Schwann cells or β1-integrin knockdown Schwann 
cells (siRNA2) at 36 hours after knockdown. Note that the β1-integrin knockdown 
cells do not migrate. C. Quantification of cell velocity, in which cells were tracked for 
12 hours. A total of 50 cells from two independent experiments were quantified 
siRNA1 and siRNA2 were tested separately, and were normalised for the average 
velocity of the Scrambled-treated cells and then combined in one graph. T-Test was 
performed. Related to movie 5.1. 
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cells. These results show that Schwann cells migrate on laminin in a β1-integrin 
dependent manner, which is consistent with previous reports (Milner et al., 1997; 
Ness et al., 2013).  
Focal adhesion complexes are large complexes consisting of integrins, which 
connect the ECM to the actin cytoskeleton through several adaptor proteins, 
including talins. To further test if focal adhesion complexes are required for 2D 
Schwann cells migration, talin 1 and talin 2, were down regulated using siRNA as 
both talin 1 and 2 are expressed by Schwann cells. Therefore, we used a 
combination of siRNAs to target both genes to ensure complete disruption of integrin 
signalling. We set up the siRNAs at several concentrations at different time points (36 
hours, 48 hours, 60 hours and 72 hours) and assessed the knockdown efficiency 
using western blot and immunostaining. It appeared that it took up to 60 hours for the 
protein to be lost using a total of 8nM siRNA, suggesting a slow turnover of talin (data 
not shown). Talin has a diffuse cytoplasmic localisation in Schwann cells, but a 
stronger localisation in puncta, which can be detected at the tip of protrusions 
(arrows), consistent with localisation in focal adhesion complexes (Figure 5.2A). In 
contrast, following efficient knockdown of talin 1 and talin 2 using combination siRNA 
1, there was a strong decrease in talin immunostaining, and importantly, talin could 
no longer be detected in the puncta, suggesting talin is no longer present in the focal 
adhesion complexes (Figure 5.2A). In contrast, knockdown of talin 1 and 2 using 
combination siRNA 2 was less efficient, as some talin could still be detected in 
puncta (Figure 5.2A). Next we tested whether knockdown of talin affects Schwann 
cell migration on 2D laminin. As expected, scrambled-treated Schwann cells 
migrated with large lamellipodia in the direction of migration (Figure 5.2B; Movie 5.2). 
Strikingly, the vast majority of Schwan cells treated with siRNA1 became more 
rounded and appeared to protrude and extend fewer processes than the β1-integrin 
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knockdown cells and they failed to migrate efficiently, resembling β1-integrin 
knockdown cells (Figure 5.2B and Movie 5.2). This shows, as might be expected that 
talin1 and talin2 are required for Schwann cell migration on laminin (Figure 5.2B). In 
contrast, while the majority of the Schwann cells treated with siRNA2 had impaired 
migration, some cells migrated normally consistent with the level of knockdown 
(Figure 5.2A and B; Movie 5.1). This indicates that 2D migration is dependent on and 
talin 1 and 2, which should block all integrin mediated-migration, and had a strikingly 
similar effect on Schwann cell migration to β1-integrin knockdown cells, further 
showing that Schwann cell migration on 2D is integrin-dependent. Moreover, this 
suggests that in 2D, Schwann cells migrate in an adhesion dependent manner that is 
mediated through the focal adhesion complex proteins β1-integrin and talin 1 and 2, 
which is consistent with a mesenchymal mode of migration that is associated with 
high levels of adhesion and low levels of confinement (Lammermann and Sixt, 2009). 
 
5.3. β1-integrin is not required for Schwann cell migration along blood 
vessels 
To test if Schwann cells require β1-integrin to interact and migrate along the blood 
vessels in 3D, we used a matrigel assay, in which HUVECs form tubule-like 
structures within 14 hours, and to which we can add Schwann cells, allowing us to 
address the effect of the siRNA knockdown of β1-integrin and talin on the migration 
of Schwann cells along the vasculature. This is in contrast to the fibrin gel system in 
which the Schwann cells and HUVECs are added together, and the analysis is done 
after 10 days, which is not suitable for the use of transfected siRNA knockdown cells.  
To do this, HUVECs were seeded onto matrigel and tubules were allowed to form. 
Scrambled- or siRNA-treated GFP-labelled Schwann cells were subsequently seeded 
onto the tubules and imaged for 24 hours using time-lapse microscopy. Scrambled-  
	   198	  
Figure 5.2. Talin 1, talin 2 and β1-integrin are required for 2D Schwann cell 
migration. 
A. Representative confocal images of Schwann cells treated with 8nM scrambled 
siRNA, combination siRNA 1 (siRNA1) or combination siRNA 2 (siRNA2) for 60 hours 
immunostained for talin (red) and costained with Hoechst (blue). Arrows indicate 
stronger talin localisation at focal adhesion foci, which is lost in the talin KD cells. 
This experiment was done by Dr. Anne-Laure Cattin. B. Representative still images 
of a time-lapse microscopy of scrambled-treated Schwann cells or talin knockdown 
Schwann cells (siRNA1) at 60 hours after knockdown. C. Quantification of the 
velocity, in which cells were tracked for 12 hours; a total of 50 cells from two 
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independent experiments were quantified. siRNA1 and siRNA2 were tested 
separately, and were normalised for the average velocity of the Scrambled-treated 
cells and then combined in one graph. T-Test was performed.. Related to Movie 5.2. 
 
 
 
 
 
 
 
Figure 5.3. Schwann cells migrate along tubules.  
Upper panel: Representative phase-contrast still images of time-lapse microscopy of 
GFP-labelled scrambled-treated Schwann cells migrating along an endothelial cell 
tubule formed in a matrigel. Lower panel: Representative GFP-images of time-lapse 
microscopy of GFP-labelled scrambled-treated Schwann cells migrating along the 
tubule (see outline). Note that the Schwann cells along the tubules adopt a more 
amoeboid-like morphology. Related to Movie 5.3. 
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treated GFP-labelled Schwann cells interacted directly with the tubules and the 
majority migrated along the tubules with forward protrusion extension and rear 
contraction, causing movements along the tubules, in a similar manner to Schwann 
cells migrating along blood vessels in fibrin gels (Movie 5.3; Figure 5.3). Interestingly, 
β1-integrin knockdown cells appeared to interact normally with the HUVECs, 
showing that loss of β1-integrin does not impair recognition of the tubules (Movie 5.3; 
Figure 5.3). Surprisingly, whilst β1-integrin knockdown dramatically inhibited 2D 
migration on laminin, in 3D the majority of the β1-integrin knockdown Schwann cells 
migrated along the tubules in a similar manner to control cells (Movie 5.3; Figure 
5.4). This indicates that in contrast to 2D migration, Schwann cell migration in 3D is 
not impaired following β1-integrin knockdown. Similarly, we tested whether Schwann 
cell migration along HUVECs was dependent on talin1 and 2 by seeding talin 1 and 
talin 2 knockdown cells onto HUVEC tubules. Interestingly, talin 1/2 knockdown cells 
also interacted with the HUVECs, and the majority migrated along the tubules 
indistinguishably to control scrambled-treated cells. This indicates that Schwann cells 
migration in 3D is independent of talin 1 and talin 2 (Movie 5.3; Figure 5.4). 
Quantification of this showed that scrambled-treated cells have a wide distribution of 
velocities, but the majority of the cells migrated efficiently along the tubules (Figure 
5.6A). Interestingly, β1-integrin knockdown Schwann cells treated with siRNA1, 
which were unable to migrate in 2D, showed a similar distribution of velocities and 
importantly there was no significant change in migration speed (Figure 5.6A). 
Similarly, β1-integrin knockdown Schwann cells treated with siRNA2 migrated at a 
similar speed to control cells (Figure 5.5A). Thus, this indicates that Schwann cell 
migration in 3D along the vasculature is independent of β1-integrin, suggesting 
Schwann cell migration along the vasculature is independent of focal adhesion 
complexes and is consistent with an amoeboid-like migration, which is associated 
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with low levels of adhesion (Figure 5.6A). Likewise, while talin knockdown with 
combination siRNA1 severely impaired 2D migration, there was no significant 
difference in migration speeds between talin knockdown cells treated with siRNA1 
and control cells (Figure 5.6B). Moreover, in siRNA2 treated cells there was a small 
but not significant change in the migration speed (Figure 5.6B). Thus this indicates 
that like β1-integrin, talin 1 and talin 2 are not required for Schwann cell migration 
along the vasculature, indicating that Schwann cell migration along the vasculature is 
independent of focal adhesion complexes. Consistent with this, focal adhesion 
complexes could be detected in 2D, but could not be detected in 3D (Cattin et al., 
2015).  
Taken together, these results show that in contrast to migration in 2D, 
Schwann cell migration along the vasculature is independent of focal adhesion 
complexes, which is consistent with an amoeboid-like migration which is associated 
with low levels of adhesion and high levels of confinement and has previously been 
reported to be independent of focal adhesion complexes (Lammermann and Sixt, 
2009; Liu et al., 2015). 
 
	   202	  
     
Figure 5.4. Schwann cell migration along endothelial cell tubules is 
independent of β1-integrin.  
Left hand side: Representative phase-contrast still images of time-lapse microscopy 
of GFP-labelled β1-integrin knockdown Schwann cells migrating along the tubule. 
Right hand side: Representative GFP-images of time-lapse microscopy of GFP-
labelled scrambled-treated Schwann cells migrating along the tubule (see outline).  
Related to movie 5.3. 
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Figure 5.5. Schwann cell migration along endothelial cell tubules is 
independent of talin. 
Left hand sidel: Representative phase-contrast still images of time-lapse microscopy 
of GFP-labelled talin knockdown Schwann cells migrating along the tubule. Right 
hand side: Representative GFP-images of time-lapse microscopy of GFP-labelled 
scrambled-treated Schwann cells migrating along the tubule (see outline). Related to 
Movie 5.3. 
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Figure 5.6. Schwann cell migration along blood vessels is independent of focal 
adhesion complexes.  
(A and B) Quantification of Figures 5.2-5.4 in which the scrambled-treated Schwann 
cells, β1 integrin knockdown cells (A) or talin knockdown cells (B), were tracked 
between 8 and 10 hours. A total of 23 cells per condition were quantified from >3 
independent experiments. siRNA1 and siRNA2 were tested in separately, and were 
normalised for the average velocity of the Scrambled-treated cells and then 
combined in one graph. T-Test was performed. 
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5.4. Chapter conclusion 
This data demonstrates that Schwann cells use different mechanisms to migrate in 
2D versus 3D. In 2D, efficient Schwann cell migration is mediated through β1-integrin 
and talin 1 and talin 2, consistent with adhesion-dependent migration, which are 
characteristics of a mesenchymal mode of migration. In contrast in 3D, Schwann cell 
migration along the vasculature is independent of the focal adhesion complex 
components β1-integrin and talin 1 and talin 2, which is consistent with an 
amoeboid–like migration that requires lower levels of adhesion. 
Cells can migrate by different mechanisms, which can be broadly divided into 
two types, mesenchymal migration and a more amoeboid mode of migration which 
differs in the use of protrusions, contractility and adhesions with the environment 
(Lammermann and Sixt, 2009). In 2D, in which many cells adopt a mesenchymal 
mode of migration, adhesion to the substrate, coupled to retrograde forces is 
required for the cells to migrate. Retrograde forces are generated by actin 
polymerisation in protrusions such as lamellipodia, which push the membrane 
forward, coupled with actomyosin-dependent contractility, which causes retraction of 
the cell rear from the substrate. In 2D, cells are coupled to the substrate via 
transmembrane receptors such as integrins, which allow traction forces to be exerted 
onto the surface. In contrast, several studies have shown that an amoeboid mode of 
migration in 3D is less dependent of adhesion to the substrate, which is consistent 
with the absence of focal adhesion complexes in 3D (Bergert et al., 2015; 
Lammermann et al., 2008). Rather, cell locomotion is mediated through a cycle of 
actin polymerisation-mediated protrusion extension, and actomyosin dependent 
contraction of the cell rear, that elicits a propulsive type of movement (Lammermann 
and Sixt, 2009; Liu et al., 2015).  
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A recent study has shown that cells are able to change their behaviour under 
high levels of confinement to adopt a more amoeboid mode of migration, which is 
associated with low levels of adhesion, and that high levels of confinement are 
required for efficient adhesion-independent migration (Liu et al., 2015). This study 
further showed that many cell types have the ability and plasticity to switch from a 
mesenchymal mode of migration to a more amoeboid-mode of migration. This switch 
in migration mode can be induced by switching from an adhesive and low 
confinement environment (e.g. 2D migration on a adhesive substrate), to a non-
adhesive confined environment (e.g. within a 3D matrix) (Liu et al., 2015). Consistent 
with these findings, we show here that Schwann cells can also change their mode of 
migration as in 2D on laminin coated dishes (high adhesion and low confinement), 
they display a mesenchymal-mode of migration, which is associated with a broad 
lammellipodia in the direction of migration. In contrast in 3D, Schwann cells in fibrin 
gels (Cattin et al., 2015) and matrigel, migrate with a cycle of forward protrusion 
extension and rear contraction (see Figure 5.7). Moreover, we found that rear 
contraction of Schwann cells migrating along the vasculature is actomyosin 
dependent (Cattin et al., 2015). Furthermore, an amoeboid-like migration is 
associated with a more efficient and faster migration (Pankova et al., 2010). Likewise 
Schwann cells migrate more efficiently along tubules than on 2D laminin (Cattin et 
al., 2015; Lammermann and Sixt, 2009). Thus, the vasculature provides a track along 
which Schwann cells can efficiently migrate, providing both directionality and speed. 
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Figure 5.7 Amoeboid-like migration of Schwann cells along the vasculature. 
a) Schwann cells migrate along blood vessels in an amoeboid-like fashion that exists 
out of a cycle of forward protrusion extension and myosin-dependent contraction of 
the rear of the cell. b) Inset of a) Schwann cell migration along the vasculature is 
mediated through blebs emerging from both Schwann cells and endothelial cells 
which provide points of direct contact, and a discontinuous, non-specific surface, 
through which sufficient forces can be generated to propel the Schwann cells 
forward; this is consistent with a lower adhesion mode of migration. 
 
How can cells in 3D exert forces required to migrate, independently of adhesion? A 
recent report shed light into how cells can migrate in the absence of adhesion to the 
substrate, the authors showed that carcinosarcoma Walker 256 cells, which are 
unable to migrate in 2D, migrate in 3D in a non-adhesive manner (Bergert et al., 
2015). While in 2D, Walker cells have clear focal adhesion foci, in 3D confinement, 
Walker cells lack these foci. Rather migration is mediated through actomyosin flow 
from the front to the rear of the cell that is coupled to non-specific friction between the 
membrane and the matrix, which propels the cell forward. Consistent with this, we 
found that while 2D migration is dependent on β1-integrin and talin, 3D migration of 
Schwann cells along endothelial cell tubules is independent of β1-integrin and talin. 
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Moreover, focal adhesion complexes, which were visualised by paxillin staining, are 
present in the protrusions of Schwann cells in 2D, but could not be detected in 
Schwann cells migrating along the vasculature, supporting the idea that Schwann cell 
migration along the vasculature is independent of adhesion complexes and suggests 
that Schwann cells may migrate as a result of non-molecular interactions (Cattin et 
al., 2015).  
One striking observation was that while the vast majority of the Schwann cells 
interact with the HUVEC tubules in fibrin gels, some Schwann cells were found within 
the matrix and although they were able to form protrusions, they were unable to 
migrate (Cattin et al., 2015). This suggests that the 3D-matrix environment alone is 
not sufficient for Schwann cells to migrate. Rather, Schwann cells require the surface 
of endothelial cells to migrate along. In contrast, fibroblasts (which do not interact 
with the HUVEC tubules) migrated within the matrix (Cattin et al., 2015), consistent 
with previous reports (Hakkinen et al., 2011). This indicates that Schwann cells in the 
matrix cannot generate enough force to migrate. What on the surface of the blood 
vessels provides an environment for the Schwann cells to efficiently migrate and 
generate traction forces? High-resolution images of a Schwann cell interacting with 
an endothelial cell in vivo, showed that blebs are emerging from both cells (Cattin et 
al., 2015). In a recent study a model was created which predicted that blebbing cells 
in confined spaces migrate more efficiently along a discontinuous surface, as friction 
between blebs and the discontinuous surface would allow cells to generate traction 
forces (Tozluoglu et al., 2013). Thus, blebs emerging from both cells could provide 
points of contact and a discontinuous surface, through which forces could be 
generated to propel the Schwann cells forward, which is consistent with a non-
molecular interaction (Bergert et al., 2015; Liu et al., 2015; Tozluoglu et al., 2013). 
Moreover, the efficiency of migration is dependent on the density of the ECM and 
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thus the ECM gap size, as increasing the gap size resulted in weak traction 
generation and in efficient migration (Tozluoglu et al., 2013). This suggests that 
Schwann cells within the matrix cannot migrate, as they cannot generate sufficient 
traction forces to propel themselves forward, possibly due to the density of the 
matrix. Though specific molecular interactions cannot be excluded, this suggests that 
blood vessels provide a non-specific discontinuous surface that allows Schwann cells 
to generate sufficient force to migrate forward.  
We propose a model in which the blood vessels in the bridge, in addition to 
providing directionality to the collectively migrating Schwann cells, provide a frictional 
surface for the Schwann cells, which allows Schwann cells to generate sufficient 
forces to efficiently migrate along the blood vessels across the bridge. Though this 
explains how Schwann cells get their directionality, what triggers the collective 
migration of Schwann cells following injury is still unknown. Collective migration is 
often mediated by chemotactic factors, which can induce cell migration (Shellard and 
Mayor, 2016). Macrophages, in the bridge, are likely to play an important role in the 
collective migration of Schwann cells, as we showed that macrophages secrete 
unknown factors that increase Schwann cell migration (Cattin et al., 2015).  However, 
this needs further investigation, which is currently done by colleagues in the lab.  
The means by which Schwann cells migrate along the surface of the blood 
vessels might have broader implications, as several other cell types have been 
shown to use blood vessels to migrate along. For example a recent study has shown 
that during the development of the nervous system, oligodendrocyte precursors 
migrate along the blood vessels (Tsai et al., 2016). Moreover, several cancer cells 
have been shown to use the vasculature as a substrate and as a mechanism to 
invade other tissues (Alexander et al., 2013; Bald et al., 2014; Bapat et al., 2011; 
Carbonell et al., 2009; Farin et al., 2006; Liebig et al., 2009).   
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Chapter Six: Conclusion 
Following severing of the nerve, Schwann cells need to cross a tissue called the 
bridge, which is formed between the two nerve stumps, in order to guide axons back 
to their target (Cattin and Lloyd, 2016). We previously showed that Schwann cells 
migrate as cellular cords, which requires both homotypic interactions, between 
Schwann cells, as well as heterotypic interactions, with surrounding cells (Cattin et 
al., 2015; Parrinello et al., 2010). We showed that Schwann cells emerging out of the 
nerve stumps form clusters when they come in contact with fibroblasts, which is 
mediated by N-cad (Parrinello et al., 2010). This adhesion is required to mediate the 
collective migration of Schwann cells as cellular cords. Moreover, recent work from 
our group showed that in addition to these interactions, interactions of Schwann cells 
with blood vessels are crucial for directionality and the efficient migration of Schwann 
cells across the nerve bridge (Cattin et al., 2015). In this current work, we further 
explored the role of homotypic and heterotypic interactions during the process of 
peripheral nerve regeneration, and how (the loss of) these interactions are 
contributing to the tumourigenic process associated with Schwann cell-derived 
neurofibromas. 
We report here that in addition to mediating adhesion, N-cad is also required 
to mediate CIL in Schwann cells (Parrinello et al., 2010). However, unlike the 
adherence junction complexes through which N-cad mediates clustering, CIL is 
independent of the intracellular binding partners α-catenin and p120-catenin, and 
independent of trans-homodimerisation. Rather, we show that the extracellular 
domain of N-cad is sufficient to revert CIL, and that it presents a repulsion (co-) 
signal to the other cell. This mechanism provides an explanation as to how N-cad 
can mediate the seemingly opposing behaviours CIL, which may produce a force to 
move the cells forward, while at the same time maintaining a cluster through 
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mediating adhesion. In addition, N-cad is required for initiating remeylination 
(Lewallen et al., 2011) and in unpublished work by this group, we also showed that 
N-cad can also mediate CIP and axonal grabbing by Schwann cells (Wingfield-Digby 
et. al. unpublished thesis; This thesis chapters three and four), further illustrating N-
cad has a complex role and can mediate several processes depending on the 
context. The mechanism, by which N-cad can mediate CIL independent of adhesion, 
could provide a general mechanism that allows N-cad to play a dual role. Indeed, it 
has been a longstanding question on how cadherins can mediate adhesion while 
allowing cellular rearrangements to occur during collective migration or 
morphogenesis (Etienne-Manneville, 2014; Hong, 2006; Peglion et al., 2014; 
Theveneau and Mayor, 2010). Moreover, other studies further suggest that similar to 
in our system in which it appears N-cad is interacting with glypican-4, cadherins 
could interact with other cells surface proteins to regulate differentiation, axonal 
growth, cell growth and cell migration (Solanas et al., 2011; Suyama et al., 2002; 
Trolice et al., 1997; Williams et al., 2001). It would be interesting to see if these 
processes are also independent of trans-homodimerisation and the adherence 
junction complex.  
N-cad is upregulated in various tumours, which is thought to result in the 
adhesion between tumour cells towards other N-cad expressing tissues such as 
stroma and the vasculature, resulting in the escape of tumour cells from the tumour 
mass and invasion of secondary tissues (Berx and van Roy, 2009; Wheelock et al., 
2008). Moreover, upregulation of N-cad appears also to be associated with an 
increase of cell speed, invasion (Hazan et al., 2000; Nieman et al., 1999) and cell 
growth (Suyama et al., 2002). The latter is dependent on heterotypic interactions in 
cis with growth receptors, causing sustained downstream signalling (Suyama et al., 
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2002) This could suggest that other N-cad-mediated adhesion independent 
mechanisms might also play a role during the tumorigenic process.  
We further showed that Schwann cells expressing oncogenic Ras lose CIL in 
a MEK-dependent manner, which may contribute to development of Schwann cell 
derived tumours in NF1. However, CIL is not lost through loss of N-cad, as N-cad is 
functional and the adherence junction complex is unaffected. Instead, oncogenic Ras 
transforms the mRNA expression levels of the Eph receptors and ephrin ligands and 
changes the array of proteins interacting with N-cad, thus likely changing the way 
Schwann cells are interacting with each other and their surrounding cells, and 
changing the way associated processes are regulated. Interestingly, recent work in 
perivascular invasion of glioblastoma suggest that loss of NF-1 or expression of 
oncogenic Ras in these tumour cells, results in a similar change in the expression 
pattern of the cell surface receptors Eph and their ligands, for example the 
upregulation of Ephrin-B2 (Krusche et al., 2016). The upregulation of Ephrin-B2 
resulted in the attractive signalling of the glioblastoma towards the vasculature, 
resulting in the perivascular invasion of the normally compartmentalised 
glioblastomas in the brain. This suggests there might be a general mechanism by 
which oncogenic Ras regulates the expression of these surface receptors and 
ligands during the tumorigenic process and the way in which these cells interact 
between each other and their surrounding cells.  
Intriguingly inhibition of the Ras/Raf/ERK pathway in Schwann cells 
expressing oncogenic Ras, led to the restoration of homotypic Schwann cell 
interactions, which we showed could revert the loss of CIL. The ability to revert the 
loss of homotypic interaction between Schwann cells expressing oncogenic Ras, and 
possibly the interactions with other cells, could provide a possible therapeutic target 
in patients with MPNSTs and Neurofibromas.  
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We recently showed that Schwann cells which are unable to migrate through 
the matrix deposed in the bridge, migrate along the surface of the polarised blood 
vessels, which form in response to hypoxia (Cattin et al., 2015). Here we show 
together with the recently published work (Cattin et al., 2015) that, while the focal 
adhesion components β1-intgerin and talin1 and 2 are required for efficient migration 
in 2D, they are dispensable for efficient migration along the blood vessel, consistent 
with an amoeboid-like mode of migration. Instead, we propose that blebs emanating 
from both Schwann cells and endothelial cells provide direct points of contact and a 
non-specific frictional surface, which can produce sufficient traction to propel the 
Schwann cells forward (Cattin et al., 2015). However, the need of other proteins to 
mediate the heterotypic interactions between Schwann cells and the vasculature 
cannot be excluded. 
A parallel can be drawn between Schwann cells migrating along the 
vasculature and the spreading of several types of tumour cells along blood vessels or 
other cell surfaces (Alexander et al., 2013; Bald et al., 2014; Bapat et al., 2011; 
Carbonell et al., 2009; Farin et al., 2006; Liebig et al., 2009). It would be interesting to 
see if these tumour cells use similar mechanisms to Schwann cells to migrate along 
the vasculature. NF1-/- Schwann cells appear to become motile during the 
tumorigenic process, as they are able to spread along the length of the nerve, 
become locally invasive and in MPNSTs are able to metastasise (Kim et al., 1997; 
Sheela et al., 1990). Moreover, neurofibroma formation recapitulates the injury 
response, in that it has the same cellular components, which could suggest that 
Schwann cells could use similar mechanisms to migrate along the vasculature, 
allowing the spreading of the tumour. Another possibility is that oncogenic Ras 
changes the way in which Schwann cells interact with the vasculature. As mentioned 
above, glioblastomas with elevated Ras signalling have more attractive signalling 
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towards the blood vessels, which is mediated by the upregulated ephrin-B2 (Krusche 
et al., 2016). Similarly, in Schwann cells expressing oncogenic Ras, ephrin-B2 is 
upregulated, suggesting this could induce the cells to migrate along the vasculature, 
and allowing the spread of these cells. 
 How does the amoeboid-like migration of single Schwann cells along the 
vasculature relate to the collective migration of Schwann cells as cellular cords in 
vivo? It is well established that collective migration relies on the same principles as 
single migrating cells, in which individual cells within the cell cluster adapt a front to 
rear polarity, which is mediated through interactions with the cell substrate, such as 
focal adhesions, as well as through extracellular signals such as chemoattractive 
factors (Mayor and Etienne-Manneville, 2016). However, recent work in the neural 
crest showed that only the cells at the edge of the group of cells adapt a front to rear 
morphology, while the trailing cells (the cells away from the edge of the group) do not 
have this polarity, which is caused by N-cad-mediated homotypic interactions that 
can regulate both adhesion and CIL (Theveneau et al., 2010). Thus, one possibility is 
that within the Schwann cell cords, the leading Schwann cells are polarised, and 
migrate in a focal adhesion-independent manner. In contrast, the trailing cells might 
lack this polarity, similar to the neural crest, due to inhibition of the protrusions at the 
site of cell-cell contact. This is mediated by N-cad, which has a dual role by 
mediating adhesion allowing the cells to be in constant contact, and in addition 
induces a repulsion response, which could provide a repulsive force towards the front 
of the cells, driving the migration of the group forward. Another possibility might be 
that Schwann cells migrate more as loose stream of cells, in which the cells can 
escape from the group through repulsive signals. These theories will be tested in 
future work using both ex vivo and in vivo live-imaging of Schwann cell cords. 
	   215	  
Homotypic and heterotypic interactions between Schwann cells and the 
surrounding cells play a complex role in regulating the Schwann cells function during 
the regenerative process and neurofibromatosis. This work highlights that single 
protein-protein interactions can regulate multiple processes or result in a variety of  
different Schwann cell responses depending on the context. 
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Appendix 
Time-lapse videos (Located on the CD at the back of the thesis) 
Movie 3.1. N-cad is required for CIL 
Related to figure 3.2. Time-lapse microscopy Schwann cells treated with either 
scrambled, or siRNA1 or siRNA2 targeting N-cad. Images were taken every 10 min 
up to 4 hours. Interacting cells are indicated by a blue and green dot.  
 
Movie 3.2. N-cad is required for contact dependent outward migration  
Related to figure 3.3 and 3.4. Time-lapse microscopy of a scratch assay of 
scrambled-treated Schwann cells or N-cad knockdown Schwann cells imaged every 
10 min for 12 hours (7fps).  
 
Movie 3.3. N-cad mediates CIL independent of trans-homodimerisation 
Related to figure 3.5 and 3.6. Time-lapse microscopy of scrambled-treated cells (red 
fluorescent-labelled) mixed with N-cad knockdown cells (green fluorescent labelled). 
Imaged every 10 min for up to 7 hours (5fps). An interacting N-cad knockdown cell 
and scrambled-treated cell are indicated by the green and red dot respectively.  
  
Movie 3.4. CIL is independent of α-catenin 
Related to figure 3.5 and 3.6. Time-lapse microscopy of scrambled-treated cells or α-
catenin knockdown cells, which were imaged every 10 min for 24 hours (5fps). 
Interacting cells are indicated by a blue and green dot. Shown is representative 
movie of 9 hours. 
 
Movie 3.5. CIL is independent of p120-catenin 
Related to figure 3.5 and 3.6. Time-lapse microscopy of Schwann cells treated with 
scrambled siRNA or with p120-catenin siRNA1 or siRNA2, which were imaged every 
10 min up to 9 hours (5fps). Interacting cells are indicated by a blue and green dot.  
 
Movie 3.6. Extracellular domain of N-cad is sufficient to mediate CIL   
Related to figure 3.17 and 3.18 Time-lapse microscopy of N-cad knockdown cells 
(green or blue dot) with N-cad knockdown cells transfected with cytoplasmic GFP 
and full-length, extracellular domain or intracellular domain of N-cad tagged with 
ptdTomato (red dot). The ptdTomato expression is only shown for the first two time 
points, and is subsequently indicated by a red dot. Cells were imaged every 10 min 
up to 15 hours (5 fps).  
 
Movie 4.1. DN-p53-Ras Schwann cells lose CIL in a MEK dependent manner 
Related to figure 4.4. Time-lapse microscopy of DNp53-SCs or DNp53-Ras-SCs 
treated with control solvent (DMSO) or MEK inhibitor PD184352 (0.75 μM) for 18 
hours, before imaging for a further 24 hours. Interacting cells are indicated by a blue 
and green dot. Cells were imaged every 10 min for up to 2 hours (5 fps).  
 
Movie 4.2. Restoration of CIL in DNp53-Ras Schwann cells is slow 
Related to figure 4.6. Time-lapse microscopy of a time-course of homotypic CIL 
between DNp53-Ras-SCs imaged for 6 hours before adding the MEK inhibitor 
PD184352 (0.75μM) and further imaging for another 12 hours. Images were taken 
every 10 min (5 fps). Cells that are invasive are indicated by a green and blue dot. 
The cell indicated by a red dot indicate a cell that is initially invasive but becomes 
repulsive overtime. 
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Movie 4.3. Homotypic CIL and Heterotypic CIL are regulated through different 
Mechanisms 
Related to figure 4.6. Time-lapse microscopy of a CIL assay between primary 
fibroblasts (blue dot) and green fluorescent-labelled scrambled or EphB2 siRNA 
treated Schwann cells (green dot), followed by a movie of EphB2 knockdown cells 
alone. Cells were imaged every 10 min up to 6 hours (5 fps).  
 
Movie 4.4. Fyn is not required for CIL 
Related to figure 4.13. Time-lapse microscopy of a CIL assay in which Schwann cells 
were treated with DMSO or the Fyn inhibitor SU6646 (250nM) for one hour before 
starting imaging for a further 24 hours. Cells were imaged every 10 min for 3 hours (5 
fps). Interacting cells are indicated by a blue and green dot. Shown is reps 
 
Movie 4.5. Glypican-4 is required for CIL 
Related to figure 4.21. Time-lapse microscopy of scrambled-treated cells or Schwann 
cells treated with Glypican siRNA 1 or siRNA2 for 48 hours before imaging for a 
further 24 hours. Cells were imaged every 10 min up to 10 hours (5 fps). Interacting 
cells are indicated by a blue and green dot.  
 
Movie 5.1. β1 integrin mediates 2D Schwann cell migration 
Related to figure 5.1. Time-lapse microscopy of scrambled-treated cells or Schwann 
cells treated with β1 integrin siRNA 1 for 36 hours before imaging for a further 24 
hours. Cells were imaged every 10 min for 4 hours (5 fps). 
 
Movie 5.2. Talin1 and Talin2 are required for 2D Schwann cell migration 
Related to figure 5.2. Time-lapse microscopy of scrambled-treated cells or Schwann 
cells treated with Talin 1 and 2 siRNA combination 1 for 60 hours before imaging for 
a further 24 hours. Cells were imaged every 10 min for 4 hours (5 fps). 
 
Movie 5.3. Schwann cell migration along endothelial tubules is independent of focal 
adhesions 
Related to figure 5.3-5.6. Time-lapse microscopy of GFP-labelled scrambled-treated 
cells, or GFP-labelled Schwann cells treated with β1 integrin siRNA 1, or Talin 1 and 
2 siRNA combination 1 for 36 hours, migrating along HUVECs in matrigel. Images 
were taken every 10 min for 4 hours. 
 
Mass spectrometry data  
Located on the CD at the back of the thesis 
Table 1  Full Mass Spec list IgG EtOH 
Table 2  Full Mass Spec list N-cad EtOH 
Table 3  Full Mass Spec list IgG TMX 
Table 4  Full Mass Spec list N-cad TMX 
 
Located in thesis 
Table 5  Comparison of N-cad EtOH sample to IgG control based on fold  
  increase (≥2.5) 
Table 6  Comparison of N-cad TMX sample to IgG control based on fold 
increase (≥2.5)  
Table 7 Proteins overlapping in EtOH and TMX  
Table 8 Proteins specifically identified in EtOH samples  
Table 9 Proteins specifically identified in TMX samples 
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Table 5 Comparison of N-cad EtOH sample to IgG control based on fold 
increase (≥2.5) 
 
 
Accession Description
Fold 
increase 
Score
D3ZCH7 Adducin 3 (Gamma), isoform CRA_b OS=Rattus norvegicus GN=Add3 PE=4 SV=2 - [D3ZCH7_RAT] 2.55
Q5FVQ2 Peter pan homolog (Drosophila) OS=Rattus norvegicus GN=Ppan PE=2 SV=1 - [Q5FVQ2_RAT] 2.83
Q6P0K8 Junction plakoglobin OS=Rattus norvegicus GN=Jup PE=1 SV=1 - [PLAK_RAT] 7.70
D3ZZZ9
Catenin (Cadherin associated protein), delta 1 (Predicted), isoform 
CRA_a OS=Rattus norvegicus GN=Ctnnd1 PE=1 SV=1 - 
[D3ZZZ9_RAT]
12.91
Q5U302 Catenin (Cadherin associated protein), alpha 1 OS=Rattus norvegicus GN=Ctnna1 PE=1 SV=1 - [Q5U302_RAT] 18.74
A0JPL2 Casein kinase 1, alpha 1, isoform CRA_d OS=Rattus norvegicus GN=Csnk1a1 PE=2 SV=1 - [A0JPL2_RAT] N/A
A2RRU1 Glycogen [starch] synthase, muscle OS=Rattus norvegicus GN=Gys1 PE=2 SV=1 - [GYS1_RAT] N/A
B0BNF5 Qk protein OS=Rattus norvegicus GN=Qk PE=2 SV=1 - [B0BNF5_RAT] N/A
B1H237 Terf2 protein OS=Rattus norvegicus GN=Terf2 PE=2 SV=1 - [B1H237_RAT] N/A
B1VKB4 Synaptopodin OS=Rattus norvegicus GN=Synpo PE=2 SV=1 - [B1VKB4_RAT] N/A
B2GUU1 YTH domain family 2 (Predicted) OS=Rattus norvegicus GN=Ythdf2 PE=2 SV=1 - [B2GUU1_RAT] N/A
B2GUY6 Srrm2 protein (Fragment) OS=Rattus norvegicus GN=Srrm2 PE=2 SV=1 - [B2GUY6_RAT] N/A
B2RYQ5 Enhancer of rudimentary homolog OS=Rattus norvegicus GN=Erh PE=2 SV=1 - [B2RYQ5_RAT] N/A
B5DF27 Lysyl oxidase homolog 2 OS=Rattus norvegicus GN=Loxl2 PE=2 SV=2 - [LOXL2_RAT] N/A
D3Z8W1 Uncharacterized protein OS=Rattus norvegicus GN=LOC680384 PE=4 SV=1 - [D3Z8W1_RAT] N/A
D3ZEI6 Nuclear receptor coactivator 5 (Predicted) OS=Rattus norvegicus GN=Ncoa5 PE=4 SV=1 - [D3ZEI6_RAT] N/A
D3ZFD0 Uncharacterized protein OS=Rattus norvegicus GN=Myo18a PE=1 SV=2 - [D3ZFD0_RAT] N/A
D3ZHB3 40S ribosomal protein S12 OS=Rattus norvegicus GN=LOC100360573 PE=3 SV=2 - [D3ZHB3_RAT] N/A
D3ZI68
PRP31 pre-mRNA processing factor 31 homolog (Yeast) 
(Predicted) OS=Rattus norvegicus GN=Prpf31 PE=4 SV=1 - 
[D3ZI68_RAT]
N/A
D3ZIX4 Protein H1fx OS=Rattus norvegicus GN=H1fx PE=3 SV=1 - [D3ZIX4_RAT] N/A
D3ZJ67 Protein Sun2 OS=Rattus norvegicus GN=Sun2 PE=4 SV=1 - [D3ZJ67_RAT] N/A
D3ZJU5 Protein Smarcc1 OS=Rattus norvegicus GN=Smarcc1 PE=4 SV=1 - [D3ZJU5_RAT] N/A
D3ZN76 Protein Sec16a OS=Rattus norvegicus GN=Sec16a PE=4 SV=1 - [D3ZN76_RAT] N/A
D3ZNH2 Protein Utp18 OS=Rattus norvegicus GN=Utp18 PE=4 SV=2 - [D3ZNH2_RAT] N/A
D3ZNP7 Protein LOC100909685 OS=Rattus norvegicus GN=Myo1b PE=4 SV=2 - [D3ZNP7_RAT] N/A
D3ZQG1 Protein Nufip2 OS=Rattus norvegicus GN=LOC687994 PE=4 SV=2 - [D3ZQG1_RAT] N/A
D3ZR53 Protein phosphatase 1 regulatory subunit 12 OS=Rattus norvegicus GN=Ppp1r12a PE=1 SV=2 - [D3ZR53_RAT] N/A
N-Cad specific Fold increase EtOH
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D3ZRT6 Protein Plekha7 OS=Rattus norvegicus GN=Plekha7 PE=4 SV=1 - [D3ZRT6_RAT] N/A
D3ZUK4 Protein Trim33 (Fragment) OS=Rattus norvegicus GN=Trim33 PE=4 SV=2 - [D3ZUK4_RAT] N/A
D3ZWZ6 Protein Igf2bp2 (Fragment) OS=Rattus norvegicus GN=Igf2bp2 PE=4 SV=2 - [D3ZWZ6_RAT] N/A
D3ZYT2 Mitochondrial ribosomal protein S5 (Predicted) OS=Rattus norvegicus GN=Mrps5 PE=3 SV=1 - [D3ZYT2_RAT] N/A
D3ZZM1 Uncharacterized protein (Fragment) OS=Rattus norvegicus PE=4 SV=2 - [D3ZZM1_RAT] N/A
D3ZZR5 Protein Snrpa1 OS=Rattus norvegicus GN=Snrpa1 PE=4 SV=1 - [D3ZZR5_RAT] N/A
D4A2B0
Polymerase (DNA-directed), delta interacting protein 3 (Predicted), 
isoform CRA_a OS=Rattus norvegicus GN=Poldip3 PE=4 SV=1 - 
[D4A2B0_RAT]
N/A
D4A2Z8
DEAH (Asp-Glu-Ala-His) box polypeptide 36 (Predicted), isoform 
CRA_a OS=Rattus norvegicus GN=Dhx36 PE=4 SV=1 - 
[D4A2Z8_RAT]
N/A
D4A554
Eukaryotic translation initiation factor 4 gamma, 3 (Predicted), 
isoform CRA_a OS=Rattus norvegicus GN=Eif4g3 PE=4 SV=2 - 
[D4A554_RAT]
N/A
D4A5G2 Protein Nop14 OS=Rattus norvegicus GN=Nop14 PE=4 SV=1 - [D4A5G2_RAT] N/A
D4A5K7 Protein Rbm28 OS=Rattus norvegicus GN=Rbm28 PE=4 SV=1 - [D4A5K7_RAT] N/A
D4A5S9 Protein Prpf39 OS=Rattus norvegicus GN=Prpf39 PE=4 SV=1 - [D4A5S9_RAT] N/A
D4AAG4 Protein Kif23 OS=Rattus norvegicus GN=Kif23 PE=3 SV=2 - [D4AAG4_RAT] N/A
D4AAW2 Protein transport protein Sec16B OS=Rattus norvegicus GN=Sec16b PE=4 SV=2 - [D4AAW2_RAT] N/A
D4ABR6 Annexin (Fragment) OS=Rattus norvegicus GN=Anxa6 PE=3 SV=2 - [D4ABR6_RAT] N/A
D4ACV3 Histone H2A OS=Rattus norvegicus GN=Hist2h2ac PE=3 SV=1 - [D4ACV3_RAT] N/A
D4AE65 Protein Rrp7a OS=Rattus norvegicus GN=Rrp7a PE=4 SV=1 - [D4AE65_RAT] N/A
D4JQY2 Chaperone protein DnaK n=3 Tax=root RepID=D4JQY2_9FIRM N/A
E9PT66 Protein Sf3b3 OS=Rattus norvegicus GN=Sf3b3 PE=4 SV=2 - [E9PT66_RAT] N/A
F1LNF1
Heterogeneous nuclear ribonucleoproteins A2/B1 (Fragment) 
OS=Rattus norvegicus GN=Hnrnpa2b1 PE=4 SV=1 - 
[F1LNF1_RAT]
N/A
F1LQB2 Structural maintenance of chromosomes protein 3 OS=Rattus norvegicus GN=Smc3 PE=4 SV=1 - [F1LQB2_RAT] N/A
F1LS65 Signal-induced proliferation-associated 1-like protein 1 (Fragment) OS=Rattus norvegicus GN=Sipa1l1 PE=4 SV=2 - [F1LS65_RAT] N/A
F1LSL1 Transcription factor Pur-beta OS=Rattus norvegicus GN=Purb PE=4 SV=2 - [F1LSL1_RAT] N/A
F1LSL2 Nuclear pore complex protein Nup107 OS=Rattus norvegicus GN=Nup107 PE=4 SV=2 - [F1LSL2_RAT] N/A
F1LSS1 Structural maintenance of chromosomes protein OS=Rattus norvegicus GN=Smc1a PE=3 SV=2 - [F1LSS1_RAT] N/A
F1LX68 Protein Spats2 OS=Rattus norvegicus GN=Spats2 PE=4 SV=2 - [F1LX68_RAT] N/A
F1M0V4 Protein Thoc2 OS=Rattus norvegicus GN=Thoc2 PE=4 SV=2 - [F1M0V4_RAT] N/A
F1M3H2 Uncharacterized protein (Fragment) OS=Rattus norvegicus GN=LOC100360367 PE=4 SV=2 - [F1M3H2_RAT] N/A
F1M3K6 Protein Bag4 (Fragment) OS=Rattus norvegicus GN=Bag4 PE=4 SV=2 - [F1M3K6_RAT] N/A
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F1M4A0 Protein Tjp1 OS=Rattus norvegicus GN=Tjp1 PE=1 SV=2 - [F1M4A0_RAT] N/A
F1M4U9 Protein Baz1a (Fragment) OS=Rattus norvegicus GN=Baz1a PE=4 SV=2 - [F1M4U9_RAT] N/A
F1MAA5 Protein Rangap1 OS=Rattus norvegicus GN=Rangap1 PE=4 SV=2 - [F1MAA5_RAT] N/A
F1MAA7 Protein Lamc1 OS=Rattus norvegicus GN=Lamc1 PE=4 SV=1 - [F1MAA7_RAT] N/A
F1SW39 PC4 and SFRS1 interacting protein 1 OS=Rattus norvegicus GN=Psip1 PE=2 SV=1 - [F1SW39_RAT] N/A
F7EM03 Protein Krt31 OS=Rattus norvegicus GN=Krt34 PE=3 SV=1 - [F7EM03_RAT] N/A
G3V6A4 Heterogeneous nuclear ribonucleoprotein D, isoform CRA_b OS=Rattus norvegicus GN=Hnrpd PE=1 SV=1 - [G3V6A4_RAT] N/A
G3V702 Smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) OS=Rattus norvegicus GN=Smu1 PE=4 SV=1 - [G3V702_RAT] N/A
G3V727 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47, isoform CRA_a OS=Rattus norvegicus GN=Ddx47 PE=3 SV=1 - [G3V727_RAT] N/A
G3V7J2
Interferon-inducible double-stranded RNA-dependent protein 
kinase activator A OS=Rattus norvegicus GN=Prkra PE=1 SV=1 - 
[G3V7J2_RAT]
N/A
G3V7K3 Ceruloplasmin OS=Rattus norvegicus GN=Cp PE=4 SV=1 - [G3V7K3_RAT] N/A
G3V7N0 Heparan sulfate 2-O-sulfotransferase 1, isoform CRA_a OS=Rattus norvegicus GN=Hs2st1 PE=4 SV=1 - [G3V7N0_RAT] N/A
G3V803 Cadherin-2 OS=Rattus norvegicus GN=Cdh2 PE=4 SV=1 - [G3V803_RAT] N/A
G3V8B3 Histone H2B OS=Rattus norvegicus GN=LOC100910200 PE=3 SV=1 - [G3V8B3_RAT] N/A
G3V8B4 Brix domain containing 2, isoform CRA_a OS=Rattus norvegicus GN=Brix1 PE=4 SV=1 - [G3V8B4_RAT] N/A
G3V8T4 DNA damage-binding protein 1 OS=Rattus norvegicus GN=Ddb1 PE=4 SV=1 - [G3V8T4_RAT] N/A
G3V9F3 Myosin phosphatase Rho-interacting protein OS=Rattus norvegicus GN=Mprip PE=4 SV=1 - [G3V9F3_RAT] N/A
G3V9R0 LUC7-like (S. cerevisiae) OS=Rattus norvegicus GN=Luc7l PE=2 SV=2 - [G3V9R0_RAT] N/A
M0R7L9 Protein LOC100911677 OS=Rattus norvegicus GN=LOC100911677 PE=4 SV=1 - [M0R7L9_RAT] N/A
M0R7Z0 Uncharacterized protein OS=Rattus norvegicus PE=4 SV=1 - [M0R7Z0_RAT] N/A
M0R8U4 Protein Rpl13a-ps1 OS=Rattus norvegicus GN=Rpl13a-ps1 PE=3 SV=1 - [M0R8U4_RAT] N/A
M0R907 Protein Snrpd3 OS=Rattus norvegicus GN=Snrpd3 PE=4 SV=1 - [M0R907_RAT] N/A
M0RCH1 Uncharacterized protein (Fragment) OS=Rattus norvegicus PE=3 SV=1 - [M0RCH1_RAT] N/A
M0RD14 Pyruvate kinase OS=Rattus norvegicus PE=3 SV=1 - [M0RD14_RAT] N/A
P04692-7 Isoform 7 of Tropomyosin alpha-1 chain n=1 Tax=Rattus norvegicus RepID=P04692-7 N/A
P05942 Protein S100-A4 OS=Rattus norvegicus GN=S100a4 PE=2 SV=1 - [S10A4_RAT] N/A
P15865 Histone H1.4 OS=Rattus norvegicus GN=Hist1h1e PE=1 SV=3 - [H14_RAT] N/A
P19637 Tissue-type plasminogen activator OS=Rattus norvegicus GN=Plat PE=2 SV=2 - [TPA_RAT] N/A
P23785 Granulins OS=Rattus norvegicus GN=Grn PE=1 SV=3 - [GRN_RAT] N/A
P24049 60S ribosomal protein L17 OS=Rattus norvegicus GN=Rpl17 PE=2 SV=3 - [RL17_RAT] N/A
P31000 Vimentin OS=Rattus norvegicus GN=Vim PE=1 SV=2 - [VIME_RAT] N/A
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P61354 60S ribosomal protein L27 OS=Rattus norvegicus GN=Rpl27 PE=2 SV=2 - [RL27_RAT] N/A
P62260 14-3-3 protein epsilon OS=Rattus norvegicus GN=Ywhae PE=1 SV=1 - [1433E_RAT] N/A
P62755 40S ribosomal protein S6 OS=Rattus norvegicus GN=Rps6 PE=1 SV=1 - [RS6_RAT] N/A
P62912 60S ribosomal protein L32 OS=Rattus norvegicus GN=Rpl32 PE=1 SV=2 - [RL32_RAT] N/A
P63259 Actin, cytoplasmic 2 OS=Rattus norvegicus GN=Actg1 PE=1 SV=1 - [ACTG_RAT] N/A
P68370 Tubulin alpha-1A chain OS=Rattus norvegicus GN=Tuba1a PE=1 SV=1 - [TBA1A_RAT] N/A
P81795 Eukaryotic translation initiation factor 2 subunit 3 OS=Rattus norvegicus GN=Eif2s3 PE=1 SV=2 - [IF2G_RAT] N/A
P84092 AP-2 complex subunit mu OS=Rattus norvegicus GN=Ap2m1 PE=1 SV=1 - [AP2M1_RAT] N/A
Q05962 ADP/ATP translocase 1 OS=Rattus norvegicus GN=Slc25a4 PE=1 SV=3 - [ADT1_RAT] N/A
Q1JU68 Eukaryotic translation initiation factor 3 subunit A OS=Rattus norvegicus GN=Eif3a PE=2 SV=2 - [EIF3A_RAT] N/A
Q3KRE8 Tubulin beta-2B chain OS=Rattus norvegicus GN=Tubb2b PE=1 SV=1 - [TBB2B_RAT] N/A
Q3MHS8 Sin3-associated polypeptide 18 OS=Rattus norvegicus GN=Sap18 PE=2 SV=1 - [Q3MHS8_RAT] N/A
Q498M4 WD repeat-containing protein 5 OS=Rattus norvegicus GN=Wdr5 PE=1 SV=1 - [WDR5_RAT] N/A
Q4FZS2 Budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) OS=Rattus norvegicus GN=Bub3 PE=2 SV=1 - [Q4FZS2_RAT] N/A
Q4KLJ1 RCG61762, isoform CRA_a OS=Rattus norvegicus GN=Srsf7 PE=2 SV=1 - [Q4KLJ1_RAT] N/A
Q4KLJ3 Guanine nucleotide binding protein-like 2 (Nucleolar) OS=Rattus norvegicus GN=Gnl2 PE=2 SV=1 - [Q4KLJ3_RAT] N/A
Q4KLM7 Protein Specc1 OS=Rattus norvegicus GN=Specc1 PE=2 SV=1 - [Q4KLM7_RAT] N/A
Q4KLN3 SFRS protein kinase 1 OS=Rattus norvegicus GN=Srpk1 PE=2 SV=1 - [Q4KLN3_RAT] N/A
Q4QQW4 Histone deacetylase 1 OS=Rattus norvegicus GN=Hdac1 PE=1 SV=1 - [HDAC1_RAT] N/A
Q4QR75 Exosome complex component RRP45 OS=Rattus norvegicus GN=Exosc9 PE=2 SV=1 - [EXOS9_RAT] N/A
Q4V7D7 Pre-mRNA-splicing factor RBM22 OS=Rattus norvegicus GN=Rbm22 PE=2 SV=1 - [RBM22_RAT] N/A
Q4V8J6 Protein Ythdf1 OS=Rattus norvegicus GN=Ythdf1 PE=2 SV=1 - [Q4V8J6_RAT] N/A
Q562C2 Ribosome biogenesis protein BOP1 OS=Rattus norvegicus GN=Bop1 PE=2 SV=1 - [BOP1_RAT] N/A
Q56A18-4
Isoform 4 of SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily E member 1 n=2 Tax=Rattus 
norvegicus RepID=Q56A18-4
N/A
Q56A27 Nuclear cap-binding protein subunit 1 OS=Rattus norvegicus GN=Ncbp1 PE=2 SV=1 - [NCBP1_RAT] N/A
Q56B11 Proline-, glutamic acid- and leucine-rich protein 1 OS=Rattus norvegicus GN=Pelp1 PE=2 SV=2 - [PELP1_RAT] N/A
Q56R17 Importin subunit alpha OS=Rattus norvegicus GN=Kpna4 PE=2 SV=1 - [Q56R17_RAT] N/A
Q5EB93 Gatad2a protein OS=Rattus norvegicus GN=Gatad2a PE=2 SV=1 - [Q5EB93_RAT] N/A
Q5I0H3 Small ubiquitin-related modifier 1 OS=Rattus norvegicus GN=Sumo1 PE=1 SV=1 - [SUMO1_RAT] N/A
Q5M7V3 LOC367586 protein OS=Rattus norvegicus GN=LOC367586 PE=2 SV=1 - [Q5M7V3_RAT] N/A
Q5RJM0 MKI67 FHA domain-interacting nucleolar phosphoprotein OS=Rattus norvegicus GN=Nifk PE=2 SV=1 - [MK67I_RAT] N/A
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Q5U2W5 Transducin beta-like protein 3 OS=Rattus norvegicus GN=Tbl3 PE=2 SV=1 - [TBL3_RAT] N/A
Q5XI01 La-related protein 7 OS=Rattus norvegicus GN=Larp7 PE=1 SV=2 - [LARP7_RAT] N/A
Q5XI32 F-actin-capping protein subunit beta OS=Rattus norvegicus GN=Capzb PE=1 SV=1 - [CAPZB_RAT] N/A
Q5XIG8 Serine-threonine kinase receptor-associated protein OS=Rattus norvegicus GN=Strap PE=1 SV=1 - [STRAP_RAT] N/A
Q63009 Protein arginine N-methyltransferase 1 OS=Rattus norvegicus GN=Prmt1 PE=1 SV=1 - [ANM1_RAT] N/A
Q642B0 Glypican 4 OS=Rattus norvegicus GN=Gpc4 PE=2 SV=1 - [Q642B0_RAT] N/A
Q66HD0 Endoplasmin OS=Rattus norvegicus GN=Hsp90b1 PE=1 SV=2 - [ENPL_RAT] N/A
Q66HT5 Cysteine rich protein 61 OS=Rattus norvegicus GN=Cyr61 PE=2 SV=1 - [Q66HT5_RAT] N/A
Q68FP1-2 Isoform 2 of Gelsolin n=2 Tax=Rattus norvegicus RepID=Q68FP1-2 N/A
Q68FR6 Elongation factor 1-gamma OS=Rattus norvegicus GN=Eef1g PE=1 SV=3 - [EF1G_RAT] N/A
Q6AXV4 Sorting and assembly machinery component 50 homolog OS=Rattus norvegicus GN=Samm50 PE=1 SV=1 - [SAM50_RAT] N/A
Q6AYA1 H/ACA ribonucleoprotein complex subunit 1 OS=Rattus norvegicus GN=Gar1 PE=2 SV=1 - [GAR1_RAT] N/A
Q6AYL5 Splicing factor 3B subunit 4 OS=Rattus norvegicus GN=Sf3b4 PE=2 SV=1 - [SF3B4_RAT] N/A
Q6AYT6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 56 OS=Rattus norvegicus GN=Ddx56 PE=2 SV=1 - [Q6AYT6_RAT] N/A
Q6AYU2 Pcbp2 protein OS=Rattus norvegicus GN=Pcbp2 PE=2 SV=1 - [Q6AYU2_RAT] N/A
Q6AZ26 C-terminal binding protein 1 OS=Rattus norvegicus GN=Ctbp1 PE=1 SV=1 - [Q6AZ26_RAT] N/A
Q6GMN8 Actn1 protein OS=Rattus norvegicus GN=Actn1 PE=2 SV=1 - [Q6GMN8_RAT] N/A
Q6MG10 Mitochondrial ribosomal protein S18B OS=Rattus norvegicus GN=Mrps18b PE=2 SV=1 - [Q6MG10_RAT] N/A
Q6P136 Hyou1 protein OS=Rattus norvegicus GN=Hyou1 PE=2 SV=1 - [Q6P136_RAT] N/A
Q6P3V8 Eukaryotic translation initiation factor 4A1 OS=Rattus norvegicus GN=Eif4a1 PE=1 SV=1 - [Q6P3V8_RAT] N/A
Q6P6G9 Hnrpa1 protein OS=Rattus norvegicus GN=Hnrnpa1 PE=2 SV=1 - [Q6P6G9_RAT] N/A
Q6P7R0 Coronin OS=Rattus norvegicus GN=Coro1b PE=2 SV=1 - [Q6P7R0_RAT] N/A
Q6P9U7 L-lactate dehydrogenase OS=Rattus norvegicus GN=Ldha PE=2 SV=1 - [Q6P9U7_RAT] N/A
Q6QLN3 Glioma tumor suppressor candidate region gene 2 OS=Rattus norvegicus GN=Gltscr2 PE=2 SV=1 - [Q6QLN3_RAT] N/A
Q6TXE9 LRRGT00050 OS=Rattus norvegicus GN=Eprs PE=1 SV=1 - [Q6TXE9_RAT] N/A
Q6U6G5 Zinc finger CCCH domain-containing protein 15 OS=Rattus norvegicus GN=Zc3h15 PE=2 SV=1 - [ZC3HF_RAT] N/A
Q925G0 Putative RNA-binding protein 3 OS=Rattus norvegicus GN=Rbm3 PE=1 SV=2 - [RBM3_RAT] N/A
Q9JKL8 Activity-dependent neuroprotector homeobox protein OS=Rattus norvegicus GN=Adnp PE=2 SV=1 - [ADNP_RAT] N/A
Q9QZK5 Serine protease HTRA1 OS=Rattus norvegicus GN=Htra1 PE=2 SV=1 - [HTRA1_RAT] N/A
Q9R1E9 Connective tissue growth factor OS=Rattus norvegicus GN=Ctgf PE=2 SV=1 - [CTGF_RAT] N/A
Q9WU82 Catenin beta-1 OS=Rattus norvegicus GN=Ctnnb1 PE=1 SV=1 - [CTNB1_RAT] N/A
	   241	  
 
Q9WUW5 Collagen type XVIII, alpha (I) chain (Fragment) OS=Rattus norvegicus GN=Col18a1 PE=2 SV=1 - [Q9WUW5_RAT] N/A
T1SRT4 Radixin isoform OS=Rattus norvegicus GN=Rdx PE=2 SV=1 - [T1SRT4_RAT] N/A
UPI0000180AB4 PREDICTED: luc7-like protein 3 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0000180AB4 N/A
UPI00001C8B75
PREDICTED: plasminogen activator inhibitor 1 RNA-binding 
protein isoform X2 n=1 Tax=Rattus norvegicus 
RepID=UPI00001C8B75
N/A
UPI00001D0F5B PREDICTED: cytokine receptor-like factor 1 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI00001D0F5B N/A
UPI0000250BD6 PREDICTED: 60S ribosomal protein L13-like n=1 Tax=Rattus norvegicus RepID=UPI0000250BD6 N/A
UPI0000250FE4 PREDICTED: myosin-14 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0000250FE4 N/A
UPI0000500E84 PREDICTED: C-Jun-amino-terminal kinase-interacting protein 4 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0000500E84 N/A
UPI0000503905 PREDICTED: DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0000503905 N/A
UPI0000DA1CD8 PREDICTED: AP-2 complex subunit alpha-1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0000DA1CD8 N/A
UPI0000DA285F PREDICTED: MAP7 domain-containing protein 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0000DA285F N/A
UPI0000DA38FD PREDICTED: homeobox protein cut-like 1 isoform X8 n=1 Tax=Rattus norvegicus RepID=UPI0000DA38FD N/A
UPI0000DBF3AC PREDICTED: fibronectin isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0000DBF3AC N/A
UPI0000DBF7D2 PREDICTED: heterogeneous nuclear ribonucleoprotein M isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0000DBF7D2 N/A
UPI000154E9E5 PREDICTED: E3 ubiquitin-protein ligase TRIM56 n=1 Tax=Rattus norvegicus RepID=UPI000154E9E5 N/A
UPI000154F802 programmed cell death 6-interacting protein n=1 Tax=Rattus norvegicus RepID=UPI000154F802 N/A
UPI0001550CCB PREDICTED: histone H1.2 n=1 Tax=Rattus norvegicus RepID=UPI0001550CCB N/A
UPI0001551E07
PREDICTED: DNA-directed RNA polymerases I, II, and III subunit 
RPABC1 isoform X3 n=1 Tax=Rattus norvegicus 
RepID=UPI0001551E07
N/A
UPI0001B7B713 PREDICTED: AT-rich interactive domain-containing protein 1A isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0001B7B713 N/A
UPI0001CF3CF5 PREDICTED: catenin alpha-3 isoform X1 n=2 Tax=Rattus norvegicus RepID=UPI0001CF3CF5 N/A
UPI0001CF3F9F YLP motif-containing protein 1 n=1 Tax=Rattus norvegicus RepID=UPI0001CF3F9F N/A
UPI0001CF734A PREDICTED: protein AHNAK2 n=1 Tax=Rattus norvegicus RepID=UPI0001CF734A N/A
UPI0003D077B6 PREDICTED: alpha-actinin-4 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D077B6 N/A
UPI0003D0839D PREDICTED: apoptotic chromatin condensation inducer 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0839D N/A
UPI0003D0841E PREDICTED: SH3 and PX domain-containing protein 2A isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0841E N/A
UPI0003D088F0 PREDICTED: polypyrimidine tract-binding protein 3 isoform X2 n=2 Tax=Rattus norvegicus RepID=UPI0003D088F0 N/A
UPI0003D08BCF PREDICTED: bcl-2-associated transcription factor 1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D08BCF N/A
UPI0003D093A2 PREDICTED: protein SON isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D093A2 N/A
UPI0003D09F77 PREDICTED: probable ATP-dependent RNA helicase DDX52 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D09F77 N/A
UPI0003D09FC6 PREDICTED: serine/threonine-protein kinase DCLK1 isoform X2 n=2 Tax=Rattus norvegicus RepID=UPI0003D09FC6 N/A
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UPI0003D0AC45 PREDICTED: protein transport protein Sec24D isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0AC45 N/A
UPI0003D0B550 PREDICTED: serine/arginine repetitive matrix protein 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0B550 N/A
UPI0003D0B91E
PREDICTED: SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily B member 1 isoform X3 n=1 
Tax=Rattus norvegicus RepID=UPI0003D0B91E
N/A
UPI0003D0BC78 PREDICTED: keratin, type I cytoskeletal 16 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0BC78 N/A
UPI0003D0C0AC PREDICTED: protein DEK isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C0AC N/A
UPI0003D0C20D
PREDICTED: PERQ amino acid-rich with GYF domain-containing 
protein 2-like isoform X6 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0C20D
N/A
UPI0003D0C2CD PREDICTED: myelin expression factor 2 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C2CD N/A
UPI0003D0C949 PREDICTED: centrosomal protein of 170 kDa isoform X11 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C949 N/A
UPI0003D0E282
PREDICTED: guanine nucleotide-binding protein G(i) subunit 
alpha-2 isoform X2 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0E282
N/A
UPI0003D0E362 PREDICTED: protein FAM98B isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0E362 N/A
UPI0003D0E707 PREDICTED: nucleolar and coiled-body phosphoprotein 1 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0E707 N/A
UPI0003D0E753 PREDICTED: 39S ribosomal protein L39, mitochondrial n=1 Tax=Rattus norvegicus RepID=UPI0003D0E753 N/A
UPI0003D0EC97 PREDICTED: RNA-binding protein 42 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0EC97 N/A
UPI0003D0F01C PREDICTED: SUN domain-containing protein 1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F01C N/A
UPI0003D0F450 PREDICTED: 28S ribosomal protein S35, mitochondrial isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F450 N/A
UPI0003D0F60C PREDICTED: protein polybromo-1-like isoform X20 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F60C N/A
UPI0003D0F9C8 PREDICTED: microtubule-actin cross-linking factor 1 isoform X10 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F9C8 N/A
UPI0003D0FC8D PREDICTED: rho guanine nucleotide exchange factor 17 n=1 Tax=Rattus norvegicus RepID=UPI0003D0FC8D N/A
UPI0003D0FD46 PREDICTED: protein PRRC2A isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0FD46 N/A
UPI0003D1005E
PREDICTED: reversion-inducing cysteine-rich protein with Kazal 
motifs isoform X2 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D1005E
N/A
UPI0004E4726C
PREDICTED: serine/threonine-protein phosphatase 1 regulatory 
subunit 10 isoform X1 n=1 Tax=Rattus norvegicus 
RepID=UPI0004E4726C
N/A
UPI0004E472EA PREDICTED: tenascin isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0004E472EA N/A
UPI0004E47558 PREDICTED: drebrin isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E47558 N/A
UPI0004E47B0A PREDICTED: ribosome-binding protein 1 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E47B0A N/A
UPI0004E47BB8 PREDICTED: methyl-CpG-binding domain protein 3 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E47BB8 N/A
UPI0004E48EAA
PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein 
LOC100910366 n=1 Tax=Rattus norvegicus 
RepID=UPI0004E48EAA
N/A
UPI0004E491F4 PREDICTED: replication factor C subunit 1 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0004E491F4 N/A
UPI0004E49349 PREDICTED: ATP-dependent RNA helicase DDX3Y isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E49349 N/A
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Table 6 Comparison of N-cad TMX sample to IgG control based on fold 
increase (≥2.5) 
 
Accession Description
Fold 
increase 
score
G3V8T5 Protein Ruvbl2 OS=Rattus norvegicus GN=Ruvbl2 PE=4 SV=1 - [G3V8T5_RAT] 2.59
D3ZZZ9
Catenin (Cadherin associated protein), delta 1 (Predicted), isoform 
CRA_a OS=Rattus norvegicus GN=Ctnnd1 PE=1 SV=1 - 
[D3ZZZ9_RAT]
2.66
P40615 H/ACA ribonucleoprotein complex subunit 4 OS=Rattus norvegicus GN=Dkc1 PE=1 SV=4 - [DKC1_RAT] 2.74
P22509 rRNA 2'-O-methyltransferase fibrillarin OS=Rattus norvegicus GN=Fbl PE=1 SV=2 - [FBRL_RAT] 2.77
D4A563 Protein RGD1312026 OS=Rattus norvegicus GN=Peak1 PE=1 SV=1 - [D4A563_RAT] 2.86
F1LV13 Heterogeneous nuclear ribonucleoprotein M OS=Rattus norvegicus GN=Hnrnpm PE=4 SV=1 - [F1LV13_RAT] 3.08
A9CMB7 Aspartyl-tRNA synthetase OS=Rattus norvegicus GN=Dars PE=3 SV=1 - [A9CMB7_RAT] 3.18
Q5XHY0 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 OS=Rattus norvegicus GN=Ddx18 PE=2 SV=1 - [Q5XHY0_RAT] 3.20
D4AAG8 Protein Smchd1 OS=Rattus norvegicus GN=Smchd1 PE=4 SV=1 - [D4AAG8_RAT] 3.30
UPI0003D08B80 PREDICTED: pre-mRNA-processing factor 6 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D08B80 3.44
Q9QZ86 Nucleolar protein 58 OS=Rattus norvegicus GN=Nop58 PE=1 SV=1 - [NOP58_RAT] 3.72
D4AEB4 Protein Nat10 OS=Rattus norvegicus GN=Nat10 PE=4 SV=1 - [D4AEB4_RAT] 3.87
F1LR02 Procollagen, type XVIII, alpha 1, isoform CRA_a OS=Rattus norvegicus GN=Col18a1 PE=4 SV=2 - [F1LR02_RAT] 3.92
D3ZNI3 Protein Pdcd11 OS=Rattus norvegicus GN=Pdcd11 PE=4 SV=1 - [D3ZNI3_RAT] 3.98
UPI000154F802 programmed cell death 6-interacting protein n=1 Tax=Rattus norvegicus RepID=UPI000154F802 4.23
Q5FVM4 Non-POU domain-containing octamer-binding protein OS=Rattus norvegicus GN=Nono PE=1 SV=3 - [NONO_RAT] 4.26
F1LW91 Protein Numa1 (Fragment) OS=Rattus norvegicus GN=Numa1 PE=4 SV=1 - [F1LW91_RAT] 4.36
P62845 40S ribosomal protein S15 OS=Rattus norvegicus GN=Rps15 PE=1 SV=2 - [RS15_RAT] 4.37
D3ZD24 Protein Syne3 OS=Rattus norvegicus GN=Syne3 PE=4 SV=2 - [D3ZD24_RAT] 4.74
G3V6H2 Pre-mRNA processing factor 8, isoform CRA_a OS=Rattus norvegicus GN=Prpf8 PE=4 SV=1 - [G3V6H2_RAT] 4.85
Q14TE9 DNA topoisomerase 2 OS=Rattus norvegicus GN=Top2b PE=2 SV=1 - [Q14TE9_RAT] 5.14
G3V7U4 Lamin-B1 OS=Rattus norvegicus GN=Lmnb1 PE=3 SV=1 - [G3V7U4_RAT] 8.91
Q09073 ADP/ATP translocase 2 OS=Rattus norvegicus GN=Slc25a5 PE=1 SV=3 - [ADT2_RAT] N/A
A1A5P2 Ribosome biogenesis regulatory protein homolog OS=Rattus norvegicus GN=Rrs1 PE=2 SV=1 - [RRS1_RAT] N/A
A2RRU3 U3 small nucleolar RNA-associated protein 15 homolog OS=Rattus norvegicus GN=Utp15 PE=2 SV=1 - [UTP15_RAT] N/A
B0BMU2 NOP16 nucleolar protein homolog (Yeast) OS=Rattus norvegicus GN=Nop16 PE=2 SV=1 - [B0BMU2_RAT] N/A
B0BMV8 Dihydrofolate reductase OS=Rattus norvegicus GN=Dhfr PE=2 SV=1 - [B0BMV8_RAT] N/A
B0BN90 DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) OS=Rattus norvegicus GN=Dimt1 PE=2 SV=1 - [B0BN90_RAT] N/A
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B0BND5 Protein Rrp9 OS=Rattus norvegicus GN=Rrp9 PE=2 SV=1 - [B0BND5_RAT] N/A
B0BNF5 Qk protein OS=Rattus norvegicus GN=Qk PE=2 SV=1 - [B0BNF5_RAT] N/A
B1H227 LOC682908 protein OS=Rattus norvegicus GN=Rcc1 PE=2 SV=1 - [B1H227_RAT] N/A
B1H269 Ddx27 protein OS=Rattus norvegicus GN=Ddx27 PE=2 SV=1 - [B1H269_RAT] N/A
B2GUZ3 Mthfd1l protein OS=Rattus norvegicus GN=Mthfd1l PE=2 SV=1 - [B2GUZ3_RAT] N/A
B2GV01 Metastasis-associated gene family, member 2 OS=Rattus norvegicus GN=Mta2 PE=2 SV=1 - [B2GV01_RAT] N/A
B2GV02 Protein LOC100909901 OS=Rattus norvegicus GN=Racgap1 PE=2 SV=1 - [B2GV02_RAT] N/A
B2RYQ5 Enhancer of rudimentary homolog OS=Rattus norvegicus GN=Erh PE=2 SV=1 - [B2RYQ5_RAT] N/A
B5DFB2 Protein Rbbp4 OS=Rattus norvegicus GN=Rbbp4 PE=2 SV=1 - [B5DFB2_RAT] N/A
B5DFG2 Hnrnpl protein (Fragment) OS=Rattus norvegicus GN=Hnrnpl PE=2 SV=1 - [B5DFG2_RAT] N/A
B5DFJ3 Ddx23 protein (Fragment) OS=Rattus norvegicus GN=Ddx23 PE=2 SV=1 - [B5DFJ3_RAT] N/A
B6RIU0 FIP1-like 1 OS=Rattus norvegicus GN=Fip1l1 PE=2 SV=1 - [B6RIU0_RAT] N/A
D3ZAY8 Protein Pnn OS=Rattus norvegicus GN=Pnn PE=4 SV=1 - [D3ZAY8_RAT] N/A
D3ZAZ0 Eukaryotic translation initiation factor 3 subunit M OS=Rattus norvegicus GN=Eif3m PE=3 SV=1 - [D3ZAZ0_RAT] N/A
D3ZBS9 Protein Smarcd1 OS=Rattus norvegicus GN=Smarcd1 PE=4 SV=1 - [D3ZBS9_RAT] N/A
D3ZC82 Protein Nufip2 OS=Rattus norvegicus GN=LOC687994 PE=4 SV=2 - [D3ZC82_RAT] N/A
D3ZC84 Ubiquitin carboxyl-terminal hydrolase OS=Rattus norvegicus GN=Usp9x PE=3 SV=1 - [D3ZC84_RAT] N/A
D3ZD73 Protein Ddx6 OS=Rattus norvegicus GN=Ddx6 PE=3 SV=1 - [D3ZD73_RAT] N/A
D3ZD97
DEAH (Asp-Glu-Ala-His) box polypeptide 15 (Predicted), isoform 
CRA_b OS=Rattus norvegicus GN=Dhx15 PE=4 SV=1 - 
[D3ZD97_RAT]
N/A
D3ZDS4
EMG1 nucleolar protein homolog (S. cerevisiae) (Predicted), 
isoform CRA_b OS=Rattus norvegicus GN=Emg1 PE=4 SV=1 - 
[D3ZDS4_RAT]
N/A
D3ZEI6 Nuclear receptor coactivator 5 (Predicted) OS=Rattus norvegicus GN=Ncoa5 PE=4 SV=1 - [D3ZEI6_RAT] N/A
D3ZF07 Protein RGD1562402 OS=Rattus norvegicus GN=RGD1562402 PE=3 SV=1 - [D3ZF07_RAT] N/A
D3ZF52 Ribosomal protein L15 OS=Rattus norvegicus GN=RGD1565767 PE=3 SV=1 - [D3ZF52_RAT] N/A
D3ZF89 Protein Ubap2 OS=Rattus norvegicus GN=Ubap2 PE=4 SV=2 - [D3ZF89_RAT] N/A
D3ZFD0 Uncharacterized protein OS=Rattus norvegicus GN=Myo18a PE=1 SV=2 - [D3ZFD0_RAT] N/A
D3ZGE6 Protein Cttn OS=Rattus norvegicus GN=Cttn PE=4 SV=2 - [D3ZGE6_RAT] N/A
D3ZGQ8 Protein Rsf1 OS=Rattus norvegicus GN=Rsf1 PE=4 SV=1 - [D3ZGQ8_RAT] N/A
D3ZGV8 Protein Prrc2c OS=Rattus norvegicus GN=Prrc2c PE=1 SV=2 - [D3ZGV8_RAT] N/A
D3ZI68
PRP31 pre-mRNA processing factor 31 homolog (Yeast) 
(Predicted) OS=Rattus norvegicus GN=Prpf31 PE=4 SV=1 - 
[D3ZI68_RAT]
N/A
D3ZJ67 Protein Sun2 OS=Rattus norvegicus GN=Sun2 PE=4 SV=1 - [D3ZJ67_RAT] N/A
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D3ZL86 HEAT repeat containing 1 (Predicted) OS=Rattus norvegicus GN=Heatr1 PE=4 SV=1 - [D3ZL86_RAT] N/A
D3ZLC1 Protein Lmnb2 OS=Rattus norvegicus GN=Lmnb2 PE=4 SV=1 - [D3ZLC1_RAT] N/A
D3ZN76 Protein Sec16a OS=Rattus norvegicus GN=Sec16a PE=4 SV=1 - [D3ZN76_RAT] N/A
D3ZNU1 Protein Cebpz OS=Rattus norvegicus GN=Cebpz PE=4 SV=1 - [D3ZNU1_RAT] N/A
D3ZUM5 Protein Trim33 (Fragment) OS=Rattus norvegicus GN=Trim33 PE=4 SV=2 - [D3ZUM5_RAT] N/A
D3ZUV3 Eukaryotic translation initiation factor 2 subunit 1 OS=Rattus norvegicus GN=Eif2a PE=4 SV=2 - [D3ZUV3_RAT] N/A
D3ZUX5
Coiled-coil-helix-coiled-coil-helix domain containing 3 (Predicted), 
isoform CRA_a OS=Rattus norvegicus GN=Chchd3 PE=4 SV=1 - 
[D3ZUX5_RAT]
N/A
D3ZV54 Protein Pwp2 OS=Rattus norvegicus GN=Pwp2 PE=4 SV=1 - [D3ZV54_RAT] N/A
D3ZY44 Protein Mrps2 OS=Rattus norvegicus GN=Mrps2 PE=3 SV=1 - [D3ZY44_RAT] N/A
D3ZZY2 Protein Utp14a OS=Rattus norvegicus GN=Utp14a PE=4 SV=2 - [D3ZZY2_RAT] N/A
D3ZZZ0 Protein Ahctf1 OS=Rattus norvegicus GN=Ahctf1 PE=4 SV=1 - [D3ZZZ0_RAT] N/A
D4A054 Protein LOC100911178 OS=Rattus norvegicus GN=Ranbp2 PE=1 SV=1 - [D4A054_RAT] N/A
D4A0E8 Protein arginine N-methyltransferase 5 OS=Rattus norvegicus GN=Prmt5 PE=3 SV=1 - [D4A0E8_RAT] N/A
D4A0H5
Cleavage and polyadenylation specific factor 1, 160kDa 
(Predicted), isoform CRA_a OS=Rattus norvegicus GN=Cpsf1 
PE=4 SV=1 - [D4A0H5_RAT]
N/A
D4A1K2 Protein Rpl7l1 OS=Rattus norvegicus GN=Rpl7l1 PE=3 SV=1 - [D4A1K2_RAT] N/A
D4A512 Protein Nemf OS=Rattus norvegicus GN=Nemf PE=4 SV=2 - [D4A512_RAT] N/A
D4A5S9 Protein Prpf39 OS=Rattus norvegicus GN=Prpf39 PE=4 SV=1 - [D4A5S9_RAT] N/A
D4A7J8 PRP4 pre-mRNA processing factor 4 homolog (Yeast) OS=Rattus norvegicus GN=Prpf4 PE=4 SV=1 - [D4A7J8_RAT] N/A
D4ACW0 Protein Rbm6 OS=Rattus norvegicus GN=Rbm6 PE=4 SV=1 - [D4ACW0_RAT] N/A
D4AE41 RNA binding motif protein, X-linked-like-1 OS=Rattus norvegicus GN=Rbmxl1 PE=3 SV=1 - [RMXL1_RAT] N/A
D4AE65 Protein Rrp7a OS=Rattus norvegicus GN=Rrp7a PE=4 SV=1 - [D4AE65_RAT] N/A
D4AEC0 Histone H2A OS=Rattus norvegicus GN=LOC685909 PE=3 SV=1 - [D4AEC0_RAT] N/A
E9PTI6 Protein Raly OS=Rattus norvegicus GN=Raly PE=4 SV=1 - [E9PTI6_RAT] N/A
E9PU01 Protein Chd4 OS=Rattus norvegicus GN=Chd4 PE=4 SV=2 - [E9PU01_RAT] N/A
F1LMV9 Coronin (Fragment) OS=Rattus norvegicus GN=Coro2b PE=3 SV=2 - [F1LMV9_RAT] N/A
F1LP60 Moesin (Fragment) OS=Rattus norvegicus GN=Msn PE=4 SV=1 - [F1LP60_RAT] N/A
F1LPQ3 Alpha-mannosidase 2C1 OS=Rattus norvegicus GN=Man2c1 PE=4 SV=1 - [F1LPQ3_RAT] N/A
F1LR39 RCG29171, isoform CRA_a OS=Rattus norvegicus GN=Wdr18 PE=4 SV=2 - [F1LR39_RAT] N/A
F1LRJ2 Protein Srrm2 OS=Rattus norvegicus GN=Srrm2 PE=1 SV=2 - [F1LRJ2_RAT] N/A
F1LSL2 Nuclear pore complex protein Nup107 OS=Rattus norvegicus GN=Nup107 PE=4 SV=2 - [F1LSL2_RAT] N/A
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F1LSL3 Inositol 1,4,5-trisphosphate receptor type 3 OS=Rattus norvegicus GN=Itpr3 PE=4 SV=2 - [F1LSL3_RAT] N/A
F1LSS1 Structural maintenance of chromosomes protein OS=Rattus norvegicus GN=Smc1a PE=3 SV=2 - [F1LSS1_RAT] N/A
F1LU69 Protein Rps27l3 OS=Rattus norvegicus GN=Rps27l3 PE=4 SV=2 - [F1LU69_RAT] N/A
F1LVD0 Protein LOC690134 (Fragment) OS=Rattus norvegicus GN=LOC690134 PE=3 SV=2 - [F1LVD0_RAT] N/A
F1LYI5 Protein RGD1564138 (Fragment) OS=Rattus norvegicus GN=RGD1564138 PE=4 SV=2 - [F1LYI5_RAT] N/A
F1M0V4 Protein Thoc2 OS=Rattus norvegicus GN=Thoc2 PE=4 SV=2 - [F1M0V4_RAT] N/A
F1M3H2 Uncharacterized protein (Fragment) OS=Rattus norvegicus GN=LOC100360367 PE=4 SV=2 - [F1M3H2_RAT] N/A
F1M3K6 Protein Bag4 (Fragment) OS=Rattus norvegicus GN=Bag4 PE=4 SV=2 - [F1M3K6_RAT] N/A
F1M4U9 Protein Baz1a (Fragment) OS=Rattus norvegicus GN=Baz1a PE=4 SV=2 - [F1M4U9_RAT] N/A
F1M5V2 Protein Glipr2 OS=Rattus norvegicus GN=Glipr2 PE=4 SV=2 - [F1M5V2_RAT] N/A
F1M6V1 Heterochromatin protein 1-binding protein 3 OS=Rattus norvegicus GN=Hp1bp3 PE=3 SV=2 - [F1M6V1_RAT] N/A
F1M779 Clathrin heavy chain OS=Rattus norvegicus GN=Cltc PE=3 SV=1 - [F1M779_RAT] N/A
F1M7A0 DNA topoisomerase 2 (Fragment) OS=Rattus norvegicus GN=Top2a PE=3 SV=2 - [F1M7A0_RAT] N/A
F1M8H5 Protein Abcf2 OS=Rattus norvegicus GN=Abcf2 PE=4 SV=2 - [F1M8H5_RAT] N/A
F1MA04 Protein Wdr36 (Fragment) OS=Rattus norvegicus GN=Wdr36 PE=4 SV=2 - [F1MA04_RAT] N/A
F1MA52 Nuclear RNA export factor 1 OS=Rattus norvegicus GN=Nxf1 PE=4 SV=1 - [F1MA52_RAT] N/A
F1SW39 PC4 and SFRS1 interacting protein 1 OS=Rattus norvegicus GN=Psip1 PE=2 SV=1 - [F1SW39_RAT] N/A
F7FFV2 Keratin, type II cytoskeletal 5 (Fragment) OS=Rattus norvegicus GN=Krt5 PE=3 SV=1 - [F7FFV2_RAT] N/A
G3V661 Bromodomain adjacent to zinc finger domain protein 1B OS=Rattus norvegicus GN=Baz1b PE=4 SV=1 - [G3V661_RAT] N/A
G3V6A8
Golgi autoantigen, golgin subfamily b, macrogolgin 1, isoform 
CRA_c OS=Rattus norvegicus GN=Golgb1 PE=1 SV=1 - 
[G3V6A8_RAT]
N/A
G3V6D3 ATP synthase subunit beta OS=Rattus norvegicus GN=Atp5b PE=3 SV=1 - [G3V6D3_RAT] N/A
G3V702 Smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) OS=Rattus norvegicus GN=Smu1 PE=4 SV=1 - [G3V702_RAT] N/A
G3V7B7 DNA-directed RNA polymerase OS=Rattus norvegicus GN=Polr1a PE=3 SV=1 - [G3V7B7_RAT] N/A
G3V7G3 Activity-dependent neuroprotector homeobox protein OS=Rattus norvegicus GN=Adnp PE=4 SV=1 - [G3V7G3_RAT] N/A
G3V7G9 Eukaryotic translation initiation factor 3 subunit L OS=Rattus norvegicus GN=Eif3l PE=2 SV=2 - [G3V7G9_RAT] N/A
G3V803 Cadherin-2 OS=Rattus norvegicus GN=Cdh2 PE=4 SV=1 - [G3V803_RAT] N/A
G3V852 Protein Tln1 OS=Rattus norvegicus GN=Tln1 PE=1 SV=1 - [G3V852_RAT] N/A
G3V8B3 Histone H2B OS=Rattus norvegicus GN=LOC100910200 PE=3 SV=1 - [G3V8B3_RAT] N/A
G3V8G5 Golgi apparatus protein 1 OS=Rattus norvegicus GN=Glg1 PE=4 SV=1 - [G3V8G5_RAT] N/A
G3V920 Protein Wdr43 OS=Rattus norvegicus GN=Wdr43 PE=4 SV=1 - [G3V920_RAT] N/A
G3V9R0 LUC7-like (S. cerevisiae) OS=Rattus norvegicus GN=Luc7l PE=2 SV=2 - [G3V9R0_RAT] N/A
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G3V9R8 Heterogeneous nuclear ribonucleoprotein C (C1/C2) OS=Rattus norvegicus GN=Hnrnpc PE=1 SV=2 - [G3V9R8_RAT] N/A
M0R3M8 Protein Rrp12 OS=Rattus norvegicus GN=Rrp12 PE=4 SV=1 - [M0R3M8_RAT] N/A
M0R3Z8 Protein Rbm15 OS=Rattus norvegicus GN=Rbm15 PE=1 SV=1 - [M0R3Z8_RAT] N/A
M0R440 Zinc finger protein 326 (Fragment) OS=Rattus norvegicus GN=Zfp326 PE=4 SV=1 - [M0R440_RAT] N/A
M0R548 Protein LOC100912029 OS=Rattus norvegicus GN=LOC100912029 PE=4 SV=1 - [M0R548_RAT] N/A
M0R7D1 La-related protein 7 OS=Rattus norvegicus GN=Larp7 PE=4 SV=1 - [M0R7D1_RAT] N/A
M0R8A7 tRNA selenocysteine 1-associated protein 1 OS=Rattus norvegicus GN=Trnau1ap PE=4 SV=1 - [M0R8A7_RAT] N/A
M0R9Q1 Protein LOC100911677 OS=Rattus norvegicus GN=LOC100911677 PE=4 SV=1 - [M0R9Q1_RAT] N/A
M0RB74 Protein Ipo5 OS=Rattus norvegicus GN=Ipo5 PE=4 SV=1 - [M0RB74_RAT] N/A
M0RD14 Pyruvate kinase OS=Rattus norvegicus PE=3 SV=1 - [M0RD14_RAT] N/A
M0RDD7 RCG29880 OS=Rattus norvegicus GN=Chtop PE=4 SV=1 - [M0RDD7_RAT] N/A
M0RDF7 Bystin OS=Rattus norvegicus GN=Bysl PE=4 SV=1 - [M0RDF7_RAT] N/A
O88656 Actin-related protein 2/3 complex subunit 1B OS=Rattus norvegicus GN=Arpc1b PE=2 SV=3 - [ARC1B_RAT] N/A
O88791 High mobility group AT-hook 2 OS=Rattus norvegicus GN=Hmga2 PE=2 SV=1 - [O88791_RAT] N/A
P04256 Heterogeneous nuclear ribonucleoprotein A1 OS=Rattus norvegicus GN=Hnrnpa1 PE=1 SV=3 - [ROA1_RAT] N/A
P05942 Protein S100-A4 OS=Rattus norvegicus GN=S100a4 PE=2 SV=1 - [S10A4_RAT] N/A
P07943 Aldose reductase OS=Rattus norvegicus GN=Akr1b1 PE=1 SV=3 - [ALDR_RAT] N/A
P09895 60S ribosomal protein L5 OS=Rattus norvegicus GN=Rpl5 PE=1 SV=3 - [RL5_RAT] N/A
P15999 ATP synthase subunit alpha, mitochondrial OS=Rattus norvegicus GN=Atp5a1 PE=1 SV=2 - [ATPA_RAT] N/A
P17136 Small nuclear ribonucleoprotein-associated protein B (Fragment) OS=Rattus norvegicus GN=Snrpb PE=2 SV=1 - [RSMB_RAT] N/A
P23785 Granulins OS=Rattus norvegicus GN=Grn PE=1 SV=3 - [GRN_RAT] N/A
P24049 60S ribosomal protein L17 OS=Rattus norvegicus GN=Rpl17 PE=2 SV=3 - [RL17_RAT] N/A
P30427 Plectin OS=Rattus norvegicus GN=Plec PE=1 SV=2 - [PLEC_RAT] N/A
P31000 Vimentin OS=Rattus norvegicus GN=Vim PE=1 SV=2 - [VIME_RAT] N/A
P38650 Cytoplasmic dynein 1 heavy chain 1 OS=Rattus norvegicus GN=Dync1h1 PE=1 SV=1 - [DYHC1_RAT] N/A
P54313 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 OS=Rattus norvegicus GN=Gnb2 PE=1 SV=4 - [GBB2_RAT] N/A
P55770 NHP2-like protein 1 OS=Rattus norvegicus GN=Nhp2l1 PE=2 SV=4 - [NH2L1_RAT] N/A
P61354 60S ribosomal protein L27 OS=Rattus norvegicus GN=Rpl27 PE=2 SV=2 - [RL27_RAT] N/A
P62138 Serine/threonine-protein phosphatase PP1-alpha catalytic subunit OS=Rattus norvegicus GN=Ppp1ca PE=1 SV=1 - [PP1A_RAT] N/A
P62142 Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Rattus norvegicus GN=Ppp1cb PE=1 SV=3 - [PP1B_RAT] N/A
P62275 40S ribosomal protein S29 OS=Rattus norvegicus GN=Rps29 PE=1 SV=2 - [RS29_RAT] N/A
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P62828 GTP-binding nuclear protein Ran OS=Rattus norvegicus GN=Ran PE=1 SV=3 - [RAN_RAT] N/A
P62859 40S ribosomal protein S28 OS=Rattus norvegicus GN=Rps28 PE=1 SV=1 - [RS28_RAT] N/A
P62912 60S ribosomal protein L32 OS=Rattus norvegicus GN=Rpl32 PE=1 SV=2 - [RL32_RAT] N/A
P68255 14-3-3 protein theta OS=Rattus norvegicus GN=Ywhaq PE=1 SV=1 - [1433T_RAT] N/A
P70501 RNA-binding protein 10 OS=Rattus norvegicus GN=Rbm10 PE=2 SV=1 - [RBM10_RAT] N/A
P70565 Plakoglobin OS=Rattus norvegicus GN=Jup PE=2 SV=1 - [P70565_RAT] N/A
P70625 Zonula occludens 2 protein (Fragment) OS=Rattus norvegicus GN=ZO-2 PE=2 SV=2 - [P70625_RAT] N/A
P81795 Eukaryotic translation initiation factor 2 subunit 3 OS=Rattus norvegicus GN=Eif2s3 PE=1 SV=2 - [IF2G_RAT] N/A
P97690 Structural maintenance of chromosomes protein 3 OS=Rattus norvegicus GN=Smc3 PE=1 SV=1 - [SMC3_RAT] N/A
Q05096-3 Isoform C of Unconventional myosin-Ib n=1 Tax=Rattus norvegicus RepID=Q05096-3 N/A
Q0D2G9 RGD1308290 protein (Fragment) OS=Rattus norvegicus GN=RGD1308290 PE=2 SV=1 - [Q0D2G9_RAT] N/A
Q14V05 Tat-binding protein-1 OS=Rattus rattus GN=TBP-1 PE=2 SV=1 - [Q14V05_RATRT] N/A
Q1JU68 Eukaryotic translation initiation factor 3 subunit A OS=Rattus norvegicus GN=Eif3a PE=2 SV=2 - [EIF3A_RAT] N/A
Q27W01 RNA-binding protein 8A OS=Rattus norvegicus GN=Rbm8a PE=2 SV=1 - [RBM8A_RAT] N/A
Q3KRE0 ATPase family AAA domain-containing protein 3 OS=Rattus norvegicus GN=Atad3 PE=1 SV=1 - [ATAD3_RAT] N/A
Q3T1K5 F-actin-capping protein subunit alpha-2 OS=Rattus norvegicus GN=Capza2 PE=1 SV=1 - [CAZA2_RAT] N/A
Q498C9 Protein Zfp207 OS=Rattus norvegicus GN=Zfp207 PE=2 SV=1 - [Q498C9_RAT] N/A
Q4FZT9 26S proteasome non-ATPase regulatory subunit 2 OS=Rattus norvegicus GN=Psmd2 PE=2 SV=1 - [PSMD2_RAT] N/A
Q4KLH7 Protein Rad21 OS=Rattus norvegicus GN=Rad21 PE=2 SV=1 - [Q4KLH7_RAT] N/A
Q4KLI7 Protein Sf3a3 OS=Rattus norvegicus GN=Sf3a3 PE=2 SV=1 - [Q4KLI7_RAT] N/A
Q4QQT3 CUGBP Elav-like family member 1 OS=Rattus norvegicus GN=Celf1 PE=2 SV=1 - [CELF1_RAT] N/A
Q4QQW4 Histone deacetylase 1 OS=Rattus norvegicus GN=Hdac1 PE=1 SV=1 - [HDAC1_RAT] N/A
Q4V8E1 GATA zinc finger domain containing 2B OS=Rattus norvegicus GN=Gatad2b PE=2 SV=1 - [Q4V8E1_RAT] N/A
Q56A18-4
Isoform 4 of SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily E member 1 n=2 Tax=Rattus 
norvegicus RepID=Q56A18-4
N/A
Q56A27 Nuclear cap-binding protein subunit 1 OS=Rattus norvegicus GN=Ncbp1 PE=2 SV=1 - [NCBP1_RAT] N/A
Q5EB56 MAK16 homolog (S. cerevisiae) OS=Rattus norvegicus GN=Mak16 PE=2 SV=1 - [Q5EB56_RAT] N/A
Q5EEY3 GTP-binding protein G-alpha-i2 splice variant b OS=Rattus norvegicus GN=Gnai2 PE=2 SV=1 - [Q5EEY3_RAT] N/A
Q5M7V8 Thyroid hormone receptor-associated protein 3 OS=Rattus norvegicus GN=Thrap3 PE=1 SV=1 - [TR150_RAT] N/A
Q5M920 EBNA1 binding protein 2 OS=Rattus norvegicus GN=Ebna1bp2 PE=2 SV=1 - [Q5M920_RAT] N/A
Q5RKJ9 RAB10, member RAS oncogene family OS=Rattus norvegicus GN=Rab10 PE=2 SV=1 - [Q5RKJ9_RAT] N/A
Q5U2W5 Transducin beta-like protein 3 OS=Rattus norvegicus GN=Tbl3 PE=2 SV=1 - [TBL3_RAT] N/A
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Q5U2Y1-2 Isoform 2 of General transcription factor II-I n=2 Tax=Rattus norvegicus RepID=Q5U2Y1-2 N/A
Q5U302 Catenin (Cadherin associated protein), alpha 1 OS=Rattus norvegicus GN=Ctnna1 PE=1 SV=1 - [Q5U302_RAT] N/A
Q5XI13 Glutamate-rich WD repeat-containing protein 1 OS=Rattus norvegicus GN=Grwd1 PE=2 SV=1 - [GRWD1_RAT] N/A
Q5XI32 F-actin-capping protein subunit beta OS=Rattus norvegicus GN=Capzb PE=1 SV=1 - [CAPZB_RAT] N/A
Q5XIB5 Coiled-coil domain-containing protein 86 OS=Rattus norvegicus GN=Ccdc86 PE=2 SV=1 - [CCD86_RAT] N/A
Q62636 Ras-related protein Rap-1b OS=Rattus norvegicus GN=Rap1b PE=2 SV=2 - [RAP1B_RAT] N/A
Q62940 E3 ubiquitin-protein ligase NEDD4 OS=Rattus norvegicus GN=Nedd4 PE=1 SV=1 - [NEDD4_RAT] N/A
Q63009 Protein arginine N-methyltransferase 1 OS=Rattus norvegicus GN=Prmt1 PE=1 SV=1 - [ANM1_RAT] N/A
Q63413 Spliceosome RNA helicase Ddx39b OS=Rattus norvegicus GN=Ddx39b PE=1 SV=3 - [DX39B_RAT] N/A
Q63692 Hsp90 co-chaperone Cdc37 OS=Rattus norvegicus GN=Cdc37 PE=1 SV=2 - [CDC37_RAT] N/A
Q63716 Peroxiredoxin-1 OS=Rattus norvegicus GN=Prdx1 PE=1 SV=1 - [PRDX1_RAT] N/A
Q641X8 Eukaryotic translation initiation factor 3 subunit E OS=Rattus norvegicus GN=Eif3e PE=2 SV=1 - [EIF3E_RAT] N/A
Q66HD0 Endoplasmin OS=Rattus norvegicus GN=Hsp90b1 PE=1 SV=2 - [ENPL_RAT] N/A
Q66HG8 Protein Red OS=Rattus norvegicus GN=Ik PE=1 SV=1 - [RED_RAT] N/A
Q6AXU3 Interferon-stimulated 20 kDa exonuclease-like 2 OS=Rattus norvegicus GN=Isg20l2 PE=2 SV=1 - [I20L2_RAT] N/A
Q6AY87 THO complex subunit 6 homolog OS=Rattus norvegicus GN=Thoc6 PE=2 SV=1 - [THOC6_RAT] N/A
Q6AYD3 Proliferation-associated 2G4 OS=Rattus norvegicus GN=Pa2g4 PE=2 SV=1 - [Q6AYD3_RAT] N/A
Q6AYU2 Pcbp2 protein OS=Rattus norvegicus GN=Pcbp2 PE=2 SV=1 - [Q6AYU2_RAT] N/A
Q6AYZ1 Tubulin alpha-1C chain OS=Rattus norvegicus GN=Tuba1c PE=1 SV=1 - [TBA1C_RAT] N/A
Q6IFU8 Keratin, type I cytoskeletal 17 OS=Rattus norvegicus GN=Krt17 PE=2 SV=1 - [K1C17_RAT] N/A
Q6P9U7 L-lactate dehydrogenase OS=Rattus norvegicus GN=Ldha PE=2 SV=1 - [Q6P9U7_RAT] N/A
Q6QLN3 Glioma tumor suppressor candidate region gene 2 OS=Rattus norvegicus GN=Gltscr2 PE=2 SV=1 - [Q6QLN3_RAT] N/A
Q6VEU8 DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 OS=Rattus norvegicus GN=Ddx24 PE=2 SV=1 - [Q6VEU8_RAT] N/A
Q8CHN6 Sphingosine-1-phosphate lyase 1 OS=Rattus norvegicus GN=Sgpl1 PE=2 SV=1 - [SGPL1_RAT] N/A
Q8K585-2 Isoform HMG-Y of High mobility group protein HMG-I/HMG-Y n=1 Tax=Rattus norvegicus RepID=Q8K585-2 N/A
Q925G0 Putative RNA-binding protein 3 OS=Rattus norvegicus GN=Rbm3 PE=1 SV=2 - [RBM3_RAT] N/A
Q9ESY8 Stau1 protein OS=Rattus norvegicus GN=Stau1 PE=2 SV=1 - [Q9ESY8_RAT] N/A
Q9QYW0 Protein AATF OS=Rattus norvegicus GN=Aatf PE=1 SV=1 - [AATF_RAT] N/A
Q9R1T1 Barrier-to-autointegration factor OS=Rattus norvegicus GN=Banf1 PE=1 SV=1 - [BAF_RAT] N/A
Q9R1Z0 Voltage-dependent anion-selective channel protein 3 OS=Rattus norvegicus GN=Vdac3 PE=1 SV=2 - [VDAC3_RAT] N/A
Q9WU82 Catenin beta-1 OS=Rattus norvegicus GN=Ctnnb1 PE=1 SV=1 - [CTNB1_RAT] N/A
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Q9WUC8 Pleiotropic regulator 1 OS=Rattus norvegicus GN=Plrg1 PE=2 SV=1 - [PLRG1_RAT] N/A
Q9Z118 Polypyrimidine tract-binding protein 3 OS=Rattus norvegicus GN=Ptbp3 PE=2 SV=1 - [PTBP3_RAT] N/A
UPI000017E2CF PREDICTED: nucleolar protein 14 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI000017E2CF N/A
UPI000017F893 proline-, glutamic acid- and leucine-rich protein 1 n=1 Tax=Rattus norvegicus RepID=UPI000017F893 N/A
UPI00001CFDCB PREDICTED: polymerase delta-interacting protein 3 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI00001CFDCB N/A
UPI00001D0F5B PREDICTED: cytokine receptor-like factor 1 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI00001D0F5B N/A
UPI0000503E75 PREDICTED: ribonucleases P/MRP protein subunit POP1 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0000503E75 N/A
UPI0000DA267A PREDICTED: filamin-C isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0000DA267A N/A
UPI0000DA3509 PREDICTED: RNA-binding protein 25 n=1 Tax=Rattus norvegicus RepID=UPI0000DA3509 N/A
UPI0000DA3DFF PREDICTED: rho GTPase-activating protein 22 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0000DA3DFF N/A
UPI0000DA4524 LAS1-like n=2 Tax=Rattus norvegicus RepID=UPI0000DA4524 N/A
UPI0000DBFEDB PREDICTED: pumilio homolog 1 isoform X11 n=1 Tax=Rattus norvegicus RepID=UPI0000DBFEDB N/A
UPI000150B091 PREDICTED: drebrin isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI000150B091 N/A
UPI000154D8C8 nuclear pore complex protein Nup160 n=1 Tax=Rattus norvegicus RepID=UPI000154D8C8 N/A
UPI0001551D2B PREDICTED: uncharacterized protein C9orf114 homolog isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0001551D2B N/A
UPI0001551E07
PREDICTED: DNA-directed RNA polymerases I, II, and III subunit 
RPABC1 isoform X3 n=1 Tax=Rattus norvegicus 
RepID=UPI0001551E07
N/A
UPI0001552819 PREDICTED: 5''''-3'''' exoribonuclease 2 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0001552819 N/A
UPI0001B79CC2 PREDICTED: probable ATP-dependent RNA helicase YTHDC2 n=1 Tax=Rattus norvegicus RepID=UPI0001B79CC2 N/A
UPI0001B7B713 PREDICTED: AT-rich interactive domain-containing protein 1A isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0001B7B713 N/A
UPI0001CF3F9F YLP motif-containing protein 1 n=1 Tax=Rattus norvegicus RepID=UPI0001CF3F9F N/A
UPI0001CF735C neuroblast differentiation-associated protein AHNAK n=1 Tax=Rattus norvegicus RepID=UPI0001CF735C N/A
UPI000268808A zinc finger RNA-binding protein n=1 Tax=Rattus norvegicus RepID=UPI000268808A N/A
UPI0003D0721E PREDICTED: fibronectin isoform X10 n=1 Tax=Rattus norvegicus RepID=UPI0003D0721E N/A
UPI0003D07514 PREDICTED: poly(U)-binding-splicing factor PUF60 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D07514 N/A
UPI0003D07629 PREDICTED: 28S ribosomal protein S29, mitochondrial isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D07629 N/A
UPI0003D0803D PREDICTED: pre-mRNA-processing factor 40 homolog A isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0803D N/A
UPI0003D080F2 PREDICTED: lupus La protein homolog isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D080F2 N/A
UPI0003D0841E PREDICTED: SH3 and PX domain-containing protein 2A isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0841E N/A
UPI0003D084DB PREDICTED: E3 ubiquitin-protein ligase TRIP12 isoform X11 n=1 Tax=Rattus norvegicus RepID=UPI0003D084DB N/A
UPI0003D0853E PREDICTED: tripeptidyl-peptidase 2 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D0853E N/A
UPI0003D08BBF PREDICTED: protein KRI1 homolog n=1 Tax=Rattus norvegicus RepID=UPI0003D08BBF N/A
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UPI0003D08BCF PREDICTED: bcl-2-associated transcription factor 1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D08BCF N/A
UPI0003D08D2D
PREDICTED: RNA-binding motif, single-stranded-interacting 
protein 1 isoform X2 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D08D2D
N/A
UPI0003D093A2 PREDICTED: protein SON isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D093A2 N/A
UPI0003D09498 PREDICTED: U3 small nucleolar RNA-associated protein 6 homolog n=1 Tax=Rattus norvegicus RepID=UPI0003D09498 N/A
UPI0003D09676 PREDICTED: unconventional myosin-VI isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D09676 N/A
UPI0003D09A07 PREDICTED: nuclear pore complex protein Nup98-Nup96 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D09A07 N/A
UPI0003D09C9B PREDICTED: heat shock 70 kDa protein 4 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D09C9B N/A
UPI0003D0A336 PREDICTED: cell division cycle and apoptosis regulator protein 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A336 N/A
UPI0003D0A51A PREDICTED: zinc finger CCHC domain-containing protein 8 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A51A N/A
UPI0003D0A55E PREDICTED: C-Jun-amino-terminal kinase-interacting protein 4 isoform X9 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A55E N/A
UPI0003D0A726 PREDICTED: UPF0568 protein C14orf166 homolog isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A726 N/A
UPI0003D0AB54 PREDICTED: telomere-associated protein RIF1-like n=1 Tax=Rattus norvegicus RepID=UPI0003D0AB54 N/A
UPI0003D0AB89 PREDICTED: ribosomal RNA processing protein 1 homolog B isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0AB89 N/A
UPI0003D0AC45 PREDICTED: protein transport protein Sec24D isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0AC45 N/A
UPI0003D0B550 PREDICTED: serine/arginine repetitive matrix protein 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0B550 N/A
UPI0003D0BDBD PREDICTED: SWI/SNF complex subunit SMARCC2-like isoform X10 n=1 Tax=Rattus norvegicus RepID=UPI0003D0BDBD N/A
UPI0003D0BE42 PREDICTED: methionine--tRNA ligase, cytoplasmic isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0BE42 N/A
UPI0003D0C20D
PREDICTED: PERQ amino acid-rich with GYF domain-containing 
protein 2-like isoform X6 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0C20D
N/A
UPI0003D0C2CD PREDICTED: myelin expression factor 2 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C2CD N/A
UPI0003D0C521
PREDICTED: LOW QUALITY PROTEIN: 
deoxynucleotidyltransferase terminal-interacting protein 2-like n=1 
Tax=Rattus norvegicus RepID=UPI0003D0C521
N/A
UPI0003D0CF50
PREDICTED: ubiquitin-associated and SH3 domain-containing 
protein B isoform X4 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0CF50
N/A
UPI0003D0CF50
PREDICTED: ubiquitin-associated and SH3 domain-containing 
protein B isoform X4 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0CF50
N/A
UPI0003D0D1B4 PREDICTED: serrate RNA effector molecule homolog isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0D1B4 N/A
UPI0003D0E753 PREDICTED: 39S ribosomal protein L39, mitochondrial n=1 Tax=Rattus norvegicus RepID=UPI0003D0E753 N/A
UPI0003D0F25F PREDICTED: nestin-like, partial n=1 Tax=Rattus norvegicus RepID=UPI0003D0F25F N/A
UPI0003D0F9C8 PREDICTED: microtubule-actin cross-linking factor 1 isoform X10 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F9C8 N/A
UPI0004E473EA PREDICTED: plectin isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E473EA N/A
UPI0004E4745E PREDICTED: TATA-binding protein-associated factor 2N-like isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4745E N/A
UPI0004E477F8 PREDICTED: band 4.1-like protein 2 isoform X7 n=1 Tax=Rattus norvegicus RepID=UPI0004E477F8 N/A
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UPI0004E4789B PREDICTED: cirhin isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E4789B N/A
UPI0004E48548 PREDICTED: nuclear pore complex protein Nup153 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E48548 N/A
UPI0004E4880A PREDICTED: ATP-dependent RNA helicase DHX36 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4880A N/A
UPI0004E48819
PREDICTED: LOW QUALITY PROTEIN: eukaryotic translation 
initiation factor 4 gamma 2-like isoform X1, partial n=1 Tax=Rattus 
norvegicus RepID=UPI0004E48819
N/A
UPI0004E4891E PREDICTED: tumor suppressor p53-binding protein 1 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4891E N/A
UPI0004E4894C PREDICTED: nucleolar protein 6 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E4894C N/A
UPI0004E489DA PREDICTED: zinc finger CCCH domain-containing protein 14 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E489DA N/A
UPI0004E48B1F PREDICTED: ataxin-2 isoform X14 n=1 Tax=Rattus norvegicus RepID=UPI0004E48B1F N/A
UPI0004E48EAA
PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein 
LOC100910366 n=1 Tax=Rattus norvegicus 
RepID=UPI0004E48EAA
N/A
UPI0004E48EB3 PREDICTED: U4/U6 small nuclear ribonucleoprotein Prp3 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0004E48EB3 N/A
UPI0004E48EEF PREDICTED: tight junction protein ZO-1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E48EEF N/A
UPI0004E48FAD PREDICTED: la-related protein 4 isoform X6 n=2 Tax=Rattus norvegicus RepID=UPI0004E48FAD N/A
UPI0004E494D5 PREDICTED: splicing factor 3B subunit 2 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E494D5 N/A
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Table 7 Proteins overlapping in EtOH and TMX  
 
Mapped proteins 
Unmapped proteins 
Unmapped proteins related to cytoskeleton 
Known N-cad interacting proteins 
 
 
 
Accession Description EtOH score TMX score
B0BNF5 Qk protein OS=Rattus norvegicus GN=Qk PE=2 SV=1 - [B0BNF5_RAT] 126.42 117.77
B2RYQ5 Enhancer of rudimentary homolog OS=Rattus norvegicus GN=Erh PE=2 SV=1 - [B2RYQ5_RAT] 77.84 87.17
D3ZEI6 Nuclear receptor coactivator 5 (Predicted) OS=Rattus norvegicus GN=Ncoa5 PE=4 SV=1 - [D3ZEI6_RAT] 88.43 112.87
D3ZFD0 Uncharacterized protein OS=Rattus norvegicus GN=Myo18a PE=1 SV=2 - [D3ZFD0_RAT] 202.13 64.01
D3ZI68
PRP31 pre-mRNA processing factor 31 homolog 
(Yeast) (Predicted) OS=Rattus norvegicus GN=Prpf31 
PE=4 SV=1 - [D3ZI68_RAT]
124.86 93.36
D3ZJ67 Protein Sun2 OS=Rattus norvegicus GN=Sun2 PE=4 SV=1 - [D3ZJ67_RAT] 160.04 142.52
D3ZN76 Protein Sec16a OS=Rattus norvegicus GN=Sec16a PE=4 SV=1 - [D3ZN76_RAT] 1165.42 1682.02
D4A5S9 Protein Prpf39 OS=Rattus norvegicus GN=Prpf39 PE=4 SV=1 - [D4A5S9_RAT] 317.49 294.02
D4AE65 Protein Rrp7a OS=Rattus norvegicus GN=Rrp7a PE=4 SV=1 - [D4AE65_RAT] 75.01 96.31
F1LSL2 Nuclear pore complex protein Nup107 OS=Rattus norvegicus GN=Nup107 PE=4 SV=2 - [F1LSL2_RAT] 88.97 158.34
F1LSS1
Structural maintenance of chromosomes protein 
OS=Rattus norvegicus GN=Smc1a PE=3 SV=2 - 
[F1LSS1_RAT]
162.50 151.80
F1M0V4 Protein Thoc2 OS=Rattus norvegicus GN=Thoc2 PE=4 SV=2 - [F1M0V4_RAT] 123.79 306.07
F1M3H2
Uncharacterized protein (Fragment) OS=Rattus 
norvegicus GN=LOC100360367 PE=4 SV=2 - 
[F1M3H2_RAT]
240.77 298.65
F1M3K6 Protein Bag4 (Fragment) OS=Rattus norvegicus GN=Bag4 PE=4 SV=2 - [F1M3K6_RAT] 137.31 161.37
F1M4U9 Protein Baz1a (Fragment) OS=Rattus norvegicus GN=Baz1a PE=4 SV=2 - [F1M4U9_RAT] 117.66 115.19
F1SW39 PC4 and SFRS1 interacting protein 1 OS=Rattus norvegicus GN=Psip1 PE=2 SV=1 - [F1SW39_RAT] 323.58 159.30
G3V702
Smu-1 suppressor of mec-8 and unc-52 homolog (C. 
elegans) OS=Rattus norvegicus GN=Smu1 PE=4 
SV=1 - [G3V702_RAT]
95.96 169.31
G3V803 Cadherin-2 OS=Rattus norvegicus GN=Cdh2 PE=4 SV=1 - [G3V803_RAT] 1026.61 1052.41
G3V8B3 Histone H2B OS=Rattus norvegicus GN=LOC100910200 PE=3 SV=1 - [G3V8B3_RAT] 971.68 995.15
G3V9R0 LUC7-like (S. cerevisiae) OS=Rattus norvegicus GN=Luc7l PE=2 SV=2 - [G3V9R0_RAT] 73.56 91.16
M0RD14 Pyruvate kinase OS=Rattus norvegicus PE=3 SV=1 - [M0RD14_RAT] 75.95 466.68
P05942 Protein S100-A4 OS=Rattus norvegicus GN=S100a4 PE=2 SV=1 - [S10A4_RAT] 91.17 90.76
P23785 Granulins OS=Rattus norvegicus GN=Grn PE=1 SV=3 - [GRN_RAT] 117.79 126.53
P24049 60S ribosomal protein L17 OS=Rattus norvegicus GN=Rpl17 PE=2 SV=3 - [RL17_RAT] 254.48 221.55
EtOH and TMX
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P31000 Vimentin OS=Rattus norvegicus GN=Vim PE=1 SV=2 - [VIME_RAT] 7580.16 6419.78
P61354 60S ribosomal protein L27 OS=Rattus norvegicus GN=Rpl27 PE=2 SV=2 - [RL27_RAT] 73.15 105.86
P62912 60S ribosomal protein L32 OS=Rattus norvegicus GN=Rpl32 PE=1 SV=2 - [RL32_RAT] 65.07 92.89
P81795
Eukaryotic translation initiation factor 2 subunit 3 
OS=Rattus norvegicus GN=Eif2s3 PE=1 SV=2 - 
[IF2G_RAT]
222.99 303.15
Q1JU68
Eukaryotic translation initiation factor 3 subunit A 
OS=Rattus norvegicus GN=Eif3a PE=2 SV=2 - 
[EIF3A_RAT]
329.28 333.31
Q4QQW4 Histone deacetylase 1 OS=Rattus norvegicus GN=Hdac1 PE=1 SV=1 - [HDAC1_RAT] 147.99 71.86
Q56A18-4
Isoform 4 of SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily E member 
1 n=2 Tax=Rattus norvegicus RepID=Q56A18-4
239.69 192.18
Q56A27 Nuclear cap-binding protein subunit 1 OS=Rattus norvegicus GN=Ncbp1 PE=2 SV=1 - [NCBP1_RAT] 118.52 81.67
Q5U2W5 Transducin beta-like protein 3 OS=Rattus norvegicus GN=Tbl3 PE=2 SV=1 - [TBL3_RAT] 68.34 69.92
Q5XI32 F-actin-capping protein subunit beta OS=Rattus norvegicus GN=Capzb PE=1 SV=1 - [CAPZB_RAT] 179.83 156.20
Q63009 Protein arginine N-methyltransferase 1 OS=Rattus norvegicus GN=Prmt1 PE=1 SV=1 - [ANM1_RAT] 471.77 532.23
Q66HD0 Endoplasmin OS=Rattus norvegicus GN=Hsp90b1 PE=1 SV=2 - [ENPL_RAT] 274.06 428.47
Q6AYU2 Pcbp2 protein OS=Rattus norvegicus GN=Pcbp2 PE=2 SV=1 - [Q6AYU2_RAT] 181.77 320.72
Q6P9U7 L-lactate dehydrogenase OS=Rattus norvegicus GN=Ldha PE=2 SV=1 - [Q6P9U7_RAT] 81.64 85.65
Q6QLN3
Glioma tumor suppressor candidate region gene 2 
OS=Rattus norvegicus GN=Gltscr2 PE=2 SV=1 - 
[Q6QLN3_RAT]
148.05 110.43
Q925G0 Putative RNA-binding protein 3 OS=Rattus norvegicus GN=Rbm3 PE=1 SV=2 - [RBM3_RAT] 169.16 157.57
Q9WU82 Catenin beta-1 OS=Rattus norvegicus GN=Ctnnb1 PE=1 SV=1 - [CTNB1_RAT] 2612.40 2529.22
UPI00001D0F5B
PREDICTED: cytokine receptor-like factor 1 isoform 
X2 n=1 Tax=Rattus norvegicus 
RepID=UPI00001D0F5B
57.57 62.08
UPI0001551E07
PREDICTED: DNA-directed RNA polymerases I, II, 
and III subunit RPABC1 isoform X3 n=1 Tax=Rattus 
norvegicus RepID=UPI0001551E07
87.32 139.85
UPI0001B7B713
PREDICTED: AT-rich interactive domain-containing 
protein 1A isoform X1 n=1 Tax=Rattus norvegicus 
RepID=UPI0001B7B713
232.56 124.20
UPI0001CF3F9F YLP motif-containing protein 1 n=1 Tax=Rattus norvegicus RepID=UPI0001CF3F9F 58.41 70.11
UPI0003D0841E
PREDICTED: SH3 and PX domain-containing protein 
2A isoform X4 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0841E
83.31 108.07
UPI0003D08BCF
PREDICTED: bcl-2-associated transcription factor 1 
isoform X4 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D08BCF
60.70 44.87
UPI0003D093A2 PREDICTED: protein SON isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D093A2 74.42 109.66
UPI0003D0AC45
PREDICTED: protein transport protein Sec24D isoform 
X2 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0AC45
134.04 140.73
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UPI0003D0B550
PREDICTED: serine/arginine repetitive matrix protein 
1 isoform X5 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0B550
58.87 69.56
UPI0003D0C20D
PREDICTED: PERQ amino acid-rich with GYF domain-
containing protein 2-like isoform X6 n=1 Tax=Rattus 
norvegicus RepID=UPI0003D0C20D
69.98 95.36
UPI0003D0C2CD PREDICTED: myelin expression factor 2 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C2CD 130.39 279.93
UPI0003D0E753
PREDICTED: 39S ribosomal protein L39, 
mitochondrial n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0E753
91.23 121.50
UPI0003D0F9C8
PREDICTED: microtubule-actin cross-linking factor 1 
isoform X10 n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0F9C8
292.24 190.22
UPI0004E48EAA
PREDICTED: LOW QUALITY PROTEIN: 
uncharacterized protein LOC100910366 n=1 
Tax=Rattus norvegicus RepID=UPI0004E48EAA
460.84 537.82
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Table 8 Proteins specifically identified in EtOH samples 
 
Mapped proteins 
Unmapped proteins 
Unmapped proteins related to cytoskeleton 
Protein of interest 
 
 
 
 
Accession Description Score
A0JPL2 Casein kinase 1, alpha 1, isoform CRA_d OS=Rattus norvegicus GN=Csnk1a1 PE=2 SV=1 - [A0JPL2_RAT] 112.73
A2RRU1 Glycogen [starch] synthase, muscle OS=Rattus norvegicus GN=Gys1 PE=2 SV=1 - [GYS1_RAT] 91.73
B1H237 Terf2 protein OS=Rattus norvegicus GN=Terf2 PE=2 SV=1 - [B1H237_RAT] 87.48
B1VKB4 Synaptopodin OS=Rattus norvegicus GN=Synpo PE=2 SV=1 - [B1VKB4_RAT] 344.34
B2GUU1 YTH domain family 2 (Predicted) OS=Rattus norvegicus GN=Ythdf2 PE=2 SV=1 - [B2GUU1_RAT] 112.64
B2GUY6 Srrm2 protein (Fragment) OS=Rattus norvegicus GN=Srrm2 PE=2 SV=1 - [B2GUY6_RAT] 166.32
B5DF27 Lysyl oxidase homolog 2 OS=Rattus norvegicus GN=Loxl2 PE=2 SV=2 - [LOXL2_RAT] 157.53
D3Z8W1 Uncharacterized protein OS=Rattus norvegicus GN=LOC680384 PE=4 SV=1 - [D3Z8W1_RAT] 73.47
D3ZHB3 40S ribosomal protein S12 OS=Rattus norvegicus GN=LOC100360573 PE=3 SV=2 - [D3ZHB3_RAT] 78.65
D3ZIX4 Protein H1fx OS=Rattus norvegicus GN=H1fx PE=3 SV=1 - [D3ZIX4_RAT] 75.06
D3ZJU5 Protein Smarcc1 OS=Rattus norvegicus GN=Smarcc1 PE=4 SV=1 - [D3ZJU5_RAT] 322.41
D3ZNH2 Protein Utp18 OS=Rattus norvegicus GN=Utp18 PE=4 SV=2 - [D3ZNH2_RAT] 134.72
D3ZNP7 Protein LOC100909685 OS=Rattus norvegicus GN=Myo1b PE=4 SV=2 - [D3ZNP7_RAT] 331.22
D3ZQG1 Protein Nufip2 OS=Rattus norvegicus GN=LOC687994 PE=4 SV=2 - [D3ZQG1_RAT] 273.92
D3ZR53 Protein phosphatase 1 regulatory subunit 12 OS=Rattus norvegicus GN=Ppp1r12a PE=1 SV=2 - [D3ZR53_RAT] 532.54
D3ZRT6 Protein Plekha7 OS=Rattus norvegicus GN=Plekha7 PE=4 SV=1 - [D3ZRT6_RAT] 96.39
D3ZUK4 Protein Trim33 (Fragment) OS=Rattus norvegicus GN=Trim33 PE=4 SV=2 - [D3ZUK4_RAT] 284.91
D3ZWZ6 Protein Igf2bp2 (Fragment) OS=Rattus norvegicus GN=Igf2bp2 PE=4 SV=2 - [D3ZWZ6_RAT] 263.64
D3ZYT2 Mitochondrial ribosomal protein S5 (Predicted) OS=Rattus norvegicus GN=Mrps5 PE=3 SV=1 - [D3ZYT2_RAT] 110.26
D3ZZM1 Uncharacterized protein (Fragment) OS=Rattus norvegicus PE=4 SV=2 - [D3ZZM1_RAT] 323.52
D3ZZR5 Protein Snrpa1 OS=Rattus norvegicus GN=Snrpa1 PE=4 SV=1 - [D3ZZR5_RAT] 146.28
D4A2B0
Polymerase (DNA-directed), delta interacting protein 3 (Predicted), 
isoform CRA_a OS=Rattus norvegicus GN=Poldip3 PE=4 SV=1 - 
[D4A2B0_RAT]
211.77
D4A2Z8 DEAH (Asp-Glu-Ala-His) box polypeptide 36 (Predicted), isoform CRA_a OS=Rattus norvegicus GN=Dhx36 PE=4 SV=1 - [D4A2Z8_RAT] 126.60
D4A554 Eukaryotic translation initiation factor 4 gamma, 3 (Predicted), isoform CRA_a OS=Rattus norvegicus GN=Eif4g3 PE=4 SV=2 - [D4A554_RAT] 70.55
D4A5G2 Protein Nop14 OS=Rattus norvegicus GN=Nop14 PE=4 SV=1 - [D4A5G2_RAT] 102.37
D4A5K7 Protein Rbm28 OS=Rattus norvegicus GN=Rbm28 PE=4 SV=1 - [D4A5K7_RAT] 77.36
EtOH specific
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D4AAG4 Protein Kif23 OS=Rattus norvegicus GN=Kif23 PE=3 SV=2 - [D4AAG4_RAT] 59.73
D4AAW2 Protein transport protein Sec16B OS=Rattus norvegicus GN=Sec16b PE=4 SV=2 - [D4AAW2_RAT] 68.83
D4ABR6 Annexin (Fragment) OS=Rattus norvegicus GN=Anxa6 PE=3 SV=2 - [D4ABR6_RAT] 214.32
D4ACV3 Histone H2A OS=Rattus norvegicus GN=Hist2h2ac PE=3 SV=1 - [D4ACV3_RAT] 348.54
D4JQY2 Chaperone protein DnaK n=3 Tax=root RepID=D4JQY2_9FIRM 125.33
E9PT66 Protein Sf3b3 OS=Rattus norvegicus GN=Sf3b3 PE=4 SV=2 - [E9PT66_RAT] 290.42
F1LNF1 Heterogeneous nuclear ribonucleoproteins A2/B1 (Fragment) OS=Rattus norvegicus GN=Hnrnpa2b1 PE=4 SV=1 - [F1LNF1_RAT] 1428.52
F1LQB2 Structural maintenance of chromosomes protein 3 OS=Rattus norvegicus GN=Smc3 PE=4 SV=1 - [F1LQB2_RAT] 387.08
F1LS65 Signal-induced proliferation-associated 1-like protein 1 (Fragment) OS=Rattus norvegicus GN=Sipa1l1 PE=4 SV=2 - [F1LS65_RAT] 130.45
F1LSL1 Transcription factor Pur-beta OS=Rattus norvegicus GN=Purb PE=4 SV=2 - [F1LSL1_RAT] 139.40
F1LX68 Protein Spats2 OS=Rattus norvegicus GN=Spats2 PE=4 SV=2 - [F1LX68_RAT] 170.56
F1M4A0 Protein Tjp1 OS=Rattus norvegicus GN=Tjp1 PE=1 SV=2 - [F1M4A0_RAT] 155.69
F1MAA5 Protein Rangap1 OS=Rattus norvegicus GN=Rangap1 PE=4 SV=2 - [F1MAA5_RAT] 95.73
F1MAA7 Protein Lamc1 OS=Rattus norvegicus GN=Lamc1 PE=4 SV=1 - [F1MAA7_RAT] 293.77
F7EM03 Protein Krt31 OS=Rattus norvegicus GN=Krt34 PE=3 SV=1 - [F7EM03_RAT] 118.76
G3V6A4 Heterogeneous nuclear ribonucleoprotein D, isoform CRA_b OS=Rattus norvegicus GN=Hnrpd PE=1 SV=1 - [G3V6A4_RAT] 313.89
G3V727 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47, isoform CRA_a OS=Rattus norvegicus GN=Ddx47 PE=3 SV=1 - [G3V727_RAT] 100.43
G3V7J2
Interferon-inducible double-stranded RNA-dependent protein kinase 
activator A OS=Rattus norvegicus GN=Prkra PE=1 SV=1 - 
[G3V7J2_RAT]
77.11
G3V7K3 Ceruloplasmin OS=Rattus norvegicus GN=Cp PE=4 SV=1 - [G3V7K3_RAT] 102.86
G3V7N0 Heparan sulfate 2-O-sulfotransferase 1, isoform CRA_a OS=Rattus norvegicus GN=Hs2st1 PE=4 SV=1 - [G3V7N0_RAT] 128.76
G3V8B4 Brix domain containing 2, isoform CRA_a OS=Rattus norvegicus GN=Brix1 PE=4 SV=1 - [G3V8B4_RAT] 67.15
G3V8T4 DNA damage-binding protein 1 OS=Rattus norvegicus GN=Ddb1 PE=4 SV=1 - [G3V8T4_RAT] 91.56
G3V9F3 Myosin phosphatase Rho-interacting protein OS=Rattus norvegicus GN=Mprip PE=4 SV=1 - [G3V9F3_RAT] 587.26
M0R7L9 Protein LOC100911677 OS=Rattus norvegicus GN=LOC100911677 PE=4 SV=1 - [M0R7L9_RAT] 391.30
M0R7Z0 Uncharacterized protein OS=Rattus norvegicus PE=4 SV=1 - [M0R7Z0_RAT] 128.03
M0R8U4 Protein Rpl13a-ps1 OS=Rattus norvegicus GN=Rpl13a-ps1 PE=3 SV=1 - [M0R8U4_RAT] 60.65
M0R907 Protein Snrpd3 OS=Rattus norvegicus GN=Snrpd3 PE=4 SV=1 - [M0R907_RAT] 88.64
M0RCH1 Uncharacterized protein (Fragment) OS=Rattus norvegicus PE=3 SV=1 - [M0RCH1_RAT] 80.38
P04692-7 Isoform 7 of Tropomyosin alpha-1 chain n=1 Tax=Rattus norvegicus RepID=P04692-7 86.79
P15865 Histone H1.4 OS=Rattus norvegicus GN=Hist1h1e PE=1 SV=3 - [H14_RAT] 506.37
P19637 Tissue-type plasminogen activator OS=Rattus norvegicus GN=Plat PE=2 SV=2 - [TPA_RAT] 136.66
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P62260 14-3-3 protein epsilon OS=Rattus norvegicus GN=Ywhae PE=1 SV=1 - [1433E_RAT] 82.49
P62755 40S ribosomal protein S6 OS=Rattus norvegicus GN=Rps6 PE=1 SV=1 - [RS6_RAT] 483.61
P63259 Actin, cytoplasmic 2 OS=Rattus norvegicus GN=Actg1 PE=1 SV=1 - [ACTG_RAT] 3505.13
P68370 Tubulin alpha-1A chain OS=Rattus norvegicus GN=Tuba1a PE=1 SV=1 - [TBA1A_RAT] 277.70
P84092 AP-2 complex subunit mu OS=Rattus norvegicus GN=Ap2m1 PE=1 SV=1 - [AP2M1_RAT] 73.22
Q05962 ADP/ATP translocase 1 OS=Rattus norvegicus GN=Slc25a4 PE=1 SV=3 - [ADT1_RAT] 201.52
Q3KRE8 Tubulin beta-2B chain OS=Rattus norvegicus GN=Tubb2b PE=1 SV=1 - [TBB2B_RAT] 444.06
Q3MHS8 Sin3-associated polypeptide 18 OS=Rattus norvegicus GN=Sap18 PE=2 SV=1 - [Q3MHS8_RAT] 136.24
Q498M4 WD repeat-containing protein 5 OS=Rattus norvegicus GN=Wdr5 PE=1 SV=1 - [WDR5_RAT] 114.30
Q4FZS2 Budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) OS=Rattus norvegicus GN=Bub3 PE=2 SV=1 - [Q4FZS2_RAT] 89.30
Q4KLJ1 RCG61762, isoform CRA_a OS=Rattus norvegicus GN=Srsf7 PE=2 SV=1 - [Q4KLJ1_RAT] 146.37
Q4KLJ3 Guanine nucleotide binding protein-like 2 (Nucleolar) OS=Rattus norvegicus GN=Gnl2 PE=2 SV=1 - [Q4KLJ3_RAT] 101.70
Q4KLM7 Protein Specc1 OS=Rattus norvegicus GN=Specc1 PE=2 SV=1 - [Q4KLM7_RAT] 101.70
Q4KLN3 SFRS protein kinase 1 OS=Rattus norvegicus GN=Srpk1 PE=2 SV=1 - [Q4KLN3_RAT] 97.64
Q4QR75 Exosome complex component RRP45 OS=Rattus norvegicus GN=Exosc9 PE=2 SV=1 - [EXOS9_RAT] 89.84
Q4V7D7 Pre-mRNA-splicing factor RBM22 OS=Rattus norvegicus GN=Rbm22 PE=2 SV=1 - [RBM22_RAT] 96.10
Q4V8J6 Protein Ythdf1 OS=Rattus norvegicus GN=Ythdf1 PE=2 SV=1 - [Q4V8J6_RAT] 142.52
Q562C2 Ribosome biogenesis protein BOP1 OS=Rattus norvegicus GN=Bop1 PE=2 SV=1 - [BOP1_RAT] 73.22
Q56B11 Proline-, glutamic acid- and leucine-rich protein 1 OS=Rattus norvegicus GN=Pelp1 PE=2 SV=2 - [PELP1_RAT] 62.22
Q56R17 Importin subunit alpha OS=Rattus norvegicus GN=Kpna4 PE=2 SV=1 - [Q56R17_RAT] 74.09
Q5EB93 Gatad2a protein OS=Rattus norvegicus GN=Gatad2a PE=2 SV=1 - [Q5EB93_RAT] 158.30
Q5I0H3 Small ubiquitin-related modifier 1 OS=Rattus norvegicus GN=Sumo1 PE=1 SV=1 - [SUMO1_RAT] 61.54
Q5I0K8 28S ribosomal protein S7, mitochondrial OS=Rattus norvegicus GN=Mrps7 PE=2 SV=2 - [RT07_RAT] 69.19
Q5RJM0 MKI67 FHA domain-interacting nucleolar phosphoprotein OS=Rattus norvegicus GN=Nifk PE=2 SV=1 - [MK67I_RAT] 204.44
Q5XI01 Glypican 4 OS=Rattus norvegicus GN=Gpc4 PE=2 SV=1 - [Q642B0_RAT] 92.19
Q5XIG8 Serine-threonine kinase receptor-associated protein OS=Rattus norvegicus GN=Strap PE=1 SV=1 - [STRAP_RAT]
Q642B0 Cysteine rich protein 61 OS=Rattus norvegicus GN=Cyr61 PE=2 SV=1 - [Q66HT5_RAT] 77.65
Q66HT5 Isoform 2 of Gelsolin n=2 Tax=Rattus norvegicus RepID=Q68FP1-2 63.28
Q68FP1-2 Elongation factor 1-gamma OS=Rattus norvegicus GN=Eef1g PE=1 SV=3 - [EF1G_RAT] 90.09
Q68FR6 Sorting and assembly machinery component 50 homolog OS=Rattus norvegicus GN=Samm50 PE=1 SV=1 - [SAM50_RAT] 83.39
Q6AXV4 H/ACA ribonucleoprotein complex subunit 1 OS=Rattus norvegicus GN=Gar1 PE=2 SV=1 - [GAR1_RAT] 55.32
	   259	  
 
Q6AYA1 Splicing factor 3B subunit 4 OS=Rattus norvegicus GN=Sf3b4 PE=2 SV=1 - [SF3B4_RAT] 120.45
Q6AYL5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 56 OS=Rattus norvegicus GN=Ddx56 PE=2 SV=1 - [Q6AYT6_RAT] 176.73
Q6AYT6 C-terminal binding protein 1 OS=Rattus norvegicus GN=Ctbp1 PE=1 SV=1 - [Q6AZ26_RAT] 72.22
Q6AZ26 Actn1 protein OS=Rattus norvegicus GN=Actn1 PE=2 SV=1 - [Q6GMN8_RAT] 747.57
Q6GMN8 Mitochondrial ribosomal protein S18B OS=Rattus norvegicus GN=Mrps18b PE=2 SV=1 - [Q6MG10_RAT] 87.56
Q6MG10 Junction plakoglobin OS=Rattus norvegicus GN=Jup PE=1 SV=1 - [PLAK_RAT] 929.77
Q6P136 Eukaryotic translation initiation factor 4A1 OS=Rattus norvegicus GN=Eif4a1 PE=1 SV=1 - [Q6P3V8_RAT] 272.79
Q6P3V8 Heterochromatin protein 1-binding protein 3 OS=Rattus norvegicus GN=Hp1bp3 PE=2 SV=1 - [HP1B3_RAT] 224.63
Q6P6G9 Hnrpa1 protein OS=Rattus norvegicus GN=Hnrnpa1 PE=2 SV=1 - [Q6P6G9_RAT] 1160.15
Q6P7R0 La-related protein 7 OS=Rattus norvegicus GN=Larp7 PE=1 SV=2 - [LARP7_RAT] 183.16
Q6TXE9 LRRGT00050 OS=Rattus norvegicus GN=Eprs PE=1 SV=1 - [Q6TXE9_RAT] 506.61
Q6U6G5 Zinc finger CCCH domain-containing protein 15 OS=Rattus norvegicus GN=Zc3h15 PE=2 SV=1 - [ZC3HF_RAT] 136.84
Q9QZK5 Serine protease HTRA1 OS=Rattus norvegicus GN=Htra1 PE=2 SV=1 - [HTRA1_RAT] 86.10
Q9QZK5 Serine protease HTRA1 OS=Rattus norvegicus GN=Htra1 PE=2 SV=1 - [HTRA1_RAT] 86.10
Q9R1E9 Connective tissue growth factor OS=Rattus norvegicus GN=Ctgf PE=2 SV=1 - [CTGF_RAT] 62.16
Q9WUW5 Collagen type XVIII, alpha (I) chain (Fragment) OS=Rattus norvegicus GN=Col18a1 PE=2 SV=1 - [Q9WUW5_RAT] 86.51
T1SRT4 Radixin isoform OS=Rattus norvegicus GN=Rdx PE=2 SV=1 - [T1SRT4_RAT] 93.78
UPI0000180AB4 PREDICTED: luc7-like protein 3 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0000180AB4 118.10
UPI00001C8B75 PREDICTED: plasminogen activator inhibitor 1 RNA-binding protein isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI00001C8B75 304.36
UPI0000250BD6 PREDICTED: 60S ribosomal protein L13-like n=1 Tax=Rattus norvegicus RepID=UPI0000250BD6 255.04
UPI0000250FE4 PREDICTED: myosin-14 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0000250FE4 266.65
UPI0000500E84 PREDICTED: C-Jun-amino-terminal kinase-interacting protein 4 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0000500E84 358.11
UPI0000503905 PREDICTED: DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0000503905 97.38
UPI0000DA1CD8 PREDICTED: AP-2 complex subunit alpha-1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0000DA1CD8 259.15
UPI0000DA285F PREDICTED: MAP7 domain-containing protein 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0000DA285F 98.05
UPI0000DA38FD PREDICTED: homeobox protein cut-like 1 isoform X8 n=1 Tax=Rattus norvegicus RepID=UPI0000DA38FD 63.55
UPI0000DBF3AC PREDICTED: fibronectin isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0000DBF3AC 1087.27
UPI0000DBF7D2 PREDICTED: heterogeneous nuclear ribonucleoprotein M isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0000DBF7D2 1804.26
UPI000154E9E5 PREDICTED: E3 ubiquitin-protein ligase TRIM56 n=1 Tax=Rattus norvegicus RepID=UPI000154E9E5 71.29
UPI000154F802 programmed cell death 6-interacting protein n=1 Tax=Rattus norvegicus RepID=UPI000154F802
UPI0001550CCB PREDICTED: histone H1.2 n=1 Tax=Rattus norvegicus RepID=UPI0001550CCB 484.41
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UPI0001CF3CF5 PREDICTED: catenin alpha-3 isoform X1 n=2 Tax=Rattus norvegicus RepID=UPI0001CF3CF5 159.76
UPI0001CF734A PREDICTED: protein AHNAK2 n=1 Tax=Rattus norvegicus RepID=UPI0001CF734A 78.76
UPI0003D077B6 PREDICTED: alpha-actinin-4 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D077B6 874.43
UPI0003D0839D PREDICTED: apoptotic chromatin condensation inducer 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0839D 188.92
UPI0003D088F0 PREDICTED: polypyrimidine tract-binding protein 3 isoform X2 n=2 Tax=Rattus norvegicus RepID=UPI0003D088F0 179.42
UPI0003D09F77 PREDICTED: probable ATP-dependent RNA helicase DDX52 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D09F77 81.50
UPI0003D09FC6 PREDICTED: serine/threonine-protein kinase DCLK1 isoform X2 n=2 Tax=Rattus norvegicus RepID=UPI0003D09FC6 144.34
UPI0003D0B91E
PREDICTED: SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily B member 1 isoform X3 n=1 Tax=Rattus 
norvegicus RepID=UPI0003D0B91E
101.21
UPI0003D0BC78 PREDICTED: keratin, type I cytoskeletal 16 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0BC78 197.49
UPI0003D0C0AC PREDICTED: protein DEK isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C0AC 69.08
UPI0003D0C949 PREDICTED: centrosomal protein of 170 kDa isoform X11 n=1 Tax=Rattus norvegicus RepID=UPI0003D0C949 68.39
UPI0003D0E282 PREDICTED: guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0E282 353.58
UPI0003D0E362 PREDICTED: protein FAM98B isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0E362 141.04
UPI0003D0E707 PREDICTED: nucleolar and coiled-body phosphoprotein 1 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0E707 95.26
UPI0003D0EC97 PREDICTED: RNA-binding protein 42 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0EC97 101.17
UPI0003D0F01C PREDICTED: SUN domain-containing protein 1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F01C 68.73
UPI0003D0F450 PREDICTED: 28S ribosomal protein S35, mitochondrial isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F450 114.55
UPI0003D0F60C PREDICTED: protein polybromo-1-like isoform X20 n=1 Tax=Rattus norvegicus RepID=UPI0003D0F60C 56.13
UPI0003D0FC8D PREDICTED: rho guanine nucleotide exchange factor 17 n=1 Tax=Rattus norvegicus RepID=UPI0003D0FC8D 116.54
UPI0003D0FD46 PREDICTED: protein PRRC2A isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0FD46 196.40
UPI0003D1005E PREDICTED: reversion-inducing cysteine-rich protein with Kazal motifs isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D1005E 106.68
UPI0004E4726C PREDICTED: serine/threonine-protein phosphatase 1 regulatory subunit 10 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4726C 75.97
UPI0004E472EA PREDICTED: tenascin isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0004E472EA 436.20
UPI0004E47558 PREDICTED: drebrin isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E47558 230.32
UPI0004E47B0A PREDICTED: ribosome-binding protein 1 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E47B0A 1004.40
UPI0004E47BB8 PREDICTED: methyl-CpG-binding domain protein 3 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E47BB8 144.46
UPI0004E491F4 PREDICTED: replication factor C subunit 1 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0004E491F4 157.82
UPI0004E49349 PREDICTED: ATP-dependent RNA helicase DDX3Y isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E49349 1520.85
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Table 9 Proteins specifically identified in TMX samples 
 
Mapped proteins 
Unmapped proteins 
Unmapped proteins related to cytoskeleton 
 
 
Accession Description Score
A1A5P2 Ribosome biogenesis regulatory protein homolog OS=Rattus norvegicus GN=Rrs1 PE=2 SV=1 - [RRS1_RAT] 225.91
A2RRU3 U3 small nucleolar RNA-associated protein 15 homolog OS=Rattus norvegicus GN=Utp15 PE=2 SV=1 - [UTP15_RAT] 73.45
B0BMU2 NOP16 nucleolar protein homolog (Yeast) OS=Rattus norvegicus GN=Nop16 PE=2 SV=1 - [B0BMU2_RAT] 81.47
B0BMV8 Dihydrofolate reductase OS=Rattus norvegicus GN=Dhfr PE=2 SV=1 - [B0BMV8_RAT] 57.83
B0BN90 DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) OS=Rattus norvegicus GN=Dimt1 PE=2 SV=1 - [B0BN90_RAT] 130.63
B0BND5 Protein Rrp9 OS=Rattus norvegicus GN=Rrp9 PE=2 SV=1 - [B0BND5_RAT] 83.85
B1H227 LOC682908 protein OS=Rattus norvegicus GN=Rcc1 PE=2 SV=1 - [B1H227_RAT] 101.18
B1H269 Ddx27 protein OS=Rattus norvegicus GN=Ddx27 PE=2 SV=1 - [B1H269_RAT] 305.69
B2GUZ3 Mthfd1l protein OS=Rattus norvegicus GN=Mthfd1l PE=2 SV=1 - [B2GUZ3_RAT] 111.47
B2GV01 Metastasis-associated gene family, member 2 OS=Rattus norvegicus GN=Mta2 PE=2 SV=1 - [B2GV01_RAT] 68.68
B2GV02 Protein LOC100909901 OS=Rattus norvegicus GN=Racgap1 PE=2 SV=1 - [B2GV02_RAT] 179.67
B5DFB2 Protein Rbbp4 OS=Rattus norvegicus GN=Rbbp4 PE=2 SV=1 - [B5DFB2_RAT] 172.55
B5DFG2 Hnrnpl protein (Fragment) OS=Rattus norvegicus GN=Hnrnpl PE=2 SV=1 - [B5DFG2_RAT] 971.96
B5DFJ3 Ddx23 protein (Fragment) OS=Rattus norvegicus GN=Ddx23 PE=2 SV=1 - [B5DFJ3_RAT] 111.47
B6RIU0 FIP1-like 1 OS=Rattus norvegicus GN=Fip1l1 PE=2 SV=1 - [B6RIU0_RAT] 67.5
D3ZAY8 Protein Pnn OS=Rattus norvegicus GN=Pnn PE=4 SV=1 - [D3ZAY8_RAT] 176.85
D3ZAZ0 Eukaryotic translation initiation factor 3 subunit M OS=Rattus norvegicus GN=Eif3m PE=3 SV=1 - [D3ZAZ0_RAT] 220.99
D3ZBS9 Protein Smarcd1 OS=Rattus norvegicus GN=Smarcd1 PE=4 SV=1 - [D3ZBS9_RAT] 120.52
D3ZC82 Protein Nufip2 OS=Rattus norvegicus GN=LOC687994 PE=4 SV=2 - [D3ZC82_RAT] 302.48
D3ZC84 Ubiquitin carboxyl-terminal hydrolase OS=Rattus norvegicus GN=Usp9x PE=3 SV=1 - [D3ZC84_RAT] 100.41
D3ZD73 Protein Ddx6 OS=Rattus norvegicus GN=Ddx6 PE=3 SV=1 - [D3ZD73_RAT] 114.07
D3ZD97 DEAH (Asp-Glu-Ala-His) box polypeptide 15 (Predicted), isoform CRA_b OS=Rattus norvegicus GN=Dhx15 PE=4 SV=1 - [D3ZD97_RAT] 395.81
D3ZDS4 EMG1 nucleolar protein homolog (S. cerevisiae) (Predicted), isoform CRA_b OS=Rattus norvegicus GN=Emg1 PE=4 SV=1 - [D3ZDS4_RAT] 165.69
D3ZF07 Protein RGD1562402 OS=Rattus norvegicus GN=RGD1562402 PE=3 SV=1 - [D3ZF07_RAT] 105.24
D3ZF52 Ribosomal protein L15 OS=Rattus norvegicus GN=RGD1565767 PE=3 SV=1 - [D3ZF52_RAT] 75.88
D3ZF89 Protein Ubap2 OS=Rattus norvegicus GN=Ubap2 PE=4 SV=2 - [D3ZF89_RAT] 733.71
D3ZGE6 Protein Cttn OS=Rattus norvegicus GN=Cttn PE=4 SV=2 - [D3ZGE6_RAT] 293.15
D3ZGQ8 Protein Rsf1 OS=Rattus norvegicus GN=Rsf1 PE=4 SV=1 - [D3ZGQ8_RAT] 86.80
TMX specific
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D3ZGV8 Protein Prrc2c OS=Rattus norvegicus GN=Prrc2c PE=1 SV=2 - [D3ZGV8_RAT] 156.03
D3ZL86 HEAT repeat containing 1 (Predicted) OS=Rattus norvegicus GN=Heatr1 PE=4 SV=1 - [D3ZL86_RAT] 107.62
D3ZLC1 Protein Lmnb2 OS=Rattus norvegicus GN=Lmnb2 PE=4 SV=1 - [D3ZLC1_RAT] 285.36
D3ZNU1 Protein Cebpz OS=Rattus norvegicus GN=Cebpz PE=4 SV=1 - [D3ZNU1_RAT] 223.53
D3ZUM5 Protein Trim33 (Fragment) OS=Rattus norvegicus GN=Trim33 PE=4 SV=2 - [D3ZUM5_RAT] 170.29
D3ZUV3 Eukaryotic translation initiation factor 2 subunit 1 OS=Rattus norvegicus GN=Eif2a PE=4 SV=2 - [D3ZUV3_RAT] 66.78
D3ZUX5 Coiled-coil-helix-coiled-coil-helix domain containing 3 (Predicted), isoform CRA_a OS=Rattus norvegicus GN=Chchd3 PE=4 SV=1 - [D3ZUX5_RAT] 82
D3ZV54 Protein Pwp2 OS=Rattus norvegicus GN=Pwp2 PE=4 SV=1 - [D3ZV54_RAT] 103.74
D3ZY44 Protein Mrps2 OS=Rattus norvegicus GN=Mrps2 PE=3 SV=1 - [D3ZY44_RAT] 104.14
D3ZZY2 Protein Utp14a OS=Rattus norvegicus GN=Utp14a PE=4 SV=2 - [D3ZZY2_RAT] 164.01
D3ZZZ0 Protein Ahctf1 OS=Rattus norvegicus GN=Ahctf1 PE=4 SV=1 - [D3ZZZ0_RAT] 106.31
D4A054 Protein LOC100911178 OS=Rattus norvegicus GN=Ranbp2 PE=1 SV=1 - [D4A054_RAT] 618.38
D4A0E8 Protein arginine N-methyltransferase 5 OS=Rattus norvegicus GN=Prmt5 PE=3 SV=1 - [D4A0E8_RAT] 60.82
D4A0H5 Cleavage and polyadenylation specific factor 1, 160kDa (Predicted), isoform CRA_a OS=Rattus norvegicus GN=Cpsf1 PE=4 SV=1 - [D4A0H5_RAT] 96.85
D4A1K2 Protein Rpl7l1 OS=Rattus norvegicus GN=Rpl7l1 PE=3 SV=1 - [D4A1K2_RAT] 59.47
D4A512 Protein Nemf OS=Rattus norvegicus GN=Nemf PE=4 SV=2 - [D4A512_RAT] 130.66
D4A7J8 PRP4 pre-mRNA processing factor 4 homolog (Yeast) OS=Rattus norvegicus GN=Prpf4 PE=4 SV=1 - [D4A7J8_RAT] 69.15
D4ACW0 Protein Rbm6 OS=Rattus norvegicus GN=Rbm6 PE=4 SV=1 - [D4ACW0_RAT] 65.49
D4AE41 RNA binding motif protein, X-linked-like-1 OS=Rattus norvegicus GN=Rbmxl1 PE=3 SV=1 - [RMXL1_RAT] 309.16
D4AEC0 Histone H2A OS=Rattus norvegicus GN=LOC685909 PE=3 SV=1 - [D4AEC0_RAT] 146.52
E9PTI6 Protein Raly OS=Rattus norvegicus GN=Raly PE=4 SV=1 - [E9PTI6_RAT] 110.3
E9PU01 Protein Chd4 OS=Rattus norvegicus GN=Chd4 PE=4 SV=2 - [E9PU01_RAT] 215.01
F1LMV9 Coronin (Fragment) OS=Rattus norvegicus GN=Coro2b PE=3 SV=2 - [F1LMV9_RAT] 158.8
F1LP60 Moesin (Fragment) OS=Rattus norvegicus GN=Msn PE=4 SV=1 - [F1LP60_RAT] 101.22
F1LPQ3 Alpha-mannosidase 2C1 OS=Rattus norvegicus GN=Man2c1 PE=4 SV=1 - [F1LPQ3_RAT] 135.14
F1LR39 RCG29171, isoform CRA_a OS=Rattus norvegicus GN=Wdr18 PE=4 SV=2 - [F1LR39_RAT] 107.57
F1LRJ2 Protein Srrm2 OS=Rattus norvegicus GN=Srrm2 PE=1 SV=2 - [F1LRJ2_RAT] 358.01
F1LSL3 Inositol 1,4,5-trisphosphate receptor type 3 OS=Rattus norvegicus GN=Itpr3 PE=4 SV=2 - [F1LSL3_RAT] 134.52
F1LU69 Protein Rps27l3 OS=Rattus norvegicus GN=Rps27l3 PE=4 SV=2 - [F1LU69_RAT] 122.83
F1LVD0 Protein LOC690134 (Fragment) OS=Rattus norvegicus GN=LOC690134 PE=3 SV=2 - [F1LVD0_RAT] 104.42
F1LYI5 Protein RGD1564138 (Fragment) OS=Rattus norvegicus GN=RGD1564138 PE=4 SV=2 - [F1LYI5_RAT] 62.79
F1M5V2 Protein Glipr2 OS=Rattus norvegicus GN=Glipr2 PE=4 SV=2 - [F1M5V2_RAT] 128.89
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F1M6V1 Heterochromatin protein 1-binding protein 3 OS=Rattus norvegicus GN=Hp1bp3 PE=3 SV=2 - [F1M6V1_RAT] 238.55
F1M779 Clathrin heavy chain OS=Rattus norvegicus GN=Cltc PE=3 SV=1 - [F1M779_RAT] 459.49
F1M7A0 DNA topoisomerase 2 (Fragment) OS=Rattus norvegicus GN=Top2a PE=3 SV=2 - [F1M7A0_RAT] 123.77
F1M8H5 Protein Abcf2 OS=Rattus norvegicus GN=Abcf2 PE=4 SV=2 - [F1M8H5_RAT] 62.84
F1MA04 Protein Wdr36 (Fragment) OS=Rattus norvegicus GN=Wdr36 PE=4 SV=2 - [F1MA04_RAT] 99.43
F1MA52 Nuclear RNA export factor 1 OS=Rattus norvegicus GN=Nxf1 PE=4 SV=1 - [F1MA52_RAT] 187.82
F7FFV2 Keratin, type II cytoskeletal 5 (Fragment) OS=Rattus norvegicus GN=Krt5 PE=3 SV=1 - [F7FFV2_RAT] 361.29
G3V661 Bromodomain adjacent to zinc finger domain protein 1B OS=Rattus norvegicus GN=Baz1b PE=4 SV=1 - [G3V661_RAT] 176.36
G3V6A8 Golgi autoantigen, golgin subfamily b, macrogolgin 1, isoform CRA_c OS=Rattus norvegicus GN=Golgb1 PE=1 SV=1 - [G3V6A8_RAT] 63.1
G3V6D3 ATP synthase subunit beta OS=Rattus norvegicus GN=Atp5b PE=3 SV=1 - [G3V6D3_RAT] 103.05
G3V7B7 DNA-directed RNA polymerase OS=Rattus norvegicus GN=Polr1a PE=3 SV=1 - [G3V7B7_RAT] 119.52
G3V7G3 Activity-dependent neuroprotector homeobox protein OS=Rattus norvegicus GN=Adnp PE=4 SV=1 - [G3V7G3_RAT] 75.42
G3V7G9 Eukaryotic translation initiation factor 3 subunit L OS=Rattus norvegicus GN=Eif3l PE=2 SV=2 - [G3V7G9_RAT] 111.6
G3V852 Protein Tln1 OS=Rattus norvegicus GN=Tln1 PE=1 SV=1 - [G3V852_RAT] 343.86
G3V8G5 Golgi apparatus protein 1 OS=Rattus norvegicus GN=Glg1 PE=4 SV=1 - [G3V8G5_RAT] 67.53
G3V920 Protein Wdr43 OS=Rattus norvegicus GN=Wdr43 PE=4 SV=1 - [G3V920_RAT] 178.54
G3V9R8 Heterogeneous nuclear ribonucleoprotein C (C1/C2) OS=Rattus norvegicus GN=Hnrnpc PE=1 SV=2 - [G3V9R8_RAT] 719.77
M0R3M8 Protein Rrp12 OS=Rattus norvegicus GN=Rrp12 PE=4 SV=1 - [M0R3M8_RAT] 243.03
M0R3Z8 Protein Rbm15 OS=Rattus norvegicus GN=Rbm15 PE=1 SV=1 - [M0R3Z8_RAT] 106.55
M0R440 Zinc finger protein 326 (Fragment) OS=Rattus norvegicus GN=Zfp326 PE=4 SV=1 - [M0R440_RAT] 90.43
M0R548 Protein LOC100912029 OS=Rattus norvegicus GN=LOC100912029 PE=4 SV=1 - [M0R548_RAT] 129.59
M0R7D1 La-related protein 7 OS=Rattus norvegicus GN=Larp7 PE=4 SV=1 - [M0R7D1_RAT] 175.62
M0R8A7 tRNA selenocysteine 1-associated protein 1 OS=Rattus norvegicus GN=Trnau1ap PE=4 SV=1 - [M0R8A7_RAT] 78.07
M0R9Q1 Protein LOC100911677 OS=Rattus norvegicus GN=LOC100911677 PE=4 SV=1 - [M0R9Q1_RAT] 561.89
M0RB74 Protein Ipo5 OS=Rattus norvegicus GN=Ipo5 PE=4 SV=1 - [M0RB74_RAT] 94.41
M0RDD7 RCG29880 OS=Rattus norvegicus GN=Chtop PE=4 SV=1 - [M0RDD7_RAT] 157.28
M0RDF7 Bystin OS=Rattus norvegicus GN=Bysl PE=4 SV=1 - [M0RDF7_RAT] 101.76
O88656 Actin-related protein 2/3 complex subunit 1B OS=Rattus norvegicus GN=Arpc1b PE=2 SV=3 - [ARC1B_RAT] 79.63
O88791 High mobility group AT-hook 2 OS=Rattus norvegicus GN=Hmga2 PE=2 SV=1 - [O88791_RAT] 193.05
P04256 Heterogeneous nuclear ribonucleoprotein A1 OS=Rattus norvegicus GN=Hnrnpa1 PE=1 SV=3 - [ROA1_RAT] 1111.8
P07943 Aldose reductase OS=Rattus norvegicus GN=Akr1b1 PE=1 SV=3 - [ALDR_RAT] 68.28
P09895 60S ribosomal protein L5 OS=Rattus norvegicus GN=Rpl5 PE=1 SV=3 - [RL5_RAT] 403.43
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P15999 ATP synthase subunit alpha, mitochondrial OS=Rattus norvegicus GN=Atp5a1 PE=1 SV=2 - [ATPA_RAT] 213.57
P17136 Small nuclear ribonucleoprotein-associated protein B (Fragment) OS=Rattus norvegicus GN=Snrpb PE=2 SV=1 - [RSMB_RAT] 67.32
P30427 Plectin OS=Rattus norvegicus GN=Plec PE=1 SV=2 - [PLEC_RAT] 10108.38
P38650 Cytoplasmic dynein 1 heavy chain 1 OS=Rattus norvegicus GN=Dync1h1 PE=1 SV=1 - [DYHC1_RAT] 447.17
P54313 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 OS=Rattus norvegicus GN=Gnb2 PE=1 SV=4 - [GBB2_RAT] 260.48
P55770 NHP2-like protein 1 OS=Rattus norvegicus GN=Nhp2l1 PE=2 SV=4 - [NH2L1_RAT] 89.96
P62138 Serine/threonine-protein phosphatase PP1-alpha catalytic subunit OS=Rattus norvegicus GN=Ppp1ca PE=1 SV=1 - [PP1A_RAT] 304.89
P62142 Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Rattus norvegicus GN=Ppp1cb PE=1 SV=3 - [PP1B_RAT] 316.31
P62275 40S ribosomal protein S29 OS=Rattus norvegicus GN=Rps29 PE=1 SV=2 - [RS29_RAT] 64.98
P62828 GTP-binding nuclear protein Ran OS=Rattus norvegicus GN=Ran PE=1 SV=3 - [RAN_RAT] 66.6
P62859 40S ribosomal protein S28 OS=Rattus norvegicus GN=Rps28 PE=1 SV=1 - [RS28_RAT] 66
P68255 14-3-3 protein theta OS=Rattus norvegicus GN=Ywhaq PE=1 SV=1 - [1433T_RAT] 124.26
P70501 RNA-binding protein 10 OS=Rattus norvegicus GN=Rbm10 PE=2 SV=1 - [RBM10_RAT] 105.63
P70565 Plakoglobin OS=Rattus norvegicus GN=Jup PE=2 SV=1 - [P70565_RAT] 1053.15
P70625 Zonula occludens 2 protein (Fragment) OS=Rattus norvegicus GN=ZO-2 PE=2 SV=2 - [P70625_RAT] 74.88
P97690 Structural maintenance of chromosomes protein 3 OS=Rattus norvegicus GN=Smc3 PE=1 SV=1 - [SMC3_RAT] 201.58
Q05096-3 Isoform C of Unconventional myosin-Ib n=1 Tax=Rattus norvegicus RepID=Q05096-3 232.36
Q09073 ADP/ATP translocase 2 OS=Rattus norvegicus GN=Slc25a5 PE=1 SV=3 - [ADT2_RAT] 274.1
Q0D2G9 RGD1308290 protein (Fragment) OS=Rattus norvegicus GN=RGD1308290 PE=2 SV=1 - [Q0D2G9_RAT] 123.28
Q14V05 Tat-binding protein-1 OS=Rattus rattus GN=TBP-1 PE=2 SV=1 - [Q14V05_RATRT] 78.51
Q27W01 RNA-binding protein 8A OS=Rattus norvegicus GN=Rbm8a PE=2 SV=1 - [RBM8A_RAT] 129.97
Q3KRE0 ATPase family AAA domain-containing protein 3 OS=Rattus norvegicus GN=Atad3 PE=1 SV=1 - [ATAD3_RAT] 83.55
Q3T1K5 F-actin-capping protein subunit alpha-2 OS=Rattus norvegicus GN=Capza2 PE=1 SV=1 - [CAZA2_RAT] 92.99
Q498C9 Protein Zfp207 OS=Rattus norvegicus GN=Zfp207 PE=2 SV=1 - [Q498C9_RAT] 66.03
Q4FZT9 26S proteasome non-ATPase regulatory subunit 2 OS=Rattus norvegicus GN=Psmd2 PE=2 SV=1 - [PSMD2_RAT] 117.94
Q4KLH7 Protein Rad21 OS=Rattus norvegicus GN=Rad21 PE=2 SV=1 - [Q4KLH7_RAT] 86.19
Q4KLI7 Protein Sf3a3 OS=Rattus norvegicus GN=Sf3a3 PE=2 SV=1 - [Q4KLI7_RAT] 76.83
Q4QQT3 CUGBP Elav-like family member 1 OS=Rattus norvegicus GN=Celf1 PE=2 SV=1 - [CELF1_RAT] 78.57
Q4V8E1 GATA zinc finger domain containing 2B OS=Rattus norvegicus GN=Gatad2b PE=2 SV=1 - [Q4V8E1_RAT] 121.64
Q5EB56 MAK16 homolog (S. cerevisiae) OS=Rattus norvegicus GN=Mak16 PE=2 SV=1 - [Q5EB56_RAT] 75.62
Q5EEY3 GTP-binding protein G-alpha-i2 splice variant b OS=Rattus norvegicus GN=Gnai2 PE=2 SV=1 - [Q5EEY3_RAT] 248.22
Q5M7V8 Thyroid hormone receptor-associated protein 3 OS=Rattus norvegicus GN=Thrap3 PE=1 SV=1 - [TR150_RAT] 164.51
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Q5M920 EBNA1 binding protein 2 OS=Rattus norvegicus GN=Ebna1bp2 PE=2 SV=1 - [Q5M920_RAT] 138.38
Q5RKJ9 RAB10, member RAS oncogene family OS=Rattus norvegicus GN=Rab10 PE=2 SV=1 - [Q5RKJ9_RAT] 69.11
Q5U2Y1-2 Isoform 2 of General transcription factor II-I n=2 Tax=Rattus norvegicus RepID=Q5U2Y1-2 93.22
Q5U302 Catenin (Cadherin associated protein), alpha 1 OS=Rattus norvegicus GN=Ctnna1 PE=1 SV=1 - [Q5U302_RAT] 2959.13
Q5XI13 Glutamate-rich WD repeat-containing protein 1 OS=Rattus norvegicus GN=Grwd1 PE=2 SV=1 - [GRWD1_RAT] 82.5
Q5XIB5 Coiled-coil domain-containing protein 86 OS=Rattus norvegicus GN=Ccdc86 PE=2 SV=1 - [CCD86_RAT] 58.31
Q62636 Ras-related protein Rap-1b OS=Rattus norvegicus GN=Rap1b PE=2 SV=2 - [RAP1B_RAT] 94.76
Q62940 E3 ubiquitin-protein ligase NEDD4 OS=Rattus norvegicus GN=Nedd4 PE=1 SV=1 - [NEDD4_RAT] 152.79
Q63413 Spliceosome RNA helicase Ddx39b OS=Rattus norvegicus GN=Ddx39b PE=1 SV=3 - [DX39B_RAT] 131.1
Q63692 Hsp90 co-chaperone Cdc37 OS=Rattus norvegicus GN=Cdc37 PE=1 SV=2 - [CDC37_RAT] 81.21
Q63716 Peroxiredoxin-1 OS=Rattus norvegicus GN=Prdx1 PE=1 SV=1 - [PRDX1_RAT] 110.87
Q641X8 Eukaryotic translation initiation factor 3 subunit E OS=Rattus norvegicus GN=Eif3e PE=2 SV=1 - [EIF3E_RAT] 208.94
Q66HG8 Protein Red OS=Rattus norvegicus GN=Ik PE=1 SV=1 - [RED_RAT] 178.45
Q6AXU3 Interferon-stimulated 20 kDa exonuclease-like 2 OS=Rattus norvegicus GN=Isg20l2 PE=2 SV=1 - [I20L2_RAT] 278.57
Q6AY87 THO complex subunit 6 homolog OS=Rattus norvegicus GN=Thoc6 PE=2 SV=1 - [THOC6_RAT] 101.05
Q6AYD3 Proliferation-associated 2G4 OS=Rattus norvegicus GN=Pa2g4 PE=2 SV=1 - [Q6AYD3_RAT] 152.33
Q6AYZ1 Tubulin alpha-1C chain OS=Rattus norvegicus GN=Tuba1c PE=1 SV=1 - [TBA1C_RAT] 625.13
Q6IFU8 Keratin, type I cytoskeletal 17 OS=Rattus norvegicus GN=Krt17 PE=2 SV=1 - [K1C17_RAT] 188.42
Q6VEU8 DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 OS=Rattus norvegicus GN=Ddx24 PE=2 SV=1 - [Q6VEU8_RAT] 355.19
Q8CHN6 Sphingosine-1-phosphate lyase 1 OS=Rattus norvegicus GN=Sgpl1 PE=2 SV=1 - [SGPL1_RAT] 90.04
Q8K585-2 Isoform HMG-Y of High mobility group protein HMG-I/HMG-Y n=1 Tax=Rattus norvegicus RepID=Q8K585-2 86.88
Q9ESY8 Stau1 protein OS=Rattus norvegicus GN=Stau1 PE=2 SV=1 - [Q9ESY8_RAT] 170.06
Q9QYW0 Protein AATF OS=Rattus norvegicus GN=Aatf PE=1 SV=1 - [AATF_RAT] 88.82
Q9R1T1 Barrier-to-autointegration factor OS=Rattus norvegicus GN=Banf1 PE=1 SV=1 - [BAF_RAT] 110.13
Q9R1Z0 Voltage-dependent anion-selective channel protein 3 OS=Rattus norvegicus GN=Vdac3 PE=1 SV=2 - [VDAC3_RAT] 62.63
Q9WUC8 Pleiotropic regulator 1 OS=Rattus norvegicus GN=Plrg1 PE=2 SV=1 - [PLRG1_RAT] 83.1
Q9Z118 Polypyrimidine tract-binding protein 3 OS=Rattus norvegicus GN=Ptbp3 PE=2 SV=1 - [PTBP3_RAT] 154.24
UPI000017E2CF PREDICTED: nucleolar protein 14 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI000017E2CF 127.69
UPI000017F893 proline-, glutamic acid- and leucine-rich protein 1 n=1 Tax=Rattus norvegicus RepID=UPI000017F893 144.82
UPI00001CFDCB PREDICTED: polymerase delta-interacting protein 3 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI00001CFDCB 89.79
UPI0000503E75 PREDICTED: ribonucleases P/MRP protein subunit POP1 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0000503E75 62.62
UPI0000DA267A PREDICTED: filamin-C isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0000DA267A 382.84
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UPI0000DA3509 PREDICTED: RNA-binding protein 25 n=1 Tax=Rattus norvegicus RepID=UPI0000DA3509 90.36
UPI0000DA3DFF PREDICTED: rho GTPase-activating protein 22 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0000DA3DFF 91.37
UPI0000DA4524 LAS1-like n=2 Tax=Rattus norvegicus RepID=UPI0000DA4524 179.85
UPI0000DBFEDB PREDICTED: pumilio homolog 1 isoform X11 n=1 Tax=Rattus norvegicus RepID=UPI0000DBFEDB 60.06
UPI000150B091 PREDICTED: drebrin isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI000150B091 368.84
UPI000154D8C8 nuclear pore complex protein Nup160 n=1 Tax=Rattus norvegicus RepID=UPI000154D8C8 80.87
UPI0001551D2B PREDICTED: uncharacterized protein C9orf114 homolog isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0001551D2B 62.13
UPI0001552819 PREDICTED: 5''''-3'''' exoribonuclease 2 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0001552819 272.67
UPI0001B79CC2 PREDICTED: probable ATP-dependent RNA helicase YTHDC2 n=1 Tax=Rattus norvegicus RepID=UPI0001B79CC2 57.63
UPI0001CF735C neuroblast differentiation-associated protein AHNAK n=1 Tax=Rattus norvegicus RepID=UPI0001CF735C 123.47
UPI000268808A zinc finger RNA-binding protein n=1 Tax=Rattus norvegicus RepID=UPI000268808A 351.66
UPI0003D0721E PREDICTED: fibronectin isoform X10 n=1 Tax=Rattus norvegicus RepID=UPI0003D0721E 974.83
UPI0003D07514 PREDICTED: poly(U)-binding-splicing factor PUF60 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D07514 250.38
UPI0003D07629 PREDICTED: 28S ribosomal protein S29, mitochondrial isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D07629 267.18
UPI0003D0803D PREDICTED: pre-mRNA-processing factor 40 homolog A isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0803D 109.22
UPI0003D080F2 PREDICTED: lupus La protein homolog isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D080F2 277.66
UPI0003D084DB PREDICTED: E3 ubiquitin-protein ligase TRIP12 isoform X11 n=1 Tax=Rattus norvegicus RepID=UPI0003D084DB 233.48
UPI0003D0853E PREDICTED: tripeptidyl-peptidase 2 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D0853E 129.52
UPI0003D08BBF PREDICTED: protein KRI1 homolog n=1 Tax=Rattus norvegicus RepID=UPI0003D08BBF 127.28
UPI0003D08D2D PREDICTED: RNA-binding motif, single-stranded-interacting protein 1 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D08D2D 166.92
UPI0003D09498 PREDICTED: U3 small nucleolar RNA-associated protein 6 homolog n=1 Tax=Rattus norvegicus RepID=UPI0003D09498 60.17
UPI0003D09676 PREDICTED: unconventional myosin-VI isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D09676 77.78
UPI0003D09A07 PREDICTED: nuclear pore complex protein Nup98-Nup96 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0003D09A07 130.13
UPI0003D0A336 PREDICTED: cell division cycle and apoptosis regulator protein 1 isoform X5 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A336 118.36
UPI0003D0A51A PREDICTED: zinc finger CCHC domain-containing protein 8 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A51A 144.9
UPI0003D0A55E PREDICTED: C-Jun-amino-terminal kinase-interacting protein 4 isoform X9 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A55E 265.06
UPI0003D0A726 PREDICTED: UPF0568 protein C14orf166 homolog isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0A726 383.1
UPI0003D0AB54 PREDICTED: telomere-associated protein RIF1-like n=1 Tax=Rattus norvegicus RepID=UPI0003D0AB54 217.61
UPI0003D0AB89 PREDICTED: ribosomal RNA processing protein 1 homolog B isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0AB89 175.37
UPI0003D0BDBD
PREDICTED: SWI/SNF complex subunit SMARCC2-like isoform X10 n=1 
Tax=Rattus norvegicus RepID=UPI0003D0BDBD
360.50
UPI0003D0BE0D PREDICTED: trinucleotide repeat-containing gene 6A protein isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0BE0D 205.97
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UPI0003D0BE42 PREDICTED: methionine--tRNA ligase, cytoplasmic isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0003D0BE42 187.43
UPI0003D0C521
PREDICTED: LOW QUALITY PROTEIN: deoxynucleotidyltransferase 
terminal-interacting protein 2-like n=1 Tax=Rattus norvegicus 
RepID=UPI0003D0C521
319.34
UPI0003D0CF50 PREDICTED: ubiquitin-associated and SH3 domain-containing protein B isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0003D0CF50 126.63
UPI0003D0D1B4 PREDICTED: serrate RNA effector molecule homolog isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0003D0D1B4 164.05
UPI0003D0F25F PREDICTED: nestin-like, partial n=1 Tax=Rattus norvegicus RepID=UPI0003D0F25F 2840.27
UPI0004E473EA PREDICTED: plectin isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E473EA 10302.63
UPI0004E4745E PREDICTED: TATA-binding protein-associated factor 2N-like isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4745E 294.9
UPI0004E477F8 PREDICTED: band 4.1-like protein 2 isoform X7 n=1 Tax=Rattus norvegicus RepID=UPI0004E477F8 120.66
UPI0004E4789B PREDICTED: cirhin isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E4789B 66.53
UPI0004E48548 PREDICTED: nuclear pore complex protein Nup153 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E48548 94.36
UPI0004E4880A PREDICTED: ATP-dependent RNA helicase DHX36 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4880A 135.6
UPI0004E48819
PREDICTED: LOW QUALITY PROTEIN: eukaryotic translation initiation 
factor 4 gamma 2-like isoform X1, partial n=1 Tax=Rattus norvegicus 
RepID=UPI0004E48819
63.71
UPI0004E4891E PREDICTED: tumor suppressor p53-binding protein 1 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E4891E 164.65
UPI0004E4894C PREDICTED: nucleolar protein 6 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E4894C 148.76
UPI0004E489DA PREDICTED: zinc finger CCCH domain-containing protein 14 isoform X2 n=1 Tax=Rattus norvegicus RepID=UPI0004E489DA 148.34
UPI0004E48B1F PREDICTED: ataxin-2 isoform X14 n=1 Tax=Rattus norvegicus RepID=UPI0004E48B1F 114.19
UPI0004E48EB3 PREDICTED: U4/U6 small nuclear ribonucleoprotein Prp3 isoform X3 n=1 Tax=Rattus norvegicus RepID=UPI0004E48EB3 111.24
UPI0004E48EEF PREDICTED: tight junction protein ZO-1 isoform X4 n=1 Tax=Rattus norvegicus RepID=UPI0004E48EEF 101.32
UPI0004E48FAD PREDICTED: la-related protein 4 isoform X6 n=2 Tax=Rattus norvegicus RepID=UPI0004E48FAD 129.83
UPI0004E494D5 PREDICTED: splicing factor 3B subunit 2 isoform X1 n=1 Tax=Rattus norvegicus RepID=UPI0004E494D5 268.27
